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ABSTRACT 
Jesse C. Lichstein: Do Community Care of North Carolina-Induced Changes Spillover to Non-Target 
Populations? 
(Under the direction of Mark Holmes) 
A robust primary care system is necessary for the delivery of high-quality, efficient health care in 
the United States. Accordingly, there has been a renewed interest in primary care redesign based off the 
successes of innovative, primary care-based, quality improvement programs. Quality improvement 
initiatives target either an entire practice or a particular group within a practice. Programs such as 
Community Care of North Carolina (CCNC) use the latter, targeting Medicaid patients within a practice.  
An important policy-relevant question is whether intervention-induced changes in how providers care 
for a patient sub-population affect care for non-target populations within the same practice; this effect 
is termed spillover. 
The objective of this dissertation was to examine spillover effects in CCNC, an enhanced primary 
care case management program for North Carolina’s Medicaid population, between 2002 and 2008. It 
examined the extent to which NC State Employees Health Plan (SHP) diabetes patients in CCNC practices 
experienced greater improvements in quality of care, utilization, and SHP paid medical expenditures 
than SHP diabetes patients in non-CCNC practices. The central hypothesis of this study was that 
improvements in quality, utilization, and costs due to CCNC-induced changes in patient care also 
accrued among non-Medicaid diabetes patients in CCNC practices.  
In the main analyses, I found evidence of spillover for only one (receipt of yearly A1c 
hemoglobin test) of the four quality of care measures, and two (primary care visits and total outpatient
iv 
visits) of the five utilization measures, though the effects on primary care visits and outpatient visits 
were not in the hypothesized direction. I found no evidence of spillover for medical expenditures.  
Overall this study found minimal evidence of spillover in CCNC. The results from this study aid in 
understanding the full effects of the innovative primary care models that are currently a focus of health 
policy, and indicate that spillover is not a foregone conclusion. My findings suggest the potential need 
for all insurers to participate in and coordinate efforts to improve the health and health care of patients. 
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CHAPTER 1: INTRODUCTION AND STUDY OVERVIEW 
 
Introduction 
Current health policy in the United States emphasizes the role of primary care practices in 
reforming and improving the U.S. health care system. This focus stems from the poor quality of care 
delivered by the weak and uncoordinated health care system; just half of patients receive recommended 
care while many patients receive contraindicated care (McGlynn et al., 2003; Mangione-Smith et al., 
2007; Schuster, McGlynn, & Brook, 2005). Lack of coordination is particularly problematic for the nearly 
two-thirds of Americans with chronic illness (Machlin, Cohen, & Beauregard, 2008), as reflected in their 
having higher emergency department (ED) utilization, more inpatient hospitalizations, and four times 
greater health care expenditures than individuals without chronic illness (Gulley, Rasch, & Chan, 2011). 
With the high and rising prevalence of chronic illness in the U.S. a robust primary care system is 
necessary for the delivery of high-quality, efficient health care. 
Consequently there has been a renewed interest in primary care redesign, based on such 
models as the chronic care model (Wagner et al., 2001; Bodenheimer, Wagner, & Grumbach, 2002) and 
the medical home model (American Academy of Family Physicians, 2007; Agency for Healthcare 
Research & Quality, n.d.). Both models emphasize an accessible, high-quality site of care, care 
coordination, and care management; the chronic care model also promotes the use of community 
resources and creation of community partnerships. It is widely believed that incentives to improve the 
quality and continuity of care delivered in primary care practices will lead to improved health outcomes 
and, subsequently, lower medical expenditures. This conception is built largely on early evidence of 
2 
improved outcomes and lower expenditures among patients managed by innovative, primary care-
based, quality improvement programs; one such program is Community Care of North Carolina (CCNC), 
which manages the care of the majority of North Carolina’s Medicaid population.  
However, to maximize the impact of state and national health policies, we must evaluate the full 
effects of these innovative primary care models. Quality improvement initiatives target either an entire 
practice or a particular group within a practice.  Programs such as CCNC use the latter, that is, targeting 
Medicaid patients within a practice.  A critical policy-relevant question is whether intervention-induced 
changes in how providers care for one sub-population within a practice affects care delivered for non-
target populations within the same practice; this effect is termed “spillover” (Baker, 1997; Chernew, 
DeCiccca, & Town, 2008; Domino, Norton, Morrissey, & Thakur, 2004).  This study examines the extent 
to which CCNC efforts to improve the quality of care for Medicaid patients have spillover benefits for 
non-Medicaid patients in those practices.  The degree of practice-level spillover could help public and 
private insurers coordinate their efforts to efficiently improve care. For example, if quality and 
utilization management initiatives spill over but care management does not, private insurers could 
supplement the quality and utilization spillover with their own care management services. Furthermore, 
health reform promotes other new care delivery models targeted to one payer population (e.g., 
Accountable Care Organizations). The presence of spillover would suggest the potential to improve the 
health and health care of a broader population without the participation of every health insurance 
provider in quality improvement. 
 
Community Care of North Carolina 
I examined spillover in CCNC, an enhanced primary care case management program for the 
state's Medicaid population between 2002 and 2008. CCNC began as a small pilot program in 1998 and 
since 2001 has since expanded to a statewide program (Dobson & Levis Hewson, 2009). In 2007, the 
3 
program managed the care of approximately 80% of the state's Medicaid population and worked with 
over 50% of primary care practices in North Carolina (Steiner et al., 2008).  
CCNC is implemented through 14 community networks that 1) link patients to a primary care 
medical home, 2) implement disease specific quality improvement initiatives, and 3) provide care 
management for high risk patients. The 14 non-profit networks receive a modest per member per 
month (PMPM) payment (ranging from $2.50 to $13.50) from the state to provide care management 
services as well as training, coordination, data feedback medical support staff, pharmacists, and 
psychiatrists (Steiner et al., 2008). Participating primary care providers also receive a PMPM payment for 
managing and coordinating care, but otherwise are reimbursed for services on a fee-for-service basis. 
CCNC builds off the concepts of the chronic care model (Bodenheimer, Wagner, & Grumbach, 
2002) and the pediatric medical home model (Sia, Tonniges, Osterhus, & Taba, 2004; American Academy 
of Pediatrics Ad Hoc Task Force on Definition of the Medical Home, 1992). These models emphasize 
accessible primary sites of care, quality improvement, care coordination, and care management. In fact, 
CCNC has developed a model of care that many people consider a “medical home” in the most general 
sense (Fields Leshen, & Patel, 2010; Takach, 2011; Bitton, Martin, & Landon, 2011), and which can be 
viewed as a potential model for medical home implementation. The logic model underlying CCNC is that 
the community resources of the networks combined with the three main elements will increase access 
to primary care, improve quality of care, reduced inpatient and ED use, and subsequently, lower total 
health care expenditures (Figure 1.1).  
Evaluations of CCNC generally indicate increases in quality of care, increases in primary care 
utilization, decreases in inpatient and ED utilization, and decreases in expenditures. One early study 
compared the change in health care expenditures and utilization among Medicaid patients with asthma 
and diabetes in CCNC and Carolina Access, from 2000 to 2002 (Ricketts, Greene, Silberman, Howard, & 
Poley, 2004). Unlike CCNC, practices in the Carolina Access program do not participate in CCNC QI 
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initiatives or receive supports such as care management from the CCNC networks. CCNC asthma 
patients had lower per member per month expenditures, fewer yearly inpatient admissions, and fewer 
yearly ED visits compared to asthma patients in Carolina Access. Results were similar, though smaller in 
magnitude, for CCNC diabetes patients compared to diabetes patients in Carolina Access (Ricketts et al., 
2004). 
Domino et al. (2009) examined expenditures and utilization from 1998 to 2001 among children 
with asthma, comparing children in CCNC, Carolina Access, and regular fee-for-service Medicaid. 
Compared to fee-for-service Medicaid, both CCNC and Carolina Access patients had greater use of 
asthma maintenance medications and rescue medications; the effect for CCNC was greater than that for 
Carolina Access. Patients in CCNC also had greater outpatient service use, while having fewer inpatient 
admissions and ED visits, than patients in fee-for-service.  Total spending was higher among CCNC 
patients compared to patients in fee-for-service, although spending for claims with an asthma diagnosis 
were not significantly different (Domino et al., 2009). 
Multiple actuarial evaluations found lower projected total PMPM expenditures for patients in 
CCNC (Mercer Consulting Group, 2007; Treo Solutions, 2010; Milliman, 2011). Two of these evaluations 
specify that the cost savings were primarily due to decreases in inpatient hospitalizations and ED visits 
(Treo Solutions, 2010; Milliman, 2011). These studies also report increases in primary care and 
pharmacy expenditures, which indicate increased access to care. The increases in primary care and 
pharmacy expenditures, however, these increases were offset by decreases in inpatient and ED 
expenditures, resulting in a net decrease in expenditures. Additionally, a more recent evaluation 
examining patterns of utilization among CCNC patients found lower inpatient and ED utilization and 
higher primary care and pharmacy utilization among CCNC-enrolled patients compared to non-CCNC 
Medicaid patients (Treo Solutions, 2012).   
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It should be noted that the majority of these evaluations did not control for selection of 
Medicaid patients or providers into CCNC (Ricketts et al., 2004; Mercer Consulting Group, 2007; Treo 
Solutions, 2010; Milliman, 2011; Treo Solutions, 2012). Because CCNC patient enrollment is generally 
voluntary, it is possible that patients who join CCNC are systemically different from those that do not 
join. If these differences are also correlated with outcomes, results could be biased. While many of the 
evaluations did adjust for patient age, gender, and health status, the majority did not adequately control 
for potential selection, which limits the ability to interpret findings as causal.  In addition, some 
evaluations do not include control groups, or adequate control groups, which again limits the ability to 
infer findings as causal.  
However, taken as a whole these evaluations of CCNC, as well as CCNC tracked performance 
measures (e.g., between 2000 and 2004, performance on diabetes quality measures increased by 15%) 
(Dobson & Levis Hewson, 2009), suggest improvements in quality of care and primary care utilization, 
decreases in inpatient and ED use, and potential cost savings for certain populations over time. While 
these results indicate improved quality and outcomes in the target population, they may understate the 
additional benefits of CCNC. Notably, because CCNC is implemented for only Medicaid patients, it is 
possible that CCNC-induced changes in how providers care for patients in the CCNC Medicaid population 
also benefit other patients in the practice. As will be discussed further in Chapter 2, changes in how 
providers care for patients in one payer population have the potential to spill over into how they care 
for patients in other payer populations. For example, Medicare-managed care, wherein managed care-
induced changes resulted in changes in provider care patterns for both managed care and non-managed 
care populations (Landon, Reschovsky, O’Malley, Pham, & Hadley, 2011; Chernew, Philip, & Town, 2008; 
Baker, 1999). Both managed care and CCNC work to change provider care patterns. Therefore, it is 
plausible that similar spillover effects will result from CCNC implementation. The success of CCNC in the 
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target population presents an excellent opportunity to evaluate the degree of practice-level spillover on 
a non-Medicaid population.  
 
Study Overview 
 The purpose of this study is to quantify the spillover effects of CCNC by examining the extent to 
which North Carolina State Employee Health Plan (SHP) diabetes patients in CCNC practices experience 
greater improvements in quality of care, utilization, and medical expenditures than SHP diabetes 
patients in non-CCNC practices.  Beginning in 2000, diabetes was the focus of one of the two initial CCNC 
disease management programs (the other being asthma) to improve both the process and outcomes of 
care. The duration and success of the initiative as well as the prevalence, morbidity, and costs of 
diabetes in both the Medicaid and SHP populations make diabetes an ideal area in which to investigate 
CCNC-induced spillover.  In particular, I address the following three aims: 
 
Aim 1: Evaluate the effect of practice participation in CCNC on the quality of care among North 
Carolina SHP diabetes patients.  
Aim 2: Estimate the effect of practice participation in CCNC on health care utilization among SHP 
diabetes patients.  
Aim 3: Quantify the effect of practice participation in CCNC on medical expenditures among SHP 
diabetes patients.  
 
Chapter 2 presents the empirical literature regarding physician behavior and behavior change; previous 
evidence of physician behavior spillover; the conceptual model of spillover in CCNC; and the hypotheses 
stemming from this conceptual model.  Chapter 3 describes the data and creation of the study sample 
for analysis. Chapter 4 details the measures used in analysis as well as the analytic methods. Chapter 5 
7 
presents the results from the main analytic models and sensitivity analysis. Chapter 6 discusses the 
clinical and policy implications of the study findings. 
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CHAPTER 2: LITERARTURE REVIEW, CONCEPTUAL MODEL, AND HYPOTHESES 
 
Literature Review 
 CCNC-induced spillover is theorized to occur at the provider level, where changes in the care 
provided to CCNC Medicaid patients result in changes in the care provided to patients in all payer 
populations due to across the board changes in processes of care. There is evidence that physicians 
adopt a generalized style of delivering care across all patients (Eisenberg, 1979; Glied & Zivin, 2002; 
Frank & Zeckhauser, 2007), as a heuristic to lighten the cognitive load of medical decision-making 
(Tversky & Kahneman, 1974; Bornstein & Emler, 2001). Incentives to induce changes in care patterns for 
only one payer group complicate provider practice by introducing variation, especially if the changes are 
for a large proportion of patients. When incentives do produce changes for one payer population, 
adjusting care patterns for all other payer groups to match the change may thus simplify practice, both 
cognitively and organizationally. 
 
Physician behavior and behavior change 
 It is generally accepted that individual physicians make consistent care decisions across patients’ 
insurance coverage (i.e., they adopt generalized styles of care) (Eisenberg, 1979; Frank & Zeckhauser, 
2007).  For example, a physician will have a generalized way of caring for a patient with diabetes, 
regardless of the patient’s type of insurance. This is not to say that a physician will not make care 
decisions incorporating information such as comorbidities, ability to pay for medications, etc., but 
instead that he/she starts from a similar care plan for each patient. This general belief is consistent with 
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the “norms” hypothesis, which contends that physicians adopt a generalized style of practice based on 
the overall incentives arrangements and do not vary care decisions based on a patient’s individual 
insurance coverage (Newhouse & Marquis, 1978). 
A number of studies support the “norms” hypothesis.  Hellerstein (1998) examines norm-
following behavior in physician choice of prescribing generic versus brand-name drugs.  After controlling 
for patient and provider characteristics, Hellerstein found that provider-level factors, both observed and 
unobserved, were the major source of variation in generic prescribing.  Approximately 30% of the 
variance in generic prescribing was due to unobserved physician factors, and the author cites this as the 
evidence for norm-following behavior (Hellerstein, 1998). Noting the increasing degree of heterogeneity 
in insurance plans served by physician practices, Glied and Zivin (2002) examined the effect of insurance 
composition (i.e., level of fee-for-service and managed care coverage) within a practice on physician 
behavior. The authors found that while some customization of care does occur, the main driver of 
physician behavior is the insurance provider of the average patient. In other words, “Physicians who 
treat mostly HMO patients appear to adopt a practice style that offers equivalent treatment intensity 
along most measurable dimensions”(pg. 353).  Frank and Zeckhauser (2007) examined the concentration 
of variation in visits and prescribing to determine if physicians use custom-made treatments (i.e., visit 
length and prescribing varies greatly among a physician’s patients) or ready to wear treatments (i.e., 
little variation in visit length and prescribing among patients). The authors found support for the use of 
ready to wear treatments, and thus norm-following behavior (Frank & Zeckhauser, 2007). Taken 
together these studies support the “norms” hypothesis that physicians adopt a generalized style of care 
common across all payer populations, though may adjust to fit the physicians patient panel. 
The existence of norm-following behaviors results largely from the use of heuristics, or pattern-
recognizing mental shortcuts (Kahneman, Slovic, & Tversky, 1982; McDonald, 1996; Marewski & 
Gigerenzer, 2012). Practicing medicine is complex:  most physicians see a diverse array of patients with 
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varying levels of health status, work with a larger number of other health care professionals, and have a 
multitude of guidelines – for a multitude of health conditions – to incorporate into practice.  In addition, 
physicians treat patients from a number of public and private health plans (35% of practices had more 
than 10 managed care contracts in 2001) (Cherry, Burt, & Woodwell, 2004). With all of these factors, 
customizing care based on a patient’s insurance coverage is both cognitively and organizationally 
challenging as well as time consuming. Under circumstances of uncertainty and time constraints, 
heuristics allow faster decision-making while alleviating the cognitive and organizational burden 
(Marewski & Gigerenzer, 2012). For example, instead of looking to see the insurance coverage of a 
diabetes patient before deciding how to treat him/her, it is faster and easier to just treat all diabetes 
patients similarly no matter the insurance coverage. From this perspective, when an intervention targets 
physician behavior change for only one payer population (e.g., Medicaid patients), physicians have two 
general options to minimize the cognitive and organizational burden: 1) do not change behavior for any 
payer population, or 2) change behavior for all payer populations. In situations where an intervention 
does elicit physician behavior change in a subpopulation, adjusting care patterns for all other payer 
groups to match the change should simplify practice. 
 
Spillover of Physician Behavior Change 
Medicare managed care 
Spillover occurred when Medicare managed care-induced changes resulted in changes for both 
managed care and non-managed care populations. Early studies examining the effect of Medicare 
managed care mainly focused on changes in health expenditures among fee-for-service Medicare 
beneficiaries. Baker (1999) found that increasing market-level health maintenance organization (HMO) 
penetration from 1990-1994 was associated with lower Part A and B expenditures among fee-for-service 
beneficiaries. These results were consistent with the others conducted during this time (Baker, 1997; 
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Baker & Sharkarkumar, 1998; Mathematica Policy Research, 1992; Bradfor & Krumholz, 2003). A more 
recent study by Chernew, DeCiccca, and Town (2008) also found that decreases in health expenditures 
among fee-for-service beneficiaries were largely driven by patients with chronic illness.  
Studies examining utilization among fee-for-service Medicare beneficiaries also found evidence 
of the effect of market level HMO penetration. Baker, Afendulis, and Heidenreich (2004) compared 
market-area rates of percutaneous transluminal coronary angioplasty (PTCA) for patients with new 
acute myocardial infarction (AMI) by HMO market share; the authors found that between 1985-1999, 
compared to areas with low HMO market share, areas with high HMO market share had lower rates of 
PTCA.  Similarly, other studies found:  lower revascularization and cardiac catheterization rates for fee-
for-service patients in areas with high HMO penetration (Bundorf et al., 2004);  lower rates of coronary 
angiography with higher HMO market share (Meara, Landrum, Ayanian, McNeil, & Guadagnoli, 2004); 
and  lower rates of angiography in high HMO areas (Heidenreich, McClellan, Frances, & Baker, 2001). 
Several studies have also examined cancer screening by HMO market share. Koroukian, Litaker, Dor, and 
Copper (2005) found that beneficiaries in areas with high HMO penetration were more likely to receive 
fecal occult blood testing (FOBT) or colonoscopy than flexible sigmoidoscopy (FLEX). A more recent 
study by Mobley et al. (2011) found that fee-for-service Medicare beneficiaries were more likely to get 
FLEX in areas with greater HMO penetration, but less likely to undergo colonoscopy. It should be noted 
that these results do not necessarily indicate that fee-for-service Medicare beneficiaries received better 
or worse quality of care, but that the care they received was similar to Medicare managed care 
beneficiaries indicating spillover of physician behavior. 
All of the aforementioned studies investigated the effect of market level HMO penetration on 
outcome measures instead of physician practice-level insurance share.  Nevertheless, statistically 
significant spillover effects were hypothesized to be in large part due to spillover of changed provider 
care patterns to fee-for-service patients.  Broader area-level infrastructure and demand changes, such 
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as shifts in mix of services or patient demand for services, are also potential mechanisms through which 
spillover could occur. However, Landon, Reshovsky, O’Malley, Pham, and Hadley (2011) examined 
spillover at the practice level and found that physicians in highly capitated practices had lower spending 
per beneficiary than those in less capitated practices as well as lower intensity of care. These findings 
support the idea that changes in provider care patterns can apply to a larger patient population.  
 
Other examples of spillover of physician behavior 
Spillover of physician behavior change has also been noted with restricted drug formularies.  In 
Illinois and Louisiana, Virabhak and Shinogle (2005) examined the effect of Medicaid preferred drug lists 
for cardiovascular medications on prescribing behavior in the non-Medicaid population. The authors 
found that in both states the prescribing of restricted cardiovascular pharmaceuticals decreased in both 
the Medicaid and non-Medicaid populations.  In another study examining the spillover effects of 
restrictive formularies, Wang and Pauly (2005) found that the increased use of Protonix (a proton pump 
inhibitor) for non-Medicaid patients was also seen in Medicaid patients, even though Medicaid had an 
open formulary.  
Valuck et al. (2007) examined the effect of the black box warning for use of selective serotonin 
reuptake inhibitors (SSRIs) among pediatric patients on use of SSRIs among adult patients with 
depression. They found that the diagnosis of depression among adults decreased after implementation 
of the black box warning for children. Furthermore adults with depression were less likely to receive an 
antidepressant (with differences greatest for SSRIs) after the black box warning, without comparable 
increases in other types of treatments. 
Recently McWilliams, Landon, and Chernew (2013) investigated the potential spillover of an 
accountable care organization (ACO) implemented by one insurer in Massachusetts. In particular, the 
authors compared the change in spending and quality among Medicare patients before and after the 
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implementation of the Blue Cross Blue Shield of Massachusetts’ Alternative Quality Contract. The results 
indicate lower spending among Medicare patients and improved quality for lipid screening; no other 
significant quality improvements were found (Williams et al., 2013).  
The literature on provider practice “norms” and spillover of changes in provider behavior 
support the idea that for programs such as CCNC that are implemented for only a subpopulation of 
patients in a practice, intervention-induced changes in physician behavior could spill over to non-target 
populations. Therefore benefits from incentivized changes in the target population could also be 
observed in non-target populations. 
 
Conceptual Model and Hypotheses 
The conceptual model driving motivating CCNC is shown in Figure 2.1. CCNC utilizes three main 
strategies to efficiently improve the health and health care of Medicaid patients: 1) linking patients to a 
medical home (PCP Link), 2) implementing evidence-based quality improvement (QI) in practices, and 3) 
care managing high risk patients (CM) (see Figure 2.1). These three strategies affect the process of care 
within a practice, thereby influencing patient outcomes. Providers receive a PMPM payment to serve as 
a patient's medical home that provides 24/7 access to care and manages patients' utilization. In this 
way, CCNC seeks to increase access/use of primary care, as well as coordination and continuity of care. 
To improve quality of care, practices also adopt statewide quality guidelines and receive regular data 
feedback on practice performance. Audit and data feedback strategies are one of the more successful 
methods for physician behavior change (Grimshaw et al., 2001; Scott, 2009; Bloom, 2005). Care 
managers primarily work with high-risk patients to help them better manage their condition. Practices 
collaborate with these care managers to discuss how to improve patient care, a process similar to 
academic detailing (Bloom, 2005); the effect on quality of care is expected to be smaller than that of the 
QI initiatives due to lower frequency of interaction (as indicated by the thin line connecting “CM” to 
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“Quality” in Figure 2.1). All three strategies work together to improve quality, utilization, and 
expenditures, but the relative effectiveness of each component is unknown.  
As described in Chapter 1, evaluations of CCNC have shown increases in quality and primary care 
utilization as well as reductions in inpatient use, ED use, and expenditures for patients under 
management (Ricketts et al., 2004; Mercer Consulting Group, 2007; Treo Solutions, 2010; Milliman, 
2011; Treo Solutions, 2012). These results indicate changes in both the quality of care and outcomes for 
the target population – CCNC Medicaid patients. My central hypothesis is that the CCNC-induced 
changes in physician behavior have spilled over to non-Medicaid patients in CCNC practices through a 
process of adoption and learning (see Figure 2.2). In other words, as processes of care change for CCNC 
patients, so too do processes of care for non-CCNC patients. For example, increased access to care 
through longer office hours is available for all payer populations who receive care in CCNC practices. 
Furthermore, as providers learn to manage utilization for CCNC patients they will apply this utilization 
management to all patients. QI guidelines may be implemented for all payer populations to simplify 
practice, and data feedback will influence changes in processes of care for both CCNC Medicaid and non-
CCNC Medicaid patients. Provider interactions with care managers will also influence care for all CCNC 
patients. Through changes in processes of care, the spillover of provider care patterns results in better 
quality of care (Aim 1), improved utilization (Aim 2), and lower medical expenditures (Aim 3) for SHP 
patients in CCNC practices. Therefore I hypothesize: 
 
H1a: Practice participation in CCNC increases the probability that SHP diabetes patients receive 
recommended diabetes care. 
H2a: Practice participation in CCNC decreases inpatient and ED utilization and increases patients’ 
use of primary care and continuity of care among SHP diabetes patients. 
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H3a: Practice participation in CCNC practices reduces medical expenditures for SHP diabetes 
patients. 
 
Additionally, changes in provider care patterns, and subsequently spillover, will depend on the 
proportion of CCNC patients in a practice (see Figure 2.3). A small proportion of CCNC patients may not 
be sufficient to trigger changes in provider care patterns; physicians report that the percentage of 
patients a plan covers influences the probability of using those plan developed processes (Bindman, 
Wholey, & Christianson, 2003). In other words, a threshold of patients is necessary to induce changes in 
practice; therefore, spillover will be moderated by CCNC patient load and I hypothesize: 
 
H1b/2b/3b: The effect of practice participation in CCNC is moderated by the proportion of CCNC 
patients in the practice. 
 
 While I hypothesize spillover to occur for the process measures for which CCNC has successfully 
implemented program changes (i.e., for the diabetes quality measures), I do not expect to see CCNC-
induced changes in process measures for which CCNC has not sought to change physician behavior.  For 
the majority of the 2000’s CCNC did not specifically seek to change physician behavior for preventive 
process measures, such as giving flu shot or breast cancer screening.  Therefore, I do not expect so see 
an effect of CCNC on these “balancing measures” (Health Resources and Services Administration, 2011) 
and hypothesize: 
 
H1c: Practice participation in CCNC does not change the probability that SHP patients receive 
recommended preventive care. 
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Nuances in Programmatic Effect 
CCNC-induced improvements in quality, utilization, and expenditures may not occur 
immediately after a practice joins CCNC, as it can take time for improvements in care to trickle down to 
patient outcomes. Certain measures, such as use of primary care and quality process measures may 
increase soon after a practice joins CCNC (as indicated by the relative indentations of “Quality” and 
“Access” in Figures 2.1 and 2.2); extended office hours may be employed soon after practice enrollment 
and quality guidelines may also be implemented quickly. For these measures it is likely that I will see 
improvement during my study period.  However, my study period may not be lengthy enough to capture 
increases in continuity of care or decreases in inpatient and ED utilization, as it may take more time for 
the CCNC-induced changes to demonstrate an effect. In this case, it is also possible that expenditures 
increase for SHP diabetes patients in CCNC practices in the period right after enrollment, as primary care 
expenditures increase initially, with increased access and care, while there is a delay before observing 
decreases in inpatient and ED utilization.  
Additionally, an increase in receipt of recommended diabetes care without a corresponding 
decrease in inpatient and ED utilization may indicate the need for individual care management to reduce 
inpatient and ED use. CCNC care managers do work with providers to improve patient care, but when it 
comes to interaction with patients, they only work directly with CCNC patients who need help with 
chronic or high risk health conditions. Individual care management services, which SHP patients do not 
receive from CCNC, may be a necessary part of CCNC’s success in reducing inpatient and ED utilization. 
These potential nuances in programmatic effect are important and will be taken into consideration 
when interpreting the study result. 
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CHAPTER 3: DATA AND SAMPLE 
 
This study used a combination of patient- and practice-level data to create a hierarchical dataset 
of North Carolina State Employees Health Plan (SHP) diabetes patients nested within North Carolina 
primary care practices over time. This data set linked Community Care of North Carolina (CCNC) practice 
participation to patient-level health and demographic information for years 2002, 2005-2008.  
 
Data Sources 
Patients’ quality of care, health care utilization, expenditures, and demographic measures were 
derived from SHP claims data for years 2002, 2005-2008. The SHP data included every health service 
reimbursed by the SHP including inpatient care, outpatient care, physician care, emergency department 
use, and prescription medications (Carolina Cost and Quality Initiative, n.d.). The data also included 
diagnoses, expenditures, and patient descriptors. The SHP claims also contained data on servicing 
provider, payment provider, provider type/specialty, and provider county for each outpatient physician 
claim and were linked to SHP administrative information on practice name, recorded date of practice 
enrollment in SHP, recorded date of disenrollment in SHP, and National Provider Identifier (NPI) 
number. The SHP data consisted of three separate files: 1) the member file, which included information 
on enrollment and disenrollment dates, Medicare start date, birth date, death date, etc.; 2) the 
combined claims file, which included all health care utilization claims; and 3) the pharmacy file, which 
included all pharmacy claims.  
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For practices that ever participated in CCNC (years 1998-2014), CCNC administrative data 
contained practice name, practice location address, CCNC network, date practice enrolled in CCNC, date 
practice disenrolled in CCNC, number of unique CCNC patients assigned to a practice in each year, 
practice type/specialty, and National Provider Identifier (NPI) number.  
 
Sample 
Patients 
The sample for this study included SHP beneficiaries who were age 18 and older, diagnosed with 
diabetes, and had at least one visit to a primary care practice (in order to attribute to a primary care 
practice) during the study period. Using ICD-9 diagnosis codes (250.XX, 357.2X, 362.0X, 366.41, 648.0X), 
individuals were identified as having a diagnosis of diabetes if they met any of the following criteria: 1) 
at least one face-to-face acute inpatient or emergency department (ED) visit with a diagnosis of diabetes 
(acute inpatient visits were identified as those with an inpatient claim type or a claim with an inpatient 
hospital place of service code during the days of a hospital admission; ED visits were identified as visits 
with an ED indicator), 2) at least two face-to-face outpatient or nonacute inpatient visits on different 
dates of service with a diabetes diagnosis (outpatient CPT codes: 92002, 92004, 92012, 92014, 99201-
99205, 99211-99215, 99217-99220, 99241-99245, 99341-99345, 99347-99350, 99384-99387, 99394-
99397, 99401-99404, 99411, 99412, 99420, 99429, 99455, 99456; nonacute inpatient CPT codes: 99301-
99313, 99315, 99316, 99318, 99321-99328, 99331-99337), or 3) at least one insulin or oral 
hypoglycemic/antihyperglycemic prescription event (HEDIS, 2008). This was based on the HEDIS criteria 
for identifying patients with diabetes (HEDIS, 2008); however, I expanded the IP and ED criteria in order 
to identify patients with diagnoses on either physician or facility claims. The HEDIS-recommended OP 
and non-acute IP CPT codes used were also somewhat restrictive, though I only excluded approximately 
400 individuals by using these restrictive codes. In addition, women who gave birth during the study 
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period were excluded to eliminate the possibility of misdiagnosis of gestational diabetes; these women 
were identified using a combination of ICD-9 and CPT codes for births, either live or otherwise. 
Patient-months were excluded if a patient was enrolled in Medicare (due to incomplete health 
services, pharmacy utilization, and cost data in SHP claims) or was retired (due to potential differences 
compared to the working age population, e.g., retired early due to illness). Observations before the first 
diagnosis of diabetes were excluded. Patient-years were excluded if a patient had less than 10 months in 
the SHP in that year (only months with full enrollment were included). Ten months was considered a 
reasonable length of time in which to accrue these outcomes at the person-year level (mean # months 
in SHP per year=9.5). Enrollment dates for SHP patients occurred at all times during the year, so the 10 
month requirement did not inadvertently require two years of enrollment, which could have occurred if 
annual enrollment was at the same time every year (e.g., July 1). In fact, of the 18,461 individuals that 
never had a year with >=10 months in the SHP, 80% of these also never had >=10 months in the SHP 
overall during my study period. Individuals without a year with >=10 months in the SHP were generally 
older than the study sample and more were male, they had fewer outpatient, inpatient, and emergency 
department visits. Patient-years before the first visit to a primary care practice were also excluded as 
patients could not be attributed to a practice in years before the first visit. The initial patient sample for 
this study was 29,694 patients (Figure 3.1). 
 
Technical Note on Recovering Missing Data 
During the course of data cleaning I discovered that the enrollment dates in the member file 
were not always correct (i.e., some patients had claims dated earlier than the enrollment date) (Figure 
3.2). Complete enrollment data was important because the enrollment file contained the Medicare start 
dates and SHP enrollment dates that I used to identify exclusion criteria (e.g., I required 10 months in 
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the SHP in each year for my sample and I could inadvertently exclude some person-years due to 
incorrect enrollment dates). 
 Following discussions with the Carolina Cost and Quality Initiative (CCQI), the holders of the SHP 
data, I was granted access to the raw member data. This raw data, as well as the combined claims and 
pharmacy data, contained two different individual identifiers: 1) individualid is unique to a patient, and 
2) newid is not unique to a patient and typically changes after any breaks in SHP coverage. For example, 
if a patient was enrolled in the SHP from 2002-2004 and then from 2006-2008 he/she should have one 
individualid and two newid numbers. The raw data set was structured so that patients could have 
multiple rows of member information; the patient had a new row, and thus new 
enrollment/disenrollment date, each time they changed insurance product and/or enrolled in the SHP. 
Therefore, in order to get a complete view of a patient’s time in the SHP, all rows for an individualid 
needed to be combined. However, a large number of rows in the raw file had missing individualids with 
only newids to identify them. Because the individualid is the only person identifier unique to a patient, it 
was necessary to recover the individualid in order to combine rows and get a complete view of a 
patients’ time the SHP. To recover individualids I first merged the rows that had missing individualids 
with the combined claims using the newid in order to recover the individualid for the enrollment file 
(Figure 3.3). Through this process I was able to update 165,237 enrollment file rows with recovered 
individualids. All the recovered individualids were duplicates of those already in the member file. In 
other words, by recovering the individualids from the claims I was able to recover 165,237 previous SHP 
spans for the 992,782 patients in the original member file with individualids. 
 
Practices 
Practice data were derived from a combination of SHP claims and administrative data as well as 
CCNC administrative data. The payment provider number from the SHP claims served as the basis for 
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identifying practices in the SHP claims because multiple servicing providers bill under one payment 
provider number. For each outpatient physician claim the servicing provider was the individual provider 
seen and the payment provider was the practice in which the patient was seen.  
 
Identifying Primary Care Practices 
To create an initial set of all primary care practices in which any SHP patient (either with or 
without diabetes) was seen during the study period, I first utilized SHP claims data to create a list of all 
payment provider identification numbers recorded in the claims during that time (N=52,510); the top 
specialties: 33% out of state, 19% multispecialty, 4.7% chiropractic, 4.5% family medicine, and 3% 
internal medicine). I then restricted the sample to practices (i.e., payment provider id numbers) with a 
primary care specialty. I defined primary care specialty as having a specialty code for family medicine, 
general medicine, internal medicine, pediatrics, public health, rural health clinic, or multispecialty with 
at least one primary care provider (i.e., a servicing provider with a specialty of family medicine, general 
medicine, internal medicine, pediatrics, physician assistant, or family nurse practitioner). I required at 
least one primary care provider for multispecialty practices in order to ensure at least some primary care 
focus.  I linked this sample to the SHP administrative information on practice name, date of practice 
enrollment in SHP, date of disenrollment in SHP, and National Provider Identifier (NPI) number. Using 
this method I identified an initial sample of 5,851 primary care practices. Of these practices, 51% were 
family practice, 30% were internal medicine, 9% were multispecialty, 6% were pediatrics, 4% were 
general practice, and 2% were public health. Distributed among these practices (i.e., payment provider 
ids) were 18,872 primary care providers (i.e., servicing provider ids) (Figure 3.4). 
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Attribution of Patients to a Primary Care Practice   
SHP patients are not administratively linked to a primary care practice as their appointed usual 
source of care. Therefore, in order to determine if a patient was in a CCNC or non-CCNC practice, I 
attributed a patient to a SHP primary care practice (i.e., payment provider number) in each year. 
Patients were attributed to a primary care practice based on a plurality of office or other outpatient 
Evaluation and Management codes (CPT codes: 99201-99205, 99211-99215, 99241-99245) to that 
practice during the measurement year. Visits were defined as a unique combination of patient, provider, 
and date of service.  If a patient had the same number of visits to multiple practices, the patient was 
attributed to the practice that had the last visit during the year (Center for Medicare and Medicaid 
Services, n.d.; The Brookings Institution and Dartmouth Institute, 2011). Using this method, SHP 
diabetes patients were attributed to a total of 2,294 primary care practices out of the initial 5,851 
primary care practices. While I attributed adult diabetes patients to under half of the total 5,851 primary 
care practices, further examination of the data indicated that many of the 5,851 practices were either 
out-of-state, pediatric practices, or in my study period for only one or two years.  
 
Identifying CCNC Practices  
I identified 2,294 primary care practices in which SHP diabetes patients were attributed. To 
determine which practices participated in CCNC, I first linked the SHP primary care practice sample with 
the CCNC administrative data using NPI. Of the 2,294 SHP primary care practices 948 practices matched 
to a CCNC record via NPI (Figure 3.5). Because the mandated use of NPI was only implemented in 2007 
(CMS, 2007), practices that closed before 2008 did not have an NPI number (N=296). Additionally some 
practices changed NPI number over time, thereby having multiple NPIs, which resulted in the possibility 
of a non-match in NPI due to different NPIs listed in the SHP or CCNC data. Therefore, for SHP practices 
that did not match to a CCNC practice via NPI, I hand matched these practices to the remaining un-
23 
matched CCNC practices using name, county, enrollment date, and disenrollment date. For example, I 
matched the SHP practice “Ahoskie Medical Associates” in Hertford County, which started in SHP in 
1974 and ended in September 2010 to the CCNC practice “Ahoskie Medical Associates” in Hertford 
County, which disenrolled from CCNC in August 2010. Using this method I was able to match an 
additional 107 practices. To verify the hand matches I linked the SHP practices to the NPI database using 
the NPI in order to recover the business location address of practices in the NPI database. I then 
compared the recovered business location address with the location address listed in the CCNC 
administrative data. I verified a total of 44 practices. Of the remaining 63 practices, 46 closed prior to 
2008 and did not have an NPI and so did not have an NPI business address to compare. Through the 
verification process also I matched an additional 14 practices that I had not previously hand matched, 
resulting in a total of 121 practices hand-matched. 
There were some practices that had multiple identification numbers, either NPI or provider 
number, in the SHP or CCNC data; therefore the count of 2,294 practices was too large as it counted 
some practices more than once. To identify practices with multiple entries I used a combination of SHP 
practice name, enrollment and disenrollment dates, and identification number; multiple entries were 
considered one practice if they had the same name as well as consecutive disenrollment and enrollment 
dates (e.g., Carolina Family Prac & Sports Med had a disenrollment date of 05/31/2008 and Carolina 
Family Practice & Sports M had an enrollment date of 06/01/2008), or same name and it was that of a 
physician (Figure 3.6). Combining entries with consecutive disenrollment and enrollment dates and 
same physician name resulted in a practice sample of 2,140 practices. I updated patient attribution so 
that patients were attributed to one of these final 2,140 practices each year (Figure 3.7), of which 878 
(42%) were ever in CCNC during my study period. In 2007 it was estimated that just over 50% of primary 
care practices in North Carolina were participating in CCNC (Steiner, 2009); because I am excluding many 
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pediatric practices, due to my study sample only including adults, 42% seems a plausible participation 
rate for my study sample. 
Additionally, in some instances multiple CCNC practices shared the same NPI, which linked to 
the same SHP practice. For example, the CCNC practices “Park Ridge Medical Associates” and “Laurel 
Park Medical Center” were both linked to one SHP practice, “Park Ridge Medical Assoc” via NPI. This 
occurred for a total of 110 CCNC practices, grouped into 26 SHP practices, with the number of CCNC 
practices per SHP practice ranging from 2-13. I identified the practices at the SHP practice level (i.e., I 
identified 26 practices) but created indicators to identify that they were a part of a multi-site practice. 
Twenty-two of the 26 practices had sites with varying CCNC enrollment dates. I created indicators to 
identify these as mixed-CCNC practices.  
 
Sample Exclusions  
The final SHP sample excluded patient-years (~1%) in which a patient was attributed to one of 
the 54 practices located outside of North Carolina. I allowed individuals to be attributed to these 
practices, as individuals living near the NC boarder could reasonably seek the majority of their care in 
another state. However, I excluded these practices from analysis because health care laws and 
regulations, as well as provider practices can vary by state leading to potential systematic differences 
between North Carolina practices and those in other states. Additionally I excluded patient-years (~5%) 
in which a patient was attributed to one of the 22 practices that had multiple practice sites with varying 
CCNC enrollment dates as the effect of CCNC would be very imprecise and noisy for these practices. 
I also excluded patient-years in which a patient was attributed to a practice that disenrolled 
from SHP before July 1 or joined SHP after July 1 of a year, as these practices were not able to provide a 
full year of services during these years. Lastly, I excluded patient-years (~1%) in which a patient was 
attributed to a practice that did not have a primary care physician. Some multispecialty practices 
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qualified for inclusion in the original practice sample because they had at least one primary care 
physician during the study period; however, practices did not necessarily have a primary care physician 
in each study year.  As this study focuses on primary care practices, I did not include practice-years in 
which a practice had no primary care physicians because they would not be considered primary care 
practices in those years.  
With these exclusions, the final patient sample was 28,293 nested within 2,038 practices, of 
which 858 were ever CCNC. The average number of patients per practice over the study period was 9.76, 
ranging from 1 to 345 patients. 
  
County Data 
Control data at the county level were obtained from several sources including the U.S. Census 
Bureau, the North Carolina Division of Medical Assistance (DMA), North Carolina Health Professions 
Data System (HPDS), and the USDA Economic Research Service. The U.S. Census Bureau holds the Small 
Area Income and Poverty Estimates, which includes the county population below the poverty line, and 
Intercensal Estimates of county racial/ethnic composition. The DMA holds data on the number of 
Medicaid patients in each county in North Carolina over the study period. The HPDS contains data on 
North Carolina county provider composition over the study period, including the number of total 
physicians and primary care physicians per county. The USDA Economic Research Service contains the 
2003 Rural-Urban Continuum Codes used to identify rural/urban status 
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CHAPTER 4: MEASURES AND METHODS 
 
This study estimated the spillover effects of Community Care of North Carolina (CCNC) by 
examining the extent to which North Carolina State Employee Health Plan (SHP) diabetes patients in 
CCNC practices experienced greater improvements in quality of care, utilization, and medical 
expenditures than SHP diabetes patients in non-CCNC practices. Aim 1 addressed quality of care by 
determining the effect of practice participation in CCNC on quality process measures (i.e., the receipt of 
recommended diabetes and preventive care). Aim 2 examined the effect of practice participation in 
CCNC on utilization, including inpatient, emergency department, and primary care utilization as well as 
continuity of care. Aim 3 quantified the effect on total medical expenditures as well as separately for 
inpatient, outpatient, and emergency department expenditures.  
 
Measures 
Dependent variables 
 The dependent variables for this study were patient-level measures of receipt of recommended 
diabetes care, receipt of recommended preventive care, health care utilization, and health care 
expenditures. All measures were derived from North Carolina State Employees Health Plan (SHP) claims 
data and collapsed to the person-year level for analysis.    
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Quality of Care 
I examined annual receipt of four diabetes quality of care measures: hemoglobin A1c test, low-
density lipoprotein (LDL) cholesterol test, eye exam, and attention for nephropathy (urine microalbumin 
test, diagnosis or treatment for nephropathy, visit to a nephrologist, or ACE/ARB prescription) (National 
Committee for Quality Assurance, 2009), each of which are: 1)  important for the continued care of 
diabetes (American Diabetes Association), 2) can be identified using claims data, and 3) were part of the 
CCNC diabetes initiative at some point during my study period. I also defined three annual preventive 
quality measures (receipt of breast cancer screening, cervical cancer screening, and flu shot) as my 
balancing measures (Health Resources and Services Administration, 2011). None of the three measures 
were part of a CCNC initiative during my study period. These measures were derived from a combination 
of CPT and ICD-9 codes (Table 4.1) and were identified in either the inpatient or outpatient setting. 
Breast cancer screening and cervical cancer screening were defined only for women within the 
recommended age ranges at the time (age 40-74 and 21-64, respectively) (NCQA, 2008). All measures 
were defined as binary indicators for receipt of care during each year (1=Yes, 0=No).  
 
Utilization 
Health care utilization included number of inpatient admissions, number of emergency 
department (ED) visits, number of primary care visits, and continuity of care during the year. I defined 
all-cause acute inpatient admissions as those with an inpatient claim type or a claim with an inpatient 
hospital place of service code during the days of a hospital admission. I used all-cause admissions 
because it is difficult to validly identify diabetes-specific admissions. Admissions were a unique 
combination of patient and date of admission. Hospital transfers, identified from discharge status codes, 
were not counted as admissions. Only 10% of the person-year sample ever had an inpatient admission, 
and of those with an admission 76% had only one during the year. Therefore, instead of using a count of 
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inpatient admissions during the year, I defined inpatient admission as a binary indicator of hospital 
admission (1=Yes, 0=No). 
 I defined ED visits as the count of all-cause ED visits that did not result in an acute inpatient 
admission. Similar to inpatient admissions, I use all-cause visits due to potential incorrectness of 
diabetes as the primary diagnosis. I first identified all all-cause ED visits (identified as visits with an 
emergency room indicator), then excluded visits with an inpatient claim type. Similar to inpatient 
admissions, only 18% of individuals had an ED visit and of those with a visit the majority (74%) only had 
one visit. Therefore, instead of using a count of inpatient admissions during the year, I defined ED visits 
as a binary indicator of an ED visit (1=Yes, 0=No). 
 I summed the number of primary care visits to any primary care practice during the year. I first 
determined the number of outpatient physician visits during the year (CPT codes: 99201-99205, 99211-
99215, 99241-99245); visits were a unique combination of patient, provider, and date of service. Visits 
were counted as primary care visits if they took place in one of the 5,851 SHP primary care practices, as 
defined previously in Chapter 3. I also calculated the number of total outpatient visits (primary care and 
specialty) during the year (CPT codes listed in Table 4.1). I examined both primary care and total 
outpatient physician visits to assess potential offsets of primary care use. For example, patients who 
decreased their use of primary care visits, but increased the use of specialty care, would have fewer 
primary care visits while total outpatient physician visits could remain the same.  
 I calculated continuity of care using a modified version of the Bice-Boxerman (Bice & Boxerman, 
1977), using the number of practices seen instead of the number of providers seen: 
 
                                                                   𝐶𝑂𝐶 =  
∑ 𝑛𝑗
2−𝑁𝑠𝑗=1
𝑁(𝑁−1)
                     (Eq. 1) 
 
29 
where N is the number of outpatient visits, j is the outpatient physician practice, and n is the number of 
visits to practice j. This measure is one of four commonly used claims-based continuity of care measures 
that are all highly correlated with one another (Pollack et al., 2013). The Bice-Boxerman measure 
calculates the concentration of  a patients total outpatient visits during a specific time period that are to 
a single practice, with the index ranging from 0 (if each visit is to a different practice) to 1 (if each visit is 
to the same practice). I first calculated the total number of outpatient visits during the year (CPT codes 
listed in Table 4.1). Visits were a unique combination of patient, provider, and date of service. I then 
created a list of all outpatient practices seen during the study period; I excluded practices with a 
specialty of pharmacy, durable medical equipment, home infusion, independent laboratory, and 
ambulance as these were not considered to be outpatient clinic visits with a physician. Some practices 
had multiple entries (N=558 of 11,839); I considered multiple entries one practice if they had the same 
name as well as consecutive disenrollment and enrollment dates (e.g., Carolina Family Prac & Sports 
Med had a disenrollment date of 05/31/2008 and Carolina Family Practice & Sports M had an 
enrollment date of 06/01/2008), or same name of a physician. I then recalculated the continuity of care 
measure using this refined set of practices for patients with three or more visits in a year, the minimum 
number needed to assess continuity of care (Pollack et al., 2013). Additionally, it should be noted that 
because I am examining continuity of care in a chronically sick group, it may be necessary and beneficial 
for individuals to seek care from a specialist and primary care physicians. Therefore, while higher 
continuity of care is generally better, a value of one is not necessarily the ideal.   
 
Expenditures 
I examined expenditures from the SHP perspective, and therefore defined total yearly health 
care expenditures as the total amount paid by SHP during the year, including inpatient, outpatient, ED, 
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physician, and pharmacy expenditures. Expenditures were adjusted for medical inflation using the 
medical Consumer Price Index to adjust to 2008 dollars (Bureau of Labor Statistics, n.d.). 
 I also created separate measures for inpatient expenditures, ED expenditures, outpatient 
expenditures, and pharmacy expenditures in order to examine differential effects of CCNC participation 
on expenditures in different areas of care. As discussed in Chapter 2, it is possible that expenditures 
increase for outpatient care as primary care use increases, but that inpatient and ED expenditures do 
not decrease until later. Because it is difficult to identify the location of some services on the same date 
of service (e.g., laboratory codes could be either in the hospital or outpatient), I defined inpatient 
expenditures as all expenditures that occurred on the date of admission through the date of discharge. I 
defined ED expenditures as all expenditures that occurred on the date of the ED visit, for which there 
was not also an inpatient admission. Pharmacy expenditures were defined as all expenditures listed in 
the pharmacy claims. The remaining expenditures were defined as outpatient expenditures.  
 
Key independent variables 
 The main independent variables of interest for this study were practice-level measures of yearly 
Community Care of North Carolina (CCNC) participation and the number of Medicaid-covered CCNC 
patients per CCNC practice. All measures were derived from CCNC administrative data and were 
collapsed to the practice-year level for analysis.    
 
Practice participation in CCNC  
Yearly practice participation in CCNC was defined as a binary indicator for a practice having an 
enrollment date in CCNC before July 1 of the year or the disenrollment date after July 1 (1=Yes, 0=No). 
This measure equates to a requirement of being enrolled in CCNC for at least six months out of the year, 
as almost no practices qualified as having six months without also fitting into the July 1 requirement 
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(e.g., they did not enroll in March and disenroll in September of the same year). As noted in Chapter 2, 
CCNC-induced improvements in quality, utilization, and expenditures may not occur immediately after a 
practice joins CCNC, as it can take time for improvements in care to trickle down to patient outcomes. 
Therefore I used a six month requirement in CCNC before considering a practice a CCNC practice. Forty-
five practices had CCNC disenrollment dates before July 1 and 131 had enrollment dates after July 1. 
Because multiple entries existed for some CCNC practices, due to multiple NPI or Medicaid provider 
numbers, I used the earliest enrollment date and latest disenrollment date for these practices.  
  
CCNC patients 
While I hypothesized in Chapter 2 that practice participation in CCNC is moderated by the 
proportion of CCNC Medicaid patients in a practice, I was not able to calculate that total number of 
patients in a practice due to data limitations; without a denominator I could not calculate the 
proportion. Therefore this variable was defined as the count of unique Medicaid CCNC patients assigned 
to a practice during the year. Not all of the patients necessarily visited the practice, nor did they all have 
diabetes; however, the number assigned serves as a proxy for CCNC caseload for a practice. Because the 
relationship between Medicaid CCNC patients and outcomes was hypothesized to be non-linear (e.g., 
potentially exhibiting a threshold effect and/or a ceiling effect) and could vary with the outcome, I 
categorized the count of patients into five categories based on the percentile distribution of CCNC 
patients per practice: very low (<100), low (100-349), medium (350-699), high (700-999), and very high 
(>=1000). Categorization of this variable allowed for a flexible and variable relationship between CCNC 
Medicaid patients and outcomes. In addition, I compared the category specification to a continuous 
variable with quadratic specification, and found that the categories were a better fit for the data. This 
variable was only defined for CCNC practices. 
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Control variables 
Patient-level  
Patients age at the beginning of the year and gender  were obtained from the SHP claims data. 
These measures capture predisposing factors of service use (Andersen and Aday, 1974).  To capture 
need for health services (Andersen and Aday, 1974), I used an adapted version of the Charlson 
comorbidity index (Charlson & Sax, 1987; Deyo, Cherkin, & Ciol, 1992), using the coding algorithms 
refined by Quan et al. (2005). The Charlson index is a commonly used measure of comorbidity in health 
services research.  Other measures of comorbidity do exist, such as the Chronis Illness and Disability 
Payment System (CDPS); however the CDPS was created for the Medicaid population (Kronick, Litaker, 
Dor, & Cooper, 2000), which potentially has a very different health profile than the SHP population. 
Therefore, for my sample of privately insured adults, I felt the Charlson index was an appropriate 
measure.  
While the index typically uses inpatient diagnoses to identify comorbidities, I used diagnoses 
from inpatient, ED, and outpatient visits in order to get a more complete view of patient comorbidities, 
especially for those patients without an inpatient visit during the year. I excluded the diabetes 
categories from the algorithm, since the entire sample had diabetes. I defined the index as the Charlson 
weighted sum, which is a weighted count of comorbidities.  
I also controlled for how a patient qualified for SHP (subscriber, spouse, or other), as illness 
severity may vary by group (e.g., sick spouses may be more likely to be covered than well spouses). The 
exact mechanism and/or difference captured by this variable is uncertain – it may be just as possible 
that a spouse chooses to be covered because they have no other insurance options instead of disease 
severity reasons – but it is included in order to capture any underlying differences. I also controlled for 
SHP plan (comprehensive major medical, Smart Choice, Smart Choice Basic, Smart Choice Plus), which 
captures cost-sharing levels.   
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Practice-level 
I controlled for practice type, practice size, and multisite practice, as these factors were found in 
previous work to influence some individual outcomes among CCNC diabetes patients (King, n.d.). 
Practice type was defined as institutional/specialty or community-based practices (King, n.d). 
Institutional/specialty practices were those with a specialty of rural health clinic, public health clinic, or 
multispecialty. The remaining practices were considered community-based practices.  
 Practice size was defined as the number of primary care providers in a practice in each year. 
Primary care providers had a specialty of internal medicine, family medicine, general medicine, 
pediatrics, physician assistant, or family nurse practitioner. To calculate the number of providers I first 
created a dataset of all providers that billed under a primary care provider payment number in each 
year. I combined providers for practices that I had previously determined to have multiple entries (see 
Chapter 3). I then excluded multiple provider entries and calculated the sum of providers per practice in 
each year. 
 Multisite practice was defined as a binary indicator of whether a SHP practice included multiple 
CCNC practice sites. I defined multisite with mixed CCNC enrollment as a binary indicator of whether a 
practice was a multisite practice for which the practice sites had different dates of CCNC enrollment. 
Both measures were determined during the SHP and CCNC matching process. 
 
County-level 
County level control variables included proportion of the population below the poverty line, 
proportion of the population non-Hispanic white, proportion of the population non-Hispanic black, 
proportion of the population Hispanic (the three racial/ethnic variables were mutually exclusive), and 
number of primary care providers per 10,000 population. I defined rural/urban status using the Rural-
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Urban Continuum Codes (United States Department of Agriculture Economic Research Service, 2003; 
USDAERS, 2004). I categorized the variable into three categories: urban, defined as codes 1-3; non-rural, 
non-urban, defined as codes 4-7; and rural, defined as codes 8-9. 
 
Methods 
This study utilized longitudinal analyses to examine changes in patient-level outcomes over time 
(years 2002, 2005-2008). I examined diabetes patients in a subsample of practices that exhibited 
common likelihood of ever joining CCNC. I first conducted bivariate analyses comparing values of 
diabetes and preventive quality measures, health care utilization, and expenditures, as well as control 
variables for patients in CCNC and non-CCNC practices. I then used multi-level models to estimate the 
effect of practice participation in CCNC on patient outcomes. 
 
Addressing Selection Bias 
In 2002, CCNC began to expand from the initial pilot networks, which encompassed 10 of North 
Carolina’s 100 counties, to a statewide program of 14 community networks. This expansion included 
both growth of the existing networks to neighboring counties and creation of new networks. As the 
networks expanded, they recruited primary care practices to voluntarily join CCNC. Some practices may 
have been more likely to join CCNC than others, for example, practices that had lower quality of care 
and were seeking support for quality improvement.  Comparing changes in patient outcomes due to 
joining CCNC without controlling for the initial quality of the two groups, or other baseline differences, 
would lead to biased estimates. Additionally, practices that joined earlier may have been more “quality 
oriented” than practices that joined later. The potential endogeneity due to this underlying, unobserved 
quality orientation could bias estimates. I theorize that the potential selection exists at the practice 
level, not the patient level, because practices voluntarily selected to become a CCNC practice while SHP 
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patients did not know if the practice they chose was, or was not, a CCNC practice. Because I used non-
CCNC practices as controls, it was necessary to ensure that non-CCNC practices were sufficiently similar 
to CCNC practices in order to produce unbiased estimates of the effect of CCNC on patient outcomes. I 
used two main strategies to mitigate this bias, as described below. 
 
Practice sample exhibiting common support   
For my analyses I included only practices that had similar probabilities of ever being enrolled in 
CCNC (i.e., exhibited common support), to create a more homogenous study sample. To create a 
practice sample that exhibited common support, I first used a method similar to calculating propensity 
scores:  logistic regression to model the likelihood of a practice ever becoming a CCNC practice during 
the study period based on observed baseline practice and county characteristics.  
 
Pr(CCNC EVER=1|X) = exp(Xβ)/(1+exp(Xβ))                                                                                      (Eq. 2) 
    with Xβ = β0 + β1V + β2W + ε 
 
where CCNC EVER is an indicator for whether a practice joined CCNC during my study period, V are 
practice characteristics, and W are county characteristics. Practice characteristics included size (count of 
primary care providers) and a binary indicator of practice type (1=community-based, 
0=institutional/specialty).  The quadratic form of practice size was used to increase model fit (Wald 
statistic=57.47, p<0.001). County characteristics included proportion of the population below the 
poverty line, racial/ethnic composition (i.e., proportion non-Hispanic white, proportion non-Hispanic 
black and proportion Hispanic), proportion of population on Medicaid, rural/urban status (i.e., urban, 
non-metropolitan urban, or rural), and number of primary care providers per 10,000 population. Many 
of these factors were previously found to influence individual outcomes among CCNC diabetes patients 
36 
(King, n.d.), or were hypothesized to influence patient outcomes. The vast majority of practices 
(N=1,734) existed in the SHP in 2002, and for these practices I used 2002 values for variables. For the 
practices that joined from 2005-2008, I used variables from the first year available (e.g., if a practice 
joined in 2005, I used 2005 values). Therefore, I included a control variable for the study year in which a 
practice was first in SHP. A Pregibon’s linktest indicated that interactions or additional higher ordered 
terms would not improve the fit of the model (hat p-value<0.001, hatsq pvalue=0.655).  
I only included practices for which the distribution of predicted probabilities for joining CCNC 
exhibited common support (Freburger, Carey, & Holmes, 2006). This strategy essentially excludes 
outliers or practices that are very dissimilar to other practices. To create the trimmed sample I first 
compared the propensity score distributions for the CCNC and non-CCNC groups; common support was 
defined as the overlapping distribution (0.0562036–0.9161462). I excluded 9 CCNC practices and 3 non-
CCNC practices whose score fell outside of the overlapping distribution, or range of common support. 
Years in which a patient was attributed to one of these 12 practices were excluded from analyses 
(N*t=4,351; N=1,386). 
I also examined covariate balance, using standardized differences, before and after trimming 
(Table 4.2). Because significant imbalance remained after trimming (indicated by a standardized 
difference >0.10), I included all variables from the propensity score-like model in the main outcome 
model. Because of the imbalance after trimming, I also examined propensity-score weighted models, 
using inverse probability of treatment weights (IPTWs). Weighting did achieve covariate balance, and 
results were very similar to results from the unweighted models. Therefore, I continued to use my 
original strategy using the unweighted models. 
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Controlling for additional selection bias   
While creating a practice sample with common support excludes very dissimilar practices, there 
was still the potential for remaining selection bias. To address observed selection bias I controlled for 
differences between practices in my main analyses using observed practice-level and county 
characteristics (as described above). To address time-invariant unobserved selection I included an 
indicator in the main analyses for whether a practice was ever enrolled in CCNC during the study period, 
which controlled for baseline differences between the two groups. For example, if practices that joined 
CCNC had higher or lower initial quality than practices that did not join, the indicator would control for 
the baseline differences in quality. I defined ever CCNC as a binary indicator of whether a practice ever 
enrolled in CCNC (1=Yes, 0=No). Additionally, I included an indicator for whether a practice enrolled in 
CCNC within the year after a CCNC network expanded to a county, which controlled for differences 
between early and late adopters. Early adopter was defined as whether a practice joined CCNC within 
the first year that a CCNC network expanded to a practice’s county. I identified the date of expansion 
into a county as the CCNC enrollment date of the practice that first enrolled in the county. Practices 
were considered early adopters if they enrolled in CCNC within one year of the first enrollment date in 
the county. During the expansion of CCNC it was possible for a few practices to join the program before 
a county joined, making the early adopter indicator potentially endogenous. However, because I have 
time varying indicators for CCNC participation, the CCNC indicators should control for this potential 
endogeneity.  
 
Use of multi-level models 
Due to the hierarchical structure of my data (patients clustered within practices), within-cluster 
correlation is likely to exist; this could violate the assumption of independence of errors and could result 
in incorrect standard errors on my parameter estimates. To account for the clustering of patients within 
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practices I used multi-level estimation, which allows for and models the correlation of errors between 
patients within a practice (Rabe-Hesketh & Skrondal, 2012). I used random intercept models with the 
practice-level random intercepts representing unobserved random differences between practices. 
In addition to correcting for the correlation of errors among patients in practices, multi-level 
models have several other beneficial properties. First they allow for inclusion of explanatory variables 
from multiple levels, such as both the patient and practice level. Second they allow for examination of 
between-cluster (i.e., between-practice) variance unaccounted for by explanatory variables in the 
model. Understanding this between practice heterogeneity can be an outcome of interest itself. The 
ability to compare between-cluster heterogeneity is an advantage of multi-level models over 
generalized estimating equations (GEE). Furthermore, multi-level models provide inferences for 
practices with very small numbers of patients through the use of partial pooling (i.e., shrinkage) (Rabe-
Hesketh & Skrondal, 2012). 
Despite these advantages, it should be noted that unbiased estimation of multi-level random 
intercept models requires the error term and variables in the model to be uncorrelated, and this 
requirement pertains to all levels of the model (e.g., patient and provider-level). For example, if there 
are unobserved practice characteristics that are correlated both with participation in CCNC and outcome 
measures, results will be biased. I conducted sensitivity analyses using fixed-effects estimation, which 
does not require this type of independence, and compared model estimates to those of the multi-level 
models (described below). 
 
Statistical Analyses 
I used random intercept multi-level models to estimate the effect of CCNC practice participation 
on patient outcomes. To test hypotheses H1a and H1c for Aim 1 (Quality) I estimated the following 
multi-level logit models: 
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Pr(ReceiptRecipct=1|Xipcn) = exp(Xβ)/(1+exp(Xβ))                                                                                           (Eq. 3) 
   with Xβ = β0 + β1Enrolledpct + β2Everpc + β3EarlyAdoptpc + β4Vipct + β5Wpct + β6Zct + β7Tt + µp + εipct  
              
where i indicates the individual, p indicates the practice, c indicates the county, and t indicates the year. 
ReceiptRec, is a binary indicator for whether an individual received recommended care (either diabetes 
care or preventive care) during the measurement year, and Enrolled is a binary indicator for time specific 
practice participation in CCNC. Ever is a binary indicator for whether a practice ever participated in 
CCNC, which controls for baseline differences between the groups. EarlyAdopt is a binary indicator for 
whether a practice enrolled in CCNC in the year after a CCNC Network expanded to a county.  V is a 
vector of individual characteristics, W is a vector of practice characteristics, Z is a vector of county 
characteristics, and T are time fixed effects. µp is the practice specific random error component and εipct 
is the patient error. Both µp and εipct are assumed to be normally distributed with mean zero. β1 is the 
coefficient of interest and will give the effect of practice participation on the receipt of recommended 
care. 
 To test hypothesis H1b I limited the sample to practices that were enrolled in CCNC in each time 
period, and estimated the following multi-level logit model: 
 
Pr(ReceiptRecipct=1|Xipcn) = exp(Xβ)/(1+exp(Xβ))                                                                                           (Eq. 4) 
   with Xβ = β0 + β1 #CCNCpct + β2Vipct + β3Wpct + β4Zct + β5Tt + µp + εipct  
 
where i indicates the individual, p indicates the practice, c indicates the county, and t indicates the year. 
#CCNC is the number of CCNC Medicaid patients in a practice. V is a vector of individual characteristics, 
W is a vector of practice characteristics, Z is a vector of county characteristics, and T are time fixed 
40 
effects. µp is the practice specific random error component and εipct is the patient error. Both µp and εipct 
are assumed to be normally distributed with mean zero. Β1 is the coefficients of interest. Because I 
categorized the number of CCNC patients, I also conducted Wald tests for the joint significance of the 
number of CCNC patient categories. 
 I used the same general analytic strategy as described for hypothesis H1a to test hypotheses 
H2a for Aim 2 (Utilization) and H3a for Aim 3 (Expenditures). To test hypothesis H2a I used a multi-level 
logit models to determine the effect of CCNC practice participation on inpatient use and ED use, a multi-
level Poisson model with reintroduced zeros (as inclusion criteria required at least one primary care visit 
and multi-level zero-truncated models are currently unavailable) to examine the effect on primary care 
visits and total outpatient physician visits, and a multi-level ordinary least squares (OLS) model with 
robust standard errors to estimate the effect on continuity of care. To test hypothesis H3a I first used a 
multi-level Poisson model with gamma variance to estimate the effect of practice participation in CCNC 
on total expenditures. Compared to a log-transformed model, the Poisson model can incorporate zero 
values, does not need smearing to recover estimates, and estimates are robust to misspecification of 
the variance function (Deb, Manning, Norton, 2006). However, estimation using this method was 
unsuccessful (i.e., models did not converge). I attempted multiple solutions, including rescaling the 
dependent variable, excluding outliers, not using adaptive quadrature, running a basic Poisson model 
and then using the matrix values as initial values for the multi-level model. Maximum likelihood 
estimates could still not be computed after these attempts (i.e., models did not converge). Therefore, I 
used multi-level OLS with bootstrapped standard errors to estimate the effect of CCNC on expenditures. 
Because I am examining expenditures from the SHP prospective (i.e., their paid amount), and their main 
focus for cost savings is typically on mean expenditures, this estimation strategy provides easily 
interpretable and useful estimates. 
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 I used the same analytic strategy as described for hypothesis H1b to test hypotheses H2b and 
H3b. For hypothesis H2b I used multi-level logit models to determine the moderating effect on inpatient 
use and ED use, a multi-level Poisson model with reintroduced zeros to examine the moderating effect 
on primary care visits and total outpatient physician visits, and a multi-level OLS with robust standard 
errors to estimate the moderating effect on continuity of care. For hypothesis H3a I used a multi-level 
OLS model with bootstrapped standard errors to estimate the effect of practice participation in CCNC on 
total expenditures. 
 All models were estimated in Stata 12. All binary outcome models were estimated using 
meqrlogit, the Stata command for multi-level mixed effects logit models, and all OLS models were 
estimated using xtmixed, and all count models were estimated using meqrpossion. All models were 
initially run using the Laplacian approximation, which is equivalent to using adaptive quadrature with 
one integration point (Rabe-Hesketh & Skrondal, 2012). More accurate approximations of the outcome 
are achieved with more integration points, however computation time also increases along with 
accuracy. Therefore, I chose one model from each of the three Aims and estimated the models with five 
quadrature points, using the matrixes from the initial models as starting values. I then estimated the 
models with eight quadrature points, using the matrixes from the previous models as starting values. 
The coefficient estimates and standard errors changed very little with increasing numbers of integration 
points; for example, for the A1c outcome the coefficients and standard errors for the CCNC indicator 
were 0.162 (0.058) for the Laplacian model, 0.161 (.058) for the model with five quadrature points, and 
0.162 (.058) for the model with eight quadrature points. Therefore, all results presented are from the 
original models using the Laplacian approximation.  
In the analyses I used the quadratic form of both age and comorbidities to allow for nonlinear 
relationships with the outcomes. For example, a patient may be more likely to receive an A1c test with 
increasing comorbidities due to increasing attention to medical conditions, but the association may 
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decrease after a certain number of comorbidities because attention cannot be adequately paid to all 
health issues during a physician visit. I conducted Wald tests to test the quadratic functional forms of 
age and comorbidities.  Both tests rejected the null that the quadratic components (e.g., age and age2) 
were simultaneously equal to zero (p-values<0.001). The used the Wald test because it approximates 
the Likelihood Ratio test, but only requires estimating the unrestricted model; because my models took 
a long time to run, the Wald test was more time efficient.  
I calculated the median odds ratio (MOR) for each model in order to quantify the between-
cluster (i.e., between-practice) heterogeneity for each outcome. The MOR compares two random 
individuals with the same covariate values but who are in two different clusters, comparing the person 
with the higher propensity to the person with the lower propensity (Rabe-Hesketh & Skrondal, 2012). It 
is calculated using the cluster-level variance as follows: 
 
𝑀𝑒𝑑𝑖𝑎𝑛 𝑂𝑑𝑑𝑠 𝑅𝑎𝑡𝑖𝑜 = exp (√2 ∗  𝜎𝑝2) ∗ (Φ
−1(0.75))                                                 (Eq. 5) 
 
where σp
2 is the cluster variance, and φ is the cumulative distribution function of the normal 
distribution. The value of the MOR is always greater than or equal to one, with a value of one indicating 
no between-cluster variation, and increasing values indicating increasing variation (Rabe-Hesketh & 
Skrondal, 2012). 
 
Fixed-Effects Estimation   
As mentioned above, unbiased estimation of multi-level models requires the error term and 
variables in the model to be uncorrelated, and this requirement pertains to all levels of the model (e.g., 
patient and provider level). To address concerns that this requirement was not met and that selection 
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bias was still present due to unobserved practice characteristics, I conducted fixed-effects estimation to 
control for all omitted time-invariant practice characteristics.  
All binary outcome models were estimated using linear probability models (LPMs) with practice-
level fixed effects (Wooldridge, 2005). I used LPMs instead of Chamberlain conditional logit models to 
ease interpretability of results. LPMs can result in out of range predictions (average of approximately 3% 
out of range predictions in my models) but they still produce the correct marginal effects that were the 
main interest of the models. I corrected for the inherent heteroskedasticity in LPMs by using cluster-
robust standard errors.  Similarly, all count models were estimated using ordinary least squares (OLS) 
with practice-level fixed effects and cluster-robust standard errors. 
I then compared the average marginal effects of CCNC from the fixed effects models to those 
from the multi-level models. In the fixed effects models, the estimated coefficients represent the 
marginal effects, while that is not the case for the multi-level logit and Poisson models. Therefore, I 
calculated the population-averaged average marginal effects from the multi-level models using recycled 
predictions. For example, I calculated the population-averaged average marginal effect of CCNC on 
receipt of A1c by predicting the average probability of receipt of A1c if everyone in the sample had 
CCNC=1 and then predicting the probability as if everyone had CCNC=0, incorporating the practice 
specific intercepts, and then taking the difference between the two predicted probabilities. I then 
bootstrapped the estimate to calculate the standard error of the estimate. I used a parametric bootstrap 
procedure using the estimated parameters and the estimated standard errors of the predicted values in 
logit space, converted to probabilities from the estimated models and assuming the independence of 
errors. I used a parametric bootstrap instead of the nonparametric due to time considerations. Each 
model took approximately 5-10 minutes to run; using a non-parametric bootstrap procedure with 1000 
replications would thus take an estimated 5000 minutes per model, of which I had 31 main models, and 
thus approximately 107 days. 
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Sensitivity analyses 
Stratification by practice size: Because it is possible for the effects of practice-level interventions to vary 
by practice size (Piatt et al., 2006), heterogeneity in the effect of CCNC by practice size could be possible. 
Therefore, I conducted sensitivity analyses wherein I stratified analyses by practice size (as measured by 
the number of primary care physicians). I examined the distribution of practice size and created three 
stratification levels based on the distribution of providers per practice and sample size of each strata 
(i.e., percentiles): 1) small/solo practices (1 primary care provider), 2) medium practices (2-3 primary 
care providers), and 3) large practices (>=3 primary care providers).  
 
Stratification by baseline quality: Practices with high initial quality may not exhibit much change over 
time, as their quality was already high. When examining changes in patient quality in a practice over 
time, it is important to control for is the initial quality of care in the practice. I had originally planned to 
use baseline (i.e., 2002) practice-level quality as a time-invariant variable in the models. However, only 
about half of the primary care practices had diabetes patients from my sample attributed to them in 
2002, and so I could not use the variable for the main analyses. Additionally baseline quality could be 
endogenous in that it is influenced by factors not controlled for in my model; therefore including this 
variable in my model could bias estimates. Therefore, I conducted sensitivity analyses stratifying 
analyses by initial quality of care. For each binary outcome, the initial practice quality was the 
proportion of diabetes patients in the practice that received the test during the year. For count patient 
outcomes and expenditures, the initial practice quality was the average value for diabetes patients in 
the practice during the year. I only included practices with at least three patients to avoid all or none 
baseline values (e.g., 0 or 1), which are more likely with a small number of patients. I created three 
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strata for each outcome based on the percentile distribution of the values – low, medium, and high - 
based on the distribution of the baseline values for that outcome and sample size considerations.  
 
Stratification by primary care use: For the quality of care models, patients with greater primary care use 
could have more opportunities for care than patients with lower primary care use, in that patients with 
more visits have greater opportunities to receive a test (e.g., A1c). However, I did not include this 
variable in my models due to the potential endogeneity of primary care visits; because outcomes and 
primary care visits are measured in the same year, there could be reverse causality in that getting a test 
would result in more primary care visits. Therefore, I stratified quality of care models by patient primary 
care use based on the percentile distribution. I categorized this variable as low use (<3 visits), medium 
use (3-5 visits), and high use (>=6 visits). Additionally, because the continuity of care measure depends 
on the total number of visits during the year, I also stratified the continuity of are analyses by patient 
primary care use.   
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CHAPTER 5: RESULTS 
 
The final study sample included 26,907 SHP diabetes patients in 2,026 North Carolina primary 
care practices (Table 5.1). Patients had an average age of 49, the majority were female, and they had an 
average Charlson index score of 1.37. Most patients were the main plan subscriber and the majority had 
the Smartchoice SHP plan (61%), followed by Smartchoice Basic.  Over the study period, just over half of 
patient-years were attributed to a primary care practice that ever participated in CCNC; the majority of 
these were attributed to a practice in years after the practice joined CCNC. In unadjusted comparisons 
patients attributed to CCNC practices were relatively similar to those attributed to non-CCNC practices, 
though they were slightly younger, more were the main plan subscriber, and more were in the 
Smartchoice Basic SHP plan. 
Nearly half of primary care practices were ever in CCNC (Table 5.2). However, of the practices 
that were ever in CCNC only about one-fifth of practice-years in my sample were prior to joining CCNC. 
This amount of pre-CCNC data was less than expected, and was most likely the result of lack of data in 
2002 for many practices. The vast majority of primary care practices were community-based, single-site, 
and urban. The average number of primary care providers (PCPs) was 3, though many of the practices 
had only 1 PCP. On average, practices were in counties with 9 PCPs per 10,000 population, with poverty 
rates of 15 percent, and with the majority of people in counties being white, non-Hispanic. Compared to 
practices not in CCNC, CCNC practices had more PCPs and more were in non-urban/non-rural (i.e., 
suburban) or rural counties. CCNC practices were also in counties with fewer PCPs per 10,000 
population, higher poverty rates, and greater proportions of non-white residents. Across the study 
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period, unadjusted yearly rates for receipt of diabetes quality measures were relatively high (76% for 
A1c testing, 70% for LDL testing, 37% for eye exam, and 81% for attention for nephropathy). Receipt of 
eye exam was low, but this is consistent with other studies (Lee, Feldman, Ostermann, Brown, & Sloan, 
2003). Yearly unadjusted rates for preventive measures were also somewhat low and averaged 34% for 
flu shot, 31% for breast cancer screening (among women age 40-74), and 22% for cervical cancer 
screening (among women age 21-64). Average yearly OP use was high (8 total outpatient visits (OP) and 
5 primary care visits), while IP and ED use was relatively low (0.14 inpatient (IP) admissions, and 0.26 ED 
visits). Average continuity of care was 0.47. Total yearly SHP paid expenditures were approximately 
$8,500.  
In unadjusted comparisons, patients in CCNC practices had lower rates of yearly A1c testing, 
yearly LDL testing, and cervical cancer screening, and higher rates of flu shots and breast cancer 
screening, compared to patients in non-CCNC practices. Patients in CCNC practices also had fewer total 
OP visits, though no difference in PCP visits, potentially indicating lower use of specialty care. In 
addition, patients in CCNC practices had more ED visits, higher continuity of care (mostly likely due to 
fewer OP visits), and higher total SHP paid expenditures. 
 
Main Results 
Quality of Care 
H1a: Practice participation in CCNC increases the probability that SHP diabetes patients receive 
recommended diabetes care. 
The effect of a practice, which was ever in CCNC, joining CCNC was only significant for yearly A1c 
testing, though the effects were positive for all diabetes quality measures (Table 5.4a). For patients in 
practices that were ever in CCNC, the practice joining CCNC resulted in a 18% increase in the odds of a 
patient receiving an A1c test (CI: 1.05,1.32), which equates to a population-averaged average marginal 
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effect of a 2.1 percentage point increase in the probability of receiving an A1c test (CI: 0.0064,0.0346). 
The effect on receiving an LDL test was a 4% increase in the odds of receiving the test (CI: 0.94,1.14), 
which equates to a 0.6 percentage point increase in the probability of receiving the LDL test (CI: -
0.010,0.022); the effect on receiving an eye exam was a 3% increase in the odds (CI: 0.95,1.12), or a 0.7 
percentage point increase in the probability of receiving an eye exam (CI: -0.011,0.025).; the effect on 
receiving attention for nephropathy was a 6% increase in the odds (CI: 0.96,1.17), or a 0.8 percentage 
point increase in the probability of receiving attention of nephropathy (CI: -0.0065,0.0217). While the 
effects were relatively small, they were in the hypothesized direction. 
The other key covariate was whether a practice was ever in CCNC, which was included to control 
for selection of practices into CCNC. Patients in practices that were ever in CCNC during the study period 
had significantly lower odds of receiving an A1c test and LDL test (OR=0.74, CI:0.61,0.90; OR=0.76, 
CI:0.64-0.90, respectively), compared to patients in practices that were never in CCNC; the effect on eye 
exam and attention for nephropathy were also negative, but not statistically significant. These results 
indicate a selection of lower quality practices into CCNC. Patients in CCNC practices that were early 
adopters of CCNC also had lower odds of receiving an A1c test, LDL test, or attention for nephropathy, 
though the effects were again insignificant.  
Age was associated with a significant increase in the odds of receiving an A1c test, LDL test, and 
attention for nephropathy, though it was negatively associated with the odds of receiving an eye exam. 
Male gender was also associated with increased odds of receiving an A1c or LDL test, and decreased 
odds of receiving and eye exam. Greater comorbidity, as measured by the Charlson index, was 
associated with significantly greater odds of receiving all diabetes quality measures, though the 
association was diminishing. Compared to SHP subscribers, spouses had significantly lower odds of 
receiving both A1c and LDL tests, and compared to patients in CMM plans, patients in all other plans had 
greater odds of receiving all the diabetes quality measures. Patients in practices in non-urban/non-rural 
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and rural counties had significantly lower odds of receiving A1c or LDL tests compared to patients in 
practices in urban counties, and patients in practices in non-urban/non-rural counties had lower odds of 
receiving attention for nephropathy, and patients in practices in rural counties had lower odds of 
receiving an eye exam. Patients in practices in counties with higher poverty rates had lower odds of 
receiving an LDL test or attention for nephropathy, and patients in practices in counties with more 
PCPs/10,000 population had lower odds of receiving all diabetes measures except eye exams, which was 
significantly positive. Both the proportion of non-white, non-Hispanic and Hispanic population in a 
county was negatively associated with the receipt of an eye exam, but positively associated with 
receiving attention for nephropathy. Most performance measures increased over time; the exception 
was receipt of A1c, which had negative and generally insignificant association with the receipt of test. 
The population-averaged average marginal effects for the main variable of interest, CCNC, from 
the multi-level models were very similar to those from the fixed effects models (Table 5.4b). For the A1c 
models, the effects were almost identical (MLM AME=0.021, FE AME=0.020), though the fixed-effect 
estimate did not reach statistical significance (p=0.091). The estimates varied more for the other 
models, though the estimates from the multi-level models fell within the confidence intervals of the 
fixed effect estimates and are likely clinically insignificant. 
 
H1b: The effect of practice participation in CCNC is moderated by the proportion of CCNC patients in the 
practice. 
 Among CCNC practices, CCNC patient load did not have a significant effect on diabetes quality 
measures (Table 5.5a).  In addition, the joint tests of significance from all models for the CCNC patient 
categories were statistically insignificant (A1c: χ2=8.70, p=0.0690; LDL: χ2=8.33, p=0.0803; Eye Exam: 
χ2=4.51, p=0.3412; Attention for Nephropathy: χ2=5.13, p=0.2739). 
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Overall, the results for these models for the other covariates were similar to the results 
presented in Table 5.4a. Patients in CCNC practices that were early adopters of CCNC had significantly 
lower odds of receiving an LDL test (OR=0.99, CI: 0.99,1.00), again indicating some selection of practices 
with lower quality. Age was associated with an increase in the odds of receiving an A1c test, LDL test, 
and attention for nephropathy, and was negatively associated with the odds of receiving an eye exam. 
Male gender was also associated with increased odds of receiving an A1c or LDL test, and decreased 
odds of receiving an eye exam. Greater comorbidity, as measured by the Charlson index, was associated 
with significantly greater odds of receiving all diabetes quality measures, though the association was 
diminishing as Charlson increased. Compared to SHP subscribers, spouses had significantly lower odds of 
receiving both A1c and LDL tests, and compared to patients in CMM plans, patients in SmartChoice plans 
had greater odds of receiving an LDL test, eye exam, and attention for nephropathy; patients in 
SmartChoice Basic plans had greater odds of receiving an LDL test; patients in SmartChoice Plus plans 
had greater odds of receiving an eye exam. Patients in practices in non-urban/non-rural and rural 
counties had significantly lower odds of receiving an eye exam or attention for nephropathy, and 
patients in practices in rural counties had lower odds of receiving an eye exam. Patients in practices in 
counties with higher poverty rates had lower odds of receiving an LDL test, and patients in practices in 
counties with more PCPs/10,000 population had lower odds of receiving all diabetes measures except 
eye exams, which was significantly positive. The proportion of non-white, non-Hispanic individuals in a 
county was negatively associated with the receipt of an eye exam, but positively associated with 
receiving attention for nephropathy. Generally, values for all diabetes measures increased over time; 
the exception was receipt of A1c, which was unchanged (statistically) over the study period. 
The population-averaged average marginal effects for the main variables of interest, the 
categories for number of CCNC patients, from the multi-level models were again similar to those from 
the fixed effects models (Table 5.5b). The estimates from the multi-level models again fell within the 
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confidence intervals of the fixed effect estimates, although the intervals for these models were generally 
wider. 
 
H1c: Practice participation in CCNC does not change the probability that SHP patients receive 
recommended preventive care. 
 Table 5.6a considers whether CCNC practices had different performance on preventive 
measures. The effect of a practice, which was ever in CCNC, joining CCNC was positive but insignificant 
for receipt of yearly flu shot and breast cancer screening, but there was a significantly inverse 
relationship for receipt of cervical cancer screening. For patients in practices that were ever in CCNC, the 
practice joining CCNC resulted in a 14% decrease in the odds of a patient receiving cervical cancer 
screening (CI: 0.75,0.99), which equates to a population-averaged average marginal effect of a 2.3 
percentage point decrease in the probability of receiving cervical cancer screening test (CI: -0.0447,-
0.0019). 
Patients in practices that were ever in CCNC during the study period had significantly lower odds 
of breast cancer screening (OR=0.81, CI:0.65-0.99), and patients in CCNC practices that were early 
adopters of CCNC also had lower odds of receiving both breast cancer screening and cervical cancer 
screening. Age was associated with a significant decrease in the odds of receiving a flu shot and 
increased odds of breast cancer screening. Male gender was also associated with decreased odds of 
receiving a flu shot. Greater comorbidity, as measured by the Charlson index, was associated with 
significantly greater odds of receiving a flu shot, though the effect was diminishing, and significantly 
lower odds of cervical cancer screening. Compared to SHP subscribers, spouses had significantly lower 
odds of receiving all preventive measures, and compared to patients in CMM plans, patients in 
SmartChoice plans had greater odds of receiving all measures. Patients in practices with more primary 
care providers had greater odds of receiving breast cancer screening but lower odds or receiving cervical 
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cancer screening. Patients in multisite practices had significantly greater odds of cervical cancer 
screening. Patients in practices in non-urban/non-rural and rural counties had significantly lower odds of 
receiving all measures, and patients in practices in counties with higher poverty rates had greater odds 
of receiving breast cancer screening and lower odds of receiving cervical cancer screening. Patients in 
practices in counties with more PCPs/10,000 population had greater odds of receiving a flu shot but 
lower odds or receiving cervical cancer screening. Both the proportion of non-white, non-Hispanic and 
Hispanic population in a county was negatively associated with the receipt of a flu shot and breast 
cancer screening, but positively associated with receiving cervical cancer screening. Year effects were 
generally positively associated with odds of receiving all measures; the exception was receipt of flu shot 
in 2005 and 2006, compared to 2002. 
The population-averaged average marginal effects for the main variable of interest, CCNC, from 
the multi-level models were very similar to those from the fixed effects models (Table 5.6b). For the 
cervical cancer screening model, the effects were almost identical (MLM AME=-0.0233, FE AME=-
0.0239) and both were significant. The estimates varied more for the other models, though the 
estimates from the multi-level models fell within the confidence intervals of the fixed effect estimates. 
 
Summary of quality of care results 
 The results indicate a small but positive spillover for receipt of A1c test among SHP diabetes 
patients in CCNC practices; although the effect of a practice joining CCNC is also positive for the other 
diabetes quality measures, it is not significant. Additionally, there is not a significant moderating effect 
of the number of CCNC patients on receipt of diabetes quality measures. In regard to preventive 
measures, a practice joining CCNC did not significantly affect the receipt of yearly flu shot or breast 
cancer screening, which is again consistent with the study hypotheses; however, it did significantly 
lower the probability of receiving cervical cancer screening. 
53 
 
Health Care Utilization 
H2a: Practice participation in CCNC decreases inpatient and emergency department utilization and 
increases patients’ use of primary care and continuity of care among SHP diabetes patients. 
The effect of a practice joining CCNC was negative for all utilization measures, though was only 
significant for number of PCP visits and number of total OP visits during the year (Table 5.7a). For 
patients in practices that were ever in CCNC, the practice joining CCNC resulted in a 5% decrease in PCP 
visits (CI: 0.93,0.97), which equates to a population-averaged average marginal effect of 0.29 fewer visits 
(CI: -0.36,-0.21), and a 4% decrease in total OP visits (CI:0.94,0.97), which equates to 0.29 fewer visits 
(CI: -0.40,-0.19).  
 Patients in practices that were ever in CCNC and those that were in practices that were early 
adopters of CCNC had higher odds of an ED visit during the year as well as greater continuity of care.  
Age was associated with lower odds of an IP admission or ED visit, fewer total OP visits, and higher 
continuity of care (the effect for continuity was diminishing). Male gender was also associated with 
decreased odds of an IP admission or ED visit, as well as fewer PCP and OP visits; male gender was 
associated with higher continuity of care. Greater comorbidity, as measured by the Charlson index, was 
associated with significantly greater odds of an IP admission and ED visit, though the effect was 
diminishing, more PCP and total OP visits, and lower continuity of care. Compared to SHP subscribers, 
spouses had significantly greater odds of an IP admission as well as more PCP and total OP visits and 
lower continuity of care. Compared to patients in CMM plans, patients in SmartChoice plans had greater 
had lower odds of and IP admission or ED visit, more total OP visits, and lower continuity of care; 
patients in SmartChoice Basic also had lower odds of an IP admission and ED visit, had fewer PCP and OP 
visits, and higher continuity of care; patients in SmartChoice Plus had greater odds of an IP admission, 
more PCP and OP visits, and lower continuity of care. Patients in practices with more primary care 
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providers had significantly more PCP and total OP visits. Compared to patients in urban counties, 
patients in practices in non-urban/non-rural counties had greater odds of an ED visit and fewer total OP 
visits, and patients in rural counties had significantly greater continuity of care. Patients in community-
based practices had lower odds of an IP admission, fewer PCP and total OP visits, and greater continuity 
of care. Patients in practices in counties with higher poverty rates had more PCP visits. The proportion of 
non-white, non-Hispanic population in a county was associated with increased odds of an ED visit, and 
the proportion of Hispanic population in a county was positively associated with continuity of care. Year 
effects were significantly positive for any ED visit and OP visits, but were negatively associated with PCP 
visits and continuity of care. 
The population-averaged average marginal effects for the main variable of interest, CCNC, from 
the multi-level models were very similar to those from the fixed effects models (Table 5.7b). In addition, 
all the estimates from the multi-level models fell within the confidence intervals of the fixed effect 
estimates. 
 
H2b: The effect of practice participation in CCNC is moderated by the proportion of CCNC patients in the 
practice. 
 Among CCNC practices, the moderating effect of CCNC patient load was significant primarily for 
total OP visits and continuity of care, though there were also significant effects for very high patient load 
on IP admission and ED visit (Table 5.8a).  Compared to patients in practices with a very low number of 
CCNC patients, SHP patients in practices with a very high number of CCNC patients had 19% lower odds 
of an IP admission (CI:0.68,0.96), which equates to a 1.6 percentage point decrease in the probability 
(CI: -0.0293,-0.0027), and 21% increased odds of an ED visit (CI:1.03,1.42), which equates to a 2.8 
percentage point increase in the probability (CI: 0.0025,0.0535). Compared to patients in practices with 
a very low number of CCNC patients, patients in all other categories had significantly fewer OP visits 
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equating to 0.34 fewer in practices with a low number of CCNC patients (CI: -0.58,-0.10), 0.50 fewer in 
practices with a medium number of CCNC patients (CI: -0.74,-0.26), 0.49 fewer in practices with a high 
number of CCNC patients (CI: -0.83,-0.15), and 0.64 fewer in practices with a very high number of CCNC 
patients (CI: -0.96,-0.32). Conversely, compared to patients in practices with a very low number of CCNC 
patients, patients in all other categories had significantly greater continuity of care equating to 0.036 
higher in practices in practices with a low number of CCNC patients (CI: 0.017,0.055), 0.044 higher in 
practices with a medium number of CCNC patients (CI: 0.026,0.062), 0.054 higher in practices with a 
high number of CCNC patients (CI: 0.029,0.079), and 0.051 higher in practices with a very high number 
of CCNC patients (CI: 0.039,0.083). In addition, the joint tests of significance for the ED visit, OP visits, 
and continuity of care models were all significant (ED: χ2=9.89, p=0.0422; OP: χ2=17.10, p=0.0018; COC: 
χ2=27.80, p<0.001). 
 Patients in practices that were early adopters of CCNC had significantly greater odds of an ED 
visit, compared to patients in practices that were not early adopters. Age was associated with lower 
odds of an ED visit, fewer total OP visits, and higher continuity of care (the effect for continuity was 
diminishing). Male gender was also associated with decreased odds of an ED visit, as well as fewer PCP 
and OP visits; male gender was associated with higher continuity of care. Greater comorbidity, as 
measured by the Charlson index, was associated with significantly greater odds of an IP admission and 
ED visit, though the effect was diminishing, more PCP and total OP visits, and lower continuity of care. 
Compared to SHP subscribers, spouses had significantly greater odds of an IP admission as well as more 
PCP and total OP visits and lower continuity of care. Compared to patients in CMM plans, patients in 
SmartChoice plans had lower odds of and IP admission or ED visit and fewer PCP visits; patients in 
SmartChoice Basic also had lower odds of an IP admission and ED visit, had fewer PCP and OP visits, and 
higher continuity of care; patients in SmartChoice Plus had greater odds of an IP admission as well as 
more PCP and OP visits. Compared to patients in urban counties, patients in practices in both non-
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urban/non-rural and rural counties had fewer total OP visits and greater continuity of care. Patients in 
practices in counties with higher poverty rates had more PCP visits. The proportion of non-white, non-
Hispanic population in a county was associated with increased odds of an ED visit, and the proportion of 
Hispanic population in a county was positively associated with fewer OP visits. Year effects were 
significantly negative PCP visits and continuity of care, but were positively associated with OP visits. 
The population-averaged average marginal effects for the main variables of interest, the 
categories for number of CCNC patients, from the multi-level models were somewhat different from 
those from the fixed effects models (Table 5.8b), though the estimates from the multi-level models 
again fell within the confidence intervals of the fixed effect estimates. In particular, the significant 
effects for very high patient load on IP admission and ED visit, as well as the significant effects of all 
categories on OP visits lost significance and were the opposite sign in the fixed effects models. In 
addition, the significant effects on continuity of care also lost significance in the fixed effects models.  
 
Summary of utilization results 
 In summary, this study does not indicate a spillover on IP or ED use, or continuity of care, though 
the signs on the estimates for IP admission and ED visits are in the hypothesized direction. However, 
there is a significant effect of a practice joining CCNC on both PCP visits and total OP visits, though the 
effects are small and opposite to the hypothesized direction – CCNC participation seems to decrease 
PCP and total OP visits. There are two potential explanations for these results: 1) increasing PCP access 
and utilization for CCNC patients resulted in reduced use among other patients in the practice to 
accommodate increased CCNC patient use, or 2) because there are no significant changes in IP 
admission, ED visit, or continuity of care, the reduced use may indicate better management of 
utilization. Also, because there were decreases in both PCP and total OP visits, it does not appear that 
patients were offsetting decreased PCP use with increased specialty use.  
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 In regard to the moderating effect of CCNC patient load, while the multi-level model estimates 
indicate a moderating effect for total OP use and continuity of care, the fixed effects estimates indicate 
no moderating effects for any outcome.  
 
Paid Medical Expenditures 
H3a: Practice participation in CCNC practices reduces medical expenditures for SHP diabetes patients. 
The effect of a practice, which was ever in CCNC, joining CCNC for medical expenditure was not 
statistically significant (Table 5.9a). Additionally, the effect sizes were all relatively small, with the largest 
effect being for OP expenditures; patients in a practice, which was ever in CCNC, and then joined CCNC 
had a $224 increase in annual OP expenditures. 
Patients in practices that were ever in CCNC had significantly lower OP expenditures and those 
that were in practices that were early adopters of CCNC had higher ED expenditures lower Rx 
expenditures.  Age was associated with lower IP expenditures and higher Rx expenditures. Male gender 
was also associated with higher IP cost and Rx expenditures, and lower ED and OP expenditures. Greater 
comorbidity, as measured by the Charlson index, was associated with significantly higher expenditures 
for all cost categories. Compared to SHP subscribers, spouses had significantly higher expenditures in all 
cost categories. Compared to patients in CMM plans, patients in SmartChoice plans had lower total, IP, 
and ED expenditures; patients in SmartChoice Basic had lower total, IP, OP, and Rx expenditures; 
patients in SmartChoice Plus had higher total, ED, OP, and Rx expenditures. Patients in practices with 
more primary care providers had significantly greater ED and Rx expenditures, though the effect sizes 
were small. Compared to patients in urban counties, patients in practices in non-urban/non-rural 
counties had higher ED expenditures. Community-based practices had lower IP and OP expenditures. 
The county proportion in poverty was negatively associated with both ED and OP expenditures. The 
proportion of non-white, non-Hispanic population in a county was associated with higher ED 
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expenditures and lower Rx expenditures. Year effects were significantly positive for all cost categories 
except IP expenditures. 
The population-averaged average marginal effects for the main variable of interest, CCNC, from 
the multi-level models were very similar to those from the fixed effects models (Table 5.9b). Similar to 
the multi-level models estimates, the fixed effects estimates were not significant. In addition, all the 
estimates from the multi-level models fell within the confidence intervals of the fixed effect estimates. 
 
H3b: The effect of practice participation in CCNC is moderated by the proportion of CCNC patients in the 
practice. 
 There were significant moderating effects of CCNC patient load on total expenditures, OP 
expenditures, and pharmacy (Rx) expenditures (Table 5.10a).  Compared to patients in CCNC practices 
with a very low number of CCNC patients, SHP patients in practices with a low number, medium 
number, and very high number of CCNC patients all had significantly lower expenditures (-$1038.01, CI:-
1962.91,-113.12; -$1265.29, CI:-2223.35,-307.22); and -$1856.86, CI:-2825.48,-888.24, respectively). In 
addition, patients in all categories of CCNC patient load had lower expenditures than patients in 
practices with a very low number of CCNC patients; patients in practices with a medium number and 
very high number of CCNC patients also had lower Rx expenditures. The joint tests of significance for the 
total expenditures, OP expenditures, and Rx expenditures models were all significant (total: χ2=16.14, 
p=0.0028; OP: χ2=22.75, p=<0.001; Rx: χ2=20.42, p<0.001). 
Patients in practices that were early adopters of CCNC had significantly higher ED expenditures 
and lower Rx expenditures.  Age was associated with higher Rx expenditures. Male gender was also 
associated with higher IP expenditures and lower ED and OP expenditures. Greater comorbidity, as 
measured by the Charlson index, was associated with significantly higher expenditures for all cost 
categories. Compared to SHP subscribers, spouses had significantly higher expenditures in all cost 
59 
categories. Compared to patients in CMM plans, patients in SmartChoice plans had lower total, IP, and 
ED expenditures; patients in SmartChoice Basic had lower total, IP, and Rx expenditures; patients in 
SmartChoice Plus had higher total, ED, OP, and Rx expenditures. Patients in practices with more primary 
care providers had significantly greater total, IP, OP, and Rx expenditures. The county proportion in 
poverty was negatively associated with ED expenditures. The proportion of non-white, non-Hispanic 
population in a county was associated with higher ED expenditures and lower Rx expenditures. Year 
effects were significantly positive for ED and Rx expenditures. 
The population-averaged average marginal effects for the main variables of interest, the 
categories for number of CCNC patients, from the multi-level models varied quite a bit from those from 
the fixed effects models (Table 5.10b), and the multilevel estimates did not always fall within the 
confidence intervals of the fixed effects estimates. In particular, the directions of the effects for almost 
all estimates were opposite in the fixed effects models compared to the multi-level models. In the fixed 
effects model, compared to patients in CCNC practices with a very low number of CCNC patients, SHP 
patients in practices with a very high number of CCNC patients had significantly higher total 
expenditures ($3180.85, CI:244.01,6117.69) as opposed to the multi-level model which indicated 
significantly lower total expenditures.  Also in the fixed effects model, compared to patients in CCNC 
practices with a very low number of CCNC patients, SHP patients in practices with a very high number of 
CCNC patients had significantly higher IP expenditures ($2167.17, CI:211.09,4113.25) as opposed to the 
multi-level model which indicated insignificantly lower expenditures. In addition, the significant 
moderating effects for OP and Rx expenditures in the multi-level models lost significance, and changed 
sign in the fixed effects models. 
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Summary of medical expenditure results 
 This study does not indicate a CCNC practice participation spillover among any of the cost 
categories.  In regard to the moderating effect of CCNC patient load, while the multi-level model 
estimates indicate a moderating effect for total expenditures, OP expenditures, and Rx expenditures, 
the fixed effects estimates indicate moderating effects only for total expenditures and IP expenditures 
that are opposite in direction from the multi-level estimates. In addition, the total cost estimates appear 
to be driven by different factors in the multi-level and fixed effects models. In the multi-level models, 
the negative moderating effect on total expenditures appears to be driven by lower OP expenditures 
among CCNC patient categories with more patients. In the fixed-effects models, the positive moderating 
effect on total expenditures appears to be driven by higher IP expenditures among CCNC patient 
categories with more CCNC patients. 
 
Sensitivity Analyses 
Stratification by practice size 
Quality of care: The effect of a practice, which was ever in CCNC, joining CCNC was positive but 
decreased in magnitude with practice size for both receipt of A1c test and LDL test (Table 5.11a); the 
effect for both models was largest in practices with only one PCP (i.e., small practices). For patients in in 
small practices that were ever in CCNC, the practice joining CCNC was associated with a 56% increase in 
the odds of a patient receiving an A1c test (CI: 1.11,2.20), which equates to a population-averaged 
average marginal effect of a 6.2 percentage point increase in the probability of receiving an A1c test (CI: 
0.017,0.106). The effect on receiving an LDL test was a 21% increase in the odds of receiving the test (CI: 
0.88,1.66), which equates to a 3 percentage point increase in the probability of receiving the LDL test 
(CI: -0.019,0.079), though the effect was not significant. For the eye exam and attention for nephropathy 
models, the effect of a practice joining CCNC was largest among medium sized practices and was 
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negative for small practices, though again the effect was not significant.  The population-averaged 
average marginal effects for the main variable of interest, CCNC, from the multi-level models were very 
similar to those from the fixed effects models for all practice sizes (Table 5.11b). For the A1c models, the 
effects among small practices were very close (MLM AME=0.62, FE AME=0.075), and both were 
statistically significant. The estimates varied more for the other models, though the estimates from the 
multi-level models fell within the confidence intervals of the fixed effect estimates. 
 The main analyses did not indicate a significant moderating effect of CCNC patient load. 
However, some moderating effects were present in the stratified analyses (Table 5.12a). For the A1C 
models patients in large practices with high and very high patient loads, compared to large practices 
with very low patient load, had significantly lower odds of receiving the test. Additionally, for the 
attention for nephropathy model, patients in large practices with low, high, and very high patient loads, 
compared to small practices with very low patient load, had significantly lower odds of receiving 
attention for nephropathy. For the eye exam model, patients in small practices with high and very high 
patient loads, compared to small practices with very low patient load, had lower odds of receiving an 
eye exam. The population-averaged average marginal effects from the multi-level models were very 
similar to those from the fixed effects models (Table 5.12b).  
  
Health care utilization: The effect of a practice, which was ever in CCNC, joining CCNC was not significant 
for >=1 IP admission or >=1 ED visit at any practice size (Table 5.13a), though the effects were most 
negative for small practices. For the PCP and total OP visits models, the effect of a practice joining CCNC 
was only significant for small and large practices; for patients in small practices, which were ever in 
CCNC, the practice joining CCNC resulted in an 8% decrease in PCP visits (CI:0.86,0.99) (or 0.63 fewer 
PCP visits (CI: -0.90,-0.36)) and a 7% decrease in PCP visits in large practices (CI: 0.90,0.95) (or 0.28 fewer 
visits (CI: -0.38,-0.17)). A practice joining CCNC was positively associated with continuity of care in small 
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and medium practices, though the effects were not significant, but significantly negatively associated 
with continuity of care in large practices. The population-averaged average marginal effects for the main 
variable of interest, CCNC, from the multi-level models were similar to those from the fixed effects 
models (Table 5.13b), with all the estimates from the multi-level models falling within the confidence 
intervals of the fixed effect estimates. However, the significant negative effect of a small practice joining 
CCNC on PCP and total OP visits failed to reach significance in the fixed effects models. 
The main analyses did not indicate a significant moderating effect of CCNC patient load. 
However, some moderating effects were present in the stratified analyses (Table 5.14a). Patients in 
small practices with low and very high CCNC patient load, compared to practices with very low patient 
load, had significantly lower odds of >=1 IP admissions. In addition, patients in medium sized practices 
with higher CCNC patient load had significantly fewer total OP visits and higher continuity of care.  The 
population-averaged average marginal effects from the multi-level models were generally similar to 
those from the fixed effects models (Table 5.14b). However, the negative effects of patient load 
category in medium practices on total OP visits changed sign, and were not significant in the fixed 
effects models; loss of significance also occurred for COC in medium practices.  Additionally, in the fixed 
effects model, patients in small practices with medium, high, and very high CCNC patient loads, 
compared to practices with very low CCNC patient load, had significantly lower probability of an ED visit. 
 
Paid health care expenditures: The effect of a practice, which was ever in CCNC, joining CCNC on total 
expenditures was positive and greatest among small practices (Table 5.15a), though none of the effects 
were significant. The effect of a practice joining CCNC on IP expenditures was only negative for large 
practices, and the effect of a practice joining CCNC on ED expenditures was only negative for small 
practices. Increases in OP expenditures due to a practice joining CCNC was largest among small 
practices, though again all effects were insignificant. The effect on Rx expenditures was also insignificant 
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and negative for both small and medium practices. The population-averaged average marginal effects 
for the main variable of interest, CCNC, from the multi-level models were again very similar to those 
from the fixed effects models (Table 5.15b). 
For practices in CCNC, there was some evidence of moderating effects of CCNC patient load in 
the stratified analyses (Table 5.16a). For patients in small practices with low and medium CCNC, patient 
load had significantly lower total health care expenditures and IP expenditures. In addition, for patients 
in large practices with medium and high CCNC patient load, compared to patients in large practices with 
very low CCNC patient load, had significantly higher IP expenditures. For total OP visits, patients in small 
and medium sized practices with higher CCNC patient loads had significantly lower total OP costs. The 
population-averaged average marginal effects from the multi-level models differed somewhat from 
those from the fixed effects models (Table 5.16b). In particular, only the positive effects of higher 
patient load on IP expenditures in large practices were significant in the fixed-effects models. 
 
Stratification by Baseline Quality 
Quality of care: The effect of a practice, which was ever in CCNC, joining CCNC was generally the most 
positive, but not significant, in practices with medium and high baseline quality (Table 5.17a). Patients in 
practices that joined CCNC that had high or medium baseline values for quality measures generally had 
greater increases in the probability of receiving a test; for practices with low baseline quality for LDL test 
and eye exam, joining CCNC was negatively associated with a patient receiving the respective tests, 
though the effects were not significant. The one exception was for attention for nephropathy, for which 
the effect was most positive for practices with low baseline quality. The population-averaged average 
marginal effects for the main variable of interest, CCNC, from the multi-level models were similar to 
those from the fixed effects models for all categories of baseline quality (Table 5.17b), and fell within 
the confidence intervals of the fixed effects estimates. 
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 For practices in CCNC, stratification by baseline quality did not indicate moderating effects of 
CCNC patient load (Table 5.18a). In addition, the population-averaged average marginal effects from the 
multi-level models were generally similar to those from the fixed effects models (Table 5.18b). 
 
Health care utilization: For IP admission and ED visits, the effect of a practice, which was ever in CCNC, 
joining CCNC was generally the most positive, but not significant, in practices with medium and high 
baseline rates of IP admissions and ED visits (Table 5.19a). For example, for patients in practices with 
high rates of IP admission, the practice joining CCNC led to 7% greater odds of >=1 IP admission (or a 0.5 
percentage point increase in the probability (CI: -0.012,0.023)). For the PCP visit models, decreases in 
PCP visits were largest in practices with low or medium baseline average practice visits; for total OP visit 
models, decreases in visits were largest in practices with high baseline average practice visits. Increases 
in continuity of care were concentrated in practices with medium baseline continuity of care values. The 
population-averaged average marginal effects for the main variable of interest, CCNC, from the multi-
level models were similar to those from the fixed effects models (Table 5.19b), with all the estimates 
from the multi-level models falling within the confidence intervals of the fixed effect estimates. 
However, the negative effect for the PCP and total OP models did not reach significance in the fixed 
effects models. 
 Stratification by baseline values did indicate some moderating effects of CCNC patient load for 
practices with high baseline values, especially for the PCP visits, total OP visits, and COC models (Table 
5.20a). However the average marginal effects from the fixed effects models (Table 5.20b) indicated 
significant effects for only total OP visits and COC. For total OP visits, patients in practices with high 
baseline total OP visits with high or very high CCNC patient load had significantly fewer total OP visits. 
For COC, patients in practices with medium baseline COC with low and medium CCNC patient load had 
significantly higher COC. 
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Paid health care expenditures: The effect of a practice, which was ever in CCNC, joining CCNC on total 
expenditures was only positive in practices with medium baseline expenditures (Table 5.21a), though 
none of the effects were significant. Decreases in IP expenditures were largest in practices with low 
baseline IP expenditures, increases in ED expenditures were largest in practices with medium baseline 
ED expenditures, increases in OP expenditures were largest in practices with low baseline OP 
expenditures, and decreases in Rx expenditures were largest in practices with medium baseline Rx 
expenditures. None of the effects, regardless of baseline expenditures, were significant.  The 
population-averaged average marginal effects for the main variable of interest, CCNC, from the multi-
level models were again very similar to those from the fixed effects models (Table 5.21b). 
 Stratification by baseline values did indicate some moderating effects of CCNC patient in the 
multi-level models (Table 5.22a); however the average marginal effects from the fixed effects models 
(Table 5.22b) indicated that the effects were not significant. In addition, the fixed effects model 
indicated that patients in practices with high baseline total expenditures with high and very high CCNC 
patient loads had significantly greater total expenditures. 
 
Stratification by Primary Care Use 
Quality of care: The effect of a practice, which was ever in CCNC, joining CCNC was generally the most 
positive, for patients with medium PCP use (Table 5.23a). For the A1c models, patients with medium PCP 
use in practices that joined CCNC had a significant 25% increase in the odds of an A1c test (CI:1.03,1.51), 
or 2.4 percentage point increase in the probability (CI: 0.0040,0.0442). The one exception was for 
receipt of eye exam, which was the most positive for patients with low PCP use. The population-
averaged average marginal effects for the main variable of interest, CCNC, from the multi-level models 
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were again very similar to those from the fixed effects models (Table 5.23b), though the estimate for 
receipt of A1C for patients with medium PCP use did not reach significance in the fixed effects model. 
 Stratification by primary care use did indicate some moderating effects of CCNC patient in the 
multi-level models (Table 5.24a), though the effects were primarily seen in the fixed effects models 
(Table 5.24b). In particular, for patients with high PCP use in practices with medium and high CCNC 
patient load, compared to patients in practices with very low CCNC patient load, had significantly lower 
probability of receiving an A1c test or attention for nephropathy. In addition, patients with low PCP use 
in practices with greater CCNC patient loads had significantly lower probabilities of receiving an eye 
exam. 
 
Health care utilization: The effect of a practice, which was ever in CCNC, joining CCNC on continuity of 
care was positive for patients with medium PCP use and negative for patients with high PCP use, though 
neither effect was significant (Table 5.25a). The population-averaged average marginal effects for the 
main variable of interest, CCNC, from the multi-level models were again very similar to those from the 
fixed effects models (Table 5.25b), though both effects were negative in the fixed effects models. In 
addition, neither the multi-level (Table 5.26a) nor the fixed effects (Table 5.26b) models indicated a 
moderating effect of CCNC patient load for the stratified analyses. 
 
Practice Heterogeneity – Median Odds Ratio 
 I calculated the median odds ratio (MOR) for each main model in order to quantify the between-
cluster (i.e., between-practice) heterogeneity for each outcome (Table 5.27). The greatest amount of 
heterogeneity occurred in the A1c and LDL models, which exhibited the highest MOR values. For 
example, if two otherwise identical patients were drawn from two random practices, the median odds 
ratio of the difference between the two would be 8.28. Because testing for A1c and LDL may be more 
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under the direct control of a provider, and thus can vary more by provider/practice-level than the other 
outcome measures in this study, it is consistent that practice-level heterogeneity is larger for these 
outcomes. 
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CHAPTER 6: DISCUSSION AND POLICY IMPLICATIONS 
 
Discussion 
With the high and rising prevalence of chronic illness in the U.S., a robust primary care system is 
necessary for the delivery of high-quality, efficient health care.  Consequently there has been a renewed 
interest in primary care redesign based off the successes of innovative, primary care-based, quality 
improvement programs such as CCNC. An important, policy-relevant question is whether quality 
improvement strategies that are targeted to one patient group can improve care for non-targeted 
patients within the same practice. In other words, are there spillover effects like those seen with 
Medicare managed care wherein managed care-induced changes resulted in changes for both Medicare 
managed care and fee-for-service Medicare populations (Baker, 1997; Baker & Sharkarkumar, 1998; 
Clement & Gleason, 1992; Bradford & Krumholz, 2003; Mobley et al., 2011; Landon et al., 2011). Overall, 
I found minimal evidence of spillover in CCNC practices. 
Several potential explanations for the lack of findings exist. First, it is possible that low statistical 
power and nuances of implementation made it difficult to detect spillover. As previously noted, the 
amount of pre-enrollment data for practices that joined CCNC was less than expected; this lack of 
variation probably contributed to wide confidence intervals and may have influenced the lack of 
significant spillover effects.  
In addition, for the diabetes quality of care measures, one potential explanation for significant 
spillover in only one measure - receipt of A1c - is that improving A1c testing rates was one of the early 
targets of the CCNC diabetes program; the other diabetes quality of care measures (LDL, eye exam, and 
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attention for nephropathy) were incorporated into the program at later points in time. Thus spillover for 
these measures may have been small during my study period. Another reason for the lack of observed 
spillover for eye exams is that they are generally not performed in primary care practices and require 
multiple steps before a patient receives an eye exam (i.e., physician recommendation of for an eye 
exam, physician referral to an eye care professional, making an appointment, going to the 
appointment). This process of care may be similar for attention for nephropathy. In both cases achieving 
the quality metric is potentially influenced more by patient behaviors (e.g., ability/motivation to get to 
an appointment) and/or other provider behaviors (e.g., appointment availability of specialists) than by 
the primary care physician behavior. Conversely, both A1c and LDL testing are conceivably more under 
the direct control of a primary care provider and can be done during a single primary care visit. This 
explanation is supported by my finding that the greatest amount of between-practice heterogeneity 
occurred in the A1c and LDL models. 
For utilization, I found significant changes only for PCP and total OP visits, though the effects 
were not in the hypothesized direction. My hypothesis was based on the assumption that patients 
needing greater access to and use of primary care have more PCP visits.  However, PCP visits were fairly 
high for my patient sample (averaging almost five yearly visits) so patients may not have needed greater 
access to or use of primary care. In fact, it is possible that they received extra or unnecessary care. If so, 
reductions in PCP visits may indicate better utilization management in CCNC practices.  On the other 
hand, it is also possible that by increasing access to and use of primary care for CCNC Medicaid patients, 
there was less available capacity for SHP patient visits. This “crowd-out” of visits seems most probable 
for small practices that have limited physician hours and resources. The sensitivity analyses indicate 
significant decreases in visits for only small and large practices. However, the results also show 
decreases in PCP visits without concurrent increases in IP or ED use, which suggests that the former 
“better utilization management” argument is more likely. For example, if a patient reduced visits due to 
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crowd-out only, one would expect to see increases in IP, ED, or specialty visits as a substitute for care, or 
as a result of less care, and my results do not display this pattern. 
Additionally, the lack of significant decreases in IP and ED use may be due, in part, to low initial 
rates of IP and ED use in my sample; because they were low at the outset, there simply may not have 
been a way to significantly decrease them further. Furthermore, it can take time for improvements in 
care to affect patient utilization. This may be particularly true for IP and ED utilization as it may take 
more time for the CCNC-induced changes to demonstrate an effect. Practice participation in CCNC was 
associated with decreases in the probability of an IP admission or ED visit as hypothesized, but the 
effects were not significant; for these outcomes, there may not have been enough time to take 
significant effect.  
 A second potential explanation is that no spillover actually occurred. I based my hypotheses on 
the theory that physicians adopt a generalized style of delivering care across all patients (Eisenberg, 
1979; Glied & Zivin, 2002; Frank & Zeckhauser, 2007), as a heuristic to lighten the cognitive load of 
medical decision-making (Tversky & Kahneman, 1974; Bornstein & Emler, 2001). However, physicians 
may be better at compartmentalizing patients and patient care than originally expected. For example, 
practices might have strategies for segmenting patients, such as flagging charts of Medicaid patients, 
which would allow providers to more easily alter care for particular groups of patients. Importantly, this 
type of segmentation may become more common with health information technology if specific 
reminders are linked to specific patients or payer groups, and should be considered in future analyses. 
The increase in receipt of recommended diabetes care without a corresponding decrease in IP 
and ED utilization may indicate the need for individual care management to reduce IP and ED use. SHP 
patients do not receive such individual care management services – which may be critical to CCNC’s 
success in reducing IP and ED utilization, as well as improving overall care – nor are the effects of CCNC 
care management expected to spillover. While I only found spillover for one diabetes quality measure, 
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the concurrent lack of spillover for ED and IP use may indicate the need for care management services 
to change ED and IP use. 
A final potential explanation for the lack of spillover is that there were only minimal effects in 
the target population, so there was little to spillover. Unfortunately, I lacked comparable data for CCNC 
patients in my study practices. Without knowing the actual effect in the target population, it is hard to 
know if the lack of spillover was due to the possibilities described above or because there was not a 
large direct effect in the target population. 
 
Policy Implications 
In order to maximize the impact of state and national health policies, it is important to evaluate 
and understand the full effects of innovative primary care models. The degree to which physician 
behaviors spillover may influence the coordination of quality improvement efforts across payers. If 
behaviors spillover, one payer benefits from the quality improvements financed by another payer, 
suggesting that the costs could be shared across payers. In this case, however, I found little evidence of 
spillover, which suggests that all payers may need to participate in, and bear the costs of, quality 
improvement initiatives to improve care among their respective patients. Moreover, it may be beneficial 
for insurers to coordinate their efforts to efficiently improve care. For example, if multiple payers align 
quality improvement measures and goals, it may make it easier for physicians to change their behaviors 
and improve the quality of care for all of their patients.  
The degree of spillover may also influence payment arrangements adopted for future models of 
care. While this study found some spillover of quality process measures, there was no evidence of 
spillovers for expenditures. Conversely, McWilliams et al. (2013) found Accountable Care Organization 
(ACO) spillover predominately among costs, similar to Medicare managed care studies (Baker, 1997; 
Mathematica Policy Research, 1992; Bradfor & Krumholz, 2003; Chernew et al., 2008). These differences 
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in areas of spillover, particularly costs, may result from differing payment structures in CCNC and the 
ACO. In CCNC, primary care providers receive a modest PMPM payment for managing and coordinating 
care, but otherwise are reimbursed for services on a fee-for-service basis (Steiner et al., 2008). In the 
ACO, “provider organizations bear financial risk for spending in excess of a global budget, [and] gain 
from reducing spending below budget” (McWilliams et al., 2013, p. 830). The explicit linkage of 
payments to reduced spending in the ACO may result in a focus on changing behaviors to reduce costs in 
the ACO – and thus spillovers in the focus area – while the lack of this linkage in CCNC may result in a 
focus on quality improvement and utilization management – and thus spillovers in these focus areas. 
Therefore policy makers may be able to enhance quality and efficiency across payers through choice of 
payment arrangements for models such as medical homes and ACOs. More research is needed to 
understand the intricacies of spillover in different care models and the degree to which spillover occurs 
over longer periods of time. 
 
Limitations 
It is important to note several limitations to this study. First, measurement error in identifying 
practices as CCNC and attributing patients to practices may have been present. However, because I used 
multiple methods to confirm practice identification and commonly used methods for attribution, I 
believe that this was not a large issue (CMS, 2012; The Brookings Institution and Dartmouth Institute, 
2011). Second, it is possible that there are remaining confounding variables that I was not able to 
control for in my analyses, such as practice affiliation with an academic medical center, which could 
result in biased estimates. Third, during my study period two other quality improvement efforts in the 
state were implemented; this may limit my ability to determine the causal effect of practice 
participation in CCNC on outcome measures. However both programs had very small penetration during 
study period limiting the potential influence of these programs on patient outcomes. Lastly, CCNC 
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practice “participation” is in some ways a black box – while we know the components that are supposed 
to be implemented, we do not necessarily know the degree to which each practice actually implements 
changes. Practices that had greater levels of implementation may have had greater changes in physician 
behavior than practices that had lower levels of implementation. This makes my main CCNC variable 
somewhat noisy, in that the variable essentially treats all implementation levels as the same.  
 
Conclusions 
Efforts to improve the quality, comprehensiveness, and coordination of primary care are now 
focused on achieving improvement through innovative, quality improvement programs. Quality 
improvement initiatives have generally focused on two modes of implementation: 1) for a particular 
payer group (such as Medicaid), or 2) at the practice level for all patients. This study examines the extent 
to which a third mode of implementation occurs, wherein the intervention is implemented for one 
payer group but affects other patients in the practice. Overall this study found little evidence of spillover 
in CCNC. The results from this study aid in understanding the full effects of the innovative primary care 
models that are currently a focus of health policy, and indicate that spillover is not a foregone 
conclusion. My findings suggest the need for all insurers to participate in and coordinate efforts to 
improve the health and health care of patients. 
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APPENDIX: TABLES AND FIGURES 
 
Chapter 1 
Figure 1.1: The CCNC Logic Model 
 
Source: King, J. (2011). Unpublished dissertation. 
 
Chapter 2 
Figure 2.1: Conceptual Model of CCNC 
 
Note: Thin line from CM to Quality indicates that effect on Quality is small. 
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Figure 2.2: Conceptual Model of CCNC Spillover 1 
 
Note: Blue dotted lines indicate spillover from main effect. Thickness of lines indicate  
 degree of effect (i.e., thinner line indicates smaller effect). 
 
 
 
Figure 2.3: Conceptual Model of CCNC Spillover2 
 
Note: Blue dotted lines indicate spillover from main effect. Thickness of lines indicate  
degree of effect (i.e., thinner line indicates smaller effect). 
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Chapter 3 
Figure 3.1: SHP Diabetes Patient Sample Selection 
 
 
Adults age 18-64
(N=1,065,805)
Excluded if on Medicare
(N= 96,001)
Non-Medicare
(N= 969,804)
Excluded if Retired
(N= 22,875)
Non-Retired
(N=946,929)
Excluded if no diagnosis of 
diabetes
(N= 895,356)
Diagnosis of diabetes
(N=51,573)
Excluded before first diagnosis of 
diabetes
(N = 469)
After first diagnosis of 
diabetes
(N= 51,104)
Excluded if gave birth during 
study period
(N = 1,175)
Never given birth during 
study period
(N=49,929)
Excluded if <10 months in SHP in 
year
(N =  18,461)
>=10 months in SEHP
(N=31,468)
Excluded if zero visits to PCP in 
year
(N =1,774)
>=1 PCP visit
(N= 29,694)
Excluded before first PCP visit
(N = 0)
Years including and after first 
PCP visit
(N= 29,694)
N=29,694
N*years=74,149
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Figure 3.2: Example of Incomplete Enrollment Data 
 
 
 
 
Figure 3.3: Example of individualid Recovery for Enrollment Data 
 
 
 
 
 
Figure 3.4: SHP Servicing Providers within Payment Providers 
 
Claim Enrollment File
individual_id 110011 individual_id 110011
date of service 3/3/2002 enrollment date 1/6/2006
date of service < enrollment date
Claim Raw Enrollment file
individual_id newid date of service individual_id newid enrollment date
110011 465 3/3/2002 465 1/1/2002
110011 465 4/12/2002 110011 615 1/6/2006
110011 615 3/4/2006 12022 617 11/24/2005
110011 615 12/3/2006 12354 211 3/4/2002
SHP Primary Care Practices
(N = 5,851)
Family Practice
(N = 2,984)
Internal Medicine
(N = 1,755)
Pediatrics
(N = 351)
General Practice
(N = 234)
Multispecialty
(N = 527)
Servicing Provider IDs
(N = 4,292)
84% Family Practice
10% Internal Medicine
3% Pediatrics
1% General Practice
2% Multispecialty
<1% Nurse Practioner
Servicing Provider IDs
(N = 3,339)
10% Family Practice
86% Internal Medicine
2% Pediatrics
<1% General Practice
<1% Multispecialty
<1% Nurse Practioner
<1% Physicians Assistant
Servicing Provider IDs
(N = 1,449)
2% Family Practice
3% Internal Medicine
94% Pediatrics
<1% General Practice
<1% Multispecialty
Servicing Provider IDs
(N = 388)
25% Family Practice
14% Internal Medicine
2% Pediatrics
57% General Practice
2% Multispecialty
Servicing Provider IDs
(N = 9,404)
29% Family Practice
50% Internal Medicine
12% Pediatrics
1% General Practice
8% Multispecialty
<1% Nurse Practitioner
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Figure 3.5: SHP Practice Matching to CCNC Practices 
 
 
 
 
 
 
Figure 3.6: Example of Identifying and Combining Multiple Practice Entries 
 
 
 
 
 
 
Figure 3.7: Example of Updated Attribution of SHP Patients to Primary Care Practices 
 
 
 
 
 
 
 
SHP Primary Care Practices
(N=2,294)
Matched to CCNC 
Practice via NPI
(N = 948)
Hand Matched to CCNC 
Practice
(N = 121)
Unmatched SHP Primary 
Care Practices
(N = 1,225 )
Practice Name
Payment 
Provider ID NPI
SHP 
Enrollment 
Date
SHP 
Disenrollment 
Date New Practice ID
Example 1 Cajahs Mountain Family 
Medical Ctr
12000 . 4/1/1997 12/31/2006
2
Cajahs Mtn Family Med Care 14506 1235227257 1/1/2007 2
Example 2 Steven R. Lawson MD 18680 1467414250 9/22/2005 9/29/2009 3
Steven R. Lawson MD 17546 1467414250 5/24/1997 7/31/2009 3
Practice Name
Payment 
Provider ID NPI
SHP 
Enrollment 
Date
SHP 
Disenrollment 
Date Year
Patient 
attributed to 
before 
combination
Patient 
attributed to 
after 
combination
Example 1 Cajahs Mountain Family 
Medical Ctr
12000 . 4/1/1997 12/31/2006
2006 12000 2
Cajahs Mtn Family Med Care 14506 1235227257 1/1/2007 . 2007 14506 2
Example 2 Steven R. Lawson MD 17546 1467414250 5/24/1997 7/31/2009 2002 17546 3
Steven R. Lawson MD 18680 1467414250 9/22/2005 9/29/2009 2006 18680 3
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Chapter 4 
Table 4.1: ICD-9 and CPT Codes 
  ICD-9 Codes CPT Codes 
Outpatient Visit – to identify 
total OP visits and COC 
   92002, 92004, 92012, 92014-99205, 
99211-99215, 99217-99220, 99241-99245, 
99347-99350, 99384-99387, 99394-99397, 
99401-99404, 99411, 99412, 99420, 99429, 
99455 
99456 
A1c test    83036, 83037 
LDL test   80061, 83700, 83701, 83704, 83721 
Eye exam   67028, 67030, 67031, 67036, 67038-67043, 
67101, 67105, 67107, 67108, 67110, 67112, 
67113, 67121, 67141, 67145, 67208, 67210, 
67218, 67220, 67221, 67227, 67228, 92002, 
92004, 92012, 92014, 92018, 92019, 92225, 
92226, 92230, 92235, 92240, 92250, 92260, 
99203-99205, 99213-99215, 99242-99245, , 
S0620, S0621, S3000 AND (specialty: 
ophthalmologist or 
optometrist) 
   V72.0 AND (specialty: 
ophthalmologist or 
optometrist) 
  
    2022F, 2024F, 2026F, 3072F, S0625, 
regardless of provider type 
Attention for nephropathy    36145, 36800, 36810, 36815, 36818, 
36819-36821, 36831-36833, 50300, 50320, 
50340, 50360, 50365, 50370, 50380, 90920, 
90921, 90924, 90925, 90935, 90937, 90939, 
90940, 90945, 90947, 90989, 90993, 90997, 
90999, 99512, 3066F, G0257, G0314-
G0319, G0322, G0323, G0326, G0327, 
G0392, G0393, S9339, 82042, 82043, 
82044, 84156. 3060F, 3061F, 81000, 81002, 
81003, 81005, 3062F 
  250.4, 403, 404, 405.01, 405.11, 
405.91, 580-588, 753.0, 753.1, 
791.0, V42.0,V45.1, V56 
  
  ACE/ARB Prescription fill   
  Nephrologist visit during year   
Breast cancer screening   77055-77057, G0202, G0204, G0206 
Cervical cancer screening    88141, 88150, 88175,G0123, Q0091 
Flu shot    90654, 90655, 90656, 90657, 90658, 
90660-62, 90672, 90685, 90686, 90688 
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Table 4.2: Standardized Differences Before and After Trimming 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Before Trimming After Trimming 
Variable
CCNC
(N=858)
Not CCNC
(N=1,180)
Standardized 
Differnce
CCNC
(N=849)
Not CCNC
(N=1,177)
Standardized 
Differnce
# Primary care providers 3.92 2.67 0.226 3.69 2.49 0.330
Community based practice 0.93 0.93 0.006 0.94 0.93 0.016
Proportion below poverty, county 0.15 0.13 0.346 0.15 0.13 0.348
Non-Hispanic, non-white, county 0.29 0.27 0.119 0.29 0.27 0.117
Hispanic 0.13 0.13 0.024 0.13 0.13 0.029
Primary care providers/10,000 pop 7.79 9.13 0.304 7.72 9.08 0.320
Urban county 0.55 0.69 0.294 0.55 0.69 0.298
Nonrural county 0.39 0.28 0.236 0.39 0.28 0.240
Rural county 0.06 0.03 0.149 0.06 0.03 0.147
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Chapter 5 
Table 5.1: Characteristics of SHP Diabetes Patients  
 
 
 
 
Overall
(Mean)
Not CCNC
(Mean)
CCNC
(Mean)
Analysis population size
Patients 26,907 11,050 15,857
Patient-years 65,218 34,725 30,493
Practices 2,026 1,177 849
Practice-years 7,082 4,502 2,580
Patient level variables
Age 49.40
 (8.09)
49.48
(7.99)
49.31**
(8.21)
Male 41.73% 41.71% 41.75%
Charlson index
 1.37
(1.14)
1.36
(1.11)
1.37
(1.17)
SHP Plan
CCM 3.98% 4.53% 3.35%**
Smartchoice 61.19% 62.57% 59.63%**
Smartchoice basic 29.75% 27.74% 32.05%**
Smartchoice plus 5.08% 5.17% 4.97%
Eligibility
Subscriber 87.69% 87.32% 88.11%**
Spouse 11.91% 12.30% 11.47%**
Other 0.40% 0.38% 0.42%
Practice level variables
Participation in CCNC 46.76% 0% 100%
Ever CCNC 54.70% 14.92% 100.00%
CCNC early adopter 23.91% 4.13% 46.43%
Size
7.88
(12.37)
6.42
(9.14)
9.55**
(15.07)
Community based 87.83% 90.26% 85.06%**
Multisite 0.64% 0.24% 1.10%**
County controls
Primary care providers/10,000
 9.80
(5.52)
10.19
(5.48)
9.36**
(5.54)
Proportion in poverty
 0.15
(0.047)
0.139
(0.042)
0.164**
(0.050)
Proportion white, non-Hispanic
 0.53
(0.15)
0.54
(0.14)
0.52**
(0.17)
Proportion nonwhite, non-Hispanic
 0.31
(0.15)
0.30
(0.13)
0.32**
(0.17)
Proportion Hispanic
 0.16
(0.15)
0.159
(0.056)
0.159
(0.075)
Rural-urban
Urban 68.76% 75.63% 60.94%**
Nonrural 28.73% 23.35% 34.86%**
Rural 2.51% 1.03% 4.20%**
Notes: Standard deviations reported in parentheses.
* p<0.05   ** p<0.01
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Table 5.2: Characteristics of SHP Primary Care Practices 
 
 
 
 
 
 
 
 
 
 
 
Overall Not CCNC CCNC
(Mean)
N = 2,026
N*t = 7,082
(Mean)
N = 1,177
N*t = 4,502
(Mean)
N = 849
N*t = 2,580
Practice variables
Participation in CCNC 36.43% 0.00% 100.00%
Ever CCNC 48.19% 18.50% 100.00%
CCNC early adopter 21.05% 6.31% 46.78%
Size
3.40
(4.86)
2.96**
(4.23)
4.18
(5.72)
Community based 94.15% 94.09% 94.26%
Multisite 0.40% 0.24% 0.66%
County controls
Primary care providers/10,000
8.72
(4.47)
9.14**
(4.58)
8.00
(4.17)
Proportion in poverty
0.149
(0.046)
0.141**
(0.040)
0.163
(0.052)
Proportion white, non-Hispanic
0.56
(0.16)
0.57**
(0.15)
0.55
(0.18)
Proportion nonwhite, non-Hispanic
0.29
(0.16)
0.28**
(0.14)
0.30
(0.17)
Proportion Hispanic
0.152
(0.068)
0.0151*
(0.063)
0.155
(0.076)
Rural-urban
Urban 64.16% 68.33%** 56.90%
Nonrural 31.83% 28.94%** 36.86%
Rural 4.01% 2.73%** 6.24%
Notes: Standard deviations reported in parentheses.
* p<0.05   ** p<0.01
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Table 5.3: Overall Unadjusted Performance  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Overall
(Mean)
Not CCNC
(Mean)
CCNC
(Mean)
N=26,907 N=11,050 N=15,857
N*t=65218 N*t=34,725 N=30,493
A1c 76.23% 78.31% 73.87%**
Lipid 69.64% 71.43% 67.60%**
Eye exam 36.66% 36.59% 36.74%
Nephropathy 80.97% 81.35% 80.54%
Flu shot 33.85% 33.14% 34.67%**
Cervical cancer screen
Breast cancer screen
Total outpatient visits
7.74
(5.73)
7.83
(5.73)
7.63***
(5.73)
Primary care vists
 4.73
(3.69)
4.73
(3.65)
4.74
(3.74)
Inpatient admissions
 0.14
(0.52)
0.13
(0.51)
0.14
(0.54)
Emergency department visits
 0.26
(0.75)
0.23
(0.69)
0.28**
(0.81)
Continuity of care
Total costs
8547.47
(20321.40)
8384.19
(19286.86)
8733.42*
(21437.62)
Notes: Standard deviations reported in parentheses.
* p<0.05   ** p<0.01
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Table 5.4a: Multi-Level Odds Ratios of the Effect of CCNC on Receipt of Yearly Diabetes Measures 
 
 
 
 
Table 5.4b: Average Marginal Effects of CCNC from Multi-Level and Fixed-Effects Models 
 
>=1 A1C Test >=1 LDL Test >=1 Eye Exam Attention for Nephropathy
OR 95% CI OR 95% CI OR 95% CI OR 95% CI
CCNC 1.18** [1.05,1.32] 1.04 [0.94,1.14] 1.03 [0.95,1.12] 1.06 [0.96,1.17]
(AME = 0.021) (AME = 0.0057) (AME = 0.0069) (AME = 0.0076)
Ever CCNC 0.74** [0.61,0.90] 0.76** [0.64,0.90] 0.97 [0.89,1.06] 0.98 [0.86,1.10]
CCNC Early Adopter 0.91 [0.74,1.13] 1.05 [0.86,1.27] 0.93 [0.87,1.01] 0.92 [0.81,1.03]
Person-level controls
Age 1.05*** [1.02,1.07] 1.11*** [1.09,1.13] 0.97*** [0.95,0.99] 1.10*** [1.08,1.12]
Age^2 1.00* [1.00,1.00] 1.00*** [1.00,1.00] 1.00*** [1.00,1.00] 1.00*** [1.00,1.00]
Male 1.17*** [1.12,1.23] 1.13*** [1.09,1.18] 0.83*** [0.80,0.85] 0.99 [0.95,1.04]
Charlson Index 4.55*** [4.34,4.77] 1.55*** [1.49,1.61] 1.71*** [1.66,1.77] 2.00*** [1.92,2.08]
Charlson Index^2 0.86*** [0.85,0.86] 0.95*** [0.95,0.96] 0.95*** [0.95,0.96] 0.94*** [0.94,0.95]
Eligibility (omitted = subscriber)
Spouse 0.81*** [0.76,0.88] 0.85*** [0.79,0.90] 0.96 [0.91,1.02] 0.94 [0.88,1.01]
Other 1.39 [0.97,2.00] 1.16 [0.84,1.61] 0.91 [0.67,1.24] 1.07 [0.79,1.45]
Plan Type (omitted = CMM)
Smart Choice 1.26*** [1.12,1.42] 1.29*** [1.16,1.42] 1.36*** [1.24,1.50] 1.21*** [1.09,1.34]
Smart Choice Basic 1.19** [1.06,1.35] 1.20*** [1.08,1.33] 1.05 [0.95,1.15] 1.13* [1.02,1.26]
Smart Choice Plus 1.26** [1.08,1.47] 1.30*** [1.14,1.48] 1.33*** [1.19,1.50] 1.31*** [1.14,1.51]
Practice and county-level controls
# Primary Care Providers 1.00 [0.99,1.01] 1.00 [0.99,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.01]
Multisite Practice 1.16 [0.40,3.37] 1.51 [0.56,4.05] 1.11 [0.80,1.55] 0.74 [0.43,1.27]
Rural-Urban
Non-urban, Non-rural 0.68*** [0.58,0.81] 0.76*** [0.65,0.89] 0.96 [0.90,1.03] 0.87** [0.79,0.97]
Rural 0.43*** [0.29,0.64] 0.39*** [0.28,0.56] 0.80** [0.68,0.94] 0.91 [0.73,1.15]
Community-based Practice 1.39* [1.04,1.85] 1.34* [1.03,1.74] 1.00 [0.91,1.11] 1.08 [0.91,1.28]
County Proportion Poverty 1.90 [0.36,10.13] 0.12** [0.03,0.54] 0.56 [0.26,1.22] 0.10*** [0.03,0.33]
Primary Care Providers/10,000 Population 0.97** [0.96,0.99] 0.96*** [0.95,0.98] 1.02*** [1.01,1.02] 0.99** [0.98,1.00]
County Proportion Race/Ethnicity
Non-white, not Hispanic 0.63 [0.37,1.05] 0.82 [0.51,1.31] 0.76* [0.62,0.94] 2.27*** [1.65,3.12]
Hispanic 2.77 [0.99,7.78] 2.88* [1.13,7.31] 0.66* [0.43,0.99] 2.25* [1.21,4.20]
Year
2005 0.91 [0.81,1.02] 1.54*** [1.40,1.70] 0.89** [0.83,0.97] 1.46*** [1.33,1.61]
2006 0.85** [0.75,0.95] 1.61*** [1.46,1.77] 0.95 [0.88,1.03] 1.44*** [1.31,1.58]
2007 0.92 [0.82,1.04] 1.85*** [1.68,2.04] 1.42*** [1.31,1.53] 1.55*** [1.40,1.70]
2008 0.91 [0.81,1.02] 1.93*** [1.75,2.13] 1.57*** [1.46,1.70] 1.52*** [1.38,1.67]
Constant 0.18*** [0.09,0.37] 0.05*** [0.03,0.09] 0.29*** [0.18,0.47] 0.10*** [0.06,0.17]
Average practice intercept 1.33*** [1.27,1.40] 1.21*** [1.16,1.27] 0.31*** [0.28,0.34] 0.61*** [0.57,0.65]
N 65218 65218 65218 65218
Notes : A1c is hemoglobin A1c test, LDL is low-density lipoprotein test. Logit models used for all outcomes.
*p<0.05,**p<0.01,***p<0.001
>=1 A1C >=1 LDL >=1 Eye Exam Attention for Nephropathy
CCNC
MLM AME
0.021**
[0.0064,0.0346]
0.006
[-0.010,0.022]
0.007
[-0.011,0.025]
0.0076
[-0.0065,0.0217]
FE AME 0.020
[-0.0031,0.0425]
0.009
[-0.015,0.033]
0.004
[-0.015,0.023]
0.0126
[-0.0057,0.0309]
Notes: Logit models used for mult-level models. Cluster robust l inear probability models used for fixed-effects models.
*p<0.05,**p<0.01,***p<0.001
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Table 5.5a: Multi-Level Odds Ratios of the Moderating Effect of CCNC Patient Load on Receipt of Yearly 
Diabetes Measures 
 
 
 
 
 
 
 
 
>=1 A1C Test >=1 LDL Test >=1 Eye Exam Attention for Nephropathy
OR 95% CI OR 95% CI OR 95% CI OR 95% CI
CCNC Patients (omitted = Very Low)
Low 1.19 [0.92,1.53] 1.08 [0.87,1.33] 0.97 [0.87,1.10] 0.85 [0.72,1.01]
(AME = 0.022) (AME = 0.001) (AME = -0.006) (AME = -0.023)
Medium 1.07 [0.81,1.41] 1.05 [0.82,1.33] 0.95 [0.84,1.07] 0.97 [0.80,1.16]
(AME = 0.007) (AME = 0.007) (AME = -0.011) (AME = -0.005)
High 0.88 [0.65,1.18] 0.87 [0.67,1.13] 0.97 [0.85,1.11] 0.94 [0.77,1.15]
(AME = -0.018) (AME = -0.023) (AME = -0.006) (AME = -0.009)
Very High 1.03 [0.76,1.40] 0.82 [0.63,1.08] 0.90 [0.79,1.02] 0.94 [0.78,1.15]
(AME = 0.004) (AME = -0.032) (AME = -0.024) (AME = -0.008)
CCNC Early Adopter 1.00 [1.00,1.01] 0.99* [0.99,1.00] 1.00 [1.00,1.01] 1.00 [1.00,1.01]
Person-level controls
Age 1.01 [0.98,1.05] 1.09*** [1.05,1.12] 0.97* [0.94,0.99] 1.10*** [1.07,1.14]
Age^2 1.00 [1.00,1.00] 1.00*** [1.00,1.00] 1.00*** [1.00,1.00] 1.00*** [1.00,1.00]
Male 1.17*** [1.09,1.25] 1.10** [1.04,1.17] 0.82*** [0.78,0.86] 1.03 [0.96,1.09]
Charlson Index 4.71*** [4.39,5.05] 1.56*** [1.48,1.65] 1.69*** [1.61,1.78] 2.07*** [1.95,2.20]
Charlson Index^2 0.86*** [0.85,0.86] 0.95*** [0.94,0.96] 0.95*** [0.95,0.96] 0.94*** [0.93,0.95]
Eligibility (omitted = subscriber)
Spouse 0.77*** [0.69,0.86] 0.81*** [0.74,0.89] 0.93 [0.86,1.01] 0.94 [0.85,1.04]
Other 0.86 [0.51,1.45] 0.74 [0.45,1.21] 0.91 [0.59,1.42] 0.94 [0.61,1.45]
Plan Type (omitted = CMM)
Smart Choice 1.14 [0.95,1.38] 1.34*** [1.14,1.57] 1.39*** [1.20,1.60] 1.26** [1.07,1.49]
Smart Choice Basic 1.06 [0.87,1.28] 1.26** [1.07,1.49] 1.06 [0.91,1.23] 1.13 [0.96,1.34]
Smart Choice Plus 1.12 [0.89,1.42] 1.19 [0.98,1.46] 1.37*** [1.14,1.63] 1.23 [1.00,1.52]
Practice and county-level controls
# Primary Care Providers 0.91 [0.72,1.15] 1.08 [0.87,1.34] 0.93 [0.86,1.01] 0.92 [0.81,1.05]
Multisite Practice 1.33 [0.37,4.78] 1.37 [0.43,4.38] 1.21 [0.85,1.72] 0.93 [0.50,1.71]
Rural-Urban
Non-urban, Non-rural 0.84 [0.64,1.10] 0.95 [0.75,1.22] 0.84*** [0.77,0.93] 0.85* [0.73,0.99]
Rural 0.69 [0.41,1.15] 0.52** [0.33,0.83] 0.73*** [0.61,0.88] 0.85 [0.65,1.12]
Community-based Practice 0.76 [0.46,1.24] 1.00 [0.64,1.56] 1.03 [0.89,1.19] 0.77* [0.59,0.99]
County Proportion Poverty 3.11 [0.26,36.56] 0.05** [0.01,0.49] 2.14 [0.73,6.30] 0.29 [0.06,1.49]
Primary Care Providers/10,000 Population 0.95*** [0.92,0.97] 0.93*** [0.91,0.95] 1.01** [1.01,1.02] 0.97*** [0.96,0.99]
County Proportion Race/Ethnicity
Non-white, not Hispanic 0.55 [0.25,1.20] 0.72 [0.36,1.44] 0.58*** [0.44,0.78] 1.58* [1.00,2.49]
Hispanic 1.17 [0.26,5.24] 2.33 [0.60,9.02] 0.60 [0.35,1.02] 1.38 [0.59,3.20]
Year
2005 0.85 [0.62,1.17] 1.79*** [1.41,2.27] 0.99 [0.80,1.22] 1.59*** [1.26,2.02]
2006 0.80 [0.58,1.09] 1.80*** [1.42,2.28] 1.01 [0.82,1.25] 1.64*** [1.30,2.08]
2007 0.86 [0.63,1.17] 2.10*** [1.66,2.66] 1.49*** [1.21,1.83] 1.71*** [1.36,2.16]
2008 0.83 [0.61,1.14] 2.11*** [1.66,2.67] 1.64*** [1.33,2.01] 1.66*** [1.32,2.10]
Constant 0.92 [0.31,2.72] 0.11*** [0.04,0.29] 0.28*** [0.14,0.56] 0.14*** [0.06,0.31]
Average practice intercept 1.42*** [1.32,1.52] 1.28*** [1.20,1.37] 0.28*** [0.24,0.32] 0.60*** [0.54,0.66]
N 30233 30233 30233 30233
Notes : A1c is hemoglobin A1c test, LDL is low-density lipoprotein test. Logit models used for all outcomes.
*p<0.05,**p<0.01,***p<0.001
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Table 5.5b: Average Marginal Moderating Effects of CCNC Patient Load from Multi-Level and Fixed-
Effects Models 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
>=1 A1C >=1 LDL >=1 Eye Exam Attention for Nephropathy
CCNC Patients (omitted=Very Low)
Low
MLM AME
0.022
[-0.0088,0.0527]
0.001
[-0.032,0.034]
̵  0.006
[-0.031,0.019]
̵  0.023
[-0.0493,0.0033]
FE AME
0.012
[-0.034,0.057]
0.012
[-0.030,0.054]
̵  0.025
[-0.079,0.028]
̵  0.061** 
[-0.100,-0.021]
Medium
MLM AME
0.007
[-0.034,0.048]
0.007
[-0.037,0.051]
̵  0.011
[-0.041,0.019]
̵  0.005
[-0.036,0.026]
FE AME
̵  0.010
[-0.071,0.051]
0.002
[-0.054,0.058]
̵  0.033
[-0.096,0.030]
̵  0.036
[-0.088,0.016]
High
MLM AME
̵  0.018
[-0.061,0.025]
̵  0.023
[-0.068,0.022]
̵  0.006
[-0.035,0.024]
̵  0.009
[-0.039,0.021]
FE AME
̵  0.036
[-0.107,0.035]
̵  0.033
[-0.102,0.037]
̵  0.036
[-0.105,0.033]
̵  0.046
[-0.106,0.014]
Very High
MLM AME
0.004
[-0.037,0.045]
̵  0.032
[-0.078,0.014]
̵  0.024
[-0.0518,0.0038]
̵  0.008
[-0.037,0.021]
FE AME
̵  0.018
[-0.096,0.059]
̵  0.051 
[-0.134,0.031]
̵  0.045
[-0.120,0.029]
̵  0.050
[-0.113,0.012]
Notes: Logit models used for mult-level models. Cluster robust l inear probability models used for fixed-effects models.
*p<0.05,**p<0.01,***p<0.001
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Table 5.6a: Multi-Level Odds Ratios of the Effect of CCNC on Receipt of Preventive Measures 
 
 
Table 5.6b: Average Marginal Effects of CCNC from Multi-Level and Fixed-Effects Models 
 
>=1 Flu Shot >=1 Breast Cancer Screen >=1 Cervical Cancer Screen
OR 95% CI OR 95% CI OR 95% CI
CCNC 1.02 [0.93,1.12] 1.08 [0.89,1.33] 0.86* [0.75,0.99]
(AME = 0.004) (AME = 0.012) (AME = -0.023)
Ever CCNC 0.93 [0.83,1.04] 0.81* [0.65,0.99] 1.05 [0.90,1.23]
CCNC Early Adopter 0.98 [0.89,1.08] 0.86* [0.76,0.98] 0.85* [0.75,0.98]
Person-level controls
Age 0.98* [0.96,1.00] 1.13** [1.04,1.23] 0.99 [0.96,1.02]
Age^2 1.00*** [1.00,1.00] 1.00* [1.00,1.00] 1.00 [1.00,1.00]
Male 0.83*** [0.80,0.86] — — — —
Charlson Index 1.32*** [1.28,1.37] 1.01 [0.96,1.06] 0.92*** [0.88,0.97]
Charlson Index^2 0.97*** [0.97,0.98] 1.00 [0.99,1.01] 1.00 [1.00,1.01]
Eligibility (omitted = subscriber)
Spouse 0.82*** [0.77,0.87] 0.88* [0.77,0.99] 0.83** [0.73,0.93]
Other 0.66* [0.46,0.94] — — 0.94 [0.49,1.80]
Plan Type (omitted = CMM)
Smart Choice 1.16** [1.05,1.29] 1.33* [1.06,1.66] 1.24** [1.05,1.45]
Smart Choice Basic 0.91 [0.82,1.02] 1.07 [0.85,1.34] 1.01 [0.86,1.19]
Smart Choice Plus 1.07 [0.94,1.21] 1.15 [0.89,1.49] 1.07 [0.88,1.30]
Practice and county-level controls
# Primary Care Providers 1.00 [1.00,1.00] 1.01** [1.00,1.02] 0.99* [0.99,1.00]
Multisite Practice 1.00 [0.64,1.57] 1.09 [0.64,1.85] 1.92* [1.09,3.40]
Rural-Urban
Non-urban, Non-rural 0.91* [0.84,1.00] 0.84** [0.75,0.94] 0.82*** [0.73,0.92]
Rural 0.90 [0.74,1.09] 0.72* [0.55,0.95] 0.58*** [0.43,0.79]
Community-based Practice 1.01 [0.88,1.16] 0.92 [0.77,1.09] 1.07 [0.89,1.29]
County Poverty 1.44 [0.55,3.80] 8.45** [2.32,30.77] 0.18* [0.05,0.70]
Primary Care Providers/10,000 Population 1.01* [1.00,1.02] 1.00 [0.99,1.01] 0.97*** [0.96,0.98]
County Race/Ethnicity
Non-white, not Hispanic 0.33*** [0.25,0.43] 0.69* [0.49,0.99] 1.92*** [1.32,2.80]
Hispanic 0.74 [0.44,1.24] 0.47* [0.24,0.93] 1.64 [0.80,3.38]
Year
2005 0.74*** [0.68,0.82] 2.36*** [1.66,3.36] 2.22*** [1.90,2.58]
2006 0.79*** [0.72,0.86] 6.09*** [4.36,8.50] 3.02*** [2.60,3.50]
2007 3.39*** [3.10,3.70] 74.67***[53.80,103.63] 3.44*** [2.97,3.99]
2008 3.58*** [3.27,3.91] 79.41***[57.16,110.31] 3.83*** [3.30,4.44]
Constant 0.20*** [0.12,0.34] 0.00*** [0.00,0.00] 0.22*** [0.11,0.47]
Average practice intercept 0.48*** [0.44,0.51] 0.49*** [0.44,0.54] 0.61*** [0.57,0.66]
N 65218 33076 37902
Notes : Breast cancer screening only for women ages of 40-74. Cervical cancer screening only for women
ages 21-64. Logit models used for all outcomes.
*p<0.05,**p<0.01,***p<0.001
>=1 Flu Shot >=1 Breast Cancer Screen >=1 Cervical Cancer Screen 
CCNC
MLM AME
0.004
[-0.014,0.022]
0.012
[-0.018,0.042]
̵̵  0.0233*
[-0.0447,-0.0019]
FE AME 0.001
[-0.020,0.021]
̵  0.002
[-0.025,0.021]
̵  0.0239*
[-0.0474,-0.0004]
Notes: Logit models used for mult-level models. Cluster robust l inear probability models used for fixed-effects models.
*p<0.05,**p<0.01,***p<0.001
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Table 5.7a: Multi-Level Estimates of the Effect of CCNC on Yearly Health Care Utilization 
 
>=1 IP Admission >=1 ED Visit # PCP Visits # OP Visits Continuity of Care
OR 95% CI OR 95% CI IRR 95% CI IRR 95% CI Coeff. 95% CI
CCNC 0.93 [0.82,1.05] 0.99 [0.90,1.10] 0.95*** [0.93,0.97] 0.96*** [0.94,0.97] -0.01173 [-0.02442,0.00096]
(AME = -0.006) (AME = -0.001) (AME = -0.287) (AME = -0.294) (AME = -0.0071)
Ever CCNC 1.08 [0.95,1.23] 1.12* [1.01,1.25] 1.03 [0.98,1.07] 1.01 [0.97,1.05] 0.028*** [0.013,0.044]
CCNC Early Adopter 1.08 [0.98,1.19] 1.13** [1.04,1.24] 1.00 [0.94,1.05] 0.96 [0.92,1.00] 0.0173** [0.0044,0.0301]
Person-level controls
Age 0.97* [0.94,1.00] 0.95*** [0.93,0.97] 1.00 [0.99,1.00] 0.98*** [0.98,0.98] 0.013*** [0.010,0.016]
Age^2 1.00 [1.00,1.00] 1.00* [1.00,1.00] 1.00* [1.00,1.00] 1.00*** [1.00,1.00] ̵  0.00015*** [-0.00018,-0.0012]
Male 0.94* [0.89,1.00] 0.74*** [0.71,0.77] 0.80*** [0.79,0.81] 0.76*** [0.76,0.77] 0.060*** [0.054,0.067]
Charlson Index 3.14*** [3.00,3.29] 1.84*** [1.77,1.91] 1.43*** [1.42,1.44] 1.45*** [1.45,1.46] ̵  0.046*** [-0.051,-0.042]
Charlson Index^2 0.93*** [0.93,0.94] 0.96*** [0.95,0.96] 0.98*** [0.98,0.98] 0.98*** [0.98,0.98] 0.0027*** [0.0021,0.0032]
Eligibility (omitted = subscriber)
Spouse 1.26*** [1.16,1.37] 0.96 [0.90,1.03] 1.07*** [1.05,1.08] 1.09*** [1.08,1.10] ̵  0.025*** [-0.033,-0.016]
Other 1.01 [0.62,1.62] 0.61** [0.43,0.86] 0.76*** [0.70,0.83] 0.80*** [0.76,0.85] ̵  0.003 [-0.049,0.042]
Plan Type (omitted = CMM)
Smart Choice 0.77*** [0.68,0.87] 0.75*** [0.67,0.83] 1.02 [1.00,1.04] 1.04*** [1.02,1.05] ̵  0.0147* [-0.0283,-0.0011]
Smart Choice Basic 0.76*** [0.67,0.88] 0.88* [0.79,0.98] 0.96** [0.94,0.99] 0.94*** [0.92,0.95] 0.01427* [0.00014,0.02840]
Smart Choice Plus 1.20* [1.02,1.41] 0.95 [0.84,1.09] 1.16*** [1.13,1.19] 1.19*** [1.17,1.22] ̵  0.029*** [-0.046,-0.012]
Practice and county-level controls
# Primary Care Providers 1.00 [1.00,1.00] 1.00 [0.99,1.00] 1.00** [1.00,1.00] 1.00* [1.00,1.00] ̵  0.00017 [-0.00066,0.00031]
Multisite Practice 0.88 [0.56,1.37] 0.89 [0.60,1.33] 1.16 [0.88,1.54] 1.18 [0.95,1.47] ̵  0.007 [-0.084,0.071]
Rural-Urban
Non-urban, Non-rural 1.07 [0.98,1.18] 1.16*** [1.07,1.25] 1.02 [0.98,1.07] 0.97* [0.93,1.00] 0.0072 [-0.0048,0.0192]
Rural 0.84 [0.67,1.06] 0.99 [0.82,1.19] 1.00 [0.91,1.10] 0.95 [0.88,1.03] 0.038** [0.011,0.064]
Community-based Practice 0.86* [0.76,0.97] 0.89 [0.79,1.00] 0.86*** [0.80,0.92] 0.94* [0.89,0.99] 0.0221* [0.0013,0.0429]
County Proportion Poverty 0.94 [0.32,2.77] 0.43 [0.17,1.10] 1.76** [1.24,2.49] 1.19 [0.91,1.55] 0.11 [-0.01,0.23]
Primary Care Providers/10,000 Population 0.99 [0.99,1.00] 1.00 [0.99,1.01] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 0.00054 [-0.00054,0.00161]
County Proportion Race/Ethnicity
Non-white, not Hispanic 0.99 [0.74,1.33] 1.39* [1.08,1.80] 1.02 [0.90,1.15] 0.97 [0.88,1.07] ̵  0.011 [-0.048,0.025]
Hispanic 0.96 [0.54,1.68] 0.87 [0.53,1.42] 1.27 [0.99,1.62] 0.9 [0.74,1.08] 0.0845* [0.0078,0.1611]
Year
2005 1.02 [0.90,1.16] 1.25*** [1.13,1.38] 0.95*** [0.93,0.97] 1.01 [1.00,1.03] ̵  0.037*** [-0.049,-0.025]
2006 1.06 [0.93,1.20] 1.25*** [1.14,1.39] 0.93*** [0.91,0.95] 1.00 [0.99,1.02] ̵  0.047*** [-0.060,-0.035]
2007 1.02 [0.90,1.15] 1.24*** [1.12,1.37] 0.97* [0.95,1.00] 1.07*** [1.05,1.09] ̵  0.061*** [-0.073,-0.048]
2008 0.95 [0.84,1.08] 1.31*** [1.18,1.45] 0.97** [0.95,0.99] 1.08*** [1.07,1.10] ̵  0.068*** [-0.081,-0.055]
Constant 0.07*** [0.03,0.16] 0.68 [0.39,1.17] 2.52*** [2.17,2.92] 6.42*** [5.74,7.18] 0.18*** [0.10,0.25]
Average practice intercept 0.27*** [0.22,0.33] 0.35*** [0.32,0.39] 0.36*** [0.35,0.38] 0.29*** [0.28,0.30] -2.62*** [-2.68,-2.55]
N 65218 65218 65218 65218 48096
Notes : Logit models used for IP and ED visits. Zero-truncated Poisson with reintroduced zeros used for PCP and OP vists. Robust OLS used for Continuity of Care.
Continuity of Care  models only for patients with >=3 OP visits during the year.
*p<0.05,**p<0.01,***p<0.001
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Table 5.7b: Average Marginal Effects of CCNC from Multi-Level and Fixed-Effects Models 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
>=1 IP Admission >=1 ED Visit # PCP Visits # OP Visits Continuity of Care
CCNC
MLM AME
̵  0.0060
[-0.0146,0.0037]
̵  0.001
[-0.015,0.013]
̵  0.287**
[-0.36,-0.21]
̵  0.294**
[-0.40,-0.19]
̵  0.0071
[-0.0207,0.0065]
FE AME
̵  0.000
[-0.013,0.013]
0.002
[-0.013,0.017]
̵  0.181*
[-0.342,-0.020]
̵  0.243*
[-0.460,-0.026]
̵  0.0088
[-0.0237,0.0062]
Notes : For multi-level models: logit models used for IP and ED visits, zero-truncated Poisson with reintroduced zeros used for PCP and OP vists,
robust OLS used for Continuity of Care. For fixed-effects models: Cluster-robust LPMs used for IP and ED visits, OLS used for PCP and OP visits and 
Contintinuity of Care. Continuity of Care  models only for patients with >=3 OP visits during the year.
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Table 5.8a: Multi-Level Estimates of the Moderating Effect of CCNC Patient Load on Yearly Health Care Utilization 
 
>=1 IP Admission >=1 ED Visit # PCP Visits # OP Visits Continuity of Care
OR 95% CI OR 95% CI IRR 95% CI IRR 95% CI Coeff. 95% CI
CCNC Patients (omitted=Very Low)
Low 0.87 [0.74,1.03] 1.02 [0.88,1.18] 0.97 [0.93,1.02] 0.95** [0.92,0.99] 0.0257** [0.0074,0.0440]
(AME = -0.011) (AME = 0.003) (AME = -0.10) (AME = -0.34) (AME = 0.036)
Medium 0.92 [0.78,1.09] 1.13 [0.96,1.31] 0.96 [0.91,1.02] 0.93*** [0.89,0.97] 0.041*** [0.021,0.060]
(AME = -0.007) (AME = 0.017) (AME = -0.14) (AME = -0.50) (AME = 0.044)
High 0.97 [0.80,1.16] 1.12 [0.95,1.33] 0.95 [0.90,1.01] 0.93** [0.89,0.97] 0.042*** [0.022,0.063]
(AME = -0.003) (AME = 0.016) (AME = -0.19) (AME = -0.49) (AME = 0.054)
Very High 0.81* [0.68,0.96] 1.21* [1.03,1.42] 0.96 [0.90,1.02] 0.91*** [0.87,0.95] 0.051*** [0.031,0.071]
(AME = -0.016) (AME = 0.028) (AME = -0.151) (AME = -0.64) (AME = 0.061)
CCNC Early Adopter 1.08 [0.98,1.20] 1.11* [1.01,1.23] 1.00 [0.95,1.05] 0.97 [0.93,1.01] 0.0107 [-0.0030,0.0245]
Person-level controls
Age 0.99 [0.94,1.03] 0.95** [0.92,0.98] 1.00 [0.99,1.01] 0.99*** [0.98,0.99] 0.0126*** [0.0085,0.0167]
Age^2 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00*** [1.00,1.00] ̵  0.00014*** [-0.00019,-0.00010]
Male 0.93 [0.85,1.01] 0.74*** [0.69,0.79] 0.78*** [0.77,0.79] 0.75*** [0.74,0.75] 0.072*** [0.062,0.081]
Charlson Index 2.99*** [2.80,3.19] 1.79*** [1.69,1.88] 1.43*** [1.42,1.44] 1.46*** [1.45,1.47] ̵  0.048*** [-0.055,-0.041]
Charlson Index^2 0.94*** [0.93,0.94] 0.96*** [0.96,0.97] 0.98*** [0.98,0.98] 0.98*** [0.98,0.98] 0.0027*** [0.0018,0.0350]
Eligibility (omitted = subscriber)
Spouse 1.42*** [1.26,1.60] 0.95 [0.86,1.06] 1.11*** [1.09,1.13] 1.12*** [1.10,1.13] ̵  0.027*** [-0.039,-0.014]
Other 0.87 [0.42,1.80] 0.71 [0.45,1.15] 0.83** [0.73,0.93] 0.82*** [0.75,0.89] 0.011 [-0.064,0.086]
Plan Type (omitted = CMM)
Smart Choice 0.77* [0.63,0.95] 0.70*** [0.60,0.82] 0.96* [0.93,0.99] 0.98 [0.96,1.00] ̵  0.003 [-0.022,0.017]
Smart Choice Basic 0.80* [0.65,0.99] 0.85 [0.72,1.00] 0.90*** [0.87,0.93] 0.89*** [0.86,0.91] 0.0251* [0.0040,0.0463]
Smart Choice Plus 1.29* [1.01,1.65] 1.01 [0.83,1.23] 1.10*** [1.06,1.15] 1.13*** [1.10,1.17] ̵  0.0234 [-0.0487,0.0018]
Practice and county-level controls
# Primary Care Providers 1.00 [1.00,1.01] 1.00 [0.99,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] ̵  0.00030 [-0.00112,0.00053]
Multisite Practice 0.70 [0.42,1.16] 0.88 [0.56,1.38] 1.15 [0.88,1.49] 1.18 [0.95,1.46] ̵  0.003 [-0.092,0.086]
Rural-Urban
Non-urban, Non-rural 1.07 [0.95,1.20] 1.12 [1.00,1.25] 0.98 [0.92,1.03] 0.92*** [0.88,0.97] 0.0203* [0.0048,0.0357]
Rural 0.88 [0.68,1.14] 0.97 [0.77,1.21] 0.95 [0.85,1.06] 0.87** [0.80,0.95] 0.054** [0.021,0.087]
Community-based Practice 0.91 [0.77,1.08] 0.91 [0.76,1.09] 1.02 [0.92,1.14] 1.04 [0.96,1.13] ̵  0.008 [-0.040,0.025]
County Proportion Poverty 0.52 [0.12,2.16] 0.22* [0.06,0.84] 1.73* [1.08,2.77] 1.06 [0.73,1.53] ̵  0.03 [-0.20,0.15]
Primary Care Providers/10,000 Population 0.99 [0.98,1.00] 1.00 [0.99,1.01] 1.00 [0.99,1.00] 1.00 [0.99,1.00] 0.0003 [-0.0015,0.0020]
County Proportion Race/Ethnicity
Non-white, not Hispanic 1.18 [0.80,1.74] 1.79** [1.25,2.56] 0.99 [0.84,1.16] 0.93 [0.82,1.06] 0.025 [-0.024,0.074]
Hispanic 1.40 [0.69,2.84] 0.96 [0.49,1.85] 1.12 [0.82,1.53] 0.77* [0.60,0.99] 0.070 [-0.025,0.155]
Year
2005 1.26 [0.88,1.80] 1.27 [0.97,1.66] 0.89*** [0.84,0.94] 1.04 [1.00,1.08] ̵  0.037*** [-0.057,-0.017]
2006 1.26 [0.88,1.80] 1.23 [0.94,1.60] 0.89*** [0.84,0.93] 1.05* [1.01,1.09] ̵  0.040*** [-0.059,-0.020]
2007 1.25 [0.88,1.78] 1.23 [0.94,1.60] 0.92*** [0.87,0.97] 1.10*** [1.06,1.15] ̵  0.063*** [-0.082,-0.044]
2008 1.14 [0.80,1.62] 1.28 [0.98,1.67] 0.91*** [0.87,0.96] 1.12*** [1.07,1.16] ̵  0.070*** [-0.090,-0.050]
Constant 0.04*** [0.01,0.14] 0.73 [0.32,1.64] 2.39*** [1.92,2.97] 5.99*** [5.06,7.09] 0.23*** [0.13,0.33]
Average practice intercept 0.19*** [0.12,0.29] 0.36*** [0.31,0.41] 0.31*** [0.29,0.33] 0.25*** [0.24,0.27] -2.77*** [-2.87,-2.67]
N 30229 30229 30229 30229 25557
Notes : Logit models used for IP and ED visits. Zero-truncated Poisson with reintroduced zeros used for PCP and OP vists. Robust OLS used for Continuity of Care.
Continuity of Care  models restricted sample to patients with >=3 visits during the year.
*p<0.05,**p<0.01,***p<0.001
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Table 5.8b: Average Marginal Moderating Effects of CCNC Patient Load from Multi-Level and Fixed-Effects Models 
 
 
 
 
 
 
 
>=1 IP Admission >=1 ED Visit # PCP Visits # OP Visits Continuity of Care
CCNC Patients (omitted=Very Low)
Low
MLM AME
̵  0.011
[-0.0235,0.0015]
0.003
[-0.017,0.023]
̵  0.100
[-0.278,0.078]
̵  0.34**
[-0.58,-0.10]
0.036**
[0.017,0.055]
FE AME
 ̵  0.007
[-0.039,0.026]
̵  0.027
[-0.069,0.015]
 0.03
[-0.23,0.29]
0.02
[-0.47,0.51]
0.025
[-0.011,0.061]
Medium
MLM AME
̵  0.007
[-0.0190,0.0050]
0.017
[-0.0030,0.0369]
̵  0.140
[-0.321,0.041]
̵  0.50**
[-0.74,-0.26]
0.044**
[0.026,0.062]
FE AME
 0.029
[-0.012,0.069]
 -0.013
[-0.065,0.040]
0.033
[-0.33,0.40]
0.051
[-0.55,0.65] 
0.021
[-0.022,0.063]
High
MLM AME
̵  0.003
[-0.18,0.17]
0.016
[-0.012,0.044]
̵  0.190
[-0.440,0.060]
̵  0.49**
[-0.83,-0.15]
0.054**
[0.029,0.079]
FE AME
0.023
[-0.022,0.068]
̵  0.022
[-0.080,0.036]
̵  0.07
[-0.51,0.36]
0.09
[-0.59,0.76] 
̵  0.001
[-0.050,0.048]
Very High
MLM AME
̵  0.0160*
[-0.0293,-0.0027]
0.0280*
[0.0025,0.0535]
̵  0.151
[-0.391,0.089]
̵  0.64**
[-0.96,-0.32]
0.061**
[0.039,0.083]
FE AME
0.017
[-0.030,0.063]
̵  0.024
[-0.086,0.037]
̵  0.027
[-0.49,0.44]
0.00
[-0.75,0.76]
0.006
[-0.046,0.057]
Notes : For multi-level models: logit models used for IP and ED visits, zero-truncated Poisson with reintroduced zeros used for PCP and OP vists,
robust OLS used for Continuity of Care. For fixed-effects models: Cluster-robust LPMs used for IP and ED visits, OLS used for PCP and OP visits and 
Contintinuity of Care. Continuity of Care  models only for patients with >=3 OP visits during the year.
*p<0.05,**p<0.01,***p<0.001
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Table 5.9a: Multi-Level Estimates of the Effect of CCNC on SHP Paid Medical Expenditures 
 
 
Total IP ED OP RX
Coeff. 95% CI Coeff. 95% CI Coeff. 95% CI Coeff. 95% CI Coeff. 95% CI
CCNC 132.03 [-520.64,784.69] -127.38 [-520.73,265.97] 10.07 [-42.02,62.15] 223.7 [-195.50,642.89] -29.86 [-140.74,81.02]
(AME = 132.03) (AME = -127.38) (AME = 10.07) (AME = 223.70) (AME = -29.86)
Ever CCNC -488.89 [-1200.80,223.01] 126.07 [-267.76,519.89] 7.15 [-46.26,60.56] -540.85* [-1048.04,-33.65] -52.64 [-187.27,81.98]
CCNC Early Adopter 201.52 [-390.30,793.35] 97.05 [-183.57,377.67] 48.65* [8.55,88.75] 145.35 [-328.20,618.90] ̵  145.15* [-271.24,-19.06]
Person-level controls
Age -12.96 [-165.59,139.68] -98.98* [-197.65,-0.30] -0.02 [-12.76,12.73] -31.16 [-125.31,62.99] 119.47*** [94.59,144.35]
Age^2 0.32 [-1.31,1.95] 1.14* [0.08,2.19] -0.09 [-0.22,0.05] 0.48 [-0.53,1.49] -1.24*** [-1.50,-0.97]
Male -243.08 [-529.52,43.35] 295.87** [111.50,480.25] -72.00*** [-95.84,-48.16] -570.81*** [-747.98,-393.64] 113.19*** [66.37,160.01]
Charlson Index 5001.60*** [4751.30,5251.89] 2010.94*** [1849.26,2172.61] 301.82*** [280.93,322.70] 1954.06*** [1799.61,2108.50] 718.79*** [677.97,759.60]
Charlson Index^2 472.62*** [440.22,505.02] 160.82*** [139.85,181.79] -10.35*** [-13.05,-7.64] 337.08*** [317.11,357.06] ̵ 16.33*** [-21.61,-11.05]
Eligibility (omitted = subscriber)
Spouse 2770.28*** [2330.51,3210.05] 651.44*** [367.67,935.21] 57.56** [20.89,94.22] 1156.30*** [884.64,1427.96] 888.52*** [816.73,960.31]
Other -930.96 [-3351.56,1489.64] -897.75 [-2464.66,669.16] 33.05 [-169.16,235.26] -1211.73 [-2704.70,281.25] 1274.93*** [880.40,1669.46]
Plan Type (omitted = CMM)
Smart Choice -1377.38***[-2094.88,-659.88] -1254.63*** [-1718.61,-790.65] -87.11** [-147.02,-27.21] -89.55 [-532.14,353.03] 61.69 [-55.26,178.65]
Smart Choice Basic -2560.16***[-3301.43,-1818.88] -1552.47*** [-2031.99,-1072.95] -37.31 [-99.21,24.59] -774.44*** [-1231.57,-317.30] -176.43** [-297.23,-55.63]
Smart Choice Plus 2572.89*** [1655.12,3490.65] 220.51 [-373.12,814.13] 81.66* [5.02,158.30] 1638.46*** [1072.54,2204.38] 643.84*** [494.29,793.39]
Practice and county-level controls
# Primary Care Providers 8.85 [-18.08,35.78] 11.62 [-0.21,23.46] 2.90** [1.09,4.70] 7.44 [-12.08,26.96] 6.80* [1.62,11.97]
Multisite Practice -1250.52 [-3897.25,1396.20] -712.39 [-1925.48,500.70] -81.42 [-255.35,92.50] -856.42 [-3068.11,1355.28] 280.9 [-308.67,870.47]
Rural-Urban
Non-urban, Non-rural 283.63 [-251.03,818.29] 193.20 [-70.23,456.62] 42.03* [4.85,79.22] 212.47 [-201.29,626.24] `-53.24 [-163.30,56.82]
Rural -576.83 [-1803.01,649.36] -288.68 [-930.28,352.92] -57.17 [-145.25,30.91] 102.02 [-833.97,1038.01] -239.7 [-488.64,9.24]
Community-based Practice -1778.73***[-2599.30,-958.15] -269.37 [-636.56,97.82] 20.75 [-33.26,74.76] -1973.12*** [-2635.52,-1310.72] -99.96 [-276.32,76.40]
County Proportion Poverty -5895.36 [-12104.25,313.53] 1370.31 [-1727.18,4467.81] -1140.75***[-1577.86,-703.64] -5803.26* [-10451.03,-1155.49] -608.81 [-1843.50,625.88]
Primary Care Providers/10,000 Population -35.00 [-80.61,10.61] -3.40 [-24.67,17.86] -1.20 [-4.26,1.86] -29.53 [-66.12,7.06] -0.33 [-10.07,9.41]
County Proportion Race/Ethnicity
Non-white, not Hispanic -281.27 [-1950.27,1387.74] -369.89 [-1206.40,466.62] 249.36*** [132.23,366.49] 416.44 [-863.17,1696.05] -514.67** [-854.94,-174.41]
Hispanic -2568.05 [-5810.31,674.21] -856.42 [-2475.39,762.55] 124.76 [-102.43,351.94] -2014.39 [-4509.35,480.56] -188.14 [-851.71,475.42]
Year
2005 1169.59*** [533.90,1805.27] 36.13 [-365.50,437.75] 168.83*** [116.61,221.04] 575.82** [174.31,977.32] 430.26*** [324.08,536.44]
2006 1534.86*** [904.32,2165.40] 113.9 [-283.03,510.83] 170.46*** [118.80,222.13] 731.29*** [331.92,1130.67] 540.45*** [434.83,646.08]
2007 1611.32*** [983.34,2239.29] 63.13 [-330.57,456.84] 181.79*** [130.48,233.10] 672.84*** [273.64,1072.04] 713.25*** [607.66,818.84]
2008 2020.44*** [1390.65,2650.23] 269.71 [-124.33,663.75] 235.60*** [184.21,286.98] 854.84*** [453.99,1255.70] 688.97*** [582.94,794.99]
Constant 3099.36 [-707.69,6906.41] 1881.67 [-517.90,4281.24] 96.21 [-215.82,408.25] 3621.95** [1197.24,6046.65] -2088.28***[-2729.73,-1446.82]
Average practice intercept 7.78*** [7.65,7.90] 6.27*** [6.00,6.55] 4.71*** [4.55,4.88] 7.78*** [7.69,7.86] 6.46*** [6.39,6.53]
N 65218 65218 65218 65218 65218
Notes : Bootstrapped OLS models used for all outcomes.
*p<0.05,**p<0.01,***p<0.001
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Table 5.9b: Average Marginal Effects of CCNC from Multi-Level and Fixed-Effects Models 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total IP ED OP Rx
CCNC
MLM AME
132.03
[-524.81,788.87]
̵  127.38
[-523.25,268.49]
10.07
[-42.35,62.49]
223.70
[-198.18,645.58]
̵  29.86
[-141.45,81.73]
FE AME 262.23
[-481.75,1006.20]
 ̵  20.95
[-567.06,525.15]
46.04
[-0.42,92.50]
242.59
[-121.64,606.82]
 ̵  5.20
[-116.09,105.70]
Notes : Bootstrapped OLS models used for all  outcomes.
*p<0.05,**p<0.01,***p<0.001
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Table 5.10a: Multi-Level Estimates of the Moderating Effect of CCNC Patient Load on SHP Paid Medical Expenditures 
 
Total IP ED OP RX
Coeff. 95% Coeff. 95% Coeff. 95% Coeff. 95% Coeff. 95%
CCNC Patients (omitted=Very Low)
Low -1038.01* [-1962.91,-113.12] -36.69 [-578.42,505.04] 4.84 [-72.42,82.09] -958.19** [-1547.90,-368.48] -88.68 [-257.50,80.14]
(AME = -1038.01) (AME = -36.69) (AME = 4.84) (AME = -958.19) (AME = -88.68)
Medium -1265.29** [-2223.35,-307.22] 190.34 [-370.88,751.56] 16.71 [-63.19,96.60] -1215.17*** [-1827.34,-603.00] -233.24* [-411.33,-55.14]
(AME = -1265.29) (AME = 190.34) (AME = 16.71) (AME = -1215.17) (AME = -233.24)
High -821.87 [-1860.00,216.27] 371.57 [-231.60,974.73] 31.3 [-55.08,117.68] -1110.06** [-1773.99,-446.13] -115.56 [-308.28,77.16]
(AME = -821.87) (AME = 371.57) (AME = 31.30) (AME = -1110.06) (AME = -115.56)
Very High -1856.86*** [-2825.48,-888.24] -126.9 [-680.83,427.02] 29.1 [-50.99,109.20] -1475.61*** [-2098.17,-853.05] -338.01*** [-523.09,-152.92]
(AME = -1856.86) (AME = -126.90) (AME = 29.10) (AME = -1475.61) (AME = -338.01)
CCNC Early Adopter 284.01 [-284.49,852.52] 121.15 [-187.29,429.59] 47.96* [1.83,94.09] 202.27 [-168.19,572.72] `-128.96* [-245.75,-12.17]
Person-level controls
Age -76.52 [-307.25,154.21] -74.36 [-222.25,73.53] 1.62 [-18.37,21.62] -96.83 [-239.66,46.00] 95.28*** [59.65,130.92]
Age^2 0.96 [-1.52,3.44] 0.75 [-0.84,2.34] -0.11 [-0.33,0.10] 1.30 [-0.23,2.84] -1.01*** [-1.39,-0.62]
Male -286.02 [-727.92,155.89] 304.27* [21.58,586.96] -78.97*** [-117.23,-40.70] -557.00*** [-830.72,-283.28] 45.74 [-22.71,114.19]
Charlson Index 5569.43*** [5194.28,5944.58] 2002.14*** [1761.74,2242.55] 320.34*** [287.83,352.85] 2518.55*** [2286.31,2750.79] 716.33*** [658.40,774.27]
Charlson Index^2 395.38*** [347.81,442.95] 168.01*** [137.49,198.53] -8.56*** [-12.68,-4.43] 257.02*** [227.58,286.45] `-19.38*** [-26.71,-12.05]
Eligibility (omitted = subscriber)
Spouse 3240.09*** [2548.21,3931.97] 950.92*** [507.98,1393.85] 61.93* [2.00,121.86] 1258.45*** [830.00,1686.91] 964.48*** [857.44,1071.51]
Other -2766.94 [-6432.05,898.17] -1680.12 [-4031.85,671.60] 27.13 [-290.61,344.87] -1544.03 [-3812.33,724.28] 554.00 [-11.76,1119.76]
Plan Type (omitted = CMM)
Smart Choice -1235.26* [-2433.84,-36.68] -1388.76*** [-2157.16,-620.35] -112.05* [-215.93,-8.18] 273.75 [-468.20,1015.70] -1.33 [-186.42,183.76]
Smart Choice Basic -2356.70*** [-3583.16,-1130.23] -1749.52*** [-2535.93,-963.11] -57.60 [-163.90,48.70] -329.64 [-1088.80,429.52] -215.23* [-404.57,-25.90]
Smart Choice Plus 3293.25*** [1798.39,4788.10] 348.24 [-609.87,1306.35] 157.80* [28.25,287.34] 2303.79*** [1378.42,3229.15] 478.50*** [247.67,709.32]
Practice and county-level controls
# Primary Care Providers 48.78** [18.91,78.64] 20.98** [6.10,35.86] 1.60 [-0.79,3.98] 26.32** [6.84,45.80] 13.39*** [7.64,19.15]
Multisite Practice -1245.26 [-3810.14,1319.63] -711.33 [-2112.32,689.66] -60.88 [-268.45,146.68] -703.81 [-2383.97,976.35] 272.78 [-279.00,824.57]
Rural-Urban
Non-urban, Non-rural -179.18 [-852.81,494.44] 250.67 [-115.34,616.68] -10.08 [-64.82,44.66] -274.01 [-712.33,164.30] -31.67 [-168.69,105.35]
Rural -711.06 [-2049.00,626.88] -292.43 [-1062.88,478.03] -65.15 [-175.93,45.64] -13.48 [-873.92,846.96] -237.18 [-498.15,23.80]
Community-based Practice 66.27 [-973.45,1106.00] -154.03 [-677.05,368.99] 10.42 [-72.04,92.88] 112.53 [-575.12,800.18] 197.33 [-30.52,425.18]
County Proportion Poverty -5055.13 [-13121.37,3011.10] 205.28 [-4238.45,4649.01] -1259.83*** [-1919.67,-599.99] -4829.64 [-10047.75,388.48] -648.65 [-2225.59,928.29]
Primary Care Providers/10,000 Population -54.73 [-116.14,6.69] -7.37 [-40.34,25.60] -2.40 [-7.36,2.56] -43.84* [-84.01,-3.67] -9.25 [-22.12,3.62]
County Proportion Race/Ethnicity
Non-white, not Hispanic -119.72 [-2278.72,2039.29] -216.24 [-1422.28,989.81] 378.11*** [201.13,555.09] 722.44 [-674.46,2119.34] -735.87*** [-1163.95,-307.79]
Hispanic -949.02 [-4902.78,3004.73] -424.65 [-2618.31,1769.01] 269.22 [-54.27,592.71] -163.73 [-2724.71,2397.25] -682.31 [-1471.14,106.53]
Year
2005 1281.82 [-512.08,3075.71] 496.21 [-643.47,1635.90] 159.71* [4.69,314.73] 363 [-749.63,1475.64] 352.22* [72.56,631.88]
2006 1396.91 [-376.35,3170.17] 465.28 [-661.69,1592.25] 151.37 [-1.87,304.62] 373.06 [-726.69,1472.81] 475.42*** [199.11,751.72]
2007 1696.99 [-66.06,3460.04] 526.82 [-593.59,1647.23] 177.40* [25.05,329.75] 402.41 [-691.14,1495.96] 636.98*** [362.07,911.89]
2008 2043.98* [283.77,3804.20] 636.5 [-481.91,1754.90] 244.37** [92.28,396.46] 609.26 [-482.61,1701.14] 616.72*** [342.08,891.36]
Constant 2591.18 [-3292.77,8475.13] 1175.08 [-2547.60,4897.75] 82.02 [-425.11,589.15] 2567.89 [-1091.46,6227.24] -1316.72** [-2254.37,-379.08]
Average practice intercept 7.36*** [7.17,7.55] 6.00*** [5.42,6.58] 4.66*** [4.36,4.96] 7.04*** [6.86,7.22] 6.20*** [6.08,6.31]
N 30229 30229 30229 30229 30229
Notes : Bootstrapped OLS models used for all outcomes.
*p<0.05,**p<0.01,***p<0.001
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Table 5.10b: Average Marginal Moderating Effects of CCNC Patient Load from Multi-Level and Fixed-Effects Models 
 
 
 
 
 
 
 
 
 
 
Total IP ED OP Rx
CCNC Patients (omitted=Very Low)
Low
MLM AME
̵  1038.01*
[-1958.77,-117.25]
̵  36.69
[-576.00,502.62]
4.84
[-72.07,81.75]
̵  958.19**
[-1545.26,-371.12]
̵  88.68
[-256.75,79.39]
FE AME
1614.77
[-158.95,3388.50]
998.72
[-166.80,2164.24]
̵  129.28
[-356.16,97.59]
512.13 
[-392.28,1416.54]
232.94
[-72.19,538.07]
Medium
MLM AME
̵  1265.29**
[-2122.56,-408.02]
190.35
[-311.82,692.52]
16.71
[-54.78,88.20]
̵  1215.17**
[-1762.94,-667.40]
̵  233.24**
[-392.60,-73.88]
FE AME
1796.15
[-266.57,3858.88]
1656.07*
[339.94,2972.20]     
̵  124.58
[-371.11,121.95]
29.16
[-1171.66,1229.99]
235.27
[-93.21,563.76]
High
MLM AME
̵  821.87
[-2016.55,372.81]
371.57
[-322.54,1065.68]
31.3
[-68.11,130.71]
̵  1110.06**
[-1874.10,-346.02]
̵  115.56
[-337.34,106.22]
FE AME
2385.58
[-356.20,5127.36]
1801.00
[-136.48,3738.47]
̵  137.26
[-416.40,141.88]
476.50
[-937.47,1890.46] 
245.34
[-131.19,621.88]
Very High
MLM AME
̵  1856.86**
[-2889.98,-823.74]
̵  126.9
[-717.71,463.91]
29.1
[-56.35,114.55]
̵  1475.61**
[-2139.63,-811.59]
̵  338.01**
[-535.42,-140.60]
FE AME
3180.85*
[244.01,6117.69]      
2167.17*
[221.09,4113.25]
̵  156.07
[-446.97,134.82]
1068.65
[-642.73,2780.04]   
99.80
[-287.99,487.60]
Notes : Bootstrapped OLS models used for all  outcomes.
*p<0.05,**p<0.01,***p<0.001
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Table 5.11a: Multi-Level Odds Ratios of the Effect of CCNC on Receipt of Yearly Diabetes Measures, by Practice Size 
 
>=1 A1C >=1 LDL >=1 Eye Exam
Small (1 PCP) Medium (2-3 PCP) Large (>3 PCP) Small (1 PCP) Medium (2-3 PCP) Large (>3 PCP)
OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI
CCNC 1.56* [1.11,2.20] 1.19 [0.98,1.45] 1.1 [0.93,1.31] 1.21 [0.88,1.66] 1.08 [0.91,1.29] 1.03 [0.90,1.18]
(AME = 0.0616) (AME = 0.0232) (AME = 0.011) (AME = 0.030) (AME = 0.013) (AME = 0.005)
Ever CCNC 1.01 [0.60,1.69] 0.98 [0.74,1.30] 0.73 [0.50,1.08] 1.4 [0.85,2.29] 1.18 [0.91,1.54] 0.83 [0.59,1.16]
CCNC Early Adopter 1.00 [1.00,1.00] 1.03 [0.95,1.12] 1.00 [0.99,1.01] 1.00 [1.00,1.00] 0.95 [0.88,1.02] 1.00 [0.99,1.00]
Person-level controls
Age 1.05 [0.97,1.12] 1.07** [1.03,1.12] 1.02 [0.99,1.06] 1.11** [1.04,1.18] 1.12*** [1.08,1.17] 1.10*** [1.07,1.13]
Age^2 1.00 [1.00,1.00] 1.00* [1.00,1.00] 1.00 [1.00,1.00] 1.00* [1.00,1.00] 1.00*** [1.00,1.00] 1.00*** [1.00,1.00]
Male 1.28*** [1.12,1.47] 1.19*** [1.10,1.30] 1.12*** [1.05,1.20] 1.21** [1.07,1.38] 1.11** [1.03,1.20] 1.13*** [1.07,1.20]
Charlson Index 3.80*** [3.34,4.32] 4.66*** [4.28,5.07] 4.78*** [4.47,5.12] 1.52*** [1.36,1.69] 1.60*** [1.49,1.71] 1.52*** [1.44,1.60]
Charlson Index^2 0.88*** [0.87,0.90] 0.85*** [0.85,0.86] 0.86*** [0.85,0.86] 0.96*** [0.95,0.97] 0.95*** [0.94,0.96] 0.95*** [0.94,0.96]
Eligibility (omitted = subscriber)
Spouse 0.95 [0.77,1.16] 0.81** [0.71,0.92] 0.79*** [0.72,0.87] 0.96 [0.79,1.16] 0.82** [0.73,0.93] 0.85*** [0.78,0.93]
Other 1.28 [0.34,4.80] 4.12*** [1.79,9.45] 0.94 [0.60,1.47] 0.87 [0.25,3.00] 1.34 [0.67,2.65] 1.24 [0.83,1.85]
Plan Type (omitted = CMM)
Smart Choice 1.58** [1.16,2.15] 1.15 [0.93,1.42] 1.25** [1.06,1.47] 1.45* [1.09,1.92] 1.17 [0.97,1.41] 1.34*** [1.17,1.54]
Smart Choice Basic 1.62** [1.18,2.24] 1.10 [0.89,1.37] 1.15 [0.97,1.37] 1.35* [1.00,1.81] 1.11 [0.92,1.34] 1.25** [1.09,1.44]
Smart Choice Plus 1.42 [0.94,2.13] 1.26 [0.96,1.67] 1.21 [0.98,1.50] 1.38 [0.95,2.01] 1.25 [0.98,1.59] 1.34** [1.12,1.60]
0.51** [0.33,0.80] 0.77 [0.58,1.01] 0.65* [0.45,0.94] 0.63* [0.41,0.96] 0.76* [0.59,0.98] 0.66* [0.48,0.90]
Practice and county-level controls
# Primary Care Providers — — 0.95 [0.26,3.45] 1.29 [0.19,8.70] — — 1.22 [0.36,4.19] 1.25 [0.23,6.70]
Multisite Practice 0.72 [0.52,1.00] 0.71** [0.56,0.91] 0.64* [0.45,0.92] 0.64** [0.47,0.87] 0.86 [0.69,1.07] 0.73 [0.53,1.01]
Rural-Urban
Non-urban, Non-rural 0.37* [0.17,0.79] 0.7 [0.41,1.18] 0.33** [0.16,0.71] 0.31** [0.15,0.65] 0.54* [0.33,0.89] 0.33*** [0.17,0.63]
Rural 1.30 [0.64,2.63] 1.67* [1.08,2.59] 1.41 [0.92,2.17] 1.05 [0.54,2.05] 1.75** [1.16,2.65] 1.43 [0.99,2.08]
Community-based Practice 0.92 [0.02,39.50] 1.05 [0.08,14.25] 25.42* [1.60,402.94] 0.96 [0.03,34.16] 0.02*** [0.00,0.18] 0.59 [0.05,6.57]
County Proportion Poverty 1.01 [0.97,1.04] 1.01 [0.98,1.03] 0.93*** [0.90,0.95] 0.99 [0.96,1.03] 0.99 [0.97,1.01] 0.93*** [0.91,0.95]
Primary Care Providers/10,000 Population
County Proportion Race/Ethnicity 0.80 [0.28,2.31] 0.66 [0.31,1.44] 0.59 [0.23,1.47] 0.57 [0.21,1.56] 0.90 [0.44,1.85] 1.01 [0.45,2.24]
Non-white, not Hispanic 6.39 [0.87,47.14] 5.07* [1.21,21.26] 0.99 [0.12,8.02] 21.49** [3.20,144.23] 4.24* [1.11,16.25] 0.75 [0.12,4.61]
Hispanic
Year
2005 0.97 [0.72,1.32] 0.97 [0.79,1.20] 0.84 [0.71,1.00] 1.44** [1.10,1.89] 1.38*** [1.15,1.67] 1.61*** [1.41,1.85]
2006 0.82 [0.61,1.10] 1.02 [0.83,1.26] 0.74*** [0.62,0.88] 1.50** [1.15,1.97] 1.44*** [1.20,1.74] 1.67*** [1.45,1.92]
2007 1.01 [0.75,1.36] 1.15 [0.93,1.41] 0.78** [0.65,0.94] 1.86*** [1.43,2.43] 1.74*** [1.44,2.09] 1.86*** [1.61,2.15]
2008 1.01 [0.74,1.36] 1.14 [0.92,1.41] 0.76** [0.64,0.91] 2.02*** [1.53,2.66] 1.76*** [1.46,2.13] 1.92*** [1.66,2.21]
Constant 0.11* [0.02,0.72] 0.06*** [0.02,0.18] 0.67 [0.24,1.89] 0.03*** [0.00,0.16] 0.04*** [0.01,0.11] 0.08*** [0.03,0.21]
Average practice intercept 1.31*** [1.18,1.46] 1.28*** [1.19,1.37] 1.31*** [1.21,1.43] 1.25*** [1.13,1.38] 1.22*** [1.13,1.30] 1.16*** [1.07,1.27]
N 7850 20393 35070 7850 20393 35070
Notes : A1c is hemoglobin A1c test, LDL is low-density lipoprotein test.PCP is primary care provider. Logit models used for all outcomes.
*p<0.05,**p<0.01,***p<0.001
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Table 5.11a: Continued 
 
>=1 Eye Exam Attention for Nephropathy
Small (1 PCP) Medium (2-3 PCP) Large (>3 PCP) Small (1 PCP) Medium (2-3 PCP) Large (>3 PCP)
OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI
CCNC 0.90 [0.69,1.18] 1.12 [0.97,1.29] 0.98 [0.87,1.11] 0.96 [0.69,1.32] 1.07 [0.90,1.27] 1.04 [0.90,1.20]
(AME =  ̵ 0.022) (AME = 0.0239) (AME = -0.003) (AME = -0.007) (AME = 0.01) (AME = 0.005)
Ever CCNC 0.82 [0.64,1.04] 0.96 [0.85,1.08] 0.94 [0.84,1.04] 0.79 [0.54,1.14] 0.94 [0.79,1.12] 0.96 [0.82,1.12]
CCNC Early Adopter 1.00 [1.00,1.00] 1.05* [1.00,1.11] 1.00 [0.99,1.00] 1.00 [1.00,1.00] 0.99 [0.93,1.06] 1.00 [0.99,1.00]
Person-level controls
Age 0.97 [0.92,1.03] 0.98 [0.94,1.01] 0.97** [0.94,0.99] 1.16*** [1.09,1.24] 1.06** [1.01,1.10] 1.10*** [1.07,1.13]
Age^2 1.00 [1.00,1.00] 1.00* [1.00,1.00] 1.00*** [1.00,1.00] 1.00*** [1.00,1.00] 1.00 [1.00,1.00] 1.00*** [1.00,1.00]
Male 0.75*** [0.68,0.84] 0.84*** [0.79,0.90] 0.84*** [0.81,0.89] 0.92 [0.81,1.04] 0.97 [0.90,1.05] 1.02 [0.96,1.08]
Charlson Index 1.70*** [1.55,1.87] 1.70*** [1.60,1.81] 1.72*** [1.64,1.79] 1.96*** [1.74,2.19] 2.04*** [1.89,2.20] 2.00*** [1.89,2.12]
Charlson Index^2 0.95*** [0.94,0.96] 0.95*** [0.94,0.96] 0.95*** [0.95,0.96] 0.95*** [0.93,0.96] 0.95*** [0.94,0.95] 0.94*** [0.94,0.95]
Eligibility (omitted = subscriber)
Spouse 0.91 [0.78,1.07] 0.99 [0.90,1.09] 0.95 [0.88,1.02] 0.94 [0.77,1.14] 0.94 [0.83,1.06] 0.95 [0.87,1.04]
Other 1.37 [0.46,4.10] 0.79 [0.41,1.51] 0.91 [0.62,1.33] 0.78 [0.25,2.41] 1.20 [0.63,2.30] 1.10 [0.76,1.61]
Plan Type (omitted = CMM)
Smart Choice 1.33* [1.02,1.72] 1.43*** [1.20,1.70] 1.30*** [1.15,1.48] 1.16 [0.86,1.57] 1.18 [0.97,1.44] 1.28*** [1.11,1.48]
Smart Choice Basic 0.96 [0.74,1.26] 1.03 [0.86,1.23] 1.05 [0.93,1.20] 1.22 [0.89,1.67] 1.04 [0.85,1.27] 1.23** [1.06,1.43]
Smart Choice Plus 1.50* [1.08,2.08] 1.36** [1.09,1.69] 1.28** [1.10,1.49] 1.37 [0.91,2.05] 1.29 [0.99,1.68] 1.39*** [1.15,1.67]
0.97 [0.74,1.27] 0.89 [0.77,1.03] 1.05 [0.91,1.20] 0.97 [0.68,1.40] 1.06 [0.87,1.29] 0.86 [0.72,1.03]
Practice and county-level controls
# Primary Care Providers — — 1.02 [0.64,1.63] 1.16 [0.72,1.86] — — 0.60 [0.29,1.23] 0.77 [0.38,1.58]
Multisite Practice 1.05 [0.89,1.23] 0.97 [0.88,1.08] 0.89* [0.80,0.99] 0.85 [0.66,1.08] 0.90 [0.77,1.04] 0.87 [0.74,1.02]
Rural-Urban
Non-urban, Non-rural 0.78 [0.50,1.21] 0.83 [0.66,1.06] 0.76* [0.59,0.97] 0.8 [0.44,1.44] 1.06 [0.76,1.47] 0.79 [0.57,1.11]
Rural 1.16 [0.80,1.67] 1.1 [0.92,1.32] 0.96 [0.85,1.09] 0.74 [0.41,1.34] 1.13 [0.86,1.50] 1.06 [0.88,1.27]
Community-based Practice 0.59 [0.08,4.41] 0.81 [0.23,2.76] 0.45 [0.14,1.50] 0.45 [0.02,9.07] 0.05*** [0.01,0.29] 0.20 [0.04,1.09]
County Proportion Poverty 1.02* [1.00,1.04] 1.02** [1.01,1.03] 1.01*** [1.01,1.02] 1.00 [0.97,1.03] 1.00 [0.99,1.02] 0.97*** [0.96,0.98]
Primary Care Providers/10,000 Population
County Proportion Race/Ethnicity 0.68 [0.39,1.16] 0.81 [0.58,1.14] 0.71* [0.53,0.97] 2.76* [1.22,6.26] 2.31** [1.40,3.80] 2.08*** [1.35,3.21]
Non-white, not Hispanic 0.43 [0.16,1.14] 0.92 [0.50,1.71] 0.51 [0.26,1.00] 3.72 [0.82,16.76] 2.22 [0.90,5.50] 1.91 [0.71,5.10]
Hispanic
Year
2005 0.88 [0.70,1.10] 0.90 [0.77,1.05] 0.92 [0.83,1.03] 1.33* [1.02,1.73] 1.51*** [1.26,1.81] 1.49*** [1.31,1.70]
2006 0.86 [0.69,1.07] 0.94 [0.81,1.10] 1.00 [0.90,1.12] 1.40* [1.07,1.82] 1.39*** [1.16,1.66] 1.49*** [1.30,1.70]
2007 1.48*** [1.20,1.83] 1.46*** [1.25,1.69] 1.46*** [1.31,1.62] 1.62*** [1.25,2.10] 1.52*** [1.28,1.82] 1.55*** [1.36,1.77]
2008 1.60*** [1.29,1.99] 1.67*** [1.43,1.94] 1.58*** [1.42,1.76] 1.66*** [1.27,2.17] 1.48*** [1.24,1.77] 1.53*** [1.34,1.74]
Constant 0.21* [0.05,0.90] 0.18*** [0.07,0.43] 0.38** [0.20,0.72] 0.03*** [0.01,0.15] 0.23** [0.08,0.63] 0.11*** [0.05,0.23]
Average practice intercept 0.38*** [0.31,0.48] 0.32*** [0.27,0.37] 0.26*** [0.23,0.31] 0.81** [0.70,0.92] 0.62*** [0.56,0.68] 0.44*** [0.39,0.49]
N 7850 20393 35070 7850 20393 35070
Notes : A1c is hemoglobin A1c test, LDL is low-density lipoprotein test.PCP is primary care provider. Logit models used for all outcomes.
*p<0.05,**p<0.01,***p<0.001
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Table 5.11b: Average Marginal Effects of CCNC from Multi-Level and Fixed-Effects Models, by Practice Size 
 
 
 
 
Table 5.11b: Contintued 
 
 
 
 
 
 
 
 
 
 
>=1 A1C >=1 LDL >=1 Eye Exam
Small (1 PCP) Medium (2-3 PCP) Large (>3 PCP) Small (1 PCP) Medium (2-3 PCP) Large (>3 PCP)
CCNC
MLM AME
0.0616**
[0.017,0.106]
0.0232
[-0.0021,0.0485]
0.011
[-0.0087,0.0315]
0.030
[-0.019,0.079]
0.013
[-0.016,0.042]
0.005
[-0.017,0.027]
FE AME
0.0749*
[0.0068,0.1429]
0.0280
[-0.0045,0.0605]
0.005
[-0.031,0.042]
0.040
[-0.026,0.107]
0.019
[-0.021,0.058] 
0.005
[-0.032,0.043]
Notes: Logit models used for mult-level models. Cluster robust l inear probability models used for fixed-effects models.
*p<0.05,**p<0.01,***p<0.001
>=1 Eye Exam Attention for Nephropathy
Small (1 PCP) Medium (2-3 PCP) Large (>3 PCP) Small (1 PCP) Medium (2-3 PCP) Large (>3 PCP)
CCNC
MLM AME
̵  0.022
[-0.077,0.033]
0.0239
[-0.0066,0.0543]
̵  0.003
[-0.029,0.023]
̵  0.007
[-0.055,0.041]
0.010
[-0.015,0.035]
0.005
[-0.015,0.025]
FE AME
̵  0.036
[-0.091,0.019]
0.0247
[-0.0054,0.0548]
̵  0.008
[-0.038,0.021]
0.018
[-0.033,0.068] 
̵  0.001
[-0.032,0.029]
0.011
[-0.016,0.039]
Notes: Logit models used for mult-level models. Cluster robust l inear probability models used for fixed-effects models.
*p<0.05,**p<0.01,***p<0.001
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Table 5.12a: Multi-Level Odds Ratios of the Moderating Effect of CCNC Patient Load on Receipt of Yearly Diabetes Measures, by Practice Size 
 
>=1 A1C >=1 LDL >=1 Eye Exam
Small (1 PCP) Medium (2-3 PCP) Large (>3 PCP) Small (1 PCP) Medium (2-3 PCP) Large (>3 PCP)
OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI
CCNC Patients (omitted = Very Low)
Low 1.60 [0.99,2.60] 1.09 [0.73,1.62] 0.75 [0.47,1.19] 1.30 [0.85,1.98] 1.02 [0.72,1.45] 0.93 [0.66,1.33]
(AME = 0.0736) (AME = 0.0116) (AME = -0.0313) (AME = 0.0456) (AME = 0.0032) (AME =  ̶ 0.01)
Medium 1.57 [0.80,3.07] 0.95 [0.62,1.44] 0.61 [0.36,1.03] 1.34 [0.74,2.44] 0.95 [0.65,1.39] 0.88 [0.58,1.34]
(AME = 0.0707) (AME = -0.0076) (AME = -0.0551) (AME = 0.0513) (AME =  ̵ 0.0083) (AME =  ̵ 0.0185)
High 0.68 [0.24,1.94] 0.96 [0.60,1.55] 0.47** [0.27,0.81] 0.88 [0.36,2.14] 0.87 [0.56,1.33] 0.72 [0.47,1.12]
(AME = -0.0654) (AME = ̵ 0.0056) (AME = -0.0888) (AME = ̵ 0.0239) (AME = ̵ 0.0241) (AME = ̵ 0.0501)
Very High 0.52 [0.17,1.53] 1.20 [0.73,1.96] 0.58* [0.34,1.00] 1.32 [0.51,3.39] 0.85 [0.54,1.33] 0.65 [0.42,1.00]
(AME = -0.1155) (AME = 0.0244) (AME = -0.0616) (AME = 0.0482) (AME = ̵ 0.0279) (AME = -0.0686)
CCNC Early Adopter 1.16 [0.68,1.98] 0.90 [0.66,1.23] 0.75 [0.47,1.19] 1.86** [1.18,2.95] 1.12 [0.84,1.49] 0.87 [0.58,1.31]
Person-level controls
Age 0.93 [0.82,1.05] 1.07* [1.00,1.14] 0.99 [0.94,1.03] 1.01 [0.90,1.14] 1.10*** [1.04,1.17] 1.08*** [1.04,1.12]
Age^2 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00* [1.00,1.00] 1.00* [1.00,1.00]
Male 1.20 [0.94,1.53] 1.19** [1.05,1.35] 1.16** [1.06,1.27] 1.15 [0.92,1.45] 1.20** [1.07,1.34] 1.05 [0.97,1.13]
Charlson Index 3.94*** [3.11,4.98] 5.44*** [4.78,6.20] 4.54*** [4.15,4.96] 1.46*** [1.20,1.78] 1.76*** [1.58,1.95] 1.49*** [1.39,1.60]
Charlson Index^2 0.88*** [0.86,0.91] 0.83*** [0.82,0.85] 0.86*** [0.85,0.87] 0.96*** [0.94,0.98] 0.94*** [0.92,0.95] 0.95*** [0.95,0.96]
Eligibility (omitted = subscriber)
Spouse 0.60** [0.41,0.87] 0.80* [0.65,0.98] 0.79** [0.69,0.91] 0.77 [0.53,1.11] 0.75** [0.63,0.90] 0.88* [0.78,0.99]
Other 0.00 [0.00,0.00] 4.32* [1.22,15.34] 0.51* [0.28,0.95] 1.38 [0.06,33.13] 1.12 [0.40,3.16] 0.77 [0.43,1.38]
Plan Type (omitted = CMM)
Smart Choice 1.47 [0.79,2.75] 1.09 [0.78,1.54] 1.09 [0.85,1.40] 1.57 [0.88,2.81] 1.07 [0.78,1.45] 1.46*** [1.19,1.79]
Smart Choice Basic 1.13 [0.60,2.13] 1.03 [0.73,1.46] 1.04 [0.80,1.34] 1.42 [0.79,2.56] 1.00 [0.74,1.37] 1.41** [1.14,1.74]
Smart Choice Plus 1.02 [0.45,2.29] 1.28 [0.82,1.98] 1.08 [0.80,1.46] 2.05 [0.95,4.44] 1.02 [0.69,1.50] 1.27 [0.99,1.64]
Practice and county-level controls
# Primary Care Providers — — 1.07 [0.94,1.22] 1.00 [0.99,1.01] — — 0.99 [0.88,1.11] 0.99* [0.99,1.00]
Multisite Practice — — 1.18 [0.24,5.70] 1.07 [0.11,10.28] — — 1.47 [0.34,6.49] 1.06 [0.14,7.87]
Rural-Urban
Non-urban, Non-rural 0.68 [0.35,1.29] 0.78 [0.55,1.10] 0.77 [0.46,1.31] 1.05 [0.60,1.84] 0.85 [0.62,1.17] 0.74 [0.46,1.19]
Rural 1.06 [0.34,3.30] 1.04 [0.52,2.07] 0.40 [0.15,1.06] 1.17 [0.43,3.21] 0.61 [0.33,1.15] 0.24** [0.10,0.56]
Community-based Practice 1.27 [0.32,4.96] 0.80 [0.37,1.74] 0.79 [0.39,1.57] 2.74 [0.84,8.94] 1.31 [0.64,2.69] 0.99 [0.54,1.83]
County Proportion Poverty 0.47 [0.00,544.07] 3.37 [0.07,157.46] 33.44 [0.81,1377.97] 0.00* [0.00,0.78] 0.03 [0.00,1.15] 0.57 [0.02,15.33]
Primary Care Providers/10,000 Population 1.05 [0.96,1.14] 0.97 [0.93,1.02] 0.92*** [0.88,0.95] 0.97 [0.90,1.05] 0.95* [0.91,0.99] 0.91*** [0.88,0.94]
County Proportion Race/Ethnicity
Non-white, not Hispanic 1.19 [0.13,10.66] 0.67 [0.22,2.07] 0.48 [0.13,1.76] 1.15 [0.17,7.74] 1.04 [0.37,2.90] 0.71 [0.23,2.25]
Hispanic 49.34* [1.38,1768.99] 3.72 [0.51,27.03] 0.31 [0.02,5.77] 272.95*** [11.60,6420.27] 6.06 [0.97,38.03] 0.31 [0.02,4.04]
Year
2005 3.50 [0.39,31.67] 1.37 [0.61,3.09] 0.77 [0.53,1.12] 3.64 [0.46,28.68] 1.69 [0.78,3.64] 1.77*** [1.36,2.32]
2006 3.40 [0.38,30.46] 1.28 [0.57,2.88] 0.71 [0.49,1.03] 3.14 [0.40,24.50] 1.53 [0.71,3.28] 1.89*** [1.45,2.47]
2007 4.30 [0.48,38.48] 1.49 [0.66,3.36] 0.75 [0.52,1.09] 4.38 [0.56,34.12] 1.99 [0.92,4.28] 2.14*** [1.63,2.81]
2008 3.84 [0.43,34.49] 1.46 [0.65,3.29] 0.72 [0.49,1.04] 4.88 [0.63,38.04] 1.89 [0.88,4.07] 2.12*** [1.62,2.78]
Constant 0.15 [0.00,8.27] 0.08* [0.01,0.59] 4.50 [0.96,21.05] 0.03 [0.00,1.36] 0.06** [0.01,0.38] 0.21* [0.06,0.78]
Average practice intercept 1.19 [0.97,1.46] 1.31*** [1.18,1.46] 1.54*** [1.38,1.72] 0.97 [0.79,1.20] 1.24*** [1.12,1.37] 1.37*** [1.22,1.53]
N 2139 9054 18500 2139 9054 18500
Notes : A1c is hemoglobin A1c test, LDL is low-density lipoprotein test.PCP is primary care provider. Logit models used for all outcomes.
*p<0.05,**p<0.01,***p<0.001
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Table 5.12a: Continued 
 
>=1 Eye Exam Attention for Nephropathy
Small (1 PCP) Medium (2-3 PCP) Large (>3 PCP) Small (1 PCP) Medium (2-3 PCP) Large (>3 PCP)
OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI
CCNC Patients (omitted = Very Low)
Low 0.90 [0.72,1.12] 0.89 [0.74,1.08] 1.01 [0.84,1.23] 0.83 [0.57,1.20] 0.91 [0.68,1.21] 0.66** [0.50,0.88]
(AME = -0.0222) (AME = -0.0247) (AME = 0.003) (AME = -0.0304) (AME = -0.0134) (AME = -0.0555)
Medium 0.94 [0.68,1.29] 0.86 [0.71,1.04] 0.98 [0.80,1.20] 0.95 [0.56,1.63] 0.92 [0.68,1.25] 0.79 [0.58,1.07]
(AME =  ̵  0.0138) (AME =  ̵ 0.0339) (AME = ̵ 0.0055) (AME = -0.0073) (AME = -0.0109) (AME = -0.0307)
High 0.57* [0.34,0.96] 0.80 [0.64,1.00] 0.99 [0.81,1.22] 0.90 [0.38,2.13] 0.93 [0.66,1.32] 0.69* [0.51,0.94]
(AME = ̵ 0.1063) (AME = ̵ 0.0484) (AME = ̵ 0.0023) (AME = -0.0162) (AME = -0.0100) (AME = -0.0493)
Very High 0.53* [0.30,0.95] 0.80* [0.64,0.99] 0.88 [0.73,1.07] 5.14* [1.48,17.85] 0.95 [0.67,1.33] 0.67** [0.50,0.90]
(AME = -0.1173) (AME = -0.0489) (AME = -0.0278) (AME = 0.1597) (AME = -0.0077) (AME = ̵ 0.0539)
CCNC Early Adopter 0.80* [0.65,0.98] 0.95 [0.84,1.07] 0.96 [0.87,1.07] 0.89 [0.60,1.30] 0.9 [0.74,1.09] 1.02 [0.86,1.21]
Person-level controls
Age 0.92 [0.83,1.02] 0.99 [0.94,1.04] 0.97 [0.93,1.00] 1.22** [1.08,1.37] 1.05 [0.99,1.12] 1.10*** [1.06,1.15]
Age^2 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00** [1.00,1.00] 1.00** [1.00,1.00] 1.00 [1.00,1.00] 1.00*** [1.00,1.00]
Male 0.77** [0.63,0.94] 0.83*** [0.75,0.91] 0.82*** [0.77,0.88] 0.91 [0.72,1.16] 0.98 [0.87,1.10] 1.06 [0.98,1.15]
Charlson Index 1.66*** [1.39,1.99] 1.67*** [1.52,1.82] 1.70*** [1.60,1.80] 2.07*** [1.67,2.56] 2.13*** [1.90,2.39] 2.06*** [1.92,2.22]
Charlson Index^2 0.96*** [0.93,0.98] 0.95*** [0.94,0.97] 0.95*** [0.95,0.96] 0.93*** [0.91,0.96] 0.94*** [0.92,0.96] 0.94*** [0.93,0.95]
Eligibility (omitted = subscriber)
Spouse 0.89 [0.65,1.22] 0.85* [0.73,0.99] 0.96 [0.87,1.06] 0.88 [0.61,1.29] 0.88 [0.73,1.07] 0.96 [0.85,1.10]
Other 6.58 [0.48,90.61] 0.78 [0.30,2.05] 0.99 [0.59,1.65] 0.25 [0.01,4.98] 1.10 [0.42,2.88] 0.93 [0.56,1.55]
Plan Type (omitted = CMM)
Smart Choice 1.77 [0.97,3.24] 1.32* [1.00,1.73] 1.36*** [1.13,1.63] 1.14 [0.60,2.16] 1.16 [0.83,1.61] 1.36** [1.10,1.67]
Smart Choice Basic 1.45 [0.79,2.69] 0.93 [0.70,1.23] 1.09 [0.91,1.32] 1.19 [0.62,2.29] 0.95 [0.68,1.33] 1.28* [1.03,1.58]
Smart Choice Plus 2.67** [1.28,5.53] 1.27 [0.90,1.79] 1.33* [1.06,1.65] 0.84 [0.37,1.90] 1.11 [0.73,1.70] 1.39* [1.07,1.81]
Practice and county-level controls
# Primary Care Providers — — 1.06 [0.98,1.15] 1.00 [0.99,1.00] — — 1.02 [0.92,1.13] 1.00 [0.99,1.01]
Multisite Practice — — 1.12 [0.66,1.88] 1.19 [0.73,1.94] — — 0.93 [0.38,2.24] 0.88 [0.40,1.93]
Rural-Urban
Non-urban, Non-rural 0.76* [0.59,0.99] 0.86* [0.75,0.99] 0.81** [0.71,0.92] 0.91 [0.57,1.46] 0.85 [0.68,1.05] 0.91 [0.74,1.12]
Rural 0.61 [0.36,1.04] 0.85 [0.64,1.11] 0.66** [0.50,0.86] 1.10 [0.47,2.55] 1.02 [0.67,1.55] 0.74 [0.50,1.10]
Community-based Practice 1.25 [0.56,2.83] 1.19 [0.88,1.59] 0.98 [0.84,1.15] 0.14 [0.02,1.25] 0.64 [0.39,1.06] 0.84 [0.65,1.09]
County Proportion Poverty 11.16 [0.45,278.71] 2.00 [0.34,11.90] 2.43 [0.55,10.76] 0.04 [0.00,11.39] 0.14 [0.01,2.18] 0.76 [0.08,6.78]
Primary Care Providers/10,000 Population 0.99 [0.95,1.04] 1.01 [0.99,1.03] 1.01** [1.00,1.02] 0.96 [0.90,1.03] 0.97 [0.94,1.00] 0.97*** [0.96,0.99]
County Proportion Race/Ethnicity
Non-white, not Hispanic 0.43 [0.16,1.14] 0.75 [0.46,1.21] 0.51*** [0.35,0.74] 7.07* [1.32,37.82] 1.58 [0.75,3.33] 1.27 [0.72,2.25]
Hispanic 0.47 [0.12,1.94] 0.91 [0.40,2.06] 0.51 [0.23,1.13] 3.77 [0.28,51.43] 1.61 [0.46,5.64] 1.30 [0.37,4.57]
Year
2005 1.87 [0.20,17.31] 1.39 [0.73,2.65] 0.94 [0.75,1.18] 0.65 [0.06,6.81] 2.22* [1.15,4.25] 1.55** [1.20,2.02]
2006 1.76 [0.19,16.14] 1.40 [0.73,2.66] 0.99 [0.79,1.24] 0.81 [0.08,8.40] 2.15* [1.13,4.12] 1.62*** [1.25,2.10]
2007 3.09 [0.34,28.30] 2.19* [1.15,4.16] 1.40** [1.12,1.75] 0.90 [0.09,9.40] 2.24* [1.17,4.28] 1.68*** [1.30,2.18]
2008 3.33 [0.36,30.39] 2.48** [1.31,4.71] 1.51*** [1.21,1.89] 0.79 [0.08,8.21] 2.29* [1.20,4.37] 1.64*** [1.27,2.13]
Constant 0.28 [0.01,8.85] 0.09** [0.02,0.41] 0.34* [0.14,0.81] 0.12 [0.00,8.27] 0.40 [0.07,2.21] 0.13*** [0.05,0.36]
Average practice intercept 0.04 [0.00,11586572.74] 0.27*** [0.21,0.36] 0.24*** [0.20,0.30] 0.70* [0.54,0.92] 0.63*** [0.54,0.73] 0.46*** [0.39,0.54]
N 2139 9054 18500 2139 9054 18500
Notes : A1c is hemoglobin A1c test, LDL is low-density lipoprotein test.PCP is primary care provider. Logit models used for all outcomes.
*p<0.05,**p<0.01,***p<0.001
  
 
1
0
1
 
Table 5.12b: Average Marginal Moderating Effects of CCNC Patient Load from Multi-Level and Fixed Effects Models, by Practice Size 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
>=1 A1C >=1 LDL >=1 Eye Exam Attention for Nephropathy
Small (1 PCP) Medium (2-3 PCP) Large (>3 PCP) Small (1 PCP) Medium (2-3 PCP) Large (>3 PCP) Small (1 PCP) Medium (2-3 PCP) Large (>3 PCP) Small (1 PCP) Medium (2-3 PCP) Large (>3 PCP)
CCNC Patients (omitted=Very Low)
Low
MLM AME
0.0736*
[0.0050,0.1422]
0.012
[-0.042,0.065]
̵  0.0313
[-0.085,0.022]
0.046
[-0.023,0.114]
0.003
[-0.053,0.060]
̵  0.010
[-0.062,0.042]
̵  0.022
[-0.066,0.022]
̵  0.025
[-0.064,0.014]
0.003
[-0.039,0.045]
̵  0.030
[-0.091,0.031]
̵  0.013
[-0.055,0.028]
  ̵  0.056*
[-0.099,-0.012]
FE AME
 0.0196
[-0.0842,0.1235]
0.0761
[-0.0096,0.1619] 
̵  0.0269
[-0.0745,0.0206]
0.0280
[-0.1007,0.1567]  
0.0180
[-0.0803,0.1163]
0.0010
[-0.0501,0.0521]
̵  0.1316**
[-0.2303,-0.0330]
 ̵  0.0235
[-0.1286,0.0815]
0.0172
[-0.0557,0.0902]   
̵  0.0918
[-0.1952,0.0117]
 ̵  0.0190
[-0.0780,0.0399]
̵  0.0954**
[-0.1554,-0.0354]
Medium
MLM AME
0.071
[-0.040,0.181]
̵  0.008
[-0.076,0.061]
̵  0.055
[-0.130,0.020]
0.051
[-0.059,0.162]
̵  0.008
[-0.081,0.064]
̵  0.019
[-0.092,0.055]
̵  0.014
[-0.087,0.050]
̵  0.034
[-0.080,0.012]
̵  0.006
[-0.058,0.047]
̵  0.007
[-0.103,0.089]
̵  0.011
[-0.060,0.038]
̵  0.031
[-0.080,0.019]
FE AME
 0.0381
[-0.1209,0.1970]
0.0828
[-0.0211,0.1868]
̵  0.0761*
[-0.1462,-0.0060]
0.0944
[-0.0918,0.2807]
̵  0.0017
[-0.1166,0.1131]
̵  0.0173
[-0.0906,0.0561]
̵  0.1934*
[-0.3754,-0.0114]
̵  0.0436
[-0.1636,0.0764]
0.0339
[-0.0520,0.1198]
̵  0.0693
[-0.2267,0.0880]
0.0022
[-0.0789,0.0832]  
̵  0.0909*
[-0.1655,-0.0162]
High
MLM AME
̵  0.07
[-0.24,0.11]
̵  0.006
[-0.075,0.063]
̵  0.089*
[-0.165,-0.013]
̵  0.02
[-0.19,0.14]
̵  0.024
[-0.101,0.050]
̵  0.050
[-0.123,0.023]
̵  0.106*
[-0.196,-0.017]
̵  0.0484
[-0.096812,0.000012]
̵  0.002
[-0.050,0.045]
̵  0.02
[-0.16,0.12]
̵  0.010
[-0.061,0.041]
̵  0.0493*
[-0.0969,-0.0017]
FE AME
̵  0.2799
[-0.6262,0.0664]
0.1001
[-0.0167,0.2168]
 ̵  0.1025*
[-0.1870,-0.0180]
̵  0.0433
[-0.4609,0.3743]
̵  0.0253
[-0.1543,0.1037]
̵  0.0440
[-0.1350,0.0470]
̵  0.4536***
[-0.6900,-0.2172]
̵  0.0184
[-0.1513,0.1144]
0.0327
[-0.0612,0.1267] 
̵  0.0939
[-0.2805,0.0926]
 0.0036
[-0.0975,0.1048]  
̵  0.1185**
[-0.2003,-0.0367]
Very High
MLM AME
̵  0.116
[-0.302,0.071]
0.024
[-0.041,0.090]
̵  0.0616
[-0.1320,0.0088]
0.05
[-0.11,0.20]
̵  0.028
[-0.100,0.055]
̵  0.0686
[-0.1431,0.0059]
̵  0.117*
[-0.215-0.020]
̵  0.0489*
[-0.0959,-0.0019]
̵  0.028
[-0.072,0.016]
0.160**
[0.080,0.240]
̵  0.008
[-0.057,0.042]
̵  0.0539*
[-0.0999,-0.0078]
FE AME
̵  0.3416
[-0.6925,0.0093]
0.1513*
[0.0094,0.2931]
̵  0.0775
[-0.1690,0.0140]
0.0136
[-0.3781,0.4053]
̵  0.0225
[-0.1843,0.1393]
̵  0.0749
[-0.1839,0.0340]
̵  0.5312**
[-0.7721,-0.2902]
̵  0.0247
[-0.1811,0.1316]
 0.0327
[-0.0659,0.1313] 

̵  0.0434
[-0.2191,0.1323]
̵  0.0106
[-0.1190,0.0979]
̵  0.1200**
[-0.2048,-0.0352]
Notes: Logit models used for mult-level models. Cluster robust l inear probability models used for fixed-effects models.
*p<0.05,**p<0.01,***p<0.001
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Table 5.13a: Multi-Level Estimates of the Effect of CCNC on Yearly Health Care Utilization, by Practice Size 
 
 
>=1 IP Admission >=1 ED Visit # PCP Visits # Total OP Visits
Small (1 PCP) Medium (2-3 PCP) Large (>3 PCP) Small (1 PCP) Medium (2-3 PCP) Large (>3 PCP) Small (1 PCP) Medium (2-3 PCP) Large (>3 PCP)
OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI IRR 95% CI IRR 95% CI IRR 95% CI
CCNC 0.87 [0.59,1.30] 1.00 [0.81,1.23] 0.93 [0.77,1.12] 0.98 [0.72,1.34] 0.95 [0.81,1.12] 1.06 [0.91,1.23] 0.92* [0.86,0.99] 0.98 [0.94,1.02] 0.93*** [0.90,0.95]
(AME = -0.01) (AME = 0.000) (AME = -0.006) (AME = -0.003) (AME = -0.007) (AME = 0.007) (AME = -0.63) (AME = -0.08) (AME = -0.278)
Ever CCNC 1.00 [0.68,1.47] 1.08 [0.88,1.33] 1.05 [0.86,1.29] 1.17 [0.86,1.59] 1.20* [1.01,1.42] 1.12 [0.95,1.33] 0.96 [0.85,1.08] 1.05 [0.98,1.12] 1.08* [1.01,1.16]
CCNC Early Adopter 1.28 [0.93,1.76] 1.02 [0.87,1.20] 1.11 [0.96,1.28] 1.19 [0.91,1.54] 1.14* [1.00,1.30] 1.05 [0.93,1.20] 1.09 [0.93,1.27] 0.95 [0.88,1.02] 1.05 [0.98,1.13]
Person-level controls
Age 1.01 [0.91,1.11] 0.99 [0.94,1.05] 0.95* [0.91,0.99] 0.96 [0.89,1.02] 0.95* [0.91,0.99] 0.94*** [0.91,0.97] 1.00 [0.99,1.01] 0.99* [0.98,1.00] 1.00 [0.99,1.01]
Age^2 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00* [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00* [1.00,1.00] 1.00 [1.00,1.00] 1.00** [1.00,1.00] 1.00 [1.00,1.00]
Male 0.90 [0.76,1.07] 1.01 [0.91,1.13] 0.93 [0.86,1.01] 0.77*** [0.67,0.87] 0.70*** [0.65,0.76] 0.77*** [0.72,0.82] 0.86*** [0.83,0.88] 0.80*** [0.79,0.81] 0.79*** [0.78,0.80]
Charlson Index 3.43*** [3.01,3.92] 3.19*** [2.93,3.47] 3.04*** [2.86,3.24] 1.88*** [1.69,2.09] 1.85*** [1.72,1.98] 1.87*** [1.77,1.97] 1.40*** [1.37,1.43] 1.42*** [1.40,1.43] 1.46*** [1.45,1.48]
Charlson Index^2 0.92*** [0.91,0.94] 0.93*** [0.92,0.94] 0.94*** [0.93,0.94] 0.96*** [0.95,0.97] 0.96*** [0.95,0.96] 0.96*** [0.95,0.96] 0.98*** [0.97,0.98] 0.98*** [0.97,0.98] 0.98*** [0.97,0.98]
Eligibility (omitted = subscriber)
Spouse 1.27* [1.01,1.61] 1.26** [1.08,1.46] 1.28*** [1.14,1.43] 0.92 [0.75,1.12] 0.97 [0.86,1.10] 0.97 [0.89,1.07] 1.07*** [1.03,1.11] 1.05*** [1.02,1.07] 1.08*** [1.06,1.10]
Other 1.51 [0.29,7.75] 2.67* [1.17,6.08] 0.63 [0.33,1.21] 0.59 [0.15,2.25] 1.08 [0.57,2.04] 0.47*** [0.30,0.73] 0.86 [0.64,1.16] 0.70*** [0.59,0.83] 0.80*** [0.72,0.89]
Plan Type (omitted = CMM)
Smart Choice 0.56*** [0.40,0.78] 0.76* [0.60,0.96] 0.82* [0.68,0.98] 0.70* [0.52,0.93] 0.70*** [0.59,0.85] 0.79** [0.69,0.92] 1.10** [1.04,1.17] 1.00 [0.96,1.04] 1.00 [0.97,1.03]
Smart Choice Basic 0.66* [0.46,0.94] 0.68** [0.53,0.87] 0.81* [0.67,0.98] 0.92 [0.69,1.24] 0.84 [0.70,1.02] 0.89 [0.77,1.04] 1.02 [0.96,1.09] 0.96* [0.92,1.00] 0.94*** [0.91,0.97]
Smart Choice Plus 0.79 [0.51,1.23] 1.14 [0.85,1.54] 1.28* [1.02,1.59] 0.78 [0.53,1.13] 0.98 [0.78,1.25] 0.97 [0.81,1.16] 1.28*** [1.19,1.38] 1.17*** [1.11,1.22] 1.14*** [1.10,1.18]
Practice and county-level controls
# Primary Care Providers — — 0.97 [0.90,1.05] 1.00 [1.00,1.01] — — 0.99 [0.93,1.05] 1.00 [1.00,1.01] — — 0.97*** [0.96,0.99] 1.00 [1.00,1.00]
Multisite Practice — — 0.74 [0.35,1.55] 0.91 [0.48,1.69] — — 1.09 [0.64,1.87] 0.80 [0.44,1.46] — — 1.28 [0.93,1.78] 1.12 [0.78,1.62]
Rural-Urban
Non-urban, Non-rural 1.10 [0.88,1.37] 1.04 [0.90,1.20] 1.13 [0.97,1.30] 1.08 [0.90,1.30] 1.16* [1.04,1.31] 1.20** [1.05,1.37] 1.08 [0.99,1.18] 0.97 [0.92,1.03] 1.07 [1.00,1.15]
Rural 1.08 [0.57,2.03] 0.82 [0.58,1.17] 0.94 [0.66,1.34] 0.71 [0.42,1.19] 0.95 [0.73,1.25] 1.27 [0.95,1.71] 1.15 [0.92,1.43] 0.94 [0.82,1.07] 0.94 [0.81,1.09]
Community-based Practice 0.82 [0.52,1.30] 0.85 [0.67,1.07] 0.85* [0.73,1.00] 0.77 [0.52,1.13] 0.79* [0.64,0.96] 0.96 [0.83,1.12] 0.88 [0.73,1.07] 0.81*** [0.73,0.90] 0.88** [0.82,0.96]
County Proportion Poverty 1.85 [0.10,32.75] 0.49 [0.08,2.86] 1.13 [0.22,5.78] 0.23 [0.02,2.39] 0.85 [0.20,3.65] 0.31 [0.07,1.33] 1.97 [0.80,4.83] 1.30 [0.74,2.30] 3.28*** [1.99,5.41]
Primary Care Providers/10,000 Population0.97 [0.94,1.00] 0.99 [0.98,1.01] 1.00 [0.99,1.01] 1.01 [0.99,1.03] 0.99 [0.98,1.00] 1.00 [0.99,1.01] 1.00 [0.99,1.01] 1.00 [0.99,1.00] 1.00 [1.00,1.01]
County Proportion Race/Ethnicity
Non-white, not Hispanic 1.01 [0.46,2.23] 1.10 [0.67,1.81] 0.94 [0.61,1.42] 0.80 [0.42,1.50] 1.13 [0.75,1.69] 2.15*** [1.48,3.13] 1.01 [0.76,1.35] 1.09 [0.90,1.30] 0.98 [0.82,1.16]
Hispanic 2.09 [0.54,8.10] 0.87 [0.36,2.11] 0.88 [0.36,2.17] 0.63 [0.20,1.98] 0.61 [0.30,1.25] 1.28 [0.56,2.93] 2.27** [1.31,3.93] 0.84 [0.59,1.19] 1.22 [0.83,1.81]
Year
2005 1.05 [0.75,1.47] 0.93 [0.74,1.17] 1.06 [0.89,1.26] 1.31 [0.99,1.72] 1.17 [0.98,1.41] 1.20* [1.04,1.38] 0.95 [0.90,1.01] 0.94** [0.90,0.97] 0.97* [0.94,0.99]
2006 0.97 [0.69,1.36] 0.93 [0.74,1.17] 1.15 [0.96,1.37] 1.28 [0.98,1.69] 1.20* [1.00,1.45] 1.19* [1.03,1.37] 0.91** [0.85,0.96] 0.91*** [0.88,0.95] 0.95*** [0.92,0.98]
2007 1.25 [0.90,1.74] 0.80 [0.64,1.01] 1.10 [0.92,1.32] 1.29 [0.99,1.69] 1.20* [1.00,1.44] 1.16* [1.01,1.34] 1.00 [0.95,1.07] 0.95** [0.91,0.98] 0.99 [0.96,1.02]
2008 1.09 [0.78,1.54] 0.83 [0.66,1.05] 1.00 [0.83,1.20] 1.34* [1.02,1.75] 1.23* [1.03,1.48] 1.23** [1.07,1.42] 0.97 [0.91,1.03] 0.94** [0.90,0.98] 0.99 [0.96,1.02]
Constant 0.03** [0.00,0.34] 0.06*** [0.01,0.25] 0.10*** [0.03,0.27] 0.71 [0.14,3.73] 0.91 [0.34,2.46] 0.64 [0.30,1.34] 1.90** [1.25,2.89] 4.17*** [3.26,5.35] 1.84*** [1.51,2.25]
Average practice intercept 0.33*** [0.19,0.55] 0.25*** [0.15,0.40] 0.25*** [0.19,0.32] 0.36*** [0.27,0.49] 0.35*** [0.29,0.41] 0.31*** [0.26,0.36] 0.44*** [0.41,0.47] 0.35*** [0.33,0.37] 0.25*** [0.23,0.28]
N 7850 20393 35070 7850 20393 35070 7850 20393 35070
Notes : PCP is primary care provider. Logit models used for IP and ED visits. Zero-truncated Poisson with reintroduced zeros used for PCP and OP vists. Robust OLS used for Continuity of Care.
Continuity of Care  models only for patients with >=3 OP visits during the year.
*p<0.05,**p<0.01,***p<0.001
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Table 5.13a: Continued 
 
# Total OP Visits Continuity of Care
Small (1 PCP) Medium (2-3 PCP) Large (>3 PCP) Small (1 PCP) Medium (2-3 PCP) Large (>3 PCP)
IRR 95% CI IRR 95% CI IRR 95% CI Coeff. 95% CI Coeff. 95% CI Coeff. 95% CI
CCNC 0.93** [0.88,0.98] 0.97 [0.95,1.00] 0.95*** [0.92,0.97] 0.0189 [-0.0151,0.0529] 0.0002 [-0.0207,0.0210] -0.0241* [-0.0451,-0.0031]
(AME = -0.51) (AME = -0.18) (AME = -0.372) (AME = 0.0126) (AME = -0.006) (AME = -0.0172)
Ever CCNC 0.93 [0.84,1.02] 1.04 [0.99,1.10] 1.05 [1.00,1.10] 0.005 [-0.0340,0.0441] 0.0219 [-0.0012,0.0450] 0.0558*** [0.0291,0.0825]
CCNC Early Adopter 1.09 [0.97,1.24] 0.92** [0.87,0.97] 0.97 [0.92,1.02] 0.017 [-0.0215,0.0555] 0.0210* [0.0019,0.0402] 0.0091 [-0.0099,0.0281]
Person-level controls
Age 0.98*** [0.97,0.99] 0.97*** [0.97,0.98] 0.99*** [0.98,0.99] 0.0088* [0.0001,0.0176] 0.0180*** [0.0129,0.0230] 0.0101*** [0.0060,0.0143]
Age^2 1.00*** [1.00,1.00] 1.00*** [1.00,1.00] 1.00*** [1.00,1.00] -0.0001* [-0.0002,-0.0000] -0.0002*** [-0.0003,-0.0001] -0.0001*** [-0.0002,-0.0001]
Male 0.79*** [0.78,0.81] 0.76*** [0.75,0.77] 0.76*** [0.75,0.77] 0.0796*** [0.0619,0.0973] 0.0743*** [0.0643,0.0843] 0.0662*** [0.0568,0.0756]
Charlson Index 1.44*** [1.42,1.46] 1.43*** [1.42,1.45] 1.48*** [1.47,1.49] -0.0542*** [-0.0650,-0.0434] -0.0557*** [-0.0635,-0.0478] -0.0495*** [-0.0566,-0.0423]
Charlson Index^2 0.98*** [0.98,0.98] 0.98*** [0.98,0.98] 0.98*** [0.98,0.98] 0.0028*** [0.0015,0.0041] 0.0030*** [0.0021,0.0039] 0.0029*** [0.0022,0.0037]
Eligibility (omitted = subscriber)
Spouse 1.09*** [1.06,1.12] 1.07*** [1.05,1.09] 1.11*** [1.10,1.12] -0.0109 [-0.0350,0.0133] -0.0276*** [-0.0430,-0.0122] -0.0257*** [-0.0378,-0.0135]
Other 0.93 [0.75,1.15] 0.72*** [0.64,0.82] 0.85*** [0.79,0.92] -0.041 [-0.2657,0.1837] 0.0077 [-0.0728,0.0882] -0.0282 [-0.0916,0.0352]
Plan Type (omitted = CMM)
Smart Choice 1.11*** [1.06,1.16] 1.02 [0.99,1.05] 1.03* [1.00,1.05] 0.0092 [-0.0225,0.0409] -0.0296* [-0.0544,-0.0049] -0.0062 [-0.0268,0.0143]
Smart Choice Basic 0.98 [0.93,1.03] 0.91*** [0.89,0.94] 0.93*** [0.91,0.95] 0.0422* [0.0065,0.0779] 0.0176 [-0.0082,0.0434] 0.0167 [-0.0049,0.0382]
Smart Choice Plus 1.33*** [1.26,1.41] 1.20*** [1.16,1.24] 1.17*** [1.14,1.20] -0.014 [-0.0578,0.0298] -0.0501** [-0.0822,-0.0181] -0.0244* [-0.0480,-0.0008]
Practice and county-level controls
# Primary Care Providers — — 0.98* [0.97,1.00] 1.00* [1.00,1.00] — — -0.0095* [-0.0172,-0.0018] 0 [-0.0004,0.0005]
Multisite Practice — — 1.36* [1.04,1.76] 0.95 [0.73,1.23] — — -0.078 [-0.1617,0.0057] 0.0843*** [0.0589,0.1098]
Rural-Urban
Non-urban, Non-rural 0.99 [0.92,1.07] 0.95* [0.90,0.99] 0.95 [0.91,1.00] 0.0135 [-0.0130,0.0400] 0.0017 [-0.0151,0.0186] 0.0316** [0.0110,0.0521]
Rural 1.12 [0.95,1.33] 0.91 [0.82,1.02] 0.85** [0.77,0.95] 0.0098 [-0.0574,0.0769] 0.0257 [-0.0142,0.0655] 0.0668** [0.0210,0.1126]
Community-based Practice 0.86* [0.74,0.99] 0.91* [0.83,0.99] 0.98 [0.92,1.03] 0.0696* [0.0110,0.1281] 0.0329 [-0.0028,0.0686] 0.0147 [-0.0115,0.0409]
County Proportion Poverty 2.64** [1.32,5.27] 0.91 [0.59,1.42] 1.25 [0.86,1.82] -0.1842 [-0.4763,0.1080] 0.0557 [-0.1414,0.2527] 0.1643 [-0.0412,0.3698]
Primary Care Providers/10,000 Population1.00 [0.99,1.01] 1.00 [0.99,1.00] 0.99** [0.99,1.00] -0.0006 [-0.0038,0.0026] 0.0004 [-0.0014,0.0021] 0.0009 [-0.0006,0.0025]
County Proportion Race/Ethnicity
Non-white, not Hispanic 0.91 [0.73,1.14] 1.02 [0.88,1.18] 0.92 [0.82,1.05] 0.0073 [-0.0780,0.0926] 0.0042 [-0.0525,0.0608] 0.0271 [-0.0265,0.0806]
Hispanic 1.67* [1.09,2.55] 0.68** [0.51,0.89] 0.76 [0.57,1.01] 0.2050** [0.0499,0.3600] 0.0573 [-0.0538,0.1684] 0.0542 [-0.0752,0.1836]
Year
2005 0.98 [0.94,1.03] 1.00 [0.97,1.03] 1.04*** [1.02,1.07] -0.0473** [-0.0761,-0.0184] -0.0494*** [-0.0710,-0.0278] -0.0271** [-0.0447,-0.0095]
2006 0.99 [0.94,1.03] 1.00 [0.96,1.03] 1.03** [1.01,1.06] -0.0582*** [-0.0866,-0.0298] -0.0577*** [-0.0799,-0.0354] -0.0395*** [-0.0571,-0.0218]
2007 1.11*** [1.06,1.16] 1.05** [1.02,1.08] 1.10*** [1.07,1.12] -0.0742*** [-0.1022,-0.0462] -0.0788*** [-0.1009,-0.0567] -0.0559*** [-0.0747,-0.0371]
2008 1.12*** [1.07,1.17] 1.05*** [1.02,1.09] 1.11*** [1.09,1.14] -0.0861*** [-0.1144,-0.0578] -0.0853*** [-0.1081,-0.0624] -0.0644*** [-0.0829,-0.0458]
Constant 4.93*** [3.60,6.75] 9.31*** [7.69,11.26] 5.52*** [4.77,6.39] 0.2739* [0.0612,0.4867] 0.1419* [0.0067,0.2771] 0.2364*** [0.1331,0.3398]
Average practice intercept 0.35*** [0.33,0.38] 0.28*** [0.27,0.30] 0.18*** [0.17,0.20] -2.4782*** [-2.6085,-2.3479] -2.5877*** [-2.6828,-2.4926] -2.7860*** [-2.8874,-2.6846]
N 7850 20393 35070 6830 17399 29573
Notes : PCP is primary care provider. Logit models used for IP and ED visits. Zero-truncated Poisson with reintroduced zeros used for PCP and OP vists. Robust OLS used for Continuity of Care.
Continuity of Care  models only for patients with >=3 OP visits during the year.
*p<0.05,**p<0.01,***p<0.001
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Table 5.13b: Average Marginal Effects of CCNC from Multi-Level and Fixed-Effects Models, by Practice Size 
 
 
 
 
Table 5.13b: Continued 
 
 
 
 
 
 
 
 
 
 
>=1 IP >=1 ED #PCP
Small (1 PCP) Medium (2-3 PCP) Large (>3 PCP) Small (1 PCP) Medium (2-3 PCP) Large (>3 PCP)
CCNC
MLM AME
̵  0.010
[-0.039,0.019]
0.000
[-0.015,0.015]
̵  0.006
[-0.020,0.0082]
̵  0.003
[-0.045,0.039]
̵  0.007
[-0.029,0.015]
0.007
[-0.010,0.024]
FE AME
̵  0.006
[-0.048,0.036]
̵  0.003
[-0.028,0.022]
 0.001
[-0.018,0.019] 
0.018
[-0.031,0.067]    
̵  0.009
[-0.038,0.019]
0.003
[-0.016,0.022]
Notes : For multi-level models: logit models used for IP and ED visits, zero-truncated Poisson with reintroduced zeros used for PCP and OP vists,
robust OLS used for Continuity of Care. For fixed-effects models: Cluster-robust LPMs used for IP and ED visits, OLS used for PCP and OP visits and 
Contintinuity of Care. Continuity of Care  models only for patients with >=3 OP visits during the year.
*p<0.05,**p<0.01,***p<0.001
#PCP #OP COC
Small (1 PCP) Medium (2-3 PCP) Large (>3 PCP) Small (1 PCP) Medium (2-3 PCP) Large (>3 PCP) Small (1 PCP) Medium (2-3 PCP) Large (>3 PCP)
CCNC
MLM AME
̵  0.63**
[-0.90,-0.36]
̵  0.08
[-0.22,0.06]
̵  0.278**
[-0.38,-0.17]
̵  0.51**
[-0.88,-0.14]
̵  0.18
[-0.372,0.012]
̵  0.372**
[-0.52,-0.22]
0.013
[-0.030,0.055]
̵  0.006
[-0.029,0.017]
̵  0.0172
[-0.0369,0.0025]
FE AME
 ̵  0.22
[-0.70,0.25]
̵  0.08
[-0.32,0.16]
̵  0.297*
[-0.547,-0.047]
̵  0.46
[-1.10,0.18]
̵  0.12
[-0.50,0.26]
̵  0.355*
[-0.673,-0.038]
0.0359
[-0.0015,0.0734]
̵  0.006
[-0.031,0.019]
̵  0.0242*
[-0.0463,-0.0021]
Notes : For multi-level models: logit models used for IP and ED visits, zero-truncated Poisson with reintroduced zeros used for PCP and OP vists,
robust OLS used for Continuity of Care. For fixed-effects models: Cluster-robust LPMs used for IP and ED visits, OLS used for PCP and OP visits and 
Contintinuity of Care. Continuity of Care  models only for patients with >=3 OP visits during the year.
*p<0.05,**p<0.01,***p<0.001
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Table 5.14a: Multi-Level Estimates of the Moderating Effect of CCNC Patient Load on Yearly Health Care Utilization, by Practice Size 
 
>=1 IP Admission >=1 ED Visit # PCP Visits # Total OP Visits
Small (1 PCP) Medium (2-3 PCP) Large (>3 PCP) Small (1 PCP) Medium (2-3 PCP) Large (>3 PCP) Small (1 PCP) Medium (2-3 PCP) Large (>3 PCP)
OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI IRR 95% CI IRR 95% CI IRR 95% CI
CCNC Patients (omitted = Very Low)
Low 0.58** [0.40,0.84] 1.04 [0.80,1.36] 0.89 [0.68,1.17] 0.99 [0.73,1.33] 1.08 [0.85,1.38] 0.97 [0.77,1.22] 0.97 [0.87,1.09] 0.99 [0.91,1.07] 0.97 [0.90,1.04]
(AME = -0.0408) (AME = 0.0033) (AME = -0.0087) (AME = -0.0020) (AME = 0.0107) (AME = -0.0044) (AME = -0.0993) (AME = -0.0489) (AME = -0.1184)
Medium 0.92 [0.55,1.54] 0.96 [0.73,1.26] 1.04 [0.78,1.38] 1.17 [0.77,1.76] 1.22 [0.95,1.56] 0.95 [0.74,1.21] 0.90 [0.77,1.06] 0.94 [0.87,1.03] 1.01 [0.93,1.10]
(AME = -0.0073) (AME = -0.0029) (AME = 0.0030) (AME = 0.0220) (AME = 0.0285) (AME = -0.0074) (AME = -0.3682) (AME = -0.2182) (AME = 0.0483)
High 1.29 [0.64,2.62] 1.00 [0.72,1.39] 1.13 [0.85,1.50] 1.34 [0.71,2.53] 1.22 [0.92,1.64] 1.09 [0.85,1.40] 0.82 [0.65,1.05] 0.90* [0.82,1.00] 1.00 [0.92,1.10]
(AME = 0.0241) (AME = 0.0002) (AME = 0.0101) (AME = 0.0428) (AME = 0.0295) (AME = 0.0126) (AME = -0.6756) (AME = -0.3748) (AME = 0.0088)
Very High 0.35* [0.13,0.92] 0.67* [0.48,0.93] 0.97 [0.74,1.27] 1.49 [0.79,2.81] 1.30 [0.99,1.73] 1.18 [0.93,1.49] 0.88 [0.70,1.11] 0.94 [0.85,1.04] 1.01 [0.92,1.10]
(AME = -0.067) (AME = -0.0268) (AME = -0.0022) (AME = 0.0607) (AME = 0.0393) (AME = 0.0234) (AME = -0.4548) (AME = -0.2475) (AME = 0.0302)
CCNC Early Adopter 1.36 [0.97,1.90] 1.06 [0.90,1.26] 1.08 [0.95,1.24] 1.24 [0.94,1.63] 1.12 [0.96,1.31] 1.01 [0.89,1.14] 1.08 [0.93,1.25] 0.96 [0.89,1.03] 1.04 [0.97,1.13]
Person-level controls
Age 1.07 [0.89,1.30] 0.99 [0.91,1.08] 0.99 [0.93,1.05] 1.06 [0.93,1.21] 0.95 [0.89,1.00] 0.94** [0.91,0.98] 1.01 [0.98,1.04] 0.98*** [0.96,0.99] 1.01** [1.00,1.02]
Age^2 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00*** [1.00,1.00] 1.00 [1.00,1.00]
Male 0.96 [0.69,1.34] 0.90 [0.76,1.06] 0.96 [0.86,1.07] 0.76* [0.59,0.97] 0.68*** [0.60,0.76] 0.77*** [0.71,0.84] 0.81*** [0.77,0.85] 0.79*** [0.77,0.81] 0.78*** [0.76,0.79]
Charlson Index 3.74*** [2.92,4.80] 3.30*** [2.91,3.75] 2.80*** [2.59,3.03] 1.85*** [1.52,2.25] 1.88*** [1.70,2.08] 1.78*** [1.66,1.90] 1.39*** [1.34,1.44] 1.42*** [1.39,1.45] 1.46*** [1.44,1.47]
Charlson Index^2 0.92*** [0.90,0.95] 0.93*** [0.91,0.94] 0.94*** [0.94,0.95] 0.97* [0.95,0.99] 0.95*** [0.94,0.97] 0.96*** [0.96,0.97] 0.98*** [0.97,0.98] 0.97*** [0.97,0.98] 0.98*** [0.98,0.98]
Eligibility (omitted = subscriber)
Spouse 1.66* [1.06,2.58] 1.56*** [1.24,1.96] 1.36*** [1.17,1.58] 0.84 [0.56,1.24] 1.03 [0.85,1.24] 0.94 [0.82,1.07] 1.21*** [1.12,1.30] 1.06** [1.02,1.10] 1.13*** [1.11,1.16]
Other 8.54 [0.32,224.82] 3.32* [1.10,10.08] 0.29 [0.08,1.03] 2.38 [0.16,35.74] 1.04 [0.41,2.61] 0.58 [0.33,1.04] 1.27 [0.57,2.83] 0.55*** [0.43,0.71] 0.98 [0.85,1.12]
Plan Type (omitted = CMM)
Smart Choice 0.89 [0.39,2.03] 0.67* [0.46,0.97] 0.81 [0.62,1.05] 0.55* [0.31,0.98] 0.56*** [0.42,0.74] 0.81 [0.66,1.00] 1.13 [0.99,1.29] 0.94* [0.89,1.00] 0.94** [0.91,0.98]
Smart Choice Basic 1.02 [0.44,2.37] 0.68* [0.46,0.99] 0.79 [0.60,1.03] 0.87 [0.49,1.56] 0.75 [0.57,1.00] 0.89 [0.72,1.11] 1.09 [0.96,1.25] 0.89*** [0.84,0.94] 0.87*** [0.84,0.91]
Smart Choice Plus 0.98 [0.35,2.74] 1.24 [0.79,1.97] 1.29 [0.95,1.76] 1.28 [0.63,2.63] 0.88 [0.61,1.26] 1.04 [0.80,1.33] 1.60*** [1.37,1.87] 1.11** [1.03,1.20] 1.06* [1.01,1.11]
Practice and county-level controls
# Primary Care Providers — — 1.02 [0.91,1.15] 1.00 [1.00,1.01] — — 1.01 [0.92,1.10] 1.00 [1.00,1.00] — — 0.99 [0.96,1.01] 1.00 [1.00,1.00]
Multisite Practice — — 0.60 [0.27,1.37] 0.91 [0.47,1.74] — — 1.05 [0.54,2.05] 0.71 [0.39,1.33] — — 1.16 [0.82,1.65] 1.11 [0.76,1.63]
Rural-Urban
Non-urban, Non-rural 0.73 [0.47,1.13] 1.03 [0.85,1.24] 1.17 [0.99,1.37] 1.19 [0.85,1.68] 1.09 [0.92,1.30] 1.22* [1.05,1.42] 0.89 [0.75,1.06] 0.95 [0.88,1.03] 1.06 [0.97,1.16]
Rural 0.99 [0.40,2.47] 1.02 [0.68,1.52] 0.93 [0.63,1.37] 0.56 [0.26,1.21] 0.90 [0.64,1.28] 1.50** [1.10,2.03] 0.81 [0.59,1.10] 0.96 [0.82,1.13] 0.93 [0.79,1.11]
Community-based Practice 1.08 [0.30,3.88] 1.03 [0.70,1.51] 0.89 [0.74,1.07] 0.57 [0.24,1.37] 0.83 [0.58,1.19] 0.97 [0.81,1.16] 1.01 [0.71,1.42] 1.08 [0.91,1.29] 1.00 [0.89,1.13]
County Proportion Poverty 90.86 [0.37,22075.23] 0.17 [0.01,2.16] 0.16 [0.02,1.08] 0.27 [0.00,18.58] 0.52 [0.06,4.88] 0.12* [0.02,0.65] 7.48* [1.37,40.90] 1.12 [0.51,2.48] 2.99*** [1.57,5.69]
Primary Care Providers/10,000 Population 0.98 [0.91,1.04] 0.99 [0.96,1.02] 1.00 [0.98,1.01] 1.00 [0.95,1.05] 1.00 [0.97,1.02] 1.01 [1.00,1.02] 1.00 [0.98,1.03] 0.99 [0.98,1.00] 1.00 [0.99,1.01]
County Proportion Race/Ethnicity
Non-white, not Hispanic 0.76 [0.14,4.02] 1.71 [0.84,3.49] 1.34 [0.80,2.22] 0.46 [0.13,1.68] 1.32 [0.71,2.45] 3.05*** [1.95,4.77] 0.70 [0.40,1.22] 1.11 [0.87,1.41] 0.96 [0.77,1.20]
Hispanic 1.49 [0.14,16.07] 2.52 [0.79,8.08] 1.14 [0.41,3.17] 0.12* [0.02,0.88] 0.83 [0.30,2.29] 1.94 [0.75,4.96] 1.78 [0.68,4.62] 0.83 [0.54,1.30] 1.57 [0.94,2.63]
Year
2005 0.76 [0.06,9.04] 1.52 [0.57,4.06] 1.12 [0.76,1.66] 0.66 [0.10,4.31] 1.18 [0.56,2.48] 1.22 [0.91,1.65] 0.96 [0.60,1.53] 0.90 [0.77,1.05] 0.86*** [0.81,0.91]
2006 0.57 [0.05,6.76] 1.34 [0.50,3.57] 1.29 [0.88,1.90] 0.65 [0.10,4.26] 1.28 [0.61,2.67] 1.16 [0.86,1.55] 0.94 [0.59,1.51] 0.90 [0.77,1.05] 0.86*** [0.81,0.91]
2007 0.91 [0.08,10.63] 1.19 [0.45,3.17] 1.26 [0.86,1.85] 0.53 [0.08,3.45] 1.28 [0.61,2.67] 1.18 [0.88,1.58] 1.12 [0.70,1.79] 0.92 [0.79,1.08] 0.88*** [0.83,0.93]
2008 0.87 [0.07,10.17] 1.29 [0.49,3.42] 1.05 [0.71,1.55] 0.59 [0.09,3.85] 1.22 [0.59,2.54] 1.24 [0.93,1.66] 1.07 [0.67,1.72] 0.91 [0.78,1.07] 0.88*** [0.83,0.93]
Constant 0.01 [0.00,1.09] 0.03** [0.00,0.33] 0.04*** [0.01,0.19] 0.31 [0.01,13.61] 1.05 [0.20,5.51] 0.62 [0.23,1.70] 1.18 [0.47,2.98] 5.45*** [3.62,8.19] 1.50** [1.13,1.99]
Average practice intercept 0.00 [0.00,0.00] 0.05 [0.00,15435.99] 0.18*** [0.10,0.31] 0.27** [0.10,0.71] 0.39*** [0.31,0.49] 0.26*** [0.20,0.33] 0.35*** [0.30,0.42] 0.32*** [0.29,0.35] 0.26*** [0.23,0.29]
N 2139 9050 18500 2139 9050 18500 2139 9050 18500
Notes : PCP is primary care provider. Logit models used for IP and ED visits. Zero-truncated Poisson with reintroduced zeros used for PCP and OP vists. Robust OLS used for Continuity of Care.
Continuity of Care  models only for patients with >=3 OP visits during the year.
*p<0.05,**p<0.01,***p<0.001
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Table 5.14a: Continued 
 
# Total OP Visits Continuity of Care
Small (1 PCP) Medium (2-3 PCP) Large (>3 PCP) Small (1 PCP) Medium (2-3 PCP) Large (>3 PCP)
IRR 95% CI IRR 95% CI IRR 95% CI Coeff. 95% CI Coeff. 95% CI Coeff. 95% CI
CCNC Patients (omitted = Very Low)
Low 0.92 [0.84,1.01] 0.93* [0.87,0.99] 0.99 [0.94,1.04] 0.0055 [-0.0352,0.0461] 0.0424** [0.0124,0.0723] 0.0291 [-0.0006,0.0587]
(AME = -0.5565) (AME = -0.4923) (AME = -0.0570) (AME = -0.0001) (AME = 0.0507) (AME = 0.0223)
Medium 0.91 [0.80,1.03] 0.89** [0.84,0.96] 0.98 [0.92,1.04] -0.0119 [-0.0608,0.0371] 0.0548*** [0.0240,0.0855] 0.0496** [0.0200,0.0792]
(AME = -0.6404) (AME = -0.7474) (AME = -0.1179) (AME = -0.0193) (AME = 0.0631) (AME = 0.0446)
High 0.81* [0.67,0.98] 0.88** [0.81,0.95] 0.98 [0.92,1.05] 0.0571 [-0.0471,0.1614] 0.0702*** [0.0349,0.1055] 0.0384** [0.0092,0.0676]
(AME = -1.3392) (AME = -0.8627) (AME = -0.1287) (AME = 0.0748) (AME = 0.0859) (AME = 0.0348)
Very High 0.80* [0.66,0.96] 0.89** [0.82,0.97] 0.96 [0.90,1.02] 0.0491 [-0.0240,0.1222] 0.0803*** [0.0464,0.1141] 0.0486*** [0.0196,0.0775]
(AME = -1.4458) (AME = -0.7779) (AME = -0.3046) (AME = 0.0794) (AME = 0.0875) (AME = 0.0449)
CCNC Early Adopter 1.05 [0.93,1.19] 0.95 [0.89,1.01] 0.97 [0.92,1.02] 0.0279 [-0.0123,0.0681] 0.0107 [-0.0094,0.0308] 0.008 [-0.0112,0.0273]
Person-level controls
Age 0.97** [0.95,0.99] 0.97*** [0.96,0.97] 1.00 [0.99,1.00] 0.0074 [-0.0071,0.0219] 0.0172*** [0.0096,0.0247] 0.0095*** [0.0042,0.0148]
Age^2 1.00*** [1.00,1.00] 1.00*** [1.00,1.00] 1.00** [1.00,1.00] -0.0001 [-0.0002,0.0001] -0.0002*** [-0.0003,-0.0001] -0.0001*** [-0.0002,-0.0001]
Male 0.75*** [0.72,0.78] 0.74*** [0.72,0.75] 0.75*** [0.74,0.76] 0.0661*** [0.0369,0.0952] 0.0828*** [0.0676,0.0980] 0.0672*** [0.0543,0.0802]
Charlson Index 1.41*** [1.38,1.45] 1.44*** [1.42,1.46] 1.48*** [1.46,1.49] -0.0495*** [-0.0686,-0.0304] -0.0545*** [-0.0659,-0.0432] -0.0430*** [-0.0530,-0.0330]
Charlson Index^2 0.98*** [0.98,0.98] 0.98*** [0.98,0.98] 0.98*** [0.98,0.98] 0.0014 [-0.0006,0.0034] 0.0026*** [0.0012,0.0040] 0.0025*** [0.0016,0.0034]
Eligibility (omitted = subscriber)
Spouse 1.12*** [1.06,1.19] 1.06*** [1.03,1.09] 1.15*** [1.13,1.17] 0.0081 [-0.0385,0.0548] -0.0266* [-0.0510,-0.0021] -0.0315*** [-0.0474,-0.0156]
Other 1.48 [0.89,2.47 0.53*** [0.44,0.64] 0.96 [0.87,1.07] -0.1598* [-0.3030,-0.0165] 0.028 [-0.1151,0.1710] -0.0058 [-0.0926,0.0809]
Plan Type (omitted = CMM)
Smart Choice 1.12* [1.01,1.24] 0.94** [0.89,0.98] 0.98 [0.95,1.01] 0.0287 [-0.0368,0.0943] -0.0218 [-0.0593,0.0156] 0.0012 [-0.0240,0.0264]
Smart Choice Basic 1.04 [0.94,1.15] 0.84*** [0.80,0.87] 0.89*** [0.86,0.91] 0.0462 [-0.0299,0.1223] 0.022 [-0.0175,0.0615] 0.0222 [-0.0046,0.0491]
Smart Choice Plus 1.49*** [1.32,1.68] 1.13*** [1.07,1.20] 1.11*** [1.07,1.15] 0.0238 [-0.0721,0.1197] -0.0533* [-0.1038,-0.0029] -0.0185 [-0.0491,0.0122]
Practice and county-level controls
# Primary Care Providers — — 0.98 [0.96,1.00] 1.00 [1.00,1.00] — — -0.0067 [-0.0176,0.0041] -0.0002 [-0.0008,0.0004]
Multisite Practice — — 1.35* [1.02,1.80] 0.88 [0.68,1.14] — — -0.0718 [-0.1717,0.0280] 0.1021** [0.0367,0.1675]
Rural-Urban
Non-urban, Non-rural 0.85* [0.73,0.98] 0.91** [0.85,0.97] 0.94* [0.88,1.00] 0.0023 [-0.0435,0.0480] 0.0118 [-0.0105,0.0341] 0.0351** [0.0102,0.0600]
Rural 0.76* [0.59,0.99] 0.91 [0.79,1.03] 0.82** [0.73,0.93] 0.0409 [-0.0540,0.1357] 0.0366 [-0.0076,0.0809] 0.0564* [0.0050,0.1079]
Community-based Practice 1.04 [0.78,1.40] 1.09 [0.94,1.27] 1.01 [0.93,1.09] -0.0211 [-0.1079,0.0658] -0.0306 [-0.0890,0.0279] 0.0052 [-0.0305,0.0410]
County Proportion Poverty 11.97***[3.08,46.56] 0.92 [0.49,1.75] 1.13 [0.70,1.83] -0.4902 [-1.0071,0.0268] -0.0133 [-0.3115,0.2849] 0.1201 [-0.1319,0.3720]
Primary Care Providers/10,000 Population 1.01 [0.99,1.03] 1.00 [0.99,1.01] 0.99** [0.99,1.00] 0.0058 [-0.0017,0.0133] 0.0007 [-0.0024,0.0037] 0.0002 [-0.0018,0.0023]
County Proportion Race/Ethnicity
Non-white, not Hispanic 0.58* [0.37,0.92] 1.02 [0.83,1.24] 0.93 [0.80,1.09] 0.1081 [-0.0671,0.2832] 0.0006 [-0.0797,0.0809] 0.0313 [-0.0298,0.0925]
Hispanic 0.68 [0.30,1.52] 0.69* [0.48,0.99] 0.93 [0.65,1.34] 0.4660** [0.1846,0.7475] 0.023 [-0.1052,0.1512] 0.0123 [-0.1389,0.1635]
Year
2005 1.56* [1.06,2.29] 0.99 [0.87,1.12] 1.02 [0.97,1.06] -0.0161 [-0.2915,0.2594] -0.0951** [-0.1590,-0.0312] -0.0330** [-0.0540,-0.0119]
2006 1.60* [1.09,2.35] 1.00 [0.89,1.14] 1.03 [0.98,1.07] -0.0046 [-0.2735,0.2643] -0.0861** [-0.1497,-0.0224] -0.0406*** [-0.0608,-0.0203]
2007 1.88** [1.28,2.76] 1.05 [0.92,1.19] 1.07** [1.02,1.12] -0.0431 [-0.3153,0.2291] -0.1131*** [-0.1761,-0.0502] -0.0605*** [-0.0797,-0.0412]
2008 1.90*** [1.30,2.79] 1.05 [0.93,1.19] 1.08*** [1.04,1.13] -0.0503 [-0.3191,0.2185] -0.1190*** [-0.1826,-0.0554] -0.0678*** [-0.0880,-0.0477]
Constant 2.75** [1.34,5.66] 11.45***[8.30,15.79] 4.53*** [3.70,5.56] 0.3018 [-0.1425,0.7461] 0.2416* [0.0229,0.4603] 0.2473*** [0.1161,0.3786]
Average practice intercept 0.31*** [0.27,0.37] 0.27*** [0.25,0.30] 0.18*** [0.16,0.20] -2.7246*** [-3.0750,-2.3742] -2.7958*** [-2.9569,-2.6347] -2.9092*** [-3.0558,-2.7625]
N 2139 9050 18500 1838 7652 15643
Notes : PCP is primary care provider. Logit models used for IP and ED visits. Zero-truncated Poisson with reintroduced zeros used for PCP and OP vists. Robust OLS used for Continuity of Care.
Continuity of Care  models only for patients with >=3 OP visits during the year.
*p<0.05,**p<0.01,***p<0.001
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Table 5.14b: Average Marginal Moderating Effects of CCNC Patient Load from Multi-Level and Fixed-Effects Models, by Practice Size 
 
 
 
 
 
 
 
 
 
 
 
 
>=1 IP >=1 ED #PCP #OP COC
Small (1 PCP) Medium (2-3 PCP) Large (>3 PCP) Small (1 PCP) Medium (2-3 PCP) Large (>3 PCP) Small (1 PCP) Medium (2-3 PCP) Large (>3 PCP) Small (1 PCP) Medium (2-3 PCP) Large (>3 PCP) Small (1 PCP) Medium (2-3 PCP) Large (>3 PCP)
CCNC Patients (omitted=Very Low)
Low
MLM AME
̵  0.041**
[-0.065,-0.017]
0.003
[-0.018,0.024]
̵  0.0087
[-0.028,0.011]
̵  0.002
[-0.043,0.039]
0.011
[-0.025,0.046]
̵  0.004
[-0.036,0.027]
̵  0.10
[-0.53,0.34]
̵  0.05
[-0.36,0.26]
̵  0.12
[-0.39,0.15]
̵  0.557
[-1.144,0.032]
̵  0.492*
[-0.904,-0.081]
̵  0.06
[-0.41,0.29]
̵  0.000
[-0.039,0.039]
0.051**
[0.021,0.081]
0.0223
[-0.0095,0.0541]
FE AME
 ̵  0.0472*
[-0.0924,-0.0019]
 0.0213
[-0.0316,0.0743]  
 0.0026
[-0.0525,0.0577] 
̵  0.0628
[-0.1426,0.0170]
 ̵  0.0350
[-0.1046,0.0347]
̵  0.0197
[-0.0825,0.0432]
0.08
[-0.83,0.99] 
 0.398
[-0.060,0.856]  
 ̵  0.15
[-0.42 ,0.12]
 ̵  0.60
[-1.97,0.77]
  0.47
[-0.33,1.27]  
 0.10
[-0.62,0.82]    
 0.049
[-0.018,0.115]
0.034
[-0.050,0.118] 
 0.018
[-0.033,0.069]
Medium
MLM AME
̵  0.007
[-0.047,0.032]
̵  0.003
[-0.021,0.015]
0.003
[-0.018,0.023]
0.022
[-0.032,0.076]
0.0285
[-0.0056,0.0626]
̵  0.007
[-0.037,0.022]
̵  0.37
[-0.88,0.15]
̵  0.218
[-0.509,0.072]
0.05
[-0.25,0.34]
̵  0.640
[-1.371,0.091]
̵  0.75**
[-1.14,-0.35]
̵  0.12
[-0.48,0.25]
̵  0.019
[-0.071,0.032]
0.063**
[0.035,0.091]
0.045**
[0.014,0.075]
FE AME
 ̵  0.0012
[-0.1015,0.0991]
 0.0705*
[0.0064,0.1346]  
0.0196
[-0.0459,0.0851]    
̵  0.1477*
[-0.2716,-0.0238]
 0.0206
[-0.0666,0.1078] 
̵  0.0328
[-0.1081,0.0426]
̵  0.48
[-1.85,0.89]
0.36
[-0.35,1.07]
0.02
[-0.36,0.39]  
 ̵  0.86
[-3.12,1.40]
0.58
[-0.44,1.61]
 0.19
[-0.67,1.04]     
 0.054
[-0.052,0.161]
0.028
[-0.060,0.117]       
0.013
[-0.050,0.075]
High
MLM AME
0.024
[-0.065,0.113]
0.000
[-0.029,0.030]
0.010
[-0.019,0.039]
0.043
[-0.077,0.162]
0.030
[-0.023,0.082]
0.013
[-0.029,0.055]
̵  0.68
[-1.60,0.25]
̵  0.375
[-0.785,0.036]
0.01
[-0.38,0.40]
̵  1.339*
[-2.650,-0.028]
̵  0.86**
[-1.44,-0.29]
̵  0.13
[-0.62,0.36]
0.075
[-0.023,0.172]
0.086**
[0.044,0.128]
0.0348
[-0.0047,0.0742]
FE AME
0.0729
[-0.0617,0.2074]
 0.0440
[-0.0321,0.1201]   
0.0211
[-0.0491,0.0913]
   ̵  0.3214**
[-0.5350,-0.1078]
̵  0.0068
[-0.1166,0.1030]
 ̵  0.0300
[-0.1121,0.0522]
̵  1.61 
[-3.59,0.37]
0.09
[-0.69,0.87]
̵  0.05
[-0.55,0.44]
  ̵  1.41
[-4.69,1.87]
  0.53
[-0.66,1.72]  
0.25
[-0.69,1.18] 
 ̵  0.01
[-0.23,0.21]
0.00
[-0.10,0.10]
̵  0.010
[-0.078,0.059]
Very High
MLM AME
̵  0.067*
[-0.119,-0.015]
̵  0.0268*
[-0.0478,-0.0058]
̵  0.002
[-0.025,0.020]
0.061
[-0.053,0.174]
0.0393
[-0.0085,0.0871]
0.023
[-0.014,0.061]
̵  0.45
[-1.32,0.41]
̵  0.25
[-0.65,0.16]
0.030
[-0.340.40]
̵  1.45*
[-2.60,-0.29]
̵  0.78**
[-1.34,-0.21]
̵  0.30
[-0.75,0.14]
0.079
[-0.013,0.171]
0.088**
[0.049,0.126]
0.0449*
[0.0098,0.0800]
FE AME
  ̵  0.0353
[-0.1890,0.1183]
 0.0411
[-0.0424,0.1246]       
0.0183
[-0.0525,0.0891]
  ̵  0.3046**
[-0.4872,-0.1221]
 0.0078
[-0.1193,0.1348]
  -0.0509
[-0.1355,0.0338] 
̵  1.39
[-3.23,0.45]
0.19
[-0.71,1.09]
  ̵  0.01
[-0.54,0.52]
̵  1.81
[-5.31,1.70]
  0.67
[-0.68,2.02] 
 0.19
[-0.84,1.22]
 0.03
[-0.18,0.25]
0.018
[-0.090,0.126]
̵  0.010
[-0.082,0.062]
Notes : For multi-level models: logit models used for IP and ED visits, zero-truncated Poisson with reintroduced zeros used for PCP and OP vists, 
robust OLS used for Continuity of Care. For fixed-effects models: Cluster-robust LPMs used for IP and ED visits, OLS used for PCP and OP visits and 
Contintinuity of Care. Continuity of Care  models only for patients with >=3 OP visits during the year.
*p<0.05,**p<0.01,***p<0.001
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Table 5.15a: Multi-Level Estimates of the Effect of CCNC on SHP Paid Medical Expenditures, by Practice Size 
 
 
 
 
Total IP ED OP
Small (1 PCP) Medium (2-3 PCP) Large (>3 PCP) Small (1 PCP) Medium (2-3 PCP) Large (>3 PCP) Small (1 PCP) Medium (2-3 PCP) Large (>3 PCP)
Coef. 95% CI Coef. 95% CI Coef. 95% CI Coef. 95% CI Coef. 95% CI Coef. 95% CI OR 95% OR 95% OR 95%
CCNC 557.58 [-1682.00,2797.17] 332.42 [-674.40,1339.24] 59.54 [-923.24,1042.32] 158.88 [-1164.44,1482.20] 232.35 [-364.50,829.19] -355.70 [-966.00,254.59] ̵ 20.69 [-168.17,126.80] 27.52 [-56.08,111.11] 9.94 [-72.16,92.04]
(AME = 557.58) (AME = 332.42) (AME = 59.54) (AME = 158.88) (AME = 232.35) (AME = -355.71) (AME = -20.69) (AME = 27.52) (AME = 9.94)
Ever CCNC -1373.95 [-3699.85,951.94] -547.30 [-1604.12,509.53] -330.45 [-1447.69,786.78] -671.87 [-1942.63,598.90] 72.91 [-519.10,664.92] 311.94 [-314.08,937.95] ̵ 21.71 [-164.01,120.59] -4.46 [-89.67,80.76] 33.86 [-52.96,120.68]
CCNC Early Adopter 1513.60 [-677.12,3704.32] -140.34 [-987.14,706.47] 330.45 [-518.11,1179.00] 766.34 [-272.97,1805.66] -332.02 [-771.84,107.80] 294.17 [-108.42,696.76] 135.12* [17.50,252.73] 60.38 [-5.33,126.09] 13.16 [-46.14,72.47]
Person-level controls
Age 205.87 [-265.98,677.72] -44.54 [-300.29,211.21] -12.29 [-224.20,199.62] -62.41 [-360.53,235.72] -91.93 [-255.21,71.35] -113.92 [-252.86,25.02] -10.37 [-43.38,22.64] 4.35 [-17.62,26.32] -3.46 [-21.75,14.84]
Age^2 -2.05 [-7.08,2.98] 0.57 [-2.17,3.31] 0.32 [-1.95,2.59] 0.95 [-2.23,4.13] 1.03 [-0.72,2.78] 1.25 [-0.24,2.74] 0.05 [-0.30,0.40] 0.13 [-0.36,0.11] -0.05 [-0.25,0.14]
Male -402.85 [-1275.88,470.18] -343.62 [-815.34,128.10] -110.42 [-511.69,290.85] 266.08 [-278.48,810.63] 183.21 [-116.50,482.92] 359.05** [96.64,621.46] -22.54 [-82.91,37.82] -71.35*** [-111.78,-30.91] -68.21*** [-102.79,-33.62]
Charlson Index 5661.73*** [4923.69,6399.77] 4544.32*** [4119.92,4968.71] 5344.23*** [4997.13,5691.32] 2986.09*** [2520.05,3452.14] 1912.99*** [1642.33,2183.65] 1965.48*** [1738.16,2192.81] 257.24*** [205.63,308.84] 288.59*** [252.15,325.03] 323.63*** [293.69,353.58]
Charlson Index^2 342.08*** [246.85,437.31] 473.54*** [416.39,530.68] 460.52*** [416.59,504.46] -45.92 [-106.13,14.29] 115.83*** [79.33,152.33] 201.94*** [173.11,230.77] -5.13 [-11.80,1.53] -10.07*** [-14.97,-5.16] -11.88*** [-15.68,-8.09]
Eligibility (omitted = subscriber)
Spouse 5176.16*** [3874.71,6477.60] 3691.20*** [2950.81,4431.59] 1674.38*** [1061.40,2287.37] 1039.35* [223.16,1855.54] 944.66*** [472.68,1416.64] 369.57 [-31.69,770.83] 11.87 [-78.55,102.30] 141.60*** [78.05,205.15] 21.08 [-31.78,73.95]
Other 6119.56 [-2791.88,15031.00] 1528.16 [-3061.25,6117.56] -2351.28 [-5456.44,753.89] 3349.23 [-2276.74,8975.20] 863.08 [-2069.52,3795.69] -2006.57 [-4044.19,31.04] -313.44 [-936.32,309.45] 266.67 [-127.66,661.00] -14.16 [-282.33,254.01]
Plan Type (omitted = CMM)
Smart Choice -1812.84 [-3894.35,268.67] -1999.51** [-3203.61,-795.41] -894.02 [-1913.57,125.53] -1402.51* [-2713.90,-91.12 -1406.41*** [-2176.11,-636.70] -1086.61** [-1755.18,-418.03] -192.10** [-337.33,-46.87] -73.60 [-177.10,29.89] -63.43 [-151.45,24.59]
Smart Choice Basic -2767.77* [-4924.63,-610.92] -3275.54*** [-4513.29,-2037.78] -2158.70***[-3213.21,-1104.19] -1257.07 [-2615.87,101.73] -1844.58*** [-2636.24,-1052.92] -1471.50*** [-2163.06,-779.94] -129.91 [-280.39,20.57] -41.20 [-147.61,65.22] -16.55 [-107.60,74.49]
Smart Choice Plus 3793.64** [1114.46,6472.82] 2289.45** [726.92,3851.99] 2583.33*** [1295.97,3870.70] 1445.25 [-245.00,3135.50] 277.47 [-721.34,1276.28] -28.24 [-872.60,816.12] ̵ 207.40* [-394.57,-20.23] 138.55* [4.25,272.85] 114.37* [3.22,225.52]
Practice and county-level controls
# Primary Care Providers — — 109.93 [-258.71,478.57] 19.67 [-9.04,48.37] — — 39.98 [-169.20,249.15] 12.89 [-0.88,26.66] — — 11.32 [-18.60,41.25] 3.34** [1.27,5.42]
Multisite Practice — — -252.26 [-3718.43,3213.91] -1238.38 [-5024.94,2548.18] — — -455.66 [-2174.91,1263.59] -467.75 [-2249.35,1313.86] — — 39.72 [-223.37,302.81] -151.96 [-413.00,109.08]
Rural-Urban
Non-urban, Non-rural 1065.98 [-397.58,2529.54] 188.79 [-547.59,925.18] 129.50 [-744.13,1003.14] 486.72 [-239.78,1213.21] 176.99 [-206.29,560.27] 258.55 [-157.87,674.96] 55.54 [-26.38,137.46] 22.62 [-34.61,79.84] 72.28* [10.91,133.65]
Rural -1285.16 [-5023.31,2452.98] -348.86 [-2032.76,1335.03] -1553.22 [-3502.65,396.20] -948.40 [-2925.88,1029.08] 392.06 [-516.24,1300.36] -585.79 [-1628.24,456.66] -36.02 [-257.58,185.55] -121.70 [-254.52,11.11] 9.83 [-136.42,156.07]
Community-based Practice 749.13 [-2584.97,4083.24] -2352.47*** [-3687.48,-1017.45] -1552.10** [-2544.97,-559.23] 43.77 [-1570.78,1658.33] -65.83 [-742.08,610.43] -377.24 [-838.47,83.99] ̵ 108.61 [-291.73,74.50] 36.11 [-66.64,138.86] 24.67 [-44.25,93.59]
County Proportion Poverty 545.68 [-17566.81,18658.17] -5339.30 [-14385.70,3707.10] -11613.78* [-21249.45,-1978.10] 2073.32 [-7178.49,11325.14] 929.56 [-3852.71,5711.83] 89.36 [-4666.69,4845.41] -1679.86** [-2721.03,-638.69] -376.24 [-1084.97,332.48] -1504.73*** [-2200.10,-809.36]
Primary Care Providers/10,000 Population -34.30 [-210.19,141.60] -43.47 [-117.98,31.03] -21.30 [-79.00,36.40] -2.64 [-94.33,89.05] ̵ 3.13 [-41.00,34.73] 3.41 [-24.29,31.11] 2.34 [-7.95,12.63] -3.82 [-9.54,1.91] 0.27 [-3.79,4.34]
County Proportion Race/Ethnicity
Non-white, not Hispanic -589.77 [-5497.76,4318.22] -719.71 [-3222.63,1783.21] 142.29 [-2297.80,2582.38] -881.04 [-3391.04,1628.95] -658.26 [-1987.54,671.02] 34.44 [-1204.19,1273.06] 282.76* [0.49,565.02] 132.28 [-64.01,328.57] 357.72*** [179.95,535.49]
Hispanic 5168.29 [-3708.99,14045.57] -3624.86 [-8115.82,866.10] -5955.56* [-11344.21,-566.91] 1954.00 [-2474.15,6382.14] -883.43 [-3253.55,1486.68] -1556.31 [-4169.98,1057.37] 186.79 [-312.15,685.73] 95.53 [-255.72,446.77] 151.72 [-230.26,533.70]
Year
2005 999.97 [-843.66,2843.60] 726.97 [-383.69,1837.63] 1509.16** [599.84,2418.49] 288.37 [-839.40,1416.14] -178.00 [-873.73,517.73] 161.67 [-419.15,742.49] 243.68*** [118.48,368.88] 117.81* [23.32,212.30] 160.37*** [83.25,237.49]
2006 1881.39* [56.70,3706.08] 1286.40* [185.26,2387.55] 1820.12*** [913.93,2726.32] 301.02 [-810.88,1412.91] -207.87 [-894.64,478.90] 323.83 [-252.80,900.45] 261.20*** [137.73,384.66] 134.89** [41.40,228.39] 154.63*** [77.97,231.29]
2007 1488.81 [-303.32,3280.93] 1286.78* [197.52,2376.05] 1994.27*** [1081.41,2907.13] 326.15 [-759.31,1411.61] -372.65 [-1050.16,304.85] 332.87 [-244.62,910.37] 236.94*** [116.34,357.55] 166.41*** [74.04,258.78] 167.73*** [90.81,244.65]
2008 2006.71* [184.61,3828.80] 1751.46** [654.40,2848.52] 2296.55*** [1389.26,3203.84] 766.03 [-331.63,1863.69] -137.73 [-815.25,539.79] 418.69 [-155.94,993.32] 289.08*** [167.09,411.08] 208.21*** [115.51,300.91] 226.57*** [150.06,303.09]
Constant -6745.98 [-18662.99,5171.04] 6021.71 [-387.69,12431.11] 2651.53 [-2638.93,7941.99] -1000.74 [-8326.20,6324.73] 2410.3 [-1612.87,6433.47] 2055.27 [-1327.32,5437.85] 525.96 [-286.72,1338.64] -68.21 [-613.82,477.40] 116.87 [-331.78,565.51]
Average practice intercept 8.32*** [8.13,8.51] 7.73*** [7.55,7.92] 7.60*** [7.42,7.79] 6.93*** [6.06,7.80] 6.14*** [5.23,7.06] 6.26*** [5.92,6.59] 4.85*** [4.38,5.33] 4.92*** [4.70,5.14] 4.66*** [4.42,4.89]
N 7850 20393 35070 7850 20393 35070 7850 20393 35070
Notes : PCP is primary care provider. Bootstrapped OLS models used for all outcomes.
*p<0.05,**p<0.01,***p<0.001
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Table 5.15a: Continued 
 
 
 
 
OP RX
Small (1 PCP) Medium (2-3 PCP) Large (>3 PCP) Small (1 PCP) Medium (2-3 PCP) Large (>3 PCP)
OR 95% OR 95% OR 95% OR 95% OR 95% OR 95%
CCNC 284.20 [-1123.43,1691.84] 226.68 [-422.90,876.25 217.24 [-411.24,845.72] -40.09 [-394.15,313.98] ̵ 141.49 [-316.23,33.24] 27.73 [-134.88,190.33]
(AME = 284.20) (AME = 226.68) (AME = 217.24) (AME = -40.09) (AME = -141.49) (AME = 27.73)
Ever CCNC -728.84 [-2206.26,748.59] -482.44 [-1177.02,212.14] -733.21 [-1728.07,261.64] 147.62 [-242.21,537.44] ̵ 98.71 [-299.53,102.11] -38.96 [-237.53,159.61]
CCNC Early Adopter 555.47 [-856.61,1967.55] 233.03 [-336.37,802.43] 68.26 [-881.91,1018.42] -17.82 [-412.30,376.65] -116.91 [-294.66,60.84] -230.52** [-393.05,-67.99]
Person-level controls
Age 170.82 [-124.18,465.82] -36.71 [-198.86,125.44] -21.40 [-149.89,107.10] 134.09*** [61.29,206.90] 89.02*** [47.45,130.59] 136.92*** [102.54,171.31]
Age^2 -1.97 [-5.12,1.17] 0.50 [-1.24,2.23] 0.43 [-0.95,1.80] -1.37*** [-2.14,-0.59] -0.92*** [-1.36,-0.47] -1.42*** [-1.79,-1.05]
Male -724.26** [-1270.71,-177.81] -495.36** [-794.75,-195.96] -541.38*** [-785.28,-297.48] 91.98 [-43.45,227.41] 55.47 [-21.50,132.43] 140.63*** [75.46,205.80]
Charlson Index 1575.69*** [1114.22,2037.15] 1675.33*** [1406.20,1944.46 2247.86*** [2037.24,2458.48] 785.94*** [672.02,899.86] 654.91*** [585.87,723.95] 772.25*** [715.91,828.58]
Charlson Index^2 431.45*** [371.90,490.99] 377.15*** [340.92,413.38] 287.73*** [261.11,314.35] -35.34*** [-50.03,-20.64] -9.30* [-18.59,-0.01] -18.47*** [-25.60,-11.34]
Eligibility (omitted = subscriber)
Spouse 2939.31*** [2125.04,3753.57] 1776.93*** [1307.32,2246.54] 358.42 [-14.01,730.85] 1178.50*** [977.00,1380.01] 812.37*** [691.81,932.92] 888.91*** [789.38,988.44]
Other 106.01 [-5467.16,5679.18] -89.10 [-2998.61,2820.41] -1558.65 [-3444.42,327.12] 3243.74*** [1866.20,4621.28 652.96 [-92.98,1398.90] 1369.00*** [865.16,1872.83]
Plan Type (omitted = CMM)
Smart Choice -351.90 [-1653.72,949.91] -663.95 [-1427.09,99.20] 276.81 [-341.58,895.19] 164.14 [-157.58,485.86] 166.62 [-28.82,362.06] -4.29 [-169.72,161.15]
Smart Choice Basic -1253.68 [-2602.63,95.27] -1403.53*** [-2187.91,-619.16] -323.88 [-963.39,315.63] -82.17 [-415.55,251.21] 56.88 [-143.92,257.68] -322.15*** [-493.25,-151.05]
Smart Choice Plus 1479.96 [-195.43,3155.34] 900.43 [-89.89,1890.74] 2158.23*** [1377.77,2938.68] 991.56*** [577.74,1405.38] 1050.49*** [796.87,1304.10] 346.18** [137.32,555.04]
Practice and county-level controls
# Primary Care Providers — — 49.55 [-191.54,290.64] 6.18 [-16.26,28.62] — — 11.21 [-56.64,79.07] 6.61* [1.48,11.75]
Multisite Practice — — -302.43 [-2661.16,2056.29] -14410.08 [-6015.59,3133.43] — — 371.70 [-391.09,1134.50] 406.55 [-333.30,1146.40]
Rural-Urban
Non-urban, Non-rural 391.31 [-547.73,1330.35] 81.77 [-412.81,576.35] 189.85 [-748.30,1127.99] 148.55 [-108.99,406.08] -97.56 [-251.06,55.94] -121.05 [-287.05,44.95]
Rural 188.15 [-2198.94,2575.23] -505.04 [-1628.39,618.31] -181.77 [-2135.74,1772.21] -225.80 [-869.68,418.08] -104.90 [-448.41,238.61] -487.05** [-845.56,-128.55]
Community-based Practice 316.51 [-1819.33,2452.34] -2361.66*** [-3261.69,-1461.63] -2049.42*** [-3140.37,-958.47] 410.24 [-169.68,990.17] -253.46 [-535.01,28.08] -5.34 [-195.19,184.51]
County Proportion Poverty -286.37 [-11864.78,11292.04] -5090.15 [-11132.09,951.80] -10975.60* [-19761.06,-2190.14] -827.83 [-3949.98,2294.31] -324.85 [-2153.47,1503.77] -296.30 [-2071.74,1479.15]
Primary Care Providers/10,000 Population -70.63 [-183.06,41.79] -34.09 [-84.44,16.25] -13.93 [-76.55,48.69] 16.19 [-14.22,46.61] 6.75 [-9.14,22.63] -9.73 [-20.72,1.26]
County Proportion Race/Ethnicity
Non-white, not Hispanic 959.96 [-2180.88,4100.79] -53.13 [-1725.88,1619.61] 826.27 [-1631.47,3284.00] -647.36 [-1500.33,205.61] -348.59 [-859.55,162.37] -805.75*** [-1259.69,-351.81]
Hispanic 2869.72 [-2825.49,8564.93] -3180.74* [-6187.61,-173.86] -3702.61 [-9366.93,1961.71] 480.76 [-1081.26,2042.78] 378.58 [-547.69,1304.85] -1540.71** [-2559.87,-521.56]
Year
2005 52.50 [-1104.21,1209.20] 429.03 [-279.26,1137.32] 806.40** [218.58,1394.21] 504.41*** [214.67,794.14] 331.16*** [145.71,516.61] 468.42*** [318.55,618.29]
2006 911.86 [-233.46,2057.19] 841.55* [138.66,1544.45] 802.93** [210.57,1395.29] 527.72*** [240.33,815.11] 458.12*** [273.66,642.58] 630.90*** [481.21,780.59]
2007 356.17 [-769.23,1481.57] 812.06* [116.24,1507.89] 800.33** [194.36,1406.31] 687.30*** [404.45,970.15] 653.43*** [470.39,836.47] 775.06*** [623.75,926.38]
2008 448.51 [-696.47,1593.48] 1021.73** [319.51,1723.95] 989.10** [389.83,1588.38] 639.14*** [350.60,927.68] 643.60*** [457.70,829.50] 750.05*** [599.81,900.29]
Constant -3145.88 [-10621.05,4329.29] 5001.00* [913.53,9088.47] 3562.87* [26.26,7099.48] -3489.07*** [-5360.65,-1617.49] -1409.79* [-2482.53,-337.05] -2200.60***[-3075.23,-1325.98]
Average practice intercept 7.91*** [7.76,8.07] 7.43*** [7.28,7.59] 8.02*** [7.88,8.16] 6.74*** [6.63,6.86] 6.49*** [6.39,6.59] 6.07*** [5.95,6.20]
N 7850 20393 35070 7850 20393 35070
Notes : PCP is primary care provider. Bootstrapped OLS models used for all outcomes.
*p<0.05,**p<0.01,***p<0.001
  
 
1
1
0
 
Table 5.15b: Average Marginal Effects of CCNC from Multi-Level and Fixed-Effects Models 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total IP ED OP RX
Small (1 PCP) Medium (2-3 PCP) Large (>3 PCP) Small (1 PCP) Medium (2-3 PCP) Large (>3 PCP) Small (1 PCP) Medium (2-3 PCP) Large (>3 PCP) Small (1 PCP) Medium (2-3 PCP) Large (>3 PCP) Small (1 PCP) Medium (2-3 PCP) Large (>3 PCP)
CCNC
MLM AME
557.58
[-1696.34,2811.50]
332.42
[-680.85,1345.69]
59.54
[-929.53,1048.61]
158.88
[-1172.91,1490.67]
232.35
[-368.32,833.02]
̵  355.71
[-969.92,258.50]
̵  20.69
[-169.12,127.74]
27.52
[-56.61,111.65]
9.94
[-72.69,92.57]
284.20
[-1132.44,1700.84]
226.68
[-427.05,880.41]
217.24
[-415.27,849.75]
̵  40.09
[-396.42,316.24]
̵  141.49
[-317.34,34.36]
27.73
[-135.91,191.37]
FE AME
1030.84
[-1115.84,3177.53]
397.99
[-1246.27,2042.25]
̵  91.65
[-965.29,782.00]
334.03
[-945.38,1613.45]
181.15
[-1100.77,1463.08]
̵  290.55
[-889.78,308.69]
43.57
[-120.92,208.06]
44.23
[-43.28,131.73]
34.03
[-30.76,98.82]
 700.29
[-705.02,2105.61]
305.60
[-356.37,967.58
133.11
[-359.15,625.37]
̵  47.05
[-479.27,385.16]
̵  132.99
[-316.15,50.18]
31.58
[-126.97,190.12]
Notes : Bootstrapped OLS models used for all  outcomes.
*p<0.05,**p<0.01,***p<0.001
  
 
1
1
1
 
Table 5.16a: Multi-Level Estimates of the Moderating Effect of CCNC Patient Load on SHP Paid Medical Expenditures, by Practice Size 
 
Total IP ED OP
Small (1 PCP) Medium (2-3 PCP) Large (>3 PCP) Small (1 PCP) Medium (2-3 PCP) Large (>3 PCP) Small (1 PCP) Medium (2-3 PCP) Large (>3 PCP)
Coeff. 95% CI Coeff. 95% CI Coeff. 95% CI Coeff. 95% CI Coeff. 95% CI Coeff. 95% CI Coeff. 95% CI Coeff. 95% CI Coeff. 95% CI
CCNC Patients (omitted = Very Low)
Low -3069.63** [-4939.42,-1199.85] -1109.77 [-2411.39,191.86] 667.73 [-988.03,2323.49] -1409.39** [-2351.04,-467.75] 58.34 [-750.31,866.99] 768.26 [-181.68,1718.19] 25.99 [-100.26,152.24] 25.90 [-107.58,159.37] 3.40 [-121.86,128.66]
(AME = -3069.64) (AME = -1109.77) (AME = 667.73) (AME = -1409.40) (AME = 58.34) (AME = 768.26) (AME = 25.99) (AME = 25.90) (AME = 3.40)
Medium -3639.18** [-6320.14,-958.23] -1109.03 [-2430.29,212.24] 187.15 [-1560.31,1934.62] -1166.54 [-2524.03,190.96] 290.73 [-528.74,1110.19] 1052.50* [50.63,2054.36] 25.22 [-157.12,207.56] 60.70 [-75.35,196.74] -80.42 [-212.47,51.63]
(AME = -3639.18) (AME = -1109.03) (AME = 187.15) (AME = -1166.54) (AME = 290.73) (AME = 1052.50) (AME = 25.22) (AME = 60.70) (AME = -80.42)
High -3724.44 [-7826.63,377.75] -1045.98 [-2613.92,521.95] 1041.90 [-714.65,2798.45] -389.02 [-2453.47,1675.44] 268.44 [-703.21,1240.10] 1431.01** [425.58,2436.44] 85.02 [-191.39,361.42] 60.42 [-100.78,221.61] -14.59 [-147.13,117.96]
(AME = -3724.44) (AME = -1045.98) (AME = 1041.90) (AME = -389.02) (AME = 268.44) (AME = 1431.01) (AME = 85.02) (AME = 60.42) (AME = -14.59)
Very High -1712.32 [-5956.48,2531.83] -2187.43** [-3702.77,-672.09] -141.47 [-1806.02,1523.08] -859.72 [-3019.05,1299.61] -357.49 [-1297.66,582.68] 904.73 [-42.21,1851.68] 418.28** [128.00,708.57] 28.91 [-127.04,184.87] -7.03 [-131.91,117.85]
(AME = -1712.33) (AME = -2187.43) (AME = -141.47) (AME =  ̵ 859.72) (AME = -357.49) (AME = 904.73) (AME = 418.28) (AME = 28.91) (AME = -7.03)
CCNC Early Adopter 577.65 [-1168.39,2323.69] 222.43 [-578.59,1023.45] 193.83 [-678.56,1066.21] 842.68 [-21.24,1706.60] -240.11 [-734.37,254.14] 228.90 [-217.53,675.32] 132.80* [17.57,248.03] 57.90 [-25.61,141.41] -1.02 [-60.32,58.28]
Person-level controls
Age -196.98 [-998.41,604.46] -110.62 [-504.26,283.02] 31.51 [-275.29,338.32] 78.02 [-356.34,512.38] -134.15 [-386.99,118.70] -58.46 [-258.67,141.75] 16.06 [-43.41,75.53] 7.81 [-29.96,45.58] -3.26 [-29.46,22.94]
Age^2 2.67 [-5.96,11.31] 1.20 [-3.02,5.43] -0.26 [-3.55,3.03] -1.01 [-5.69,3.67] 1.42 [-1.30,4.13] 0.59 [-1.56,2.74] -0.18 [-0.82,0.46] ̵  0.2 [-0.61,0.20] -0.06 [-0.34,0.22]
Male -764.48 [-2274.84,745.89] -413.75 [-1141.44,313.95] -122.75 [-714.95,469.44] -95.7 [-912.53,721.14] 182.41 [-284.42,649.25] 449.75* [63.96,835.55] -24.15 [-135.92,87.62] -76.51* [-146.50,-6.53] -73.21** [-123.70,-22.72]
Charlson Index 5636.03*** [4339.05,6933.02] 4391.97*** [3719.07,5064.86] 6011.78*** [5524.35,6499.21] 2663.40*** [1959.48,3367.32] 1484.75*** [1052.58,1916.93] 2082.31*** [1764.45,2400.17] 212.68*** [116.25,309.10] 317.78*** [253.21,382.35] 333.68*** [292.08,375.28]
Charlson Index^2 405.51*** [236.92,574.09] 555.85*** [460.31,651.39] 342.77*** [283.80,401.75] 58.41 [-33.11,149.94] 221.65*** [160.26,283.05] 165.07*** [126.56,203.58] 6.17 [-6.37,18.71] -4.71 [-13.87,4.45] -11.53*** [-16.57,-6.50]
Eligibility (omitted = subscriber)
Spouse 6459.38*** [4053.36,8865.40] 5078.63*** [3896.74,6260.51] 2052.64*** [1143.69,2961.59] 2461.50*** [1159.96,3763.05] 1576.46*** [817.75,2335.18] 504.45 [-87.94,1096.85] 64.36 [-113.75,242.47] 284.74*** [171.21,398.27] -28.82 [-106.35,48.71]
Other -1211.00 [-21630.83,19208.82] -396.95 [-7328.88,6534.98] -3240.06 [-7790.43,1310.31] -712.77 [-11785.49,10359.96] -68.31 [-4521.41,4384.79] -2340.89 [-5313.80,632.02] -164.12 [-1680.81,1352.56] 82.73 [-582.42,747.89] ̵  6.18 [-395.20,382.84]
Plan Type (omitted = CMM)
Smart Choice 1911.98 [-2088.59,5912.55] -2281.81* [-4294.18,-269.43] -1182.66 [-2796.35,431.02] -228.50 [-2394.70,1937.71] -2115.86** [-3408.44,-823.28] -1197.22* [-2250.75,-143.69] -122.31 [-418.85,174.23] -146.96 [-340.03,46.11] -92.28 [-230.14,45.59]
Smart Choice Basic 738.91 [-3344.73,4822.55] -3376.28** [-5422.39,-1330.17] -2470.83** [-4126.79,-814.87] -704.23 [-2915.21,1506.74] -2570.64*** [-3885.12,-1256.16] -1649.53** [-2730.51,-568.54] -104.77 [-407.43,197.90] -80.32 [-276.57,115.92] -47.87 [-189.33,93.59]
Smart Choice Plus 7881.77** [2707.06,13056.48] 3976.97** [1397.76,6556.19] 2540.84* [565.67,4516.01] 1261.02 [-1541.38,4063.42] 1259.84 [-396.61,2916.29] -96.94 [-1386.20,1192.32] 82.88 [-300.75,466.52] 142.46 [-105.07,389.98] 150.32 [-18.40,319.04]
Practice and county-level controls
# Primary Care Providers — — 280.92 [-255.86,817.70] 41.18* [7.11,75.24] — — -69.62 [-406.70,267.47] 19.78* [2.55,37.02] — — 18.24 [-35.75,72.22] 1.75 [-0.55,4.05]
Multisite Practice — — -164.19 [-3447.34,3118.96] -1529.09 [-5488.21,2430.04] — — -728.02 [-2716.81,1260.77] -57.89 [-2153.43,2037.66] — — 136.30 [-217.96,490.57] -187.33 [-464.61,89.95]
Rural-Urban
Non-urban, Non-rural 13.83 [-2185.15,2212.82] -375.98 [-1267.20,515.24] -35.30 [-1093.83,1023.23] 596.67 [-500.30,1693.64] 57.23 [-491.19,605.66] 419.20 [-116.87,955.28] -23.93 [-170.71,122.85] -58.50 [-151.86,34.85] 58.17 [-13.15,129.48]
Rural -6241.16** [-10608.88,-1873.45] -498.35 [-2302.19,1305.49] -1236.46 [-3409.30,936.38] -2751.25* [-4977.16,-525.33] 306.13 [-813.89,1426.16] -547.09 [-1772.53,678.36] -72.59 [-372.01,226.84] -225.39* [-411.56,-39.23] 90.67 [-70.95,252.30]
Community-based Practice 1969.74 [-4198.74,8138.22] 1174.92 [-685.42,3035.26] -276.07 [-1535.82,983.68] -257.21 [-3520.03,3005.62] 328.34 [-807.62,1464.29] -316.41 [-941.24,308.41] -439.56 [-883.71,4.58] 58.45 [-139.20,256.11] 33.82 [-49.51,117.15]
County Proportion Poverty 28570.51* [1674.63,55466.38] -3406.31 [-15403.46,8590.85] -14270.90* [-26434.43,-2107.38] 15316.92* [1813.91,28819.92] 613.23 [-6817.11,8043.58] -4725.68 [-11164.18,1712.82] -875.75 [-2683.68,932.18] 120.72 [-1119.14,1360.58] ̵  1855.01*** [-2709.63,-1000.39]
Primary Care Providers/10,000 Population209.97 [-122.90,542.85] -151.04* [-286.24,-15.83] -38.99 [-116.21,38.23] 146.85 [-21.59,315.30] -25.27 [-109.14,58.61] -1.82 [-42.42,38.77] -6.49 [-29.10,16.12] -8.52 [-22.48,5.44] 0.24 [-5.14,5.63]
County Proportion Race/Ethnicity
Non-white, not Hispanic ̵  8324.60* [-16523.93,-125.27] -447.15 [-3746.71,2852.41] 1598.66 [-1507.94,4705.27] -5717.61** [-9832.44,-1602.78] -558.87 [-2607.74,1490.01] 946.64 [-738.14,2631.42] 130.94 [-419.57,681.45] 88.32 [-251.48,428.12] 610.60*** [387.67,833.54]
Hispanic -6257.69 [-18161.61,5646.22] 93.41 [-5354.32,5541.15] -1565.43 [-8085.87,4955.00] -4405.22 [-10303.03,1492.58] 483.03 [-2896.44,3862.49] -941.89 [-4341.85,2458.08] -401.52 [-1189.00,385.95] 123.70 [-438.49,685.89] 520.75* [69.68,971.82]
Year
2005 4965.78 [-8875.82,18807.39] 688.45 [-3712.39,5089.30] 1180.11 [-887.70,3247.93] 1497.95 [-5992.39,8988.28] 373.02 [-2445.71,3191.75] 413.17 [-920.63,1746.96] 219.85 [-805.51,1245.21] 23.29 [-401.77,448.35] 156.25 [-18.44,330.95]
2006 7671.42 [-6126.62,21469.47] 1174.11 [-3200.53,5548.75] 1258.95 [-781.92,3299.83] 2182.35 [-5284.89,9649.59] 481.17 [-2320.73,3283.07] 363.60 [-952.79,1679.99] 308.66 [-713.55,1330.87] 56.90 [-365.68,479.48] 150.78 [-21.63,323.19]
2007 7434.83 [-6338.95,21208.61] 1465.89 [-2899.73,5831.50] 1590.37 [-441.15,3621.89] 2390.84 [-5061.82,9843.50] 307.20 [-2488.40,3102.81] 537.02 [-772.03,1846.06] 305.77 [-714.40,1325.93] 78.28 [-343.59,500.15] 184.98* [13.53,356.44]
2008 7792.83 [-5969.04,21554.71] 2033.80 [-2322.97,6390.57] 1718.77 [-305.76,3743.30] 2880.47 [-4565.07,10326.00] 675.86 [-2113.86,3465.58] 338.66 [-965.93,1643.24] 318.78 [-700.39,1337.95] 144.08 [-277.03,565.18] 252.90** [82.03,423.77]
Constant -9279.59 [-33627.84,15068.67] 4623.36 [-6196.74,15443.45] -223.11 [-8002.89,7556.68] -5952.91 [-19094.95,7189.14] 3736.69 [-3191.22,10664.60] 214.42 [-4780.19,5209.03] 57.08 [-1740.64,1854.79] -38.9 [-1084.81,1007.01] 116.38 [-537.78,770.54]
Average practice intercept 7.49*** [6.62,8.36] 6.76*** [5.79,7.72] 7.45*** [7.22,7.68] 6.05* [1.36,10.74] -8.08*** [-10.14,-6.03] 6.12*** [5.45,6.78] -10.93*** [-14.85,-7.01] 5.05*** [4.72,5.38] 4.18*** [3.50,4.87]
N 2139 9050 18500 2139 9050 18500 2139 9050 18500
Notes : PCP is primary care provider. Bootstrapped OLS models used for all outcomes.
*p<0.05,**p<0.01,***p<0.001
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Table 5.16a: Continued 
 
OP RX
Small (1 PCP) Medium (2-3 PCP) Large (>3 PCP) Small (1 PCP) Medium (2-3 PCP) Large (>3 PCP)
Coeff. 95% CI Coeff. 95% CI Coeff. 95% CI Coeff. 95% CI Coeff. 95% CI Coeff. 95% CI
CCNC Patients (omitted = Very Low)
Low -1339.29* [-2494.45,-184.12] -1197.23** [-2070.70,-323.76] -268.08 [-1293.71,757.55] -425.95* [-842.75,-9.15] -128.16 [-385.19,128.88] 138.57 [-136.85,414.00]
(AME = -1339.29) (AME = -1197.23) (AME = -268.08) (AME = -425.95) (AME = -128.16) (AME = 138.57)
Medium -1816.38* [-3480.01,-152.74] -1301.43** [-2191.58,-411.29] -667.02 [-1750.86,416.82] -791.22** [-1382.31,-200.13] -286.20* [-553.06,-19.34] 11.58 [-280.62,303.77]
(AME = -1816.38) (AME = -1301.43) (AME = -667.02) (AME = -791.22) (AME = -286.20) (AME = 11.58)
High -2760.19* [-5294.10,-226.27] -1324.90* [-2379.69,-270.10] -447.10 [-1536.56,642.36] -833.72 [-1730.67,63.23] -166.59 [-477.40,144.22] 81.55 [-212.13,375.23]
(AME = -2760.19) (AME = -1324.90) (AME = -447.10) (AME = -833.72) (AME = -166.59) (AME = 81.55)
Very High -726.82 [-3371.51,1917.86] -1542.33** [-2562.76,-521.89] -865.63 [-1899.25,167.99] -441.02 [-1355.27,473.24] -302.65 [-609.26,3.97] -271.90 [-551.37,7.57]
(AME = -726.82) (AME = ̵ 1542.33) (AME = -865.63) (AME = -441.02) (AME = -302.65) (AME = -271.90)
CCNC Early Adopter -367.47 [-1430.41,695.47] 473.47 [-72.66,1019.59] 61.48 [-488.32,611.27] -104.45 [-531.98,323.08] -88.16 [-261.81,85.49] -181.38* [-335.09,-27.67]
Person-level controls
Age -348.06 [-874.45,178.32] -43.05 [-290.77,204.67] ̵  22.09 [-208.36,164.18] 67.73 [-66.69,202.16] 67.07* [8.29,125.85] 111.68*** [63.90,159.45]
Age^2 4.54 [-1.13,10.21] 0.59 [-2.07,3.25] 0.45 [-1.55,2.45] -0.78 [-2.23,0.67] -0.66* [-1.30,-0.03] -1.20*** [-1.71,-0.69]
Male -700.6 [-1690.86,289.67] -524.30* [-983.29,-65.32] -537.53** [-897.15,-177.91] 51.65 [-203.37,306.66] 0.25 [-109.29,109.80] 41.15 [-51.14,133.43]
Charlson Index 1896.57***[1043.71,2749.42] 1972.26*** [1548.74,2395.77] 2791.09*** [2495.14,3087.05] 852.44*** [635.63,1069.25] 618.08*** [517.57,718.59] 785.44*** [709.52,861.37]
Charlson Index^2 393.75*** [282.87,504.63] 355.66*** [295.57,415.74] 214.37*** [178.57,250.17] -50.66*** [-78.83,-22.49] -18.14* [-32.38,-3.90] -22.22*** [-31.40,-13.03]
Eligibility (omitted = subscriber)
Spouse 2429.44** [851.62,4007.25] 2297.73*** [1553.12,3042.34] 568.89* [16.93,1120.84] 1362.08*** [955.85,1768.31] 837.85*** [660.58,1015.12] 1044.09*** [902.46,1185.72]
Other -1353.12 [-14769.50,12063.26] -862.74 [-5225.44,3499.97] -1386.25 [-4148.56,1376.06] 945.28 [-2527.91,4418.46] 488.29 [-549.51,1526.08] 636.76 [-71.61,1345.13]
Plan Type (omitted = CMM)
Smart Choice 1608.95 [-1016.56,4234.47] -187.80 [-1454.18,1078.57] 297.29 [-682.37,1276.96] 651.89 [-22.29,1326.08] 182.00 [-118.23,482.23] -186.04 [-437.30,65.22]
Smart Choice Basic 1155.20 [-1524.62,3835.01] -793.49 [-2080.69,493.72] -327.89 [-1333.23,677.45] 348.46 [-340.25,1037.18] 80.43 [-224.50,385.35] -456.12*** [-713.96,-198.27]
Smart Choice Plus 4817.70** [1421.14,8214.27] 1963.95* [340.44,3587.46] 2205.01*** [1005.87,3404.14] 1577.20*** [706.23,2448.17] 670.59*** [285.31,1055.86] 240.93 [-66.61,548.48]
Practice and county-level controls
# Primary Care Providers — — 236.99 [-116.50,590.47] 25.42* [4.16,46.69] — — 36.71 [-61.32,134.75] 12.25*** [6.48,18.02]
Multisite Practice — — 225.42 [-2088.78,2539.62] -1446.30 [-3938.28,1046.21] — — 375.97 [-429.48,1181.42] 108.87 [-587.89,805.62]
Rural-Urban
Non-urban, Non-rural -1130.13 [-2477.60,217.34] -304.66 [-915.08,305.77] -271.27 [-938.32,395.78] 448.20 [-80.43,976.83] -91.10 [-287.01,104.98] -129.12 [-315.41,57.16]
Rural -2242.93 [-4968.11,482.25] -608.74 [-1826.60,609.11] -237.94 [-1591.44,1115.56] -1294.60** [-2264.40,-324.79] -65.27 [-446.58,316.04] -420.95* [-790.38,-51.52]
Community-based Practice 2617.31 [-1351.16,6585.79] 403.50 [-888.35,1695.34] -40.56 [-835.81,754.68] 122.01 [-1094.61,1338.62] 333.93 [-93.47,761.33] 196.27 [-26.71,419.26]
County Proportion Poverty 13544.40 [-3031.21,30120.01] -2595.18 [-10706.35,5515.99] -10215.71** [-17821.99,-2609.42] 1875.69 [-4217.43,7968.82] -1013.89 [-3477.95,1450.16] 479.61 [-1605.47,2564.70]
Primary Care Providers/10,000 Population-20.99 [-227.46,185.49] -94.49* [-185.80,-3.18] -34.13 [-82.63,14.37] 95.93* [20.89,170.97] -15.25 [-43.44,12.95] -19.54** [-33.01,-6.07]
County Proportion Race/Ethnicity
Non-white, not Hispanic -98.17 [-5150.72,4954.38] 212.60 [-2010.56,2435.76] 1423.34 [-518.65,3365.32] -3168.90*** [-5024.25,-1313.55] -288.44 [-966.76,389.88] -998.58*** [-1531.79,-465.37]
Hispanic 1675.76 [-5577.64,8929.16] -884.64 [-4562.53,2793.25] -424.67 [-4522.03,3672.69] -3101.94* [-6008.10,-195.78] 14.46 [-1124.40,1153.32] -835.46 [-1973.21,302.30]
Year
2005 2439.67 [-6639.24,11518.58] 120.67 [-2666.61,2907.96] 362.52 [-894.92,1619.96] 731.84 [-1628.56,3092.23] 158.49 [-521.93,838.92] 342.56* [18.84,666.28]
2006 4113.20 [-4937.64,13164.04] 351.63 [-2419.38,3122.64] 299.48 [-941.60,1540.56] 1046.78 [-1305.22,3398.79] 194.59 [-482.47,871.65] 512.29** [192.77,831.81]
2007 3556.51 [-5476.95,12589.96] 622.00 [-2144.31,3388.31] 251.24 [-984.41,1486.90] 1215.41 [-1134.21,3565.02] 384.17 [-292.60,1060.93] 640.54*** [322.25,958.84]
2008 3436.45 [-5588.47,12461.38] 739.63 [-2021.63,3500.90] 565.21 [-666.21,1796.63] 1176.65 [-1172.55,3525.85] 421.63 [-254.65,1097.91] 610.75*** [293.54,927.97]
Constant -1994.50 [-17930.53,13941.54] 1959.34 [-4898.84,8817.53] 1059.86 [-3678.30,5798.03] -1653.17 [-5862.68,2556.34] -1013.44 [-2699.37,672.48] -1482.45* [-2707.57,-257.34]
Average practice intercept 6.48*** [4.59,8.38] 6.91*** [6.56,7.26] 7.04*** [6.80,7.28] 6.71*** [6.45,6.97] 6.34*** [6.20,6.47] 5.85*** [5.65,6.06]
N 2139 9050 18500 2139 9050 18500
Notes : PCP is primary care provider. Bootstrapped OLS models used for all outcomes.
*p<0.05,**p<0.01,***p<0.001
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Table 5.16b: Average Marginal Moderating Effects of CCNC Patient Load from Multi-Level and Fixed-Effects Models, by Practice Size 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total IP ED OP RX
Small (1 PCP) Medium (2-3 PCP) Large (>3 PCP) Small (1 PCP) Medium (2-3 PCP) Large (>3 PCP) Small (1 PCP) Medium (2-3 PCP) Large (>3 PCP) Small (1 PCP) Medium (2-3 PCP) Large (>3 PCP) Small (1 PCP) Medium (2-3 PCP) Large (>3 PCP)
CCNC Patients (omitted=Very Low)
Low
MLM AME
̵  3069.64**
[-4931.07,-1208.21]
̵  1109.77
[-2405.58,186.04]
667.73
[-980.64,2316.10]
̵  1409.40**
[-2346.84,-471.96]
58.34
[-746.69,863.37]
768.26
[-177.43,1713.95]
25.99
[-99.69,151.67]
25.90
[-106.98,158.78]
3.40
[-121.30,128.10]
̵  1339.29*
[-2489.30.189.28]
̵  1197.23**
[-2066.80,-327.66]
̵  268.08
[-1289.13,752.96]
̵  425.95*
[-840.89,-11.01]
̵  128.16
[-384.05,127.72]
138.57
[-135.62,412.76]
FE AME
 -1008.90
[-4499.48,2481.68]
2796.23
[-1175.90,6768.36] 
2218.25
[-417.83,4854.34]   
̵  657.96
[-1696.05,380.14]
2224.52
[-1346.15,5795.19] 
1460.45*
[70.51,2850.40] 
̵ 125.73
[-376.76,125.30]
̵  84.42
[-259.79,90.96]
̵  192.92
[-627.15,241.30]
101.28
[-2732.34,2934.90]
526.21
[-915.58,1968.01]       
 527.91
[-836.75,1892.56]
 ̵  326.49
[-1432.82,779.85]
129.91
[-285.36,545.17]       
422.87*
[21.09,824.65]
Medium
MLM AME
̵  3639.18**
[-6038.07,-1240.29]
̵  1109.03
[-2291.28,73.22]
187.15
[-1376.46,1750.76]
̵  1166.54
[-2381.21,48.13]
290.73
[-442.52,1023.98]
1052.50*
[156.04,1948.96]
25.22
[-137.94,188.38]
60.70
[-62.21,183.61]
̵  80.42
[-198.57,37.73]
̵  1816.38*
[-3304.99,-327.77]
̵  1301.43**
[-2097.92,-504.93]
̵  667.02
[-1636.83,302.79]
̵  791.22**
[-1320.12,-262.32]
̵  286.20*
[-524.98,-47.42]
11.58
[-249.87,273.03]
FE AME
 ̵  1456.53
[-6732.86,3819.81]
3983.67
[-426.47,8393.81]
 1661.95
[-1381.06,4704.95] 
 434.87
[-2295.53,3165.27]
3205.32
[-656.40,7067.04]      
1822.01*
[242.87,3401.16]  
̵  80.42
[-465.45,304.60]
 ̵  26.13
[-310.26,258.01]
 ̵  238.28
[-681.62,205.07]
̵  1513.11
[-4888.68,1862.46]
  678.16
[-1105.07,2461.39]
̵  323.59
[-2240.57,1593.39]
 ̵  297.86
[-1540.64,944.92]
 126.32
[-326.25,578.89]
401.96
[-48.70,852.61]
High
MLM AME
̵  3724.44
[-8445.21,996.33]
̵  1045.98
[-2850.35,758.39]
1041.90
[-979.52,3063.32]
̵  389.02
[-2764.77,1986.73]
268.44
[-849.73,1386.61]
1431.01*
[273.97,2588.05]
85.02
[-233.07,403.11]
60.42
[-125.08,245.92]
̵  14.59
[-167.12,137.94]
̵  2760.19
[-5676.20,155.82]
̵  1324.90*
[-2538.75,-111.05]
̵  447.10
[-1700.84,806.64]
̵  833.72
[-1865.92,198.48]
̵  166.59
[-524.27,191.09]
81.55
[-256.41,419.51]
FE AME
  2729.12
[-5095.41,10553.65]
 1335.90
[-4428.86,7100.66]      
3104.86
[-262.38,6472.10]      
1619.82
[-2221.74,5461.38] 
975.46
[-3791.28,5742.19]
2740.51**
[662.62,4818.40]
̵  480.31
[-1414.13,453.51]
  ̵  173.03
[-645.88,299.81]
̵  233.40
[-695.15,228.35]
1764.53
[-4919.03,8448.10]  
451.97
[-1846.77,2750.70]       
  170.14
[-1877.05,2217.33]   
 ̵   174.92
[-1811.60,1461.76]
81.51
[-403.18,566.19]
427.98
[-108.74,964.70]
Very High
MLM AME
̵  1712.33
[-6239.09,2814.43]
̵  2187.43**
[-3803.68,-571.18]
̵  141.47
[-1916.85,1633.91]
̵  859.72
[-3162.83,1443.39]
̵  357.49
[-1360.26,645.28]
904.73
[-105.27,1914.73]
418.28**
[108.67,727.89]
28.91
[-137.43,195.25]
̵  7.03
[-140.22.126.16]
̵  726.82
[-3547.61,2093.97]
̵  1542.33**
[-2630.71,-453.95]
̵  865.63
[-1968.07,236.81]
̵  441.02
[-1416.15,534.11]
̵  302.65
[-629.69,24.39]
̵  271.90
[-569.98,26.18]
FE AME
2109.60
[-5214.71,9433.92]
1345.22
[-4541.42,7231.87]      
4139.58*
[533.38,7745.77] 
19.81
[-3736.10,3775.72]
  1323.73
[-3420.17,6067.64] 
3231.82**
[1104.00,5359.63]  
̵ 319.65
[-1384.17,744.87]
̵  229.92
[-744.69,284.85]
̵  285.16
[-752.72,182.40]
  2332.10
[-4369.87,9034.06] 
157.37
[-2536.39,2851.13]
 930.70
[-1415.71,3277.10]   
77.35
[-1416.77,1571.48]  
94.04
[-502.92,691.00] 
262.53
[-281.00,806.05]
Notes : Bootstrapped OLS models used for all  outcomes.
*p<0.05,**p<0.01,***p<0.001
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Table 5.17a: Multi-Level Odds Ratios of the Effect of CCNC on Receipt of Yearly Diabetes Measures, by Baseline Values 
 
>=1 A1C >=1 LDL >=1 Eye Exam
Low (<80%) Medium (80-95%) Medium (80-95%) Low (<56%) Medium (56-73%) High (>73%)
OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI
CCNC 1.03 [0.84,1.26] 1.17 [0.93,1.48] 1.26 [0.90,1.78] 0.89 [0.73,1.07] 1.17 [0.96,1.41] 1.04 [0.83,1.30]
(AME = 0.004) (AME = 0.018) (AME = 0.021) (AME = -0.021) (AME = 0.027) (AME = 0.005)
Ever CCNC 0.37*** [0.23,0.59] 0.84 [0.61,1.16] 0.61* [0.39,0.95] 0.57* [0.37,0.89] 0.98 [0.72,1.33] 0.74 [0.54,1.01]
CCNC Early Adopter 1.90* [1.16,3.13] 0.85 [0.63,1.15] 0.66* [0.44,0.97] 1.50 [0.94,2.39] 0.91 [0.66,1.25] 0.99 [0.72,1.36]
Person-level controls
Age 1.03 [0.98,1.08] 1.03 [0.98,1.09] 1.06* [1.00,1.12] 1.08*** [1.04,1.13] 1.09*** [1.05,1.14] 1.15*** [1.10,1.20]
Age^2 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00* [1.00,1.00] 1.00** [1.00,1.00] 1.00*** [1.00,1.00]
Male 0.99 [0.90,1.09] 1.19*** [1.08,1.32] 1.25*** [1.12,1.40] 1.06 [0.98,1.16] 1.15** [1.05,1.25] 1.21*** [1.10,1.32]
Charlson Index 3.22*** [2.95,3.52] 6.36*** [5.69,7.12] 7.69*** [6.80,8.69] 1.39*** [1.29,1.50] 1.58*** [1.46,1.72] 1.69*** [1.55,1.84]
Charlson Index^2 0.89*** [0.88,0.90] 0.84*** [0.82,0.85] 0.82*** [0.81,0.83] 0.96*** [0.95,0.97] 0.94*** [0.93,0.95] 0.94*** [0.93,0.95]
Eligibility (omitted = subscriber)
Spouse 0.86* [0.75,0.98] 0.73*** [0.62,0.85] 0.86 [0.72,1.03] 0.86* [0.76,0.99] 0.84** [0.74,0.95] 0.78*** [0.68,0.89]
Other 1.04 [0.54,2.00] 1.24 [0.60,2.55] 1.51 [0.60,3.83] 0.73 [0.36,1.50] 1.66 [0.91,3.03] 1.04 [0.51,2.09]
Plan Type (omitted = CMM)
Smart Choice 1.25* [1.02,1.54] 1.29* [1.01,1.65] 0.92 [0.65,1.29] 1.31** [1.07,1.59] 1.19 [0.97,1.46] 1.17 [0.94,1.46]
Smart Choice Basic 1.17 [0.94,1.45] 1.22 [0.95,1.58] 0.84 [0.60,1.19] 1.23* [1.00,1.50] 1.12 [0.91,1.38] 1.10 [0.88,1.38]
Smart Choice Plus 1.43* [1.08,1.88] 1.07 [0.78,1.48] 0.89 [0.59,1.34] 1.42** [1.10,1.82] 1.25 [0.96,1.63] 1.30 [0.97,1.75]
Practice and county-level controls
# Primary Care Providers 1.00 [1.00,1.01] 1.00 [0.99,1.02] 0.99 [0.97,1.01] 1.00 [0.99,1.00] 1.00 [0.99,1.02] 0.99 [0.97,1.01]
Multisite Practice — — 4.55 [0.66,31.33] 1.86 [0.25,13.88] 2.37 [0.18,31.11] 1.72 [0.45,6.51] 3.03 [0.55,16.69]
Rural-Urban
Non-urban, Non-rural 0.75 [0.48,1.15] 1.00 [0.74,1.36] 0.67* [0.47,0.95] 0.78 [0.52,1.19] 0.93 [0.70,1.24] 1.00 [0.75,1.34]
Rural — — 0.31* [0.12,0.80] 1.14 [0.55,2.36] 1.45 [0.48,4.45] 0.41* [0.17,0.99] 0.52 [0.26,1.03]
Community-based Practice 1.07 [0.46,2.44] 1.07 [0.76,1.51] 1.96* [1.02,3.76] 0.96 [0.45,2.07] 1.23 [0.82,1.83] 1.28 [0.83,1.97]
County Proportion Poverty 36.27* [1.03,1272.53]0.13 [0.01,2.70] 1.38 [0.04,48.77] 0.02* [0.00,0.42] 0.54 [0.03,10.68] 4.48 [0.22,89.24]
Primary Care Providers/10,000 Population 0.98 [0.95,1.01] 0.99 [0.97,1.01] 0.98 [0.95,1.01] 0.95*** [0.92,0.98] 1.00 [0.97,1.02] 0.99 [0.96,1.01]
County Proportion Race/Ethnicity
Non-white, not Hispanic 0.14** [0.04,0.45] 2.83* [1.14,6.99] 2.11 [0.73,6.11] 1.04 [0.34,3.16] 2.11 [0.88,5.06] 0.59 [0.25,1.41]
Hispanic 0.27 [0.02,4.40] 1.00 [0.16,6.12] 0.26 [0.03,2.21] 0.71 [0.06,8.14] 0.71 [0.13,4.00] 1.24 [0.18,8.60]
Year
2005 2.43*** [1.96,3.00] 0.78* [0.62,0.98] 0.01*** [0.00,0.02] 3.89*** [3.18,4.75] 1.47*** [1.22,1.76] 0.60*** [0.48,0.74]
2006 2.37*** [1.91,2.95] 0.76* [0.60,0.96] 0.01*** [0.00,0.02] 4.47*** [3.64,5.49] 1.52*** [1.26,1.82] 0.58*** [0.47,0.71]
2007 2.64*** [2.09,3.32] 0.83 [0.66,1.05] 0.01*** [0.00,0.02] 5.08*** [4.11,6.30] 1.76*** [1.46,2.12] 0.69*** [0.56,0.86]
2008 2.70*** [2.15,3.39] 0.75* [0.59,0.96] 0.01*** [0.00,0.02] 5.55*** [4.49,6.87] 1.70*** [1.42,2.05] 0.70** [0.57,0.88]
Constant 0.21* [0.04,0.98] 0.31 [0.08,1.16] 31.94***[4.53,225.07] 0.06*** [0.02,0.27] 0.05*** [0.01,0.14] 0.06*** [0.02,0.23]
Average practice intercept 1.29*** [1.16,1.43] 0.50*** [0.42,0.60] 0.89 [0.78,1.01] 1.26*** [1.13,1.40] 0.58*** [0.50,0.68] 0.67*** [0.58,0.77]
N 14051 14983 15933 14586 13993 16388
Notes : A1c is hemoglobin A1c test, LDL is low-density lipoprotein test. Logit models used for all outcomes.
*p<0.05,**p<0.01,***p<0.001
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Table 5.17a: Continued 
 
>=1 Eye Exam Attention for Nephropathy
Low (<25%) Medium (25-40%) High (>40%) Low (<71%) Medium (71-84%) High (>84%)
OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI
CCNC 0.94 [0.77,1.14] 0.97 [0.84,1.13] 1.07 [0.90,1.27] 1.14 [0.97,1.34] 0.86 [0.69,1.06] 1.01 [0.78,1.31]
(AME = -0.012) (AME = -0.006) (AME = 0.015) (AME = 0.0219) (AME = -0.0210) (AME = 0.001)
Ever CCNC 0.93 [0.74,1.16] 0.96 [0.82,1.13] 1.05 [0.87,1.26] 0.99 [0.81,1.22] 1.04 [0.80,1.36] 1.02 [0.75,1.38]
CCNC Early Adopter 1.05 [0.89,1.24] 0.91 [0.80,1.04] 0.99 [0.84,1.16] 0.90 [0.73,1.10] 0.93 [0.74,1.16] 0.99 [0.76,1.29]
Person-level controls
Age 0.95* [0.91,1.00] 0.95** [0.92,0.98] 0.97 [0.94,1.01] 1.08*** [1.03,1.12] 1.10*** [1.05,1.15] 1.08** [1.03,1.14]
Age^2 1.00** [1.00,1.00] 1.00*** [1.00,1.00] 1.00* [1.00,1.00] 1.00** [1.00,1.00] 1.00** [1.00,1.00] 1.00* [1.00,1.00]
Male 0.78*** [0.71,0.85] 0.87*** [0.81,0.92] 0.79*** [0.73,0.85] 0.97 [0.89,1.05] 1.09 [1.00,1.20] 0.93 [0.84,1.02]
Charlson Index 1.78*** [1.63,1.95] 1.63*** [1.54,1.73] 1.93*** [1.80,2.07] 1.82*** [1.69,1.96] 1.99*** [1.82,2.18] 2.34*** [2.12,2.58]
Charlson Index^2 0.94*** [0.93,0.96] 0.96*** [0.95,0.97] 0.94*** [0.93,0.95] 0.96*** [0.95,0.97] 0.94*** [0.93,0.95] 0.92*** [0.91,0.93]
Eligibility (omitted = subscriber)
Spouse 1.04 [0.91,1.19] 0.94 [0.86,1.04] 0.99 [0.89,1.11] 1.02 [0.89,1.16] 0.86* [0.75,1.00] 0.90 [0.77,1.04]
Other 0.25* [0.08,0.77] 0.60 [0.30,1.22] 1.36 [0.81,2.31] 0.91 [0.52,1.57] 1.50 [0.76,2.99] 0.55 [0.27,1.13]
Plan Type (omitted = CMM)
Smart Choice 1.38** [1.09,1.75] 1.19* [1.02,1.40] 1.48*** [1.23,1.77] 1.18 [0.98,1.43] 1.19 [0.96,1.49] 1.29* [1.00,1.66]
Smart Choice Basic 1.14 [0.90,1.46] 0.91 [0.77,1.07] 1.17 [0.97,1.42] 1.01 [0.82,1.23] 1.23 [0.98,1.54] 1.14 [0.88,1.48]
Smart Choice Plus 1.32 [0.98,1.78] 1.19 [0.97,1.45] 1.32* [1.05,1.67] 1.26 [0.98,1.62] 1.39* [1.03,1.88] 1.10 [0.80,1.51]
Practice and county-level controls
# Primary Care Providers 1.01 [0.99,1.03] 1.01 [1.00,1.02] 1.00 [0.99,1.00] 1.00 [1.00,1.01] 1.00 [0.99,1.01] 0.99 [0.98,1.00]
Multisite Practice 1.43 [0.86,2.40] 1.27 [0.62,2.60] — — 1.02 [0.52,1.97] — — 1.67 [0.41,6.84]
Rural-Urban
Non-urban, Non-rural 0.90 [0.77,1.05] 0.95 [0.84,1.08] 0.92 [0.78,1.08] 0.87 [0.72,1.04] 0.92 [0.74,1.14] 0.91 [0.70,1.18]
Rural 0.71 [0.47,1.06] 0.61* [0.39,0.93] 0.98 [0.70,1.38] 0.75 [0.45,1.24] 1.23 [0.80,1.91] 0.91 [0.44,1.86]
Community-based Practice 0.73* [0.56,0.95] 1.09 [0.89,1.33] 0.98 [0.82,1.18] 0.84 [0.63,1.12] 1.08 [0.81,1.44] 0.76 [0.48,1.19]
County Proportion Poverty 0.96 [0.14,6.50] 1.06 [0.25,4.45] 0.59 [0.10,3.50] 0.18 [0.02,1.47] 0.17 [0.02,1.80] 0.09 [0.01,1.49]
Primary Care Providers/10,000 Population 0.99 [0.98,1.01] 1.01 [1.00,1.02] 1.01 [1.00,1.02] 0.99 [0.98,1.00] 1.01 [0.99,1.03] 0.98* [0.96,1.00]
County Proportion Race/Ethnicity
Non-white, not Hispanic 0.94 [0.56,1.59] 0.74 [0.50,1.10] 0.82 [0.51,1.32] 2.17** [1.22,3.86] 1.78 [0.94,3.38] 2.32* [1.04,5.15]
Hispanic 0.25* [0.08,0.76] 0.38* [0.16,0.87] 0.82 [0.30,2.26] 1.00 [0.31,3.27] 2.15 [0.49,9.33] 1.19 [0.24,5.89]
Year
2005 2.95*** [2.36,3.69] 0.99 [0.87,1.14] 0.48*** [0.41,0.56] 2.75*** [2.33,3.24] 1.65*** [1.35,2.01] 0.32*** [0.24,0.42]
2006 3.21*** [2.56,4.03] 1.12 [0.98,1.28] 0.48*** [0.41,0.56] 2.84*** [2.41,3.35] 1.57*** [1.29,1.91] 0.31*** [0.24,0.41]
2007 5.50*** [4.38,6.91] 1.62*** [1.42,1.85] 0.65*** [0.56,0.76] 3.40*** [2.86,4.03] 1.55*** [1.27,1.89] 0.31*** [0.24,0.41]
2008 6.02*** [4.79,7.57] 1.80*** [1.57,2.06] 0.71*** [0.61,0.83] 3.10*** [2.62,3.67] 1.50*** [1.23,1.83] 0.33*** [0.25,0.43]
Constant 0.21* [0.06,0.70] 0.47 [0.19,1.14] 0.54 [0.21,1.40] 0.09*** [0.03,0.27] 0.07*** [0.02,0.22] 1.35 [0.36,5.04]
Average practice intercept 0.26*** [0.20,0.33] 0.22*** [0.18,0.28] 0.21*** [0.16,0.28] 0.37*** [0.31,0.45] 0.37*** [0.30,0.45] 0.52*** [0.44,0.61]
N 11620 19488 13859 14971 14381 15615
Notes : A1c is hemoglobin A1c test, LDL is low-density lipoprotein test. Logit models used for all outcomes.
*p<0.05,**p<0.01,***p<0.001
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Table 5.17b: Average Marginal Effects of CCNC from Multi-Level and Fixed-Effects Models, by Baseline Values 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
>=1 A1C >=1 LDL >=1 Eye Exam Attention for Nephropathy
Low Medium High Low Medium High Low Medium High Low Medium High
CCNC
MLM AME
0.004
[-0.028,0.036]
0.018
[-0.0079,0.0431]
0.021
[-0.0089,0.0513]
̵  0.021
[-0.055,0.013]
0.027
[-0.0058,0.0598]
0.005
[-0.025,0.035]
̵  0.012
[-0.049,0.025]
̵  0.006
[-0.039,0.027]
0.015
[-0.024,0.054]
0.0219
[-0.0046,0.0484]
̵  0.02102
[-0.052,0.010]
0.001
[-0.029,0.031]
FE AME
0.007
[-0.058,0.072]
0.012
[-0.016,0.039]
̵  0.005
[-0.032,0.022]
̵  0.017
[-0.075,0.041]
0.016
[-0.019,0.051] 
̵  0.001
[-0.040,0.037]
̵  0.007
[-0.037,0.024]
0.003
[-0.020,0.025]
0.001
[-0.041,0.042]
0.0228
[-0.0076,0.0533] 
̵  0.02260
[-0.04600,0.00080]
0.006
[-0.026,0.037]
Notes: Logit models used for mult-level models. Cluster robust l inear probability models used for fixed-effects models.
*p<0.05,**p<0.01,***p<0.001
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Table 5.18a: Multi-Level Odds Ratios of the Moderating Effect of CCNC Patient Load on Receipt of Yearly Diabetes Measures, by Baseline Values 
 
>=1 A1C >=1 LDL >=1 Eye Exam
Low (<78%) High (>=78%) Low (<50%) Medium (50-72%) High (>72%)
OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI
CCNC Patients (omitted = Very Low)
Low 1.23 [0.75,2.01] 1.01 [0.69,1.47] 0.81 [0.45,1.44] 1.18 [0.79,1.77] 0.90 [0.62,1.33]
(AME = 0.0313) (AME = 0.0014) (AME = -0.0358) (AME = 0.0288) (AME = -0.013)
Medium 0.88 [0.52,1.51] 0.94 [0.63,1.40] 0.67 [0.36,1.24] 1.21 [0.76,1.93] 0.85 [0.55,1.31]
(AME= -0.0194) (AME = -0.0072) (AME = -0.0683) (AME = 0.0333) (AME = -0.0211)
High 0.85 [0.47,1.51] 0.81 [0.53,1.23] 0.68 [0.35,1.30] 1.02 [0.63,1.66] 0.63* [0.40,0.99]
(AME = -0.0263) (AME = -0.0244) (AME = -0.0669) (AME = 0.0049) (AME = -0.0655)
Very High 1.32 [0.72,2.44] 0.88 [0.58,1.33] 0.67 [0.33,1.33] 1.11 [0.69,1.78] 0.64 [0.40,1.00]
(AME = 0.0424) (AME = -0.0142) (AME = -0.0696) (AME = 0.0179) (AME = -0.0638)
CCNC Early Adopter 2.08** [1.23,3.52] 0.70* [0.53,0.92] 1.92* [1.12,3.27] 1.21 [0.86,1.71] 0.89 [0.63,1.26]
Person-level controls
Age 1.00 [0.94,1.06] 1.06* [1.01,1.11] 1.05 [0.99,1.12] 1.09*** [1.03,1.14] 1.19*** [1.12,1.27]
Age^2 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00* [1.00,1.00] 1.00*** [1.00,1.00]
Male 0.96 [0.86,1.09] 1.29*** [1.17,1.43] 0.99 [0.88,1.11] 1.11 [1.00,1.23] 1.22** [1.08,1.38]
Charlson Index 3.19*** [2.85,3.56] 6.57*** [5.91,7.30] 1.29*** [1.17,1.42] 1.59*** [1.44,1.76] 1.88*** [1.67,2.12]
Charlson Index^2 0.89*** [0.88,0.91] 0.82*** [0.81,0.83] 0.98*** [0.97,0.99] 0.94*** [0.93,0.95] 0.93*** [0.91,0.94]
Eligibility (omitted = subscriber)
Spouse 0.69*** [0.57,0.83] 0.82* [0.70,0.96] 0.85 [0.71,1.03] 0.80** [0.68,0.94] 0.80* [0.66,0.97]
Other 0.81 [0.36,1.85] 1.06 [0.49,2.31] 1.13 [0.44,2.88] 0.85 [0.37,1.98] 0.77 [0.29,2.02]
Plan Type (omitted = CMM)
Smart Choice 1.16 [0.85,1.58] 1.06 [0.80,1.40] 1.43* [1.06,1.93] 1.41* [1.07,1.86] 1.07 [0.76,1.49]
Smart Choice Basic 1.05 [0.77,1.44] 0.99 [0.74,1.32] 1.30 [0.96,1.76] 1.32 [0.99,1.76] 0.96 [0.68,1.36]
Smart Choice Plus 1.21 [0.83,1.77] 0.94 [0.67,1.33] 1.33 [0.93,1.93] 1.27 [0.90,1.78] 0.90 [0.58,1.39]
Practice and county-level controls
# Primary Care Providers 1.00 [1.00,1.01] 1.02 [1.00,1.04] 0.99 [0.99,1.00] 0.98 [0.96,1.01] 0.99 [0.97,1.01]
Multisite Practice 4.37 [0.39,49.38] 2.41 [0.25,23.15] 5.79 [0.27,122.24] 1.19 [0.19,7.44] 5.06 [0.47,54.53]
Rural-Urban
Non-urban, Non-rural 1.11 [0.61,2.02] 0.94 [0.69,1.28] 1.05 [0.58,1.90] 1.35 [0.92,1.98] 0.88 [0.61,1.29]
Rural 0.44 [0.17,1.15] 1.11 [0.55,2.22] 0.32* [0.12,0.87] 0.51 [0.18,1.45] 0.83 [0.41,1.69]
Community-based Practice 0.82 [0.22,3.00] 0.98 [0.57,1.68] 1.06 [0.26,4.37] 0.60 [0.32,1.11] 0.94 [0.46,1.90]
County Proportion Poverty 3.54 [0.03,367.41] 0.95 [0.04,22.58] 0.23 [0.00,21.27] 0.03 [0.00,1.07] 0.17 [0.00,8.98]
Primary Care Providers/10,000 Population 0.96 [0.92,1.00] 0.97* [0.93,1.00] 0.92*** [0.88,0.96] 1.01 [0.97,1.05] 0.97 [0.93,1.02]
County Proportion Race/Ethnicity
Non-white, not Hispanic 0.31 [0.06,1.64] 1.03 [0.40,2.66] 0.99 [0.19,5.12] 0.77 [0.24,2.45] 0.52 [0.16,1.64]
Hispanic 0.26 [0.01,8.06] 0.89 [0.15,5.19] 0.06 [0.00,1.97] 0.46 [0.05,4.08] 5.23 [0.66,41.52]
Year
2005 3.75*** [2.20,6.39] 0.18*** [0.09,0.34] 3.12*** [1.75,5.57] 1.66** [1.19,2.32] 0.35 [0.12,1.03]
2006 4.00*** [2.36,6.78] 0.16*** [0.08,0.30] 3.31*** [1.87,5.87] 1.83*** [1.31,2.54] 0.33* [0.11,0.95]
2007 4.23*** [2.49,7.16] 0.17*** [0.09,0.32] 4.10*** [2.31,7.29] 2.05*** [1.47,2.86] 0.39 [0.14,1.13]
2008 4.59*** [2.71,7.77] 0.16*** [0.08,0.30] 4.42*** [2.49,7.83] 1.95*** [1.41,2.70] 0.39 [0.13,1.13]
Constant 0.12 [0.01,1.10] 1.68 [0.37,7.53] 0.08* [0.01,0.81] 0.13** [0.03,0.57] 0.10* [0.01,0.84]
Average practice intercept 1.60*** [1.41,1.82] 0.98 [0.87,1.10] 1.47*** [1.28,1.69] 0.82* [0.69,0.96] 0.91 [0.78,1.06]
N 8463 16918 7445 9599 8337
Notes : A1c is hemoglobin A1c test, LDL is low-density lipoprotein test. Logit models used for all outcomes.
*p<0.05,**p<0.01,***p<0.001
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Table 5.18a: Continued 
 
>=1 Eye Exam Attention for Nephropathy
Low (<25%) Medium (25-40%) High (>40%) Low (<71%) Medium (71-86%) High (>86%)
OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI
CCNC Patients (omitted = Very Low)
Low 0.96 [0.72,1.28] 1.12 [0.90,1.40] 1.12 [0.89,1.42] 0.71* [0.51,0.99] 1.06 [0.72,1.55] 0.80 [0.55,1.18]
(AME = -0.0074) (AME = 0.0256) (AME = 0.0271) (AME = -0.0535) (AME = 0.0066) (AME = -0.0268)
Medium 1.01 [0.76,1.34] 1.03 [0.81,1.30] 0.95 [0.75,1.21] 0.83 [0.59,1.17] 0.89 [0.59,1.34] 0.86 [0.59,1.27]
(AME = 0.0018) (AME = 0.0055) (AME = -0.0129) (AME = -0.028) (AME = -0.0202) (AME = -0.0179)
High 0.96 [0.72,1.30] 1.10 [0.84,1.44] 1.07 [0.83,1.38] 0.81 [0.57,1.16] 0.95 [0.62,1.44] 1.04 [0.69,1.59]
(AME = -0.0074) (AME = 0.0217) (AME = 0.0157) (AME = -0.032) (AME = -0.0094) (AME = 0.0054)
Very High 0.91 [0.67,1.23] 0.91 [0.71,1.16] 0.96 [0.77,1.21] 0.82 [0.58,1.15] 1.16 [0.76,1.75] 0.95 [0.63,1.44]
(AME = -0.0184) (AME = -0.0207) (AME = -0.0094) (AME = -0.0306) (AME = 0.0193) (AME = -0.0057)
CCNC Early Adopter 0.99 [0.87,1.14] 0.92 [0.78,1.07] 0.94 [0.80,1.10] 0.94 [0.76,1.15] 0.88 [0.68,1.14] 1.08 [0.84,1.40]
Person-level controls
Age 0.96 [0.91,1.02] 0.97 [0.92,1.02] 0.97 [0.92,1.01] 1.10*** [1.05,1.15] 1.13*** [1.06,1.20] 1.13*** [1.06,1.21]
Age^2 1.00 [1.00,1.00] 1.00* [1.00,1.00] 1.00* [1.00,1.00] 1.00** [1.00,1.00] 1.00** [1.00,1.00] 1.00** [1.00,1.00]
Male 0.80*** [0.72,0.88] 0.85*** [0.77,0.94] 0.78*** [0.71,0.86] 1.03 [0.93,1.14] 1.09 [0.96,1.24] 0.96 [0.84,1.10]
Charlson Index 1.67*** [1.50,1.85] 1.73*** [1.59,1.89] 1.78*** [1.64,1.94] 1.73*** [1.58,1.89] 2.20*** [1.95,2.48] 2.66*** [2.34,3.03]
Charlson Index^2 0.95*** [0.94,0.97] 0.96*** [0.94,0.97] 0.95*** [0.94,0.96] 0.96*** [0.95,0.97] 0.93*** [0.92,0.95] 0.91*** [0.89,0.92]
Eligibility (omitted = subscriber)
Spouse 1.02 [0.86,1.21] 0.86* [0.74,0.99] 0.92 [0.80,1.07] 0.93 [0.78,1.10] 0.92 [0.76,1.12] 0.77* [0.63,0.94]
Other 0.19* [0.04,0.89] 1.01 [0.36,2.85] 1.24 [0.64,2.40] 1.16 [0.60,2.24] 0.93 [0.33,2.57] 1.02 [0.39,2.65]
Plan Type (omitted = CMM)
Smart Choice 1.59** [1.16,2.18] 1.17 [0.90,1.52] 1.41** [1.10,1.80] 1.27 [0.98,1.65] 1.35 [0.98,1.85] 1.29 [0.87,1.91]
Smart Choice Basic 1.22 [0.88,1.68] 0.86 [0.66,1.13] 1.10 [0.85,1.42] 1.11 [0.86,1.45] 1.23 [0.89,1.70] 1.09 [0.73,1.63]
Smart Choice Plus 1.66** [1.13,2.44] 1.20 [0.87,1.65] 1.31 [0.96,1.78] 1.25 [0.91,1.73] 1.47 [0.95,2.27] 0.97 [0.60,1.57]
Practice and county-level controls
# Primary Care Providers 1.02* [1.00,1.04] 1.01 [0.99,1.02] 1.00 [0.99,1.00] 1.00 [1.00,1.01] 0.98* [0.97,1.00] 1.00 [0.98,1.02]
Multisite Practice 1.35 [0.83,2.22] — — 0.95 [0.39,2.32] 1.07 [0.48,2.42] — — 1.28 [0.26,6.44]
Rural-Urban
Non-urban, Non-rural 0.85* [0.73,0.99] 0.86 [0.72,1.04] 0.79* [0.66,0.96] 0.80 [0.64,1.01] 0.82 [0.61,1.09] 0.91 [0.67,1.24]
Rural 0.62** [0.46,0.84] 0.48** [0.29,0.81] 0.81 [0.58,1.15] 0.66 [0.41,1.08] 1.03 [0.61,1.73] 0.98 [0.57,1.69]
Community-based Practice 0.89 [0.68,1.17] 1.06 [0.82,1.37] 1.02 [0.74,1.41] 0.76 [0.50,1.15] 0.76 [0.52,1.11] 0.47 [0.18,1.23]
County Proportion Poverty 1.59 [0.23,11.16] 2.63 [0.32,21.41] 2.31 [0.25,21.52] 0.54 [0.03,8.26] 3.12 [0.09,110.77] 0.05 [0.00,1.40]
Primary Care Providers/10,000 Population 0.99 [0.97,1.01] 1.01 [1.00,1.03] 1.01 [1.00,1.03] 0.98* [0.96,1.00] 1.01 [0.97,1.04] 0.98 [0.95,1.00]
County Proportion Race/Ethnicity
Non-white, not Hispanic 0.77 [0.45,1.32] 0.51* [0.28,0.91] 0.70 [0.39,1.25] 1.08 [0.51,2.29] 1.10 [0.42,2.88] 1.69 [0.66,4.30]
Hispanic 0.30* [0.11,0.87] 0.38 [0.13,1.18] 1.14 [0.41,3.23] 1.10 [0.27,4.51] 0.87 [0.13,5.83] 2.45 [0.47,12.84]
Year
2005 3.16** [1.32,7.58] 1.04 [0.75,1.44] 0.66* [0.47,0.93] 2.34*** [1.71,3.20] 1.04 [0.58,1.87] 0.38* [0.17,0.86]
2006 3.07* [1.28,7.34] 1.20 [0.87,1.66] 0.62** [0.44,0.88] 2.51*** [1.84,3.41] 1.16 [0.65,2.07] 0.33** [0.15,0.75]
2007 5.24*** [2.20,12.51] 1.79*** [1.30,2.46] 0.83 [0.59,1.17] 2.78*** [2.04,3.78] 1.15 [0.65,2.04] 0.33** [0.15,0.74]
2008 5.90*** [2.47,14.09] 1.93*** [1.41,2.65] 0.92 [0.66,1.29] 2.69*** [1.98,3.64] 1.12 [0.63,2.00] 0.32** [0.14,0.73]
Constant 0.12* [0.02,0.65] 0.22* [0.06,0.79] 0.41 [0.11,1.48] 0.10*** [0.03,0.39] 0.06*** [0.01,0.32] 0.65 [0.08,5.12]
Average practice intercept 0.21*** [0.14,0.31] 0.24*** [0.17,0.34] 0.27*** [0.20,0.35] 0.46*** [0.38,0.57] 0.43*** [0.33,0.56] 0.63*** [0.53,0.76]
N 7675 9051 8655 9852 7493 8036
Notes : A1c is hemoglobin A1c test, LDL is low-density lipoprotein test. Logit models used for all outcomes.
*p<0.05,**p<0.01,***p<0.001
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Table 5.18b: Average Marginal Moderating Effects of CCNC Patient Load from Multi-Level and Fixed Effects Models, by Baseline Values 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
>=1 A1C >=1 LDL >=1 Eye Exam Attention for Nephropathy
Low High Low Medium High Low Medium High Low Medium High
CCNC Patients (omitted=Very Low)
Low
MLM AME
0.031
[-0.040,0.103]
0.001
[-0.040,0.043]
̵  0.036
[-0.132,0.060]
0.029
[-0.036,0.094]
̵  0.013
[-0.064,0.038]
̵  0.007
[-0.064,0.049]
0.026
[-0.022,0.073]
0.027
[-0.024,0.079]
̵  0.0535
[-0.1096,0.0026]
0.007*
[0.011,0.121]
̵  0.027
[-0.079,0.026]
FE AME
0.0478
[-0.0417,0.1373]
̵  0.0176
[-0.0569,0.0217]
0.0205
[-0.0956,0.1365] 
̵  0.0010 
[-0.0941,0.0920]
  -0.0471
[-0.1201,0.0259] 
̵  0.0711
[-0.3013,0.1591]
 0.0208
[-0.0471,0.0888] 
 0.0318
[-0.0402,0.1038] 
̵  0.0732*
[-0.1427,-0.0037]
0.0031
[-0.0670,0.0732]
0.0259
[-0.0554,0.1072]
Medium
MLM AME
̵  0.019
[-0.114,0.075]
̵  0.007
[-0.061,0.046]
̵  0.068
[-0.186,0.049]
0.033
[-0.054,0.120]
̵  0.021
[-0.090,0.048]
0.002
[-0.065,0.069]
0.005
[-0.054,0.065]
̵  0.013
[-0.072,0.047]
̵  0.028
[-0.091,0.035]
̵  0.020
[-0.096,0.055]
̵  0.018
[-0.077,0.041]
FE AME
  -0.0126
[-0.1251,0.0999]
 -0.0411
[-0.1025,0.0203]
 0.0025
[-0.1265,0.1315] 
 -0.0192
[-0.1434,0.1050] 
̵  0.0942
[-0.2098,0.0214]
̵  0.0276
[-0.2672,0.2120]
̵  0.0010
[-0.0942,0.0922]
  -0.0050
[-0.1107,0.1007] 
 -0.0650
[-0.1518,0.0217] 
̵  0.0021
[-0.1355,0.1313]
 0.0497
[-0.0463,0.1456]
High
MLM AME
̵  0.026
[-0.119,0.067]
̵  0.024
[-0.078,0.029]
̵  0.067
[-0.180,0.046]
0.005
[-0.082,0.092]
̵  0.0655
[-0.1392,0.0082]
̵  0.007
[-0.070,0.055]
0.022
[-0.039,0.083]
0.016
[-0.042,0.074]
̵  0.032
[-0.091,0.027]
̵  0.009
[-0.075,0.056]
0.005
[-0.046,0.057]
FE AME
̵  0.0139
[-0.1400,0.1122]
̵  0.0677
[-0.1480,0.0126]
 -0.0233
[-0.1603,0.1138]    
̵  0.0464
[-0.1922,0.0993]
 -0.1416
[-0.2918,0.0087]
̵  0.061
[-0.3077,0.1856]
 0.0347
[-0.0804,0.1499]
0.0321
[-0.0735,0.1378] 
 -0.0998
[-0.2013,0.0017]
0.0300
[-0.1268,0.1868]    
0.0989
[-0.0017,0.1995]
Very High
MLM AME
0.042
[-0.048,0.133]
̵  0.014
[-0.064,0.036]
̵  0.070
[-0.189,0.050]
0.018
[-0.063,0.099]
̵  0.0638
[-0.1361,0.0085]
̵  0.018
[-0.081,0.045]
̵  0.021
[-0.074,0.033]
̵  0.009
[-0.061,0.042]
̵  0.031
[-0.087,0.026]
0.019
[-0.039,0.077]
̵  0.006
[-0.058,0.046]
FE AME
 0.0400
[-0.0957,0.1757]
̵  0.0566
[-0.1463,0.0331]
̵  0.0469
[-0.2099,0.1160]
̵  0.0248
[-0.1687,0.1191]
  ̵  0.1397
[-0.3155,0.0362]
̵  0.0555
[-0.3091,0.1981]
  0.0328
[-0.0939,0.1595]
 0.0204
[-0.0935,0.1343]
 ̵  0.1137*
[-0.2175,-0.0098]
0.0527
[-0.1061,0.2114]
 0.0977
[-0.0033,0.1987]
Notes: Logit models used for mult-level models. Cluster robust l inear probability models used for fixed-effects models.
*p<0.05,**p<0.01,***p<0.001
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Table 5.19a: Multi-Level Estimates of the Effect of CCNC on Yearly Health Care Utilization, by Baseline Values 
 
 
>=1 IP Admission >=1 ED Visit # PCP Visits # Total OP Visits
Low (<12.5%) High (>=12.5%) Low (<6%) Medium (6-17%) High (>17%) Low (<4.2) Medium (4.2-5.3) High (>5.3)
OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI IRR 95% CI IRR 95% CI IRR 95% CI
CCNC 0.97 [0.76,1.24] 1.07 [0.88,1.29] 0.92 [0.69,1.23] 1.03 [0.82,1.29] 1.03 [0.88,1.21] 0.95* [0.91,1.00] 0.94* [0.90,0.99] 0.99 [0.95,1.02]
(AME = -0.002) (AME = 0.0057) (AME =  ̵ 0.0092) (AME = 0.0034) (AME = 0.0046) (AME = -0.152) (AME = -0.2093) (AME = -0.0524)
Ever CCNC 1.08 [0.83,1.39] 0.93 [0.77,1.13] 1.19 [0.88,1.63] 1.10 [0.85,1.42] 1.00 [0.84,1.19] 1.09 [1.00,1.19] 0.94 [0.86,1.02] 0.97 [0.89,1.05]
CCNC Early Adopter 1.11 [0.94,1.30] 1.14 [0.97,1.34] 1.31* [1.05,1.63] 0.96 [0.79,1.17] 1.26** [1.09,1.45] 0.93 [0.85,1.03] 1.12** [1.03,1.22] 1.04 [0.95,1.13]
Person-level controls
Age 0.96 [0.91,1.01] 0.96 [0.91,1.01] 0.93* [0.88,0.99] 0.96 [0.92,1.00] 0.94** [0.90,0.98] 1.01 [1.00,1.02] 1.00 [0.99,1.01] 1.00 [0.99,1.01]
Age^2 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00]
Male 0.96 [0.87,1.06] 0.89* [0.80,0.99] 0.79*** [0.70,0.88] 0.74*** [0.67,0.81] 0.73*** [0.67,0.80] 0.82*** [0.81,0.84] 0.79*** [0.78,0.81] 0.76*** [0.75,0.77]
Charlson Index 3.36*** [3.11,3.64] 2.81*** [2.60,3.04] 1.79*** [1.61,2.00] 1.80*** [1.67,1.94] 1.87*** [1.73,2.03] 1.51*** [1.48,1.53] 1.41*** [1.38,1.43] 1.45*** [1.43,1.47]
Charlson Index^2 0.92*** [0.91,0.93] 0.95*** [0.94,0.95] 0.96*** [0.95,0.97] 0.96*** [0.95,0.97] 0.95*** [0.94,0.96] 0.97*** [0.97,0.97] 0.98*** [0.97,0.98] 0.98*** [0.98,0.98]
Eligibility (omitted = subscriber)
Spouse 1.22** [1.06,1.41] 1.26** [1.09,1.46] 0.86 [0.71,1.04] 0.98 [0.85,1.13] 0.99 [0.87,1.13] 0.98 [0.96,1.01] 1.06*** [1.03,1.09] 1.14*** [1.11,1.17]
Other 1.00 [0.44,2.27] 0.38 [0.12,1.16] 0.37 [0.13,1.06] 0.56 [0.30,1.05] 0.59 [0.27,1.29] 0.86 [0.71,1.06] 0.70** [0.56,0.89] 0.79** [0.69,0.92]
Plan Type (omitted = CMM)
Smart Choice 0.73** [0.59,0.90] 0.91 [0.72,1.14] 0.72* [0.54,0.97] 0.74** [0.61,0.91] 0.77** [0.64,0.92] 1.01 [0.96,1.06] 0.93** [0.88,0.97] 1.08*** [1.04,1.12]
Smart Choice Basic 0.73** [0.59,0.91] 0.92 [0.72,1.17] 0.80 [0.59,1.09] 0.79* [0.64,0.97] 0.90 [0.74,1.08] 0.94* [0.90,0.99] 0.89*** [0.85,0.94] 1.00 [0.96,1.04]
Smart Choice Plus 1.17 [0.90,1.52] 1.47** [1.10,1.95] 0.95 [0.66,1.37] 0.84 [0.65,1.08] 0.96 [0.75,1.22] 1.15*** [1.08,1.22] 1.03 [0.97,1.09] 1.22*** [1.17,1.28]
Practice and county-level controls
# Primary Care Providers 1.00 [0.99,1.01] 1.00 [1.00,1.01] 0.99 [0.97,1.02] 1.00 [0.99,1.00] 1.00 [0.99,1.01] 1.00* [0.99,1.00] 1.00 [1.00,1.01] 1.00 [1.00,1.00]
Multisite Practice 0.89 [0.35,2.29] 0.59 [0.31,1.12] 1.10 [0.42,2.87] 0.88 [0.40,1.92] 0.62 [0.30,1.31] — — — — 1.07 [0.81,1.42]
Rural-Urban
Non-urban, Non-rural 1.10 [0.94,1.29] 1.07 [0.91,1.26] 1.45*** [1.18,1.78] 1.13 [0.92,1.39] 1.18* [1.02,1.35] 0.93 [0.86,1.02] 1.02 [0.94,1.10] 1.06 [0.99,1.15]
Rural 0.84 [0.52,1.34] 0.74 [0.46,1.18] 0.93 [0.59,1.47] 1.93** [1.18,3.15] 1.00 [0.66,1.53] 1.02 [0.81,1.27] 0.89 [0.75,1.05] 0.94 [0.73,1.20]
Community-based Practice 0.74** [0.60,0.91] 0.80 [0.64,1.00] 1.02 [0.68,1.53] 1.09 [0.87,1.35] 0.87 [0.71,1.06] 0.91 [0.77,1.08] 0.84** [0.75,0.94] 0.85** [0.76,0.96]
County Proportion Poverty 0.99 [0.16,6.28] 1.18 [0.18,7.96] 0.34 [0.03,3.81] 4.15 [0.50,34.70] 0.32 [0.06,1.73] 4.24*** [2.03,8.84] 7.60*** [3.65,15.85] 1.81 [0.96,3.39]
Primary Care Providers/10,000 Population 1.00 [0.99,1.01] 1.00 [0.98,1.01] 1.01 [0.99,1.03] 1.01 [0.99,1.02] 0.99 [0.98,1.00] 1.00 [1.00,1.01] 1.00 [0.99,1.01] 1.00 [1.00,1.01]
County Proportion Race/Ethnicity
Non-white, not Hispanic 1.10 [0.67,1.80] 0.95 [0.54,1.67] 1.67 [0.91,3.07] 1.04 [0.54,1.98] 1.64* [1.05,2.57] 0.94 [0.75,1.18] 0.72** [0.57,0.92] 1.06 [0.84,1.34]
Hispanic 1.55 [0.53,4.50] 0.94 [0.32,2.74] 1.78 [0.47,6.71] 1.42 [0.44,4.61] 2.02 [0.76,5.37] 1.06 [0.61,1.86] 1.47 [0.92,2.35] 1.03 [0.66,1.62]
Year
2005 3.06*** [2.39,3.93] 0.46*** [0.38,0.56] 61.76*** [22.75,167.65] 1.37** [1.12,1.67] 0.61*** [0.52,0.71] 1.21*** [1.15,1.26] 0.90*** [0.86,0.95] 0.82*** [0.79,0.85]
2006 3.27*** [2.55,4.19] 0.43*** [0.36,0.53] 57.74*** [21.25,156.87] 1.49*** [1.22,1.82] 0.59*** [0.50,0.69] 1.24*** [1.18,1.30] 0.88*** [0.84,0.92] 0.78*** [0.76,0.81]
2007 3.27*** [2.54,4.20] 0.41*** [0.33,0.50] 62.61*** [23.00,170.44] 1.38** [1.13,1.68] 0.59*** [0.50,0.70] 1.30*** [1.23,1.36] 0.95* [0.91,1.00] 0.80*** [0.77,0.83]
2008 2.92*** [2.27,3.76] 0.37*** [0.30,0.45] 67.60*** [24.82,184.09] 1.50*** [1.23,1.83] 0.58*** [0.50,0.69] 1.34*** [1.28,1.40] 0.95* [0.91,1.00] 0.78*** [0.75,0.81]
Constant 0.02*** [0.01,0.08] 0.24* [0.06,0.93] 0.01*** [0.00,0.09] 0.25* [0.09,0.75] 1.80 [0.63,5.09] 1.19 [0.85,1.66] 2.16*** [1.57,2.97] 3.03*** [2.34,3.92]
Average practice intercept 0.24*** [0.17,0.33] 0.14*** [0.07,0.29] 0.30*** [0.22,0.40] 0.23*** [0.18,0.31] 0.23*** [0.17,0.30] 0.22*** [0.20,0.25] 0.17*** [0.15,0.20] 0.24*** [0.21,0.27]
N 27487 17480 11349 16810 16808 16095 12266 16606
Notes : Logit models used for IP and ED visits. Zero-truncated Poisson with reintroduced zeros used for PCP and OP vists. Robust OLS used for Continuity of Care.
Continuity of Care  models only for patients with >=3 OP visits during the year.
*p<0.05,**p<0.01,***p<0.001
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Table 5.19a: Continued 
 
# Total OP Visits Continuity of Care
Low (<6.5) Medium (6.5-8.1) High (>8.1) Low (<0.46) Medium (0.46 -0.58) High (>0.58)
IRR 95% CI IRR 95% CI IRR 95% CI Coeff. 95% CI Coeff. 95% CI Coeff. 95% CI
CCNC 0.98 [0.94,1.01] 0.97 [0.94,1.00] 0.97* [0.94,1.00] -0.0153 [-0.0455,0.0148] 0.0214 [-0.0006,0.0435] -0.0148 [-0.0385,0.0089]
(AME = -0.1322) (AME = -0.1924) (AME = -0.2348) (AME = -0.0047) (AME = 0.0073) (AME = ̵ 0.013)
Ever CCNC 1.00 [0.93,1.07] 1.01 [0.95,1.08] 0.97 [0.91,1.03] 0.027 [-0.0024,0.0564] 0.0029 [-0.0210,0.0269] 0.0259 [-0.0040,0.0557]
CCNC Early Adopter 0.91* [0.84,0.98] 1.03 [0.97,1.10] 1.05 [0.98,1.12] 0.0105 [-0.0172,0.0381] -0.0079 [-0.0336,0.0179] 0.0019 [-0.0237,0.0275]
Person-level controls
Age 0.97*** [0.97,0.98] 0.98*** [0.98,0.99] 0.99*** [0.98,0.99] 0.0071* [0.0011,0.0130] 0.0180*** [0.0126,0.0233] 0.0112** [0.0042,0.0183]
Age^2 1.00*** [1.00,1.00] 1.00*** [1.00,1.00] 1.00*** [1.00,1.00] -0.0001** [-0.0001,-0.0000] -0.0002***[-0.0003,-0.0001] -0.0001*** [-0.0002,-0.0001]
Male 0.76*** [0.75,0.78] 0.76*** [0.75,0.77] 0.74*** [0.73,0.75] 0.0682*** [0.0558,0.0807] 0.0617*** [0.0467,0.0768] 0.0725*** [0.0586,0.0864]
Charlson Index 1.50*** [1.48,1.52] 1.47*** [1.45,1.48] 1.46*** [1.44,1.47] -0.0541***[-0.0690,-0.0392] -0.0478***[-0.0571,-0.0384] -0.0616*** [-0.0709,-0.0523]
Charlson Index^2 0.97*** [0.97,0.98] 0.98*** [0.98,0.98] 0.98*** [0.98,0.98] 0.0042*** [0.0033,0.0050] 0.0023*** [0.0014,0.0033] 0.0031*** [0.0020,0.0041]
Eligibility (omitted = subscriber)
Spouse 1.12*** [1.10,1.15] 1.07*** [1.05,1.09] 1.10*** [1.08,1.12] -0.0075 [-0.0238,0.0088] -0.0245** [-0.0428,-0.0062] -0.0362*** [-0.0573,-0.0150]
Other 0.78** [0.66,0.91] 0.76*** [0.66,0.87] 0.85** [0.76,0.95] 0.0096 [-0.0652,0.0844] 0.0079 [-0.0885,0.1043] -0.0429 [-0.1510,0.0652]
Plan Type (omitted = CMM)
Smart Choice 1.00 [0.96,1.03] 1.00 [0.97,1.03] 1.10*** [1.06,1.13] -0.0246 [-0.0567,0.0075] -0.0024 [-0.0286,0.0239] -0.0004 [-0.0290,0.0282]
Smart Choice Basic 0.88*** [0.85,0.92] 0.92*** [0.89,0.95] 0.98 [0.95,1.01] 0.009 [-0.0251,0.0431] 0.0142 [-0.0139,0.0422] 0.0349* [0.0037,0.0661]
Smart Choice Plus 1.13*** [1.08,1.19] 1.15*** [1.10,1.19] 1.20*** [1.16,1.24] -0.0253 [-0.0605,0.0100] -0.0052 [-0.0402,0.0299] -0.0205 [-0.0554,0.0145]
Practice and county-level controls
# Primary Care Providers 1.00 [1.00,1.01] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 0.0002 [-0.0001,0.0006] -0.0009 [-0.0020,0.0002] -0.0032** [-0.0055,-0.0008]
Multisite Practice — — 0.78 [0.58,1.03] 1.13 [0.87,1.45] — — 0.0859* [0.0120,0.1598] 0.0059 [-0.0621,0.0740]
Rural-Urban
Non-urban, Non-rural 0.93* [0.87,0.99] 0.99 [0.93,1.05] 1.02 [0.96,1.08] 0.0073 [-0.0182,0.0328] 0.0240* [0.0010,0.0470] 0.0171 [-0.0071,0.0412]
Rural 0.92 [0.77,1.10] 0.87* [0.76,0.99] 0.85 [0.72,1.00] 0.1086** [0.0304,0.1868] 0.0816*** [0.0355,0.1277] 0.0119 [-0.0653,0.0891]
Community-based Practice 0.99 [0.83,1.18] 0.94 [0.86,1.02] 0.91* [0.84,0.99] 0.0590*** [0.0336,0.0843] -0.0296 [-0.0650,0.0058] -0.048 [-0.1044,0.0084]
County Proportion Poverty 1.74 [0.98,3.09] 1.46 [0.86,2.45] 1.21 [0.74,1.99] 0.0635 [-0.1834,0.3103] 0.1352 [-0.0965,0.3670] 0.0376 [-0.2326,0.3079]
Primary Care Providers/10,000 Population 1.00 [0.99,1.00] 1.00 [0.99,1.00] 1.00 [0.99,1.00] -0.0006 [-0.0027,0.0015] 0.0011 [-0.0008,0.0029] 0.0026** [0.0009,0.0044]
County Proportion Race/Ethnicity
Non-white, not Hispanic 0.92 [0.77,1.10] 0.91 [0.76,1.08] 1.09 [0.91,1.30] 0.0525 [-0.0271,0.1322] -0.0105 [-0.0814,0.0604] -0.0138 [-0.0888,0.0612]
Hispanic 0.57* [0.37,0.88] 1.19 [0.82,1.73] 0.88 [0.62,1.25] 0.096 [-0.1033,0.2952] -0.0478 [-0.1857,0.0902] 0.0674 [-0.0965,0.2313]
Year
2005 1.30*** [1.26,1.35] 1.01 [0.98,1.04] 0.87*** [0.84,0.89] 0.0539*** [0.0303,0.0775] -0.0419***[-0.0593,-0.0245] -0.1345*** [-0.1568,-0.1122]
2006 1.31*** [1.26,1.37] 1.00 [0.97,1.03] 0.85*** [0.82,0.88] 0.0422** [0.0169,0.0674] -0.0483***[-0.0665,-0.0302] -0.1450*** [-0.1676,-0.1224]
2007 1.41*** [1.36,1.47] 1.06*** [1.03,1.09] 0.89*** [0.87,0.92] 0.0308* [0.0040,0.0575] -0.0632***[-0.0805,-0.0459] -0.1774*** [-0.2017,-0.1531]
2008 1.45*** [1.40,1.51] 1.08*** [1.05,1.12] 0.89*** [0.86,0.92] 0.0223 [-0.0050,0.0495] -0.0745***[-0.0933,-0.0557] -0.1851*** [-0.2097,-0.1606]
Constant 5.44*** [4.10,7.23] 5.61*** [4.55,6.91] 6.25*** [5.11,7.63] 0.1939* [0.0431,0.3448] 0.1708* [0.0243,0.3172] 0.4739*** [0.2980,0.6497]
Average practice intercept 0.19*** [0.17,0.21] 0.13*** [0.11,0.15] 0.18*** [0.16,0.20] -2.9997***[-3.1772,-2.8221] -3.0886***[-3.2668,-2.9104] -2.9894*** [-3.1701,-2.8086]
N 13525 16015 15427 13600 12731 11776
Notes : Logit models used for IP and ED visits. Zero-truncated Poisson with reintroduced zeros used for PCP and OP vists. Robust OLS used for Continuity of Care.
Continuity of Care  models only for patients with >=3 OP visits during the year.
*p<0.05,**p<0.01,***p<0.001
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Table 5.19b: Average Marginal Effects of CCNC from Multi-Level and Fixed-Effects Models, by Baseline Values 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
>=1 IP >=1 ED # PCP # OP COC
Low High Low Medium High Low Medium High Low Medium High Low Medium High
CCNC
MLM AME
̵  0.002
[-0.018,0.014]
0.0057
[-0.012,0.023]
̵̵  0.009
[-0.040,0.022]
0.003
[-0.026,0.033]
0.005
[-0.020,0.029]
̵  0.152*
[-0.2941,-0.0099]
̵  0.209*
[-0.373,-0.045]
̵  0.05
[-0.21,0.10]
̵  0.132
[-0.346,0.081]
̵  0.192
[-0.412,0.027]
̵  0.235*
[-0.446,-0.023]
̵  0.005
[-0.031,0.022]
0.007
[-0.022,0.037]
̵  0.013
[-0.038,0.012]
FE AME
0.0038
[-0.0128,0.0204]
 0.0117
[-0.0118,0.0352]  
0.0190
[-0.0051,0.0431] 
0.0010
[-0.0262,0.0282]
0.0114
[-0.0126,0.0354]
̵  0.1028
[-0.2951,0.0895]
̵  0.2013
[-0.5558,0.1532]
̵  0.1049
[-0.4444,0.2347]
̵  0.1561
[-0.5258,0.2136]
̵  0.1172
[-0.4669,0.2325]
 ̵  0.2329
[-0.6987,0.2329]
̵  0.0151
[-0.0466,0.0163]
0.0267*
[0.0009,0.0525]
̵  0.015
[-0.0405,0.0104]
Notes : For multi-level models: logit models used for IP and ED visits, zero-truncated Poisson with reintroduced zeros used for PCP and OP vists,
robust OLS used for Continuity of Care. For fixed-effects models: Cluster-robust LPMs used for IP and ED visits, OLS used for PCP and OP visits and 
Contintinuity of Care. Continuity of Care  models only for patients with >=3 OP visits during the year.
*p<0.05,**p<0.01,***p<0.001
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Table 5.20a: Multi-Level Estimates of the Moderating Effect of CCNC Patient Load on Yearly Health Care Utilization, by Baseline Values 
 
>=1 IP Admission >=1 ED Visit # PCP Visits # Total OP Visits
Low (<12.5%) High (>=12.5%) Low (<14%) High (>=14%) Low (<4.3) Medium (4.3-5.5) High (>5.5)
OR 95% CI OR 95% CI OR 95% CI OR 95% CI IRR 95% CI IRR 95% CI IRR 95% CI
CCNC Patients (omitted = Very Low)
Low 0.78* [0.61,0.99] 1.02 [0.77,1.35] 1.11 [0.86,1.44] 1.16 [0.90,1.50] 1.02 [0.93,1.11] 1.00 [0.91,1.10] 0.90* [0.81,1.00]
(AME = -0.0188) (AME = 0.0015) (AME = 0.0132) (AME = 0.0207) (AME = 0.0583) (AME = -0.0011) (AME = -0.5202)
Medium 0.88 [0.68,1.12] 1.04 [0.78,1.39] 1.19 [0.91,1.54] 1.34* [1.03,1.74] 0.93 [0.83,1.04] 1.05 [0.94,1.16] 0.83** [0.74,0.94]
(AME = -0.0103) (AME = 0.003) (AME = 0.0211) (AME = 0.0412) (AME = -0.2285) (AME = 0.1658) (AME = -0.8275)
High 0.89 [0.69,1.15] 1.26 [0.93,1.70] 1.31 [0.99,1.74] 1.20 [0.91,1.57] 0.93 [0.83,1.04] 1.06 [0.94,1.19] 0.87* [0.77,0.98]
(AME = -0.009) (AME = 0.0203) (AME = 0.0351) (AME = 0.0249) (AME = -0.2441) (AME = 0.1987) (AME = -0.6473)
Very High 0.76* [0.59,0.97] 1.05 [0.80,1.37] 1.42* [1.09,1.86] 1.25 [0.96,1.63] 1.01 [0.90,1.13] 0.96 [0.85,1.08] 0.87* [0.77,0.98]
(AME = -0.0205) (AME = 0.0042) (AME = 0.0461) (AME = 0.0313) (AME = 0.0262) (AME = -0.1493) (AME = -0.6692)
CCNC Early Adopter 1.10 [0.97,1.25] 1.13 [0.95,1.35] 1.08 [0.93,1.26] 1.22* [1.05,1.43] 0.98 [0.89,1.08] 1.13** [1.03,1.24] 0.99 [0.89,1.10]
Person-level controls
Age 0.99 [0.92,1.06] 0.97 [0.90,1.04] 0.94* [0.89,0.99] 0.96 [0.91,1.00] 1.00 [0.99,1.01] 1.03*** [1.02,1.04] 0.99 [0.98,1.01]
Age^2 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00*** [1.00,1.00] 1.00 [1.00,1.00]
Male 0.92 [0.81,1.04] 0.95 [0.82,1.10] 0.74*** [0.67,0.82] 0.73*** [0.66,0.80] 0.81*** [0.79,0.83] 0.75*** [0.73,0.77] 0.78*** [0.76,0.80]
Charlson Index 3.41*** [3.08,3.77] 2.70*** [2.45,2.97] 1.82*** [1.66,1.99] 1.75*** [1.62,1.90] 1.45*** [1.41,1.48] 1.41*** [1.38,1.44] 1.46*** [1.44,1.49]
Charlson Index^2 0.92*** [0.91,0.93] 0.95*** [0.94,0.96] 0.96*** [0.95,0.97] 0.96*** [0.95,0.97] 0.97*** [0.97,0.98] 0.98*** [0.98,0.98] 0.98*** [0.97,0.98]
Eligibility (omitted = subscriber)
Spouse 1.33** [1.12,1.58] 1.45*** [1.20,1.77] 0.86 [0.73,1.03] 1.00 [0.86,1.17] 0.98 [0.94,1.02] 1.11*** [1.07,1.16] 1.19*** [1.16,1.23]
Other 1.78 [0.67,4.69] 0.39 [0.10,1.50] 0.43 [0.18,1.02] 0.82 [0.41,1.66] 0.75* [0.59,0.96] 0.82 [0.62,1.08] 0.88 [0.72,1.08]
Plan Type (omitted = CMM)
Smart Choice 0.63*** [0.48,0.82] 1.09 [0.76,1.58] 0.65** [0.51,0.85] 0.77* [0.61,0.97] 0.99 [0.92,1.07] 0.83*** [0.78,0.87] 1.11*** [1.06,1.17]
Smart Choice Basic 0.65** [0.49,0.86] 1.13 [0.78,1.66] 0.73* [0.56,0.95] 0.94 [0.75,1.19] 0.92* [0.85,0.99] 0.79*** [0.74,0.83] 1.02 [0.96,1.08]
Smart Choice Plus 1.21 [0.87,1.69] 1.70* [1.10,2.63] 0.96 [0.70,1.32] 1.08 [0.81,1.44] 1.15** [1.05,1.26] 0.90** [0.84,0.96] 1.26*** [1.18,1.34]
Practice and county-level controls
# Primary Care Providers 1.00 [0.99,1.01] 1.00 [1.00,1.01] 1.00 [0.98,1.01] 1.00 [0.99,1.00] 0.99** [0.99,1.00] 1.00 [1.00,1.01] 1.00 [1.00,1.00]
Multisite Practice 0.82 [0.32,2.10] 0.61 [0.29,1.30] 1.04 [0.33,3.21] 0.64 [0.32,1.29] — — 0.93 [0.59,1.48] 1.17 [0.76,1.80]
Rural-Urban
Non-urban, Non-rural 1.13 [0.97,1.32] 1.01 [0.83,1.24] 1.15 [0.96,1.39] 1.12 [0.93,1.34] 0.98 [0.87,1.10] 0.98 [0.89,1.09] 0.96 [0.86,1.07]
Rural 1.04 [0.74,1.46] 0.52* [0.31,0.87] 1.05 [0.76,1.46] 0.77 [0.49,1.23] 1.05 [0.85,1.28] 0.85 [0.71,1.01] 0.78 [0.60,1.02]
Community-based Practice 0.94 [0.78,1.14] 0.75 [0.55,1.01] 1.09 [0.72,1.64] 0.93 [0.73,1.18] 1.01 [0.79,1.30] 0.98 [0.81,1.18] 0.95 [0.79,1.14]
County Proportion Poverty 0.19 [0.03,1.18] 2.51 [0.19,32.82] 0.19 [0.02,1.64] 0.75 [0.09,6.45] 0.98 [0.38,2.51] 3.46* [1.34,8.93] 1.95 [0.84,4.50]
Primary Care Providers/10,000 Population 1.00 [0.98,1.01] 1.00 [0.98,1.02] 1.01 [0.99,1.02] 1.00 [0.98,1.01] 1.00 [0.99,1.01] 1.00 [0.99,1.01] 1.00 [0.99,1.01]
County Proportion Race/Ethnicity
Non-white, not Hispanic 1.23 [0.75,2.01] 1.03 [0.49,2.18] 2.14** [1.21,3.77] 1.73 [0.94,3.17] 1.07 [0.79,1.45] 0.88 [0.66,1.18] 0.91 [0.66,1.26]
Hispanic 1.47 [0.60,3.63] 0.44 [0.12,1.65] 1.03 [0.37,2.89] 1.33 [0.38,4.59] 0.70 [0.37,1.32] 1.83* [1.08,3.12] 0.78 [0.40,1.50]
Year
2005 1.83* [1.12,2.99] 0.42** [0.23,0.75] 3.11*** [1.67,5.78] 0.78 [0.56,1.09] 1.08 [0.95,1.23] 0.81*** [0.75,0.88] 0.84*** [0.76,0.93]
2006 2.08** [1.28,3.37] 0.39** [0.22,0.70] 3.19*** [1.72,5.90] 0.76 [0.55,1.05] 1.16* [1.02,1.32] 0.83*** [0.77,0.90] 0.80*** [0.72,0.88]
2007 2.12** [1.31,3.44] 0.37*** [0.21,0.65] 3.16*** [1.71,5.84] 0.78 [0.56,1.07] 1.19* [1.04,1.35] 0.85*** [0.78,0.92] 0.81*** [0.73,0.89]
2008 1.83* [1.13,2.97] 0.34*** [0.19,0.60] 3.55*** [1.92,6.56] 0.72* [0.52,1.00] 1.23** [1.08,1.40] 0.86*** [0.79,0.93] 0.78*** [0.70,0.86]
Constant 0.03*** [0.01,0.16] 0.18 [0.03,1.23] 0.27 [0.06,1.20] 0.71 [0.22,2.29] 2.10** [1.32,3.36] 1.21 [0.79,1.84] 3.60*** [2.41,5.39]
Average practice intercept 0.00 [0.00,0.00] 0.00 [0.00,0.00] 0.34*** [0.26,0.43] 0.33*** [0.26,0.41] 0.30*** [0.26,0.34] 0.22*** [0.18,0.25] 0.29*** [0.25,0.34]
N 15802 9579 12058 13323 8244 8651 8486
Notes : Logit models used for IP and ED visits. Zero-truncated Poisson with reintroduced zeros used for PCP and OP vists. Robust OLS used for Continuity of Care.
Continuity of Care  models only for patients with >=3 OP visits during the year.
*p<0.05,**p<0.01,***p<0.001
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Table 5.20a: Continued 
 
# Total OP Visits Continuity of Care
Low (<6.7) Medium (6.7-8.4) High (>8.4) Low (<0.46) Medium (0.46 -0.58) High (>0.58)
IRR 95% CI IRR 95% CI IRR 95% CI Coeff. 95% CI Coeff. 95% CI Coeff. 95% CI
CCNC Patients (omitted = Very Low)
Low 0.94 [0.88,1.01] 1.07 [1.00,1.16] 0.92* [0.86,1.00] 0.0119 [-0.0209,0.0446] 0.0253 [-0.0027,0.0533] -0.0094 [-0.0528,0.0339]
(AME = -0.3579) (AME = 0.4673) (AME = -0.6041) (AME = 0.0119) (AME = 0.0253) (AME = -0.0094)
Medium 0.89** [0.82,0.97] 1.06 [0.98,1.16] 0.89** [0.82,0.97] 0.0294 [-0.0029,0.0618] 0.0502*** [0.0223,0.0782] 0.0087 [-0.0359,0.0532]
(AME = -0.6736) (AME = 0.3949) (AME = -0.8903) (AME = 0.0294) (AME = 0.0502) (AME = 0.0087)
High 0.90* [0.82,0.98] 1.11* [1.02,1.22] 0.89** [0.81,0.97] 0.0414* [0.0085,0.0743] 0.0393 [-0.0032,0.0818] 0.0082 [-0.0353,0.0517]
(AME = -0.665) (AME = 0.7063) (AME = ̵ 0.9106) (AME = 0.0414) (AME = 0.0393) (AME = 0.0082)
Very High 0.90* [0.82,0.99] 1.04 [0.95,1.14] 0.88** [0.81,0.97] 0.0599*** [0.0250,0.0948] 0.0680*** [0.0293,0.1068] 0.0064 [-0.0373,0.0500]
(AME = -0.6424) (AME = 0.2616) (AME = -0.9298) (AME = 0.0599) (AME = 0.068) (AME = 0.0064)
CCNC Early Adopter 1.00 [0.93,1.08] 0.96 [0.90,1.03] 1.04 [0.95,1.13] 0.0024 [-0.0237,0.0284] -0.0034 [-0.0306,0.0237] -0.0024 [-0.0294,0.0247]
Person-level controls
Age 0.98*** [0.97,0.99] 1.00 [0.99,1.01] 0.99 [0.98,1.00] 0.0127** [0.0035,0.0219] 0.0139*** [0.0075,0.0203] 0.0058 [-0.0027,0.0144]
Age^2 1.00*** [1.00,1.00] 1.00* [1.00,1.00] 1.00* [1.00,1.00] -0.0001** [-0.0002,-0.0000] -0.0002*** [-0.0002,-0.0001] -0.0001 [-0.0002,0.0000]
Male 0.75*** [0.74,0.76] 0.75*** [0.74,0.76] 0.73*** [0.72,0.74] 0.0665*** [0.0502,0.0828] 0.0621*** [0.0402,0.0839] 0.0819*** [0.0662,0.0975]
Charlson Index 1.50*** [1.47,1.52] 1.46*** [1.44,1.48] 1.46*** [1.44,1.48] -0.0534*** [-0.0788,-0.0281] -0.0385*** [-0.0497,-0.0272] -0.0524*** [-0.0630,-0.0418]
Charlson Index^2 0.97*** [0.97,0.98] 0.98*** [0.98,0.98] 0.98*** [0.98,0.98] 0.0044*** [0.0032,0.0057] 0.0015* [0.0002,0.0027] 0.0021*** [0.0010,0.0031]
Eligibility (omitted = subscriber)
Spouse 1.14*** [1.11,1.17] 1.06*** [1.03,1.09] 1.15*** [1.12,1.18] -0.0008 [-0.0213,0.0196] -0.0299* [-0.0534,-0.0063] -0.0546*** [-0.0796,-0.0296]
Other 0.68*** [0.55,0.83] 0.79** [0.66,0.94] 0.90 [0.77,1.05] 0.0754 [-0.0118,0.1627] 0.0096 [-0.1136,0.1328] -0.0402 [-0.2751,0.1948]
Plan Type (omitted = CMM)
Smart Choice 0.99 [0.94,1.05] 0.94** [0.90,0.98] 1.07** [1.03,1.12] -0.0099 [-0.0499,0.0302] 0.0042 [-0.0312,0.0397] 0.0112 [-0.0251,0.0475]
Smart Choice Basic 0.87*** [0.82,0.91] 0.87*** [0.83,0.91] 0.96* [0.91,1.00] 0.0147 [-0.0294,0.0589] 0.0261 [-0.0104,0.0626] 0.0396 [-0.0004,0.0797]
Smart Choice Plus 1.14*** [1.07,1.21] 1.15*** [1.09,1.21] 1.15*** [1.09,1.21] -0.0268 [-0.0780,0.0243] -0.0097 [-0.0535,0.0342] -0.0191 [-0.0675,0.0293]
Practice and county-level controls
# Primary Care Providers 1.00 [1.00,1.01] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 0.0004 [-0.0001,0.0009] -0.0021** [-0.0036,-0.0007] -0.0023 [-0.0054,0.0008]
Multisite Practice — — 0.73 [0.52,1.02] 1.06 [0.75,1.50] 0.1131* [0.0269,0.1993] — — 0.0042 [-0.0793,0.0877]
Rural-Urban
Non-urban, Non-rural 0.92 [0.85,1.00] 0.95 [0.88,1.03] 0.92 [0.84,1.01] 0.0304 [-0.0018,0.0626] 0.0499** [0.0195,0.0804] 0.0193 [-0.0094,0.0481]
Rural 0.84* [0.72,0.99] 0.84* [0.71,0.98] 0.75** [0.63,0.90] 0.1061*** [0.0506,0.1615] 0.0802** [0.0258,0.1345] 0.0353 [-0.0385,0.1090]
Community-based Practice 1.08 [0.87,1.33] 0.95 [0.84,1.08] 0.93 [0.79,1.09] 0.0739*** [0.0337,0.1141] -0.0604** [-0.1002,-0.0206] -0.031 [-0.0980,0.0360]
County Proportion Poverty 1.39 [0.67,2.86] 1.17 [0.61,2.24] 0.49 [0.24,1.00] 0.1181 [-0.2070,0.4432] -0.117 [-0.4279,0.1940] -0.2006 [-0.5297,0.1284]
Primary Care Providers/10,000 Population 1.00 [0.99,1.00] 0.99* [0.98,1.00] 1.00 [0.99,1.01] 0.0003 [-0.0026,0.0032] 0.0015 [-0.0011,0.0042] 0.002 [-0.0009,0.0049]
County Proportion Race/Ethnicity
Non-white, not Hispanic 0.84 [0.67,1.07] 1.00 [0.81,1.24] 1.13 [0.86,1.50] -0.0341 [-0.1239,0.0557] 0.0954* [0.0104,0.1803] 0.0331 [-0.0543,0.1204]
Hispanic 0.69 [0.43,1.10] 1.26 [0.80,1.98] 0.58* [0.34,0.97] 0.0844 [-0.1383,0.3070] 0.0227 [-0.1360,0.1814] 0.0054 [-0.1650,0.1758]
Year
2005 1.19*** [1.08,1.32] 0.98 [0.92,1.04] 0.93 [0.84,1.02] 0.0318 [-0.0114,0.0751] -0.0226 [-0.0491,0.0040] -0.0969*** [-0.1543,-0.0394]
2006 1.24*** [1.12,1.36] 0.99 [0.94,1.05] 0.91 [0.83,1.00] 0.0189 [-0.0252,0.0630] -0.023 [-0.0524,0.0065] -0.0972*** [-0.1513,-0.0431]
2007 1.33*** [1.21,1.47] 1.03 [0.97,1.09] 0.93 [0.84,1.03] 0.001 [-0.0436,0.0456] -0.0474*** [-0.0746,-0.0202] -0.1364*** [-0.1942,-0.0785]
2008 1.38*** [1.25,1.52] 1.04 [0.98,1.10] 0.94 [0.86,1.04] -0.0088 [-0.0534,0.0357] -0.0528*** [-0.0811,-0.0245] -0.1438*** [-0.2016,-0.0860]
Constant 4.75*** [3.29,6.85] 4.33*** [3.23,5.81] 7.27*** [5.24,10.08] 0.0572 [-0.1506,0.2649] 0.2151* [0.0371,0.3932] 0.5751*** [0.3644,0.7858]
Average practice intercept 0.24*** [0.21,0.27] 0.16*** [0.13,0.18] 0.24*** [0.21,0.27] -2.9869*** [-3.2189,-2.7549] -3.1524*** [-3.4120,-2.8929] -2.8347*** [-3.0270,-2.6425]
N 8396 8713 8272 6648 7205 7511
Notes : Logit models used for IP and ED visits. Zero-truncated Poisson with reintroduced zeros used for PCP and OP vists. Robust OLS used for Continuity of Care.
Continuity of Care  models only for patients with >=3 OP visits during the year.
*p<0.05,**p<0.01,***p<0.001
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Table 5.20b: Average Marginal Moderating Effects of CCNC Patient Load from Multi-Level and Fixed-Effects Models, by Baseline Values 
 
 
 
 
 
 
 
 
 
 
 
 
>=1 IP >=1 ED # PCP # OP COC
Low High Low High Low Medium High Low Medium High Low Medium High
CCNC Patients (omitted=Very Low)
Low
MLM AME
̵  0.0188*
[-0.0358,-0.0018]
0.002
[-0.022,0.025]
0.013
[-0.019,0.046]
0.021
[-0.016,0.057]
0.06
[-0.24,0.36]
̵  0.00
[-0.35,0.35]
̵  0.520*
[-0.993,-0.047]
̵  0.358
[-0.789,0.073]
0.467
[-0.020,0.955]
̵  0.604*
[-1.179-0.029]
0.012
[-0.01,0.043]
0.025
[-0.011,0.061]
̵  0.009
[-0.052,0.033]
FE AME
  ̵  0.0054
[-0.0553,0.0445]
 0.0021
[-0.0493,0.0535]
̵ 0.0077
[-0.0764,0.0610]
   -0.0268
[-0.0856,0.0320] 
̵  0.10
[-0.54,0.34]
̵  0.07
[-0.71,0.57]
 ̵  0.27
[-0.83,0.29]
  0.00
[-0.59, 0.60] 
̵  0.5446
[-1.0970,0.0078]
 ̵  1.05
[-2.30,0.21]
̵  0.000
[-0.067,0.067]
 0.0579*   
[0.0071,0.1087]
 ̵  0.000
[-0.088,0.087]
Medium
MLM AME
̵  0.0103
[-0.0269,0.0063]
0.003
[-0.019,0.025]
0.0211
[-0.0094,0.0516]
0.0412*
[0.0047,0.0776]
̵  0.229
[-0.53,0.071]
0.17
[-0.19,0.52]
̵  0.83**
[-1.26,-0.40]
̵  0.67**
[-1.10,-0.25]
0.39
[-0.10,0.89]
̵  0.89**
[-1.43,-0.35]
0.0294*
[0.00020, 0.05860]
0.050**
[0.017,0.084]
0.009
[-0.032,0.049]
FE AME
   0.0195
[-0.0409,0.0799]
0.0567
[-0.0145,0.1280]      
 0.0136
[-0.0692,0.0965]   
̵  0.0191
[-0.0932,0.0550]
 ̵  0.50
[-1.19,0.20]
̵  0.06
[-0.94,0.81]
 ̵  0.37
[-1.14,0.39]
 ̵  0.09
[-0.83,0.65]
 ̵  0.61
[-1.95,0.72]
̵  0.18
[-2.16,1.80]
̵  0.014
[-0.091,0.064]
 0.0683*   
[0.0010,0.1355]  
̵  0.010
[-0.112,0.092]
High
MLM AME
̵  0.009
[-0.030,0.014]
0.020
[-0.014,0.055]
0.035
[-0.011,0.081]
0.0249
[-0.021,0.071]
̵  0.24
[-0.66,0.17]
0.20
[-0.32,0.72]
̵  0.647*
[-1.25,-0.042]
̵  0.665*
[-1.26,-0.070]
0.7063
[-0.00812,1.4207]
̵  0.91*
[-1.67,-0.15]
0.0414*
[0.000044,0.082756]
0.039
[-0.010,0.089]
0.008
[-0.044,0.061]
FE AME
0.0171
[-0.0476,0.0817]
 0.0400
[-0.0372,0.1172] 
  0.0248
[-0.0678,0.1173] 
 -0.0353
[-0.1168,0.0462] 
̵  0.42
[-1.16,0.32]
̵  0.30
[-1.13,0.54]
 ̵  0.18
[-1.04,0.67]
0.03
[-0.78,0.84]
 1.27
[-0.23,2.77]
 ̵  3.08*
[-5.68,-0.49]
 ̵  0.026
[-0.113,0.060]
0.016
[-0.082,0.113]
̵  0.043
[-0.151,0.066]
Very High
MLM AME
̵̵  0.0205*
[-0.0388,-0.0022]
0.004
[-0.020,0.029]
0.0461*
[0.0041,0.0881]
0.031
[-0.011,0.073]
0.03
[-0.39,0.44]
̵  0.15
[-0.59,0.29]
̵  0.67*
[-1.24,-0.10]
̵  0.642*
[-1.219,-0.066]
0.26
[-0.36,0.88]
̵  0.93*
[-1.64,-0.22]
0.060**
[0.021,0.098]
0.068*
[0.025,0.111]
0.006
[-0.042,0.055]
FE AME
 0.0124
[-0.0537,0.0784] 
0.0407
[-0.0387,0.1200]
 0.0265
[-0.0693,0.1223]
  -0.0477
[-0.1318,0.0365]
̵  0.10
[-0.87,0.68]]
̵  0.29
[-1.41,0.84]
̵  0.20
[-1.12,0.71]
 0.04
[-0.86, 0.94]   
 1.11
[-0.60,2.82] 
 ̵  6.04***
[-8.74,-3.33]
 ̵  0.012
[-0.100,0.076]
   0.027
[-0.078,0.132]
̵ 0.050
[-0.161,0.061]
Notes : For multi-level models: logit models used for IP and ED visits, zero-truncated Poisson with reintroduced zeros used for PCP and OP vists, 
robust OLS used for Continuity of Care. For fixed-effects models: Cluster-robust LPMs used for IP and ED visits, OLS used for PCP and OP visits and 
Contintinuity of Care. Continuity of Care  models only for patients with >=3 OP visits during the year.
*p<0.05,**p<0.01,***p<0.001
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Table 5.21a: Multi-Level Estimates of the Effect of CCNC on SHP Paid Medical Expenditures, by Baseline Values 
 
 
 
 
 
 
 
Total IP ED OP
Low (<2318) Medium (2318-4877) High (>4877) Low (<1519) High (>=1519) Low (<5) Medium (5-151) High (>151)
Coeff. 95% CI Coeff. 95% CI Coeff. 95% CI Coeff. 95% CI Coeff. 95% CI Coeff. 95% CI Coeff. 95% CI Coeff. 95% CI
CCNC -641.22 [-1721.82,439.38] 518.31 [-651.19,1687.81] -16.92 [-1444.06,1410.22] -163.5 [-670.10,343.09] -114.24 [-979.21,750.73] 2.00 [-93.14,97.13] 44.94 [-45.20,135.08] -22.53 [-146.94,101.87]
(AME = -641.22) (AME = 518.31) (AME = -16.92) (AME = -163.50) (AME = -114.24) (AME = 2.00) (AME = 44.94) (AME = -22.53)
Ever CCNC 594.30 [-586.01,1774.62] -215.89 [-1433.28,1001.50] -536.35 [-2131.37,1058.68] 195.07 [-317.79,707.94] 84.27 [-821.20,989.74] 11.93 [-84.98,108.85] 73.00 [-97.03,89.57] -8.38 [-146.67,129.91]
CCNC Early Adopter -52.49 [-1047.47,942.49] 227.73 [-702.49,1157.94] 838.56 [-408.88,2085.99] 153.29 [-207.72,514.31] 3.28 [-665.78,672.33] 80.81* [6.09,155.53] -20.37 [-90.49,49.75] 124.85* [24.23,225.48]
Person-level controls
Age -303.70* [-582.29,-25.10] -42.42 [-312.68,227.84] -6.07 [-364.65,352.51] -138.08* [-263.77,-12.40] -100.39 [-337.10,136.33] -0.75 [-25.67,24.18] 1.96 [-20.50,24.43] 1.88 [-29.38,33.15]
Age^2 3.77* [0.78,6.76] 0.62 [-2.27,3.50] 0.41 [-3.43,4.25] 1.58* [0.23,2.92] 1.21 [-1.32,3.75] -0.07 [-0.34,0.20] -0.08 [-0.33,0.16] 0.12 [-0.45,0.21]
Male -215.71 [-722.61,291.19] -371.84 [-869.46,125.78] -5.43 [-701.33,690.48] 247.44* [16.26,478.61] 362.82 [-89.77,815.41] -47.07* [-91.86,-2.28] -62.73** [-106.21,-19.24] -96.24** [-153.93,-38.56]
Charlson Index 2630.29*** [2130.64,3129.95] 4697.09*** [4261.91,5132.27] 6054.68*** [5469.80,6639.55] 1522.03*** [1301.75,1742.30] 2330.99*** [1960.65,2701.34] 183.61*** [140.83,226.40] 252.16*** [213.62,290.70] 404.71*** [355.82,453.60]
Charlson Index^2 701.69*** [632.09,771.28] 447.19*** [389.47,504.91] 467.53*** [395.78,539.27] 202.36*** [171.76,232.96] 195.98*** [151.42,240.54] -7.02* [-12.84,-1.20] -8.12** [-13.26,-2.98] -19.09*** [-25.12,-13.06]
Eligibility (omitted = subscriber)
Spouse 2018.00*** [1221.93,2814.07] 2483.14*** [1715.51,3250.77] 1571.94** [530.51,2613.37] 526.77** [166.74,886.80] 218.31 [-461.05,897.68] 9.71 [-58.16,77.58] 87.63** [21.42,153.83] 45.29 [-44.61,135.19]
Other -3306.85 [-8796.32,2182.62] -680.43 [-4845.77,3484.91] -4136.43 [-9543.92,1271.06] -902.77 [-3048.50,1242.97] -2732.56 [-6270.15,805.04] 264.49 [-148.46,677.43] -73.55 [-426.42,279.31] -127.55 [-633.52,378.42]
Plan Type (omitted = CMM)
Smart Choice -1909.25** [-3166.61,-651.89] -426.18 [-1626.75,774.39] -537.40 [-2229.65,1154.86] -961.00*** [-1526.58,-395.42] -1227.80* [-2331.58,-124.02] -118.91* [-233.21,-4.61] -82.3 [-190.61,26.01] 8.03 [-125.89,141.96]
Smart Choice Basic -2743.73***[-4037.20,-1450.26] -1546.21* [-2795.91,-296.50] -1812.78* [-3571.30,-54.27] -1123.43***[-1709.71,-537.15] -1642.51** [-2786.96,-498.06] -138.28* [-256.71,-19.85] -54.99 [-166.79,56.82] 73.06 [-66.57,212.68]
Smart Choice Plus 1518.64 [-126.65,3163.94] 3978.25*** [2420.96,5535.55] 2305.37* [165.97,4444.77] 510.15 [-228.44,1248.75] 148.9 [-1243.31,1541.10] 47.99 [-99.79,195.76] 107.43 [-29.52,244.37] 61.22 [-114.16,236.60]
Practice and county-level controls
# Primary Care Providers -51.79 [-148.20,44.62] 37.93 [-26.08,101.94] 37.26* [2.70,71.82] 5.89 [-19.06,30.84] 14.37 [-5.12,33.87] 0.28 [-8.88,9.45] 1.28 [-2.84,5.41] 2.91* [0.00,5.83]
Multisite Practice — — -1409.33 [-4164.31,1345.64] -3823.63 [-10421.90,2774.63] -400.06 [-1838.96,1038.84] -2238.17 [-6274.39,1798.05] -198.23 [-555.16,158.70] ̵  90.93 [-308.75,126.89] — —
Rural-Urban
Non-urban, Non-rural -22.79 [-948.67,903.10] 601.07 [-289.45,1491.59] -250.04 [-1500.58,1000.50] 253.42 [-92.55,599.38] 172.7 [-495.25,840.66] 101.98** [33.66,170.30] -7.01 [-76.34,62.32] -11.19 [-116.08,93.70]
Rural -1036.28 [-3482.39,1409.84] -1412 [-3735.21,911.21] 33.28 [-3350.40,3416.96] -285.8 [-1248.81,677.22] 208.22 [-1652.42,2068.86] 38.17 [-110.49,186.83] 56.45 [-162.09,274.99] -207.78 [-538.17,122.60]
Community-based Practice 187.59 [-1730.46,2105.65] 170.70 [-1090.13,1431.53] -792.14 [-2239.82,655.55] 62 [-473.01,597.01] -364.62 [-1141.45,412.21] 112.81 [-24.82,250.45] 84.98 [-5.08,175.05] 9.02 [-122.01,140.04]
County Proportion Poverty -1863.41 [-12980.21,9253.40] -8640.44 [-18630.01,1349.12] -6175.74 [-20524.37,8172.90] -76.9 [-4198.56,4044.76] -1010.52 [-8887.45,6866.41] -957.68* [-1799.61,-115.75] -100.07 [-920.48,720.34] -1577.96**[-2753.58,-402.34]
Primary Care Providers/10,000 Population-36.05 [-117.94,45.83] -3.78 [-60.38,52.83] -57.92 [-160.01,44.17] 5.12 [-21.06,31.30] ̵  10.53 [-60.97,39.91] 3.51 [-3.18,10.20] -5.73 [-11.47,0.01] -2.96 [-9.17,3.25]
County Proportion Race/Ethnicity
Non-white, not Hispanic -260.57 [-3054.42,2533.27] -766.88 [-3577.87,2044.11] 815.89 [-3552.91,5184.69] -139.58 [-1198.32,919.16] 440.9 [-2055.00,2936.79] 167.09 [-37.95,372.13] 120.31 [-96.06,336.68] 410.06* [44.32,775.79]
Hispanic -1416.1 [-7645.57,4813.37] -2168.83 [-7915.62,3577.95] 1666.04 [-7078.36,10410.44] 59.67 [-2237.61,2356.95] -776.46 [-5525.49,3972.57] 369.91 [-89.30,829.12] 75.73 [-357.73,509.19] 41.69 [-709.71,793.08]
Year
2005 3657.84*** [2624.58,4691.10] 2201.04*** [1183.55,3218.52] -1478.55 [-2966.14,9.04] 1426.94*** [961.75,1892.13] -1899.85***[-2847.89,-951.81] 298.33*** [207.20,389.47] 205.64*** [118.86,292.43] -30.25 [-155.34,94.84]
2006 3617.71*** [2573.89,4661.54] 2527.09*** [1515.87,3538.31] -1598.33* [-3069.66,-127.00] 1391.27*** [927.86,1854.68] -1971.55***[-2911.37,-1031.73] 312.28*** [220.87,403.69] 181.49*** [95.45,267.53] -6.55 [-130.06,116.96]
2007 3837.73*** [2799.16,4876.30] 2407.52*** [1401.15,3413.89] -1098.30 [-2595.45,398.85] 1364.21*** [902.90,1825.52] -1928.97***[-2872.64,-985.30] 304.32*** [212.69,395.96] 203.02*** [116.94,289.09] 10.31 [-112.94,133.56]
2008 3948.66*** [2901.09,4996.23] 2828.00*** [1818.28,3837.71] -812.53 [-2289.80,664.75] 1515.25*** [1055.78,1974.72] -1951.16***[-2896.42,-1005.90] 339.41*** [247.64,431.17] 253.79*** [168.30,339.28] 62.15 [-61.07,185.37]
Constant 6472.01 [-580.65,13524.66] 128.52 [-6529.37,6786.42] 1955.98 [-6846.90,10758.86] 1119.08 [-1941.41,4179.57] 3734.44 [-2016.37,9485.26] -66.87 [-680.09,546.35] -120.42 [-672.14,431.30] 193.93 [-575.55,963.40]
Average practice intercept 7.45*** [7.21,7.69] 6.91*** [6.55,7.28] 7.37*** [7.08,7.67] 6.07*** [5.55,6.58] 6.18*** [5.49,6.86] 4.44*** [3.99,4.88] 4.07*** [3.49,4.66] 4.89*** [4.56,5.22]
N 12383 16667 15917 27694 17273 11254 17772 15941
Notes : Bootstrapped OLS models used for all outcomes.
*p<0.05,**p<0.01,***p<0.001
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Table 5.21a: Continued 
 
OP RX
Low (<1572) Medium (1572-3119) High (>3119) Low (<958) Medium (958-1432) High (>1432)
Coeff. 95% CI Coeff. 95% CI Coeff. 95% CI Coeff. 95% CI Coeff. 95% Coeff. 95% CI
CCNC 97.64 [-547.93,743.21] -101.73 [-787.57,584.10] 85.18 [-778.57,948.94] -162.09 [-343.08,18.89] -169.53 [-365.08,26.01] 181.29 [-73.25,435.84]
(AME = 97.64) (AME = -101.73) (AME = 85.18) (AME = -162.09) (AME = -169.53) (AME = 181.29)
Ever CCNC -150.09 [-838.91,538.73] 88.33 [-626.01,802.66] -112.04 [-1067.68,843.60] 108.93 [-115.57,333.43] -17.85 [-265.39,229.70] -240.30 [-518.90,38.30]
CCNC Early Adopter 486.19 [-81.76,1054.13] -311.80 [-826.99,203.40] 890.45* [90.61,1690.28] -170.77 [-360.62,19.08] -211.56 [-439.75,16.63] -29.00 [-290.57,232.56]
Person-level controls
Age -77.96 [-255.80,99.88] -90.63 [-253.14,71.87] -127.55 [-331.93,76.82] 20.08 [-22.76,62.91] 114.89*** [68.26,161.52] 200.50*** [139.46,261.54]
Age^2 1.00 [-0.91,2.90] 1.24 [-0.50,2.98] 1.67 [-0.52,3.86] -0.21 [-0.67,0.25] -1.11*** [-1.60,-0.61] -2.16*** [-2.82,-1.51]
Male -860.22*** [-1178.19,-542.24] -410.73** [-713.03,-108.44] -436.77* [-834.86,-38.68] 45.43 [-33.92,124.78] 46.69 [-38.25,131.62] 267.89*** [149.15,386.62]
Charlson Index 754.52*** [443.53,1065.51] 2725.78*** [2469.06,2982.51] 1383.06*** [1035.05,1731.06] 564.00*** [487.17,640.82] 673.80*** [598.85,748.76] 910.64*** [810.75,1010.54]
Charlson Index^2 413.67*** [370.15,457.20] 155.94*** [124.35,187.52] 522.58*** [477.43,567.74] 0.20 [-10.69,11.09] -4.90 [-14.96,5.16] -27.54*** [-39.51,-15.58]
Eligibility (omitted = subscriber)
Spouse 1456.14*** [961.22,1951.06] 440.49 [-29.71,910.69] 492.16 [-101.81,1086.13] 498.42*** [374.95,621.89] 693.90*** [562.55,825.25] 1228.44*** [1051.33,1405.55]
Other -1467.63 [-5007.33,2072.07] -944.44 [-3675.90,1787.02] -2681.54 [-5570.93,207.85] -76.17 [-761.92,609.58] 456.75 [-356.72,1270.22] 2388.12*** [1466.21,3310.02]
Plan Type (omitted = CMM)
Smart Choice -548.80 [-1334.41,236.81] 257.65 [-476.87,992.18] 516.21 [-447.27,1479.69] -54.67 [-235.72,126.37] 186.08 [-31.19,403.36] 218.72 [-73.01,510.46]
Smart Choice Basic -1057.13* [-1864.42,-249.85] -543.55 [-1306.62,219.51] 58.71 [-945.52,1062.93] -287.13** [-473.86,-100.41] -79.68 [-304.60,145.23] -15.04 [-318.75,288.68]
Smart Choice Plus 1730.91** [696.65,2765.18] 738.79 [-197.46,1675.04] 2899.84*** [1666.22,4133.46] 302.53* [58.32,546.75] 882.18*** [604.02,1160.33] 383.35* [19.58,747.12]
Practice and county-level controls
# Primary Care Providers -31.56 [-84.93,21.81] 28.67 [-2.12,59.46] 19.14 [-1.18,39.47] -3.87 [-15.59,7.85] 2.67 [-10.31,15.65] 10.17** [3.00,17.34]
Multisite Practice — — -1173.09 [-3411.82,1065.63] -1418.46 [-3820.72,983.80] -9.75 [-979.52,960.01] 340.69 [-658.21,1339.59] -524.25 [-1611.46,562.97]
Rural-Urban
Non-urban, Non-rural 28.57 [-495.59,552.73] -255.37 [-759.14,248.40] 117.53 [-677.19,912.25] 72.30 [-98.82,243.42] -125.04 [-337.77,87.69] -167.75 [-423.67,88.17]
Rural -928.62 [-2200.83,343.59] -369.97 [-1792.50,1052.56] 703.41 [-1504.17,2910.98] 48.00 [-352.79,448.79] -322.49 [-821.44,176.45] 274.53 [-627.63,1176.69]
Community-based Practice 101.94 [-933.46,1137.34] -39.99 [-808.25,728.27] -163.89 [-1002.36,674.58] 78.54 [-223.58,380.65] 35.91 [-243.67,315.49] -405.64* [-790.96,-20.31]
County Proportion Poverty -6671.62 [-13427.08,83.85] 1812.69 [-4030.26,7655.64] -9134.16* [-17532.55,-735.76] -1030.41 [-2954.32,893.50] 484.30 [-1930.83,2899.43] 228.57 [-2648.92,3106.06]
Primary Care Providers/10,000 Population-39.51 [-86.59,7.58] -26.88 [-64.61,10.86] -15.31 [-69.60,38.97] -2.56 [-16.89,11.77] -2.84 [-19.08,13.40] -16.28 [-34.16,1.59]
County Proportion Race/Ethnicity
Non-white, not Hispanic 219.26 [-1488.47,1926.98] -452.83 [-1998.20,1092.55] 1937.90 [-608.20,4484.00] -173.91 [-712.86,365.03] -693.95* [-1349.26,-38.65] -952.68* [-1729.80,-175.57]
Hispanic -1523.09 [-4984.48,1938.30] 206.10 [-3231.36,3643.56] 2203.02 [-3281.31,7687.35] -207.06 [-1412.31,998.19] -998.62 [-2321.67,324.43] -233.81 [-1923.74,1456.12]
Year
2005 1885.13*** [1248.66,2521.60] 1348.82*** [716.21,1981.43] -1650.05***[-2497.04,-803.06] 799.96*** [633.15,966.76] 449.38*** [264.51,634.25] 91.84 [-155.99,339.66]
2006 1923.57*** [1288.91,2558.24] 1229.74*** [594.41,1865.08] -1566.19***[-2404.18,-728.21] 863.42*** [697.18,1029.65] 641.45*** [455.18,827.73] 213.33 [-33.54,460.19]
2007 1862.94*** [1236.49,2489.39] 1378.15*** [740.84,2015.45] -1699.31***[-2551.08,-847.53] 1089.47***[922.32,1256.62] 851.88*** [665.76,1038.00] 334.32** [84.21,584.42]
2008 1934.82*** [1301.34,2568.29] 1327.53*** [689.40,1965.67] -1173.75** [-2013.59,-333.90] 1016.24***[848.22,1184.26] 783.85*** [597.85,969.85] 355.41** [107.42,603.40]
Constant 3030.49 [-1383.16,7444.14] 67.64 [-3962.05,4097.34] 4361.43 [-666.09,9388.95] -141.94 [-1232.60,948.71] -2231.38***[-3414.24,-1048.53] -3051.67***[-4601.17,-1502.18]
Average practice intercept 6.79*** [6.53,7.05] 6.35*** [5.99,6.71] 6.85*** [6.56,7.14] 5.95*** [5.79,6.11] 6.04*** [5.86,6.22] 5.89*** [5.62,6.17]
N 12743 16541 15683 13507 15923 15537
Notes : Bootstrapped OLS models used for all outcomes.
*p<0.05,**p<0.01,***p<0.001
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Table 5.21b: Average Marginal Effects of CCNC from Multi-Level and Fixed-Effects Models, by Baseline Values 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total IP ED OP Rx
Low Medium High Low High Low Medium High Low Medium High Low Medium High
CCNC
MLM AME
̵  641.22
[-1728.74,446.30]
518.31
[-658.68,1695.30]
̵  16.92
[-1453.20,1419.36]
̵  163.5
[-673.34,346.34]
̵  114.24
[-984.74,756.26]
2.00
[-93.75,97.75]
44.94
[-45.78,135.66]
̵  22.53
[-147.73,102.67]
97.64
[-552.06,747.34]
̵  101.73
[-791.95,588.49]
85.18
[-784.11,954.47]
̵  162.09
[-344.23,20.05]
̵  169.53
[-366.33,27.27]
181.29
[-74.88,437.46]
FE AME
̵  560.33
[-2365.40,1244.73]
258.43
[-879.27,1396.12]
1002.99
[-422.87,2428.85] 
̵  316.92
[-1147.10,513.27]
424.63
[-603.06,1452.32]        
50.38
[-44.19,144.95]
56.35
[-18.07,130.77]        
64.08
[-32.51,160.68]
64.03
[-379.11,507.16] 

158.00
[-425.35,741.34]
 460.61
[-514.13,1435.34]
̵  114.44
[-235.42,6.55]
222.37
[-74.82,519.57]
851.59
[-1247.07,2950.25]
Notes : Bootstrapped OLS models used for all  outcomes.
*p<0.05,**p<0.01,***p<0.001
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Table 5.22a: Multi-Level Estimates of the Moderating Effect of CCNC Patient Load on SHP Paid Medical Expenditures, by Baseline Values 
 
 
 
Total IP ED OP
Low (<2318) Medium (2318-4877) High (>4877) Low (<1519) High (>=1519) Low (<5) Medium (5-151) High (>151)
Coeff. 95% CI Coeff. 95% CI Coeff. 95% CI Coeff. 95% CI Coeff. 95% CI Coeff. 95% CI Coeff. 95% CI Coeff. 95% CI
CCNC Patients (omitted = Very Low)
Low -869.82 [-2416.49,676.86] -1899.44 [-3904.08,105.20] -835.96 [-2891.02,1219.10] -58.82 [-700.82,583.19] -436.54 [-1785.54,912.46] 73.58 [-40.50,187.65] 119.77 [-14.92,254.46] 48.60 [-138.98,236.18]
(AME = -869.82) (AME = -1899.44) (AME = -835.96) (AME = -58.82) (AME = -436.54) (AME = 72.39) (AME = 119.77) (AME = 34.52)
Medium -1410.24 [-2907.49,87.01] -1588.27 [-3660.86,484.33] -337.92 [-2563.98,1888.14] 62.97 [-573.36,699.30] 660.78 [-762.18,2083.74] 61.36 [-49.06,171.77] -35.42 [-185.10,114.26] 109.97 [-84.58,304.51]
(AME = -1410.24) (AME = -1588.27) (AME = -337.92) (AME = 62.97) (AME = 660.78) (AME = 62.39) (AME = -36.12) (AME = 121.52)
High -1217.78 [-2843.53,407.98] -2218.79* [-4436.87,-0.70] 1395.05 [-893.40,3683.50] -44.65 [-721.43,632.14] 1848.56* [341.14,3355.99] 142.23* [13.36,271.10] -5.41 [-147.96,137.14] 41.92 [-156.37,240.21]
(AME = -1217.78) (AME = -2218.79) (AME = 1395.05) (AME = -44.65) (AME = 1848.57) (AME = 148.55) (AME = -4.25) (AME = 52.92)
Very High -1786.83* [-3395.05,-178.60] -2475.66* [-4618.89,-332.43] -543.22 [-2625.01,1538.57] 79.02 [-581.13,739.17] -71.67 [-1353.48,1210.14] 115.49 [-5.43,236.40] 24.68 [-111.57,160.93] 25.71 [-155.03,206.44]
(AME = -1786.83) (AME = -2475.66) (AME = -543.22) (AME = 79.02) (AME = -71.67) (AME = 111.70) (AME = 25.23) (AME = 13.40)
CCNC Early Adopter 144.95 [-662.91,952.82] 340.47 [-896.45,1577.39] 1363.22 [-4.99,2731.43] 205.98 [-147.80,559.76] 224.51 [-519.50,968.53] 32.50 [-31.07,96.06] -2.71 [-80.27,74.86] 120.30* [20.01,220.59]
Person-level controls
Age -382.87* [-739.10,-26.65] 39.62 [-448.16,527.41] 37.40 [-416.75,491.55] -176.95* [-352.23,-1.67] -33.77 [-341.02,273.48] -3.81 [-36.70,29.08] -4.73 [-37.73,28.27] 12.76 [-33.43,58.95]
Age^2 4.56* [0.73,8.39] -0.71 [-5.93,4.51] -0.45 [-5.32,4.43] 1.92* [0.04,3.80] 0.27 [-3.03,3.58] -0.06 [-0.42,0.29] -0.01 [-0.36,0.35] 0.23 [-0.72,0.27]
Male -1074.53** [-1722.01,-427.06] -879.33 [-1800.67,42.01] 495.59 [-399.51,1390.68] 2.31 [-319.28,323.91] 628.89* [20.26,1237.52] -74.38* [-133.49,-15.28] -57.27 [-122.52,7.98] -103.04* [-190.93,-15.15]
Charlson Index 4047.03*** [3420.37,4673.69] 5554.29*** [4812.17,6296.42] 6552.15*** [5827.10,7277.20] 1957.70*** [1652.54,2262.86] 2211.28*** [1737.93,2684.62] 198.75*** [142.47,255.03] 283.15*** [228.21,338.09] 420.77*** [350.61,490.92]
Charlson Index^2 441.40*** [352.38,530.43] 408.76*** [313.02,504.51] 369.19*** [282.06,456.33] 117.16*** [73.60,160.71] 198.36*** [143.56,253.17] 2.89 [-5.25,11.02] -8.06* [-15.15,-0.97] -19.51*** [-27.80,-11.22]
Eligibility (omitted = subscriber)
Spouse 3201.27*** [2132.34,4270.20] 4254.30*** [2857.44,5651.16] 2040.23** [673.56,3406.89] 1015.68*** [502.49,1528.86] 527.14 [-397.00,1451.29] 38.88 [-53.78,131.55] 46.93 [-53.54,147.39] 1.73 [-136.56,140.01]
Other -562.40 [-6820.65,5695.85] -3240.35 [-10658.07,4177.36] -5402.20 [-12532.87,1728.47] -896.60 [-3721.49,1928.28] -2953.87 [-7864.25,1956.52] -21.98 [-560.87,516.92] 75.65 [-516.20,667.49] 33.73 [-640.46,707.93]
Plan Type (omitted = CMM)
Smart Choice -2808.54** [-4607.44,-1009.64] -1128.31 [-3613.98,1357.37] 937.78 [-1374.39,3249.95] -2068.65*** [-2953.63,-1183.66] -663.95 [-2241.07,913.17] -105.54 [-272.40,61.32] -79.15 [-256.66,98.36] -60.14 [-282.26,161.98]
Smart Choice Basic -3881.24*** [-5714.23,-2048.24] -2551.18* [-5095.51,-6.84] -231.34 [-2614.58,2151.90] -2414.71*** [-3319.34,-1510.08] -972.88 [-2594.97,649.21] -97.66 [-268.21,72.88] -16.95 [-198.42,164.53] -0.92 [-229.85,228.02]
Smart Choice Plus -148.37 [-2398.11,2101.37] 7671.11*** [4549.94,10792.27] 3442.48* [572.04,6312.93] -50.00 [-1165.91,1065.91] 787.88 [-1154.28,2730.05] 82.23 [-124.91,289.37] 233.03* [15.24,450.83] 113.56 [-170.25,397.37]
Practice and county-level controls
# Primary Care Providers -29.99 [-136.32,76.34] -2.21 [-139.91,135.50] 53.92* [11.78,96.06] -12.52 [-48.18,23.14] 27.49* [3.52,51.46] 3.17 [-5.86,12.20] -4.38 [-11.19,2.42] 1.39 [-1.57,4.34]
Multisite Practice — — -1425.54 [-5332.72,2481.65] -2601.52 [-10761.23,5558.19] 16.93 [-1588.17,1622.03] -1291.92 [-6418.49,3834.65] -171.98 [-602.94,258.97] -162.23 [-415.37,90.91] — —
Rural-Urban
Non-urban, Non-rural -252.62 [-1186.20,680.96] -57.80 [-1556.35,1440.75] -175.00 [-1735.42,1385.42] 176.92 [-240.64,594.48] 548.07 [-237.55,1333.69] 32.51 [-43.34,108.36] -360.88 [-127.69,53.94] -5.80 [-113.85,102.25]
Rural -359.61 [-2239.11,1519.89] -510.42 [-3451.53,2430.70] -721.77 [-3972.71,2529.18] -168.68 [-1033.25,695.90] -258.16 [-2108.48,1592.17] -10.80 [-137.04,115.45] 46.24 [-195.85,288.33] -222.40 [-559.59,114.78]
Community-based Practice 707.17 [-1442.90,2857.23] 785.92 [-1353.67,2925.51] -1010.14 [-3037.12,1016.84] 302.86 [-406.21,1011.93] -111.90 [-1143.37,919.58] 171.12 [-10.08,352.32] 143.83* [16.54,271.11] -15.43 [-148.85,117.99]
County Proportion Poverty -6284.59 [-17887.84,5318.66] -4370.45 [-21778.53,13037.63] -8192.97 [-27141.12,10755.18] -2491.29 [-7519.88,2537.29] ̵  2764.18 [-12949.61,7421.25] -653.77 [-1611.03,303.49] -208.85 [-1299.75,882.06] -2435.63** [-3986.11,-885.15]
Primary Care Providers/10,000 Population -53.14 [-149.50,43.23] -4.20 [-124.55,116.14] -67.18 [-207.56,73.20] -4.08 [-42.97,34.81] 2.64 [-69.35,74.64] 3.17 [-4.58,10.93] -5.36 [-15.15,4.43] -2.09 [-10.79,6.61]
County Proportion Race/Ethnicity
Non-white, not Hispanic 354.65 [-2668.79,3378.08] -1591.33 [-6317.38,3134.72] 950.52 [-4547.18,6448.22] -25.80 [-1340.74,1289.15] -118.19 [-3191.73,2955.35] 290.39* [53.35,527.43] 339.85* [28.20,651.50] 416.69 [-19.25,852.63]
Hispanic -2263.54 [-7953.26,3426.17] -2374.53 [-11235.43,6486.37] 2871.30 [-7935.75,13678.35] -893.41 [-3399.75,1612.92] -1808.23 [-7519.72,3903.26] 416.35* [7.73,824.98] 549.09 [-38.20,1136.38] -355.78 [-1265.59,554.03]
Year
2005 3431.95* [160.05,6703.86] 3276.41 [-80.28,6633.09] -763.92 [-3879.04,2351.19] 1550.68* [200.05,2901.31] -278.71 [-2376.95,1819.54] 327.55 [-27.48,682.59] 90.34 [-113.85,294.52] 91.26 [-250.96,433.47]
2006 3513.59* [265.11,6762.06] 4087.52* [786.83,7388.21] -1375.58 [-4450.27,1699.12] 1744.67* [409.28,3080.06] -688.08 [-2760.66,1384.49] 333.57 [-19.24,686.39] 126.27 [-74.31,326.85] 87.73 [-251.68,427.14]
2007 3824.65* [591.70,7057.60] 3727.34* [445.00,7009.69] -633.72 [-3697.02,2429.58] 1823.06** [493.99,3152.13] -662.26 [-2729.33,1404.81] 346.93 [-4.64,698.50] 165.98 [-32.79,364.74] 98.68 [-239.76,437.13]
2008 4469.26** [1226.76,7711.76] 3953.15* [674.84,7231.46] -511.73 [-3559.03,2535.56] 2039.48** [709.10,3369.87] ̵  890.97 [-2946.08,1164.14] 394.15* [42.45,745.85] 217.27* [20.05,414.49] 180.96 [-156.97,518.90]
Constant 9879.45* [338.19,19420.70] -582.01 [-12863.81,11699.79] -950.24 [-12465.58,10565.09] 3136.95 [-1312.66,7586.56] 717.21 [-6967.91,8402.32] -208.40 [-1096.80,680.01] -112.02 [-940.40,716.36] -7.34 [-1162.58,1147.90]
Average practice intercept 7.15*** [6.70,7.60] 7.24*** [6.74,7.73] 7.41*** [7.04,7.78] 6.01*** [5.22,6.80] -5.13** [-8.59,-1.67] 6.78*** [6.42,7.13] 6.74*** [6.21,7.28] 6.95*** [6.46,7.43]
N 7939 6937 10505 14616 10765 7847 8925 8609
Notes : Bootstrapped OLS models used for all outcomes.
*p<0.05,**p<0.01,***p<0.001
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Table 5.22a: Continued 
 
OP RX
Low (<1572) Medium (1572-3119) High (>3119) Low (<958) Medium (958-1432) High (>1432)
Coeff. 95% CI Coeff. 95% CI Coeff. 95% CI Coeff. 95% CI Coeff. 95% Coeff. 95% CI
CCNC Patients (omitted = Very Low)
Low -311.69 [-1330.71,707.33] -2221.91*** [-3268.60,-1175.21] -1020.81 [-2447.74,406.13] 94.10 [-174.80,362.99] -12.12 [-299.75,275.50] 355.34 [-48.12,758.81]
(AME = -311.69) (AME = -2221.91) (AME = -1020.81) (AME = 94.10) (AME = -12.12) (AME = 355.34)
Medium -904.98 [-1880.13,70.18] -2410.09*** [-3498.32,-1321.85] -632.81 [-2230.85,965.23] -66.56 [-350.43,217.32] -190.96 [-492.75,110.83] 32.78 [-350.92,416.49]
(AME = -904.98) (AME = -2410.09) (AME = -632.81) (AME = -66.56) (AME = -190.96) (AME = 32.78)
High -930.55 [-2020.14,159.05] -2276.06*** [-3445.59,-1106.54] -501.58 [-2048.13,1044.96] 108.58 [-195.71,412.86] -107.88 [-437.10,221.34] 95.41 [-291.46,482.28]
(AME = -930.55) (AME = -2276.06) (AME = -501.58) (AME = 108.58) (AME = -107.88) (AME = 95.41)
Very High -1207.66* [-2263.97,-151.34] -2505.49*** [-3624.52,-1386.45] -1189.31 [-2660.90,282.28] -207.28 [-504.63,90.07] -257.78 [-571.73,56.17] -88.40 [-477.23,300.43]
(AME = -1207.66) (AME = -2505.49) (AME = -1189.31) (AME = -207.28) (AME = -257.78) (AME = -88.40)
CCNC Early Adopter 474.39 [-60.27,1009.06] -294.83 [-944.04,354.37] 1326.78** [344.58,2308.98] -71.68 [-222.69,79.34] -169.44 [-368.38,29.50] -192.64 [-461.27,75.98]
Person-level controls
Age -137.47 [-380.22,105.28] 99.60 [-141.29,340.48] -224.56 [-541.69,92.56] 16.64 [-35.19,68.46] 168.07*** [104.25,231.89] 130.09** [48.41,211.77]
Age^2 1.61 [-0.99,4.21] -1.11 [-3.70,1.47] 2.81 [-0.59,6.22] -0.17 [-0.73,0.39] -1.69*** [-2.37,-1.01] -1.51*** [-2.39,-0.63]
Male -1420.47*** [-1848.62,-992.31] -161.58 [-633.11,309.96] -252.14 [-877.98,373.71] 6.84 [-89.85,103.52] -17.3 [-133.75,99.15] 147.65 [-16.15,311.44]
Charlson Index 1368.70*** [957.65,1779.74] 3477.12*** [3102.63,3851.61] 2128.97*** [1605.98,2651.96] 673.69*** [581.80,765.58] 646.48*** [550.75,742.22] 834.36*** [702.08,966.64]
Charlson Index^2 348.18*** [289.79,406.56] 75.32*** [30.84,119.80] 421.84*** [355.93,487.74] -29.58*** [-42.81,-16.35] -8.92 [-21.65,3.80] -20.18** [-35.48,-4.88]
Eligibility (omitted = subscriber)
Spouse 2624.31*** [1919.55,3329.06] 258.68 [-474.68,992.04] 1026.14* [90.15,1962.13] 681.33*** [525.57,837.09] 605.77*** [426.94,784.60] 1559.72*** [1309.81,1809.63]
Other -1736.26 [-6238.09,2765.56] -743.17 [-4763.73,3277.40] -2908.54 [-7472.32,1655.24] -262.94 [-1054.72,528.85] 343.37 [-780.28,1467.03] 870.52 [-419.74,2160.78]
Plan Type (omitted = CMM)
Smart Choice 83.72 [-1065.37,1232.81] 1044.16 [-237.96,2326.27] 677.81 [-959.29,2314.91] -46.97 [-293.40,199.46] 275.54 [-39.13,590.21] 201.77 [-251.28,654.82]
Smart Choice Basic -537.01 [-1707.26,633.25] -18.53 [-1334.16,1297.11] 239.33 [-1445.70,1924.36] -313.13* [-564.21,-62.04] 33.61 [-289.24,356.45] 110.53 [-355.30,576.36]
Smart Choice Plus 2292.63** [843.07,3742.18] 1581.63 [-1.71,3164.97] 3389.18** [1345.18,5433.19] 433.06** [116.36,749.77] 1087.13*** [691.10,1483.15] 127.47 [-419.52,674.46]
Practice and county-level controls
# Primary Care Providers 5.89 [-71.82,83.61] 31.99 [-18.75,82.74] 26.45 [-1.28,54.19] 3.37 [-8.91,15.66] 14.03 [-2.16,30.22] 16.22*** [7.63,24.81]
Multisite Practice — — 22.49 [-2980.63,3025.62] -1629.40 [-4837.23,1578.42] -101.89 [-1083.82,880.04] 20.93 [-909.64,951.50] -580.43 [-1831.31,670.45]
Rural-Urban
Non-urban, Non-rural -346.85 [-962.71,269.01] -951.24* [-1703.28,-199.20] 551.58 [-644.44,1747.61] -79.91 [-254.14,94.31] 144.32 [-91.61,380.25] ̵  357.20* [-660.60,-53.80]
Rural -575.30 [-1775.61,625.01] -1136.04 [-2763.92,491.84] 2510.41* [317.77,4703.05] 127.90 [-180.46,436.27] -260.95 [-702.99,181.10] -340.44 [-1139.48,458.60]
Community-based Practice 657.82 [-528.48,1844.12] -805.75 [-2187.85,576.35] -340.30 [-1656.01,975.41] 166.72 [-151.61,485.06] 174.85 [-160.62,510.31] -79.35 [-687.73,529.02]
County Proportion Poverty ̵  6682.02 [-14755.42,1391.39] 2118.15 [-7036.71,11273.01] ̵  13346.57* [-26098.34,-594.80] -914.74 [-2945.68,1116.21] 326.48 [-2484.47,3137.42] -769.27 [-4464.58,2926.04]
Primary Care Providers/10,000 Population -78.33* [-149.29,-7.37] -32.10 [-99.48,35.27] -11.75 [-104.17,80.66] -5.90 [-25.09,13.28] -9.68 [-30.68,11.33] -33.37* [-59.22,-7.52]
County Proportion Race/Ethnicity
Non-white, not Hispanic 1030.73 [-1083.57,3145.02] 1534.34 [-838.52,3907.20] 1701.59 [-2029.84,5433.01] -111.87 [-671.42,447.68] -1024.71** [-1788.62,-260.81] -572.85 [-1587.67,441.96]
Hispanic 149.43 [-3542.41,3841.28] -3011.82 [-7651.09,1627.44] 6293.74 [-1583.89,14171.37] 517.03 [-573.24,1607.31] -853.98 [-2141.14,433.19] -845.53 [-2887.94,1196.88]
Year
2005 1932.62* [192.30,3672.94] 2323.51* [157.53,4489.49] -1294.26 [-3367.24,778.72] 663.42*** [308.35,1018.50] 287.16 [-382.43,956.76] 104.44 [-451.69,660.57]
2006 1958.78* [238.24,3679.32] 2117.76 [-25.70,4261.22] -1483.21 [-3523.08,556.66] 769.95*** [420.46,1119.43] 414.12 [-252.26,1080.50] 263.24 [-284.83,811.31]
2007 1899.60* [190.43,3608.78] 2288.53* [153.61,4423.45] -1592.45 [-3629.37,444.48] 959.48*** [611.67,1307.29] 653.60 [-11.12,1318.32] 292.91 [-254.38,840.19]
2008 2100.46* [386.76,3814.17] 2438.17* [308.29,4568.05] -1120.84 [-3150.57,908.89] 893.88*** [546.19,1241.57] 595.17 [-70.10,1260.45] 348.86 [-194.56,892.29]
Constant 3241.51 [-2919.29,9402.30] -2866.81 [-9227.01,3493.40] 5576.59 [-2471.15,13624.33] -319.28 [-1652.71,1014.14] -3433.41*** [-5154.94,-1711.88] -1277.06 [-3447.43,893.30]
Average practice intercept 5.80*** [5.59,6.01] 5.88*** [5.62,6.14] 5.82*** [5.26,6.38] 330.22 [266.59,409.04] 357.68 [276.98,461.89] 336.65   [192.03,590.19]
N 8033 8549 8799 8778 7766 8837
Notes : Bootstrapped OLS models used for all outcomes.
*p<0.05,**p<0.01,***p<0.001
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Table 5.22b: Average Marginal Moderating Effects of CCNC Patient Load from Multi-Level and Fixed-Effects Models, by Baseline Values 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total IP ED OP Rx
Low Medium High Low High Low Medium High Low Medium High Low Medium High
CCNC Patients (omitted=Very Low)
Low
MLM AME
̵  869.82
[-2409.59,669.95]
̵  1899.44
[-3895.12,96.24]
̵  835.96
[-2881.83,1209.91]
̵  58.82
[-697.96,580.32]
̵  436.54
[-1779.51,906.43]
72.39
[-43.71,188.50]
119.77
[3.67,235.88]
34.52
[-98.36,167.40]
̵  311.69
[-1326.16,702.78]
̵  2221.91**
[-3263.93,-1179.89]
̵  1020.81
[-2447.25,405.63]
94.10
[-173.59,361.79]
̵  12.12
[-298.46,274.22]
355.34
[-46.32,757.00]
FE AME
971.81
[-4895.39,6839.02]
1114.74
[-1949.20,4178.68]
1707.31
[-98.83,3513.46]
965.25
[-1069.92,3000.43]
182.05
[-941.60,1305.70] 
̵  167.05
[-388.26,54.16]
46.91
[-146.08,239.91]
 ̵  34.31
[-200.11,131.50]
̵  1859.56*
[-3648.79,-70.34]
  ̵ 412.90
[-1821.41,995.61]
1812.52*
[367.48,3257.55]
 341.49
[-33.75,716.74]
124.32
[-164.26,412.90]
231.13
[-29.15,491.42]
Medium
MLM AME
̵  1410.24*
[-2749.96,-70.52]
̵  1588.27
[-3442.81,266.27]
̵  337.92
[-2329.78,1653.94]
62.97
[-506.41 ,632.35]
660.78
[-612.47,1934.03]
62.39
[-38.89,163.67]
̵  36.12
[-137.40,65.16]
121.52
[-1.39,244.43]
̵  904.98*
[-1777.54,-32.42]
̵  2410.09**
[-3383.83,-1436.35]
̵  632.81
[-2062.72,797.10]
̵  66.56
[-320.57,187.45]
̵  190.96
[-461.00,79.08]
32.78
[-310.56,376.12]
FE AME
 771.99
[-5375.59,6919.56]   
 1168.00
[-3168.89,5504.89]
1152.81
[-1316.68,3622.31] 
1300.01
[-919.77,3519.78]
1286.84
[-594.63,3168.31] 
̵  152.49
[-419.84,114.86]
225.61
[-563.39,112.17]
 ̵  42.38
[-266.22,181.47]
̵  2118.74
[-4255.28,17.79]
 ̵ 1925.27
[-4156.84,306.30]
 1275.89
[-1116.46,3668.23]
  383.39
[-44.32,811.09] 
182.45
[-188.91,553.80]     
̵  134.87
[-552.29,282.54]
High
MLM AME
̵  1217.78
[-3088.69,653.13]
̵  2218.79
[-4771.34, 333.76]
1395.05
[-1238.48,4028.58]
̵  44.65
[-823.49,734.19]
1848.57*
[113.84,3583.30]
148.55
[-3.35,300.45]
̵  4.25
[-156.15,147.65]
52.92
[-132.58,238.42]
̵  930.55
[-2184.45,323.35]
̵  2276.06**
[-3621.94,-930.18]
̵  501.58
[-2281.33,1278.17]
108.58
[-241.58,458.75]
̵  107.88
[-486.74,270.98]
95.41
[-349.80,540.62]
FE AME
 1611.60
[-4851.51,8074.70]
̵  2841.71
[-8469.02,2785.60]
4478.81*
[743.78,8213.84] 
1456.42
[-1064.96,3977.79]
 592.63
[-4107.67,5292.93]
 ̵  61.73
[-363.18,239.72]
̵  81.28
[-444.19,281.63]
̵  179.81
[-535.23,175.60]
̵  1984.49
[-4345.58,376.61]
 ̵  2306.15
[-4722.92,110.61]
  2565.71
[-521.00,5652.43]  
  402.11
[-50.15,854.37] 
260.25
[-210.51,731.02]  
̵  327.49
[-967.31,312.34]
Very High  
MLM AME
̵  1786.83*
[-3502.14,-71.52]
̵  2475.66*
[-4761.60,-189.72]
̵  543.22
[-2763.63,1677.19]
79.02
[-625.34,783.38]
̵  71.67
[-1438.83,1295.49]
111.70
[-20.61,244.01]
25.23
[-107.08,157.54]
13.40
[-152.94,179.74]
̵  1207.66*
[-2334.31,-81.01]
̵  2505.49**
[-3699.04,-1311.94]
̵  1189.31
[-2758.89,380.27]
̵  207.28
[-524.43,109.87]
̵  257.78
[-592.64,77.08]
̵  88.40
[-503.12,326.32]
FE AME
  1623.37
[-4957.46,8204.20] 
̵  645.62
[-7035.30,5744.07]
 4346.03*
[36.64,8655.43]
2283.41
[-268.87,4835.69]
283.55
[-4249.95,4817.05]  
 ̵  266.18
[-676.92,144.57]
30.67
[-354.43,415.77]
̵  231.14
[-614.83,152.55]
 ̵  2076.29
[-4743.23,590.66]
 ̵  1159.34
[-3772.34,1453.66]
 2822.67
[-760.35,6405.70] 
 172.08
[-386.27,730.44]
50.55
[-408.95,510.06] 
̵  447.16
[-1126.41,232.09]
Notes : Bootstrapped OLS models used for all  outcomes.
*p<0.05,**p<0.01,***p<0.001
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Table 5.23a: Multi-Level Odds Ratios of the Effect of CCNC on Receipt of Yearly Diabetes Measures, by Primary Care Visits 
 
A1C LDL Eye Exam
Low (<3) Medium (3-5) High (>5) Low (<3) Medium (3-5) High (>5)
OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI
CCNC 1.19 [0.98,1.44] 1.25* [1.03,1.51] 1.22 [0.99,1.50] 0.99 [0.83,1.18] 1.16 [1.00,1.36] 1.04 [0.87,1.25]
(AME = 0.026) (AME = 0.0241) (AME = 0.023) (AME = -0.003) (AME = 0.0225) (AME = 0.006)
Ever CCNC 0.86 [0.69,1.08] 1.04 [0.79,1.37] 0.93 [0.71,1.22] 0.98 [0.80,1.19] 1.09 [0.86,1.39] 1.11 [0.87,1.41]
CCNC Early Adopter 1.00 [0.99,1.01] 1.00 [0.99,1.01] 1.00 [0.99,1.00] 1.00 [0.99,1.00] 0.99* [0.98,1.00] 0.99* [0.98,1.00]
Person-level controls
Age 1.00 [0.96,1.04] 1.06** [1.02,1.11] 1.07** [1.02,1.13] 1.10*** [1.06,1.15] 1.12*** [1.08,1.16] 1.10*** [1.05,1.15]
Age^2 1.00 [1.00,1.00] 1.00* [1.00,1.00] 1.00* [1.00,1.00] 1.00*** [1.00,1.00] 1.00*** [1.00,1.00] 1.00** [1.00,1.00]
Male 1.15*** [1.06,1.25] 1.32*** [1.22,1.43] 1.25*** [1.13,1.39] 1.15*** [1.07,1.24] 1.30*** [1.22,1.40] 1.17*** [1.07,1.27]
Charlson Index 7.47*** [6.77,8.25] 5.71*** [5.22,6.24] 2.09*** [1.94,2.26] 1.95*** [1.80,2.11] 1.51*** [1.41,1.62] 1.03 [0.97,1.09]
Charlson Index^2 0.78*** [0.77,0.80] 0.83*** [0.82,0.84] 0.93*** [0.93,0.94] 0.92*** [0.91,0.93] 0.94*** [0.93,0.95] 0.99* [0.98,1.00]
Eligibility (omitted = subscriber)
Spouse 0.83** [0.73,0.94] 0.84** [0.74,0.96] 0.86* [0.75,1.00] 0.84** [0.75,0.94] 0.90 [0.81,1.00] 0.85* [0.75,0.96]
Other 1.45 [0.84,2.51] 1.71 [0.88,3.33] 0.89 [0.39,2.02] 1.46 [0.89,2.42] 1.34 [0.76,2.34] 0.94 [0.44,2.03]
Plan Type (omitted = CMM)
Smart Choice 1.21 [0.99,1.47] 1.36** [1.11,1.67] 1.18 [0.94,1.48] 1.21* [1.01,1.44] 1.40*** [1.19,1.65] 1.17 [0.97,1.42]
Smart Choice Basic 1.16 [0.94,1.42] 1.28* [1.04,1.58] 1.14 [0.90,1.44] 1.14 [0.95,1.37] 1.28** [1.08,1.52] 1.16 [0.95,1.41]
Smart Choice Plus 1.12 [0.86,1.47] 1.39* [1.07,1.81] 1.15 [0.87,1.52] 1.06 [0.84,1.35] 1.27* [1.02,1.57] 1.44** [1.13,1.84]
Practice and county-level controls
# Primary Care Providers 0.78* [0.61,0.99] 0.62*** [0.47,0.80] 0.65** [0.50,0.86] 0.82 [0.66,1.02] 0.67*** [0.53,0.84] 0.73** [0.58,0.93]
Multisite Practice 0.91 [0.30,2.79] 0.96 [0.26,3.49] 1.36 [0.40,4.59] 0.70 [0.26,1.84] 1.79 [0.54,5.96] 2.08 [0.67,6.50]
Rural-Urban
Non-urban, Non-rural 0.80* [0.65,0.98] 0.67*** [0.53,0.85] 0.58*** [0.46,0.73] 0.80* [0.67,0.96] 0.73** [0.60,0.90] 0.77* [0.63,0.94]
Rural 0.58* [0.37,0.90] 0.43** [0.26,0.72] 0.48** [0.29,0.80] 0.48*** [0.32,0.71] 0.40*** [0.25,0.62] 0.42*** [0.26,0.66]
Community-based Practice 1.26 [0.91,1.74] 1.41 [0.96,2.07] 1.22 [0.86,1.75] 1.25 [0.94,1.66] 1.26 [0.90,1.76] 1.34 [0.98,1.84]
County Proportion Poverty 0.42 [0.04,3.92] 0.91 [0.08,10.48] 1.09 [0.09,13.74] 0.05** [0.01,0.34] 0.06* [0.01,0.54] 0.03** [0.00,0.33]
Primary Care Providers/10,000 Population 0.98* [0.96,1.00] 0.97** [0.95,0.99] 0.96*** [0.94,0.98] 0.97*** [0.95,0.98] 0.96*** [0.94,0.98] 0.96*** [0.95,0.98]
County Proportion Race/Ethnicity
Non-white, not Hispanic 0.68 [0.37,1.27] 0.69 [0.34,1.40] 0.94 [0.46,1.92] 0.90 [0.53,1.55] 0.78 [0.42,1.45] 1.26 [0.67,2.38]
Hispanic 1.06 [0.32,3.55] 3.57 [0.88,14.41] 4.69* [1.15,19.14] 2.04 [0.70,5.96] 2.84 [0.84,9.67] 2.23 [0.64,7.74]
Year
2005 1.06 [0.88,1.29] 0.87 [0.72,1.05] 0.92 [0.75,1.14] 1.77*** [1.50,2.09] 1.56*** [1.34,1.81] 1.54*** [1.29,1.83]
2006 0.95 [0.79,1.14] 0.86 [0.71,1.04] 0.90 [0.73,1.12] 1.83*** [1.55,2.16] 1.73*** [1.49,2.01] 1.60*** [1.34,1.91]
2007 1.15 [0.95,1.39] 0.88 [0.73,1.07] 0.88 [0.71,1.09] 2.05*** [1.74,2.42] 1.97*** [1.69,2.29] 1.83*** [1.53,2.19]
2008 1.19 [0.98,1.44] 0.83 [0.69,1.01] 0.85 [0.69,1.06] 2.28*** [1.93,2.69] 1.97*** [1.69,2.29] 1.88*** [1.57,2.24]
Constant 0.31* [0.11,0.90] 0.17** [0.06,0.50] 0.46 [0.13,1.70] 0.03*** [0.01,0.09] 0.06*** [0.02,0.15] 0.18** [0.06,0.56]
Average practice intercept 1.16*** [1.08,1.24] 1.52*** [1.44,1.62] 1.36*** [1.26,1.45] 0.99 [0.92,1.06] 1.35*** [1.27,1.43] 1.23*** [1.15,1.31]
N 17973 27940 19305 17973 27940 19305
Notes : A1c is hemoglobin A1c test, LDL is low-density lipoprotein test. Logit models used for all outcomes.
*p<0.05,**p<0.01,***p<0.001
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Table 5.23a: Continued 
 
Eye Exam Attention for Nephropathy
Low (<3) Medium (3-5) High (>5) Low (<3) Medium (3-5) High (>5)
OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI
CCNC 1.09 [0.92,1.29] 1.03 [0.92,1.17] 1.07 [0.93,1.23] 1.00 [0.84,1.19] 1.15 [0.99,1.34] 1.07 [0.89,1.29]
(AME = 0.017) (AME = 0.007) (AME = 0.016) (AME = 0.000) (AME = 0.0192) (AME = 0.0080)
Ever CCNC 0.83** [0.74,0.94] 0.96 [0.87,1.06] 0.98 [0.87,1.10] 0.96 [0.83,1.11] 0.87 [0.75,1.01] 0.99 [0.82,1.18]
CCNC Early Adopter 1.00 [1.00,1.01] 1.00 [1.00,1.01] 1.00 [0.99,1.00] 1.00 [0.99,1.01] 1.00 [0.99,1.00] 1.00 [0.99,1.01]
Person-level controls
Age 0.98 [0.94,1.01] 0.96** [0.93,0.99] 0.96* [0.93,1.00] 1.11*** [1.07,1.15] 1.10*** [1.06,1.13] 1.07** [1.02,1.13]
Age^2 1.00* [1.00,1.00] 1.00*** [1.00,1.00] 1.00*** [1.00,1.00] 1.00*** [1.00,1.00] 1.00*** [1.00,1.00] 1.00* [1.00,1.00]
Male 0.83*** [0.77,0.89] 0.84*** [0.80,0.89] 0.88*** [0.82,0.94] 1.10* [1.02,1.18] 1.04 [0.97,1.12] 0.99 [0.90,1.09]
Charlson Index 1.94*** [1.80,2.09] 1.74*** [1.64,1.84] 1.44*** [1.36,1.51] 2.44*** [2.26,2.64] 1.85*** [1.73,1.99] 1.39*** [1.30,1.49]
Charlson Index^2 0.93*** [0.92,0.95] 0.95*** [0.94,0.95] 0.97*** [0.96,0.98] 0.92*** [0.91,0.93] 0.94*** [0.93,0.95] 0.98*** [0.97,0.98]
Eligibility (omitted = subscriber)
Spouse 1.01 [0.91,1.12] 0.95 [0.88,1.04] 0.95 [0.86,1.05] 0.91 [0.81,1.02] 1.05 [0.94,1.17] 0.91 [0.79,1.04]
Other 0.83 [0.50,1.39] 0.97 [0.59,1.59] 1.18 [0.61,2.28] 0.94 [0.59,1.50] 1.34 [0.80,2.23] 1.52 [0.67,3.44]
Plan Type (omitted = CMM)
Smart Choice 1.30** [1.08,1.57] 1.38*** [1.20,1.60] 1.38*** [1.18,1.61] 1.23* [1.03,1.47] 1.16 [0.97,1.37] 1.23* [1.00,1.52]
Smart Choice Basic 0.94 [0.78,1.14] 1.08 [0.93,1.26] 1.10 [0.93,1.29] 1.13 [0.94,1.36] 1.13 [0.95,1.35] 1.15 [0.93,1.43]
Smart Choice Plus 1.32* [1.04,1.68] 1.35** [1.12,1.61] 1.29** [1.06,1.56] 1.27 [0.99,1.63] 1.24 [0.99,1.55] 1.33* [1.02,1.74]
Practice and county-level controls
# Primary Care Providers 0.91 [0.77,1.07] 1.00 [0.88,1.13] 0.94 [0.81,1.08] 0.97 [0.81,1.17] 0.95 [0.80,1.12] 0.90 [0.73,1.10]
Multisite Practice 0.81 [0.47,1.40] 1.28 [0.83,1.99] 1.18 [0.74,1.87] 0.80 [0.42,1.52] 0.64 [0.34,1.21] 0.79 [0.38,1.63]
Rural-Urban
Non-urban, Non-rural 0.93 [0.83,1.04] 0.97 [0.88,1.06] 0.95 [0.85,1.05] 0.85* [0.75,0.97] 0.91 [0.80,1.04] 0.82* [0.70,0.96]
Rural 0.90 [0.69,1.16] 0.78* [0.63,0.97] 0.75* [0.58,0.97] 0.96 [0.72,1.29] 0.90 [0.68,1.20] 0.89 [0.62,1.30]
Community-based Practice 1.03 [0.88,1.20] 0.98 [0.86,1.12] 1.01 [0.87,1.18] 0.94 [0.76,1.15] 1.00 [0.81,1.23] 1.33* [1.05,1.68]
County Proportion Poverty 0.63 [0.18,2.24] 0.33* [0.12,0.96] 0.54 [0.16,1.87] 0.10** [0.02,0.45] 0.02*** [0.01,0.11] 0.09* [0.01,0.62]
Primary Care Providers/10,000 Population 1.01 [1.00,1.02] 1.02*** [1.01,1.02] 1.02*** [1.01,1.03] 0.99* [0.98,1.00] 0.99* [0.98,1.00] 0.98** [0.97,0.99]
County Proportion Race/Ethnicity
Non-white, not Hispanic 0.71* [0.51,0.99] 0.73* [0.55,0.97] 0.99 [0.70,1.38] 1.95** [1.30,2.93] 2.83*** [1.89,4.23] 3.20*** [1.92,5.34]
Hispanic 0.36** [0.18,0.72] 0.75 [0.43,1.30] 0.71 [0.38,1.35] 2.17 [0.97,4.88] 1.28 [0.58,2.80] 4.73** [1.75,12.75]
Year
2005 0.92 [0.78,1.08] 0.94 [0.84,1.07] 0.84* [0.73,0.96] 1.59*** [1.35,1.87] 1.58*** [1.36,1.82] 1.33** [1.10,1.60]
2006 1.07 [0.91,1.26] 0.98 [0.87,1.10] 0.87* [0.76,1.00] 1.49*** [1.27,1.75] 1.54*** [1.34,1.78] 1.44*** [1.20,1.75]
2007 1.66*** [1.41,1.94] 1.47*** [1.30,1.65] 1.23** [1.08,1.41] 1.61*** [1.37,1.89] 1.66*** [1.44,1.92] 1.45*** [1.20,1.75]
2008 1.87*** [1.59,2.19] 1.63*** [1.45,1.83] 1.37*** [1.20,1.57] 1.73*** [1.47,2.04] 1.53*** [1.33,1.77] 1.39*** [1.15,1.68]
Constant 0.22*** [0.09,0.54] 0.35** [0.17,0.73] 0.40* [0.16,0.99] 0.05*** [0.02,0.13] 0.16*** [0.07,0.37] 0.30* [0.09,0.98]
Average practice intercept 0.28*** [0.22,0.35] 0.32*** [0.28,0.36] 0.38*** [0.33,0.43] 0.52*** [0.46,0.59] 0.60*** [0.54,0.66] 0.66*** [0.58,0.75]
N 17973 27940 19305 17973 27940 19305
Notes : A1c is hemoglobin A1c test, LDL is low-density lipoprotein test. Logit models used for all outcomes.
*p<0.05,**p<0.01,***p<0.001
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Table 5.23b: Average Marginal Effects of CCNC from Multi-Level and Fixed-Effects Models, by Primary Care Visits 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
>=1 A1C >=1 LDL >=1 Eye Exam Attention for Nephropathy
Low Medium High Low Medium High Low Medium High Low Medium High
CCNC
MLM AME
0.026
[-0.002,0.0546]
0.0241*
[0.0040,0.0442]
0.023
[-0.0010,0.0472]
̵ 0.003
[-0.036,0.030]
0.0225
[-0.00022,0.04522]
0.006
[-0.020,0.032]
0.017
[-0.018,0.052]
0.007
[-0.020,0.034]
0.016
[-0.015,0.047]
0.000
[-0.029,0.029]
0.0192
[-0.00060,0.03900]
0.008
[-0.014,0.030]
FE AME
0.027
[-0.012,0.066]
0.0216
[-0.0058, 0.0491] 
0.019
[-0.015,0.052]
̵  0.007
[-0.047,0.034]
0.0272
[-0.0034,0.0578]
 0.013
[-0.025,0.051]
̵  0.007
[-0.042,0.027]
0.003
[-0.028,0.034]       
0.016
[-0.022,0.055]
0.011
[-0.028,0.050]
0.0258
[-0.0003,0.0519]
0.004
[-0.026,0.033]
Notes: Logit models used for mult-level models. Cluster robust l inear probability models used for fixed-effects models.
*p<0.05,**p<0.01,***p<0.001
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Table 5.24a: Multi-Level Odds Ratios of the Moderating Effect of CCNC Patient Load on Receipt of Yearly Diabetes Measures, by Primary Care 
Visits 
 
A1C LDL Eye Exam
Low (<3) Medium (3-5) High (>5) Low (<3) Medium (3-5) High (>5)
OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI
CCNC Patients (omitted = Very Low)
Low 1.03 [0.73,1.46] 1.27 [0.87,1.85] 1.22 [0.81,1.83] 0.89 [0.66,1.20] 1.19 [0.87,1.62] 1.25 [0.87,1.79]
(AME = 0.0047) (AME = 0.0264) (AME = 0.0248) (AME = -0.0225) (AME = 0.0252) (AME = 0.0331)
Medium 1.00 [0.69,1.45] 1.08 [0.72,1.62] 1.17 [0.77,1.79] 0.95 [0.69,1.31] 1.20 [0.85,1.70] 1.24 [0.84,1.83]
(AME = -0.0003) (AME = 0.0087) (AME = 0.0202) (AME = -0.0101) (AME = 0.0267) (AME = 0.0326)
High 0.91 [0.61,1.36] 1.05 [0.68,1.63] 0.84 [0.53,1.32] 0.79 [0.56,1.11] 1.17 [0.81,1.70] 0.96 [0.64,1.45]
(AME = -0.0145) (AME = 0.0058) (AME = -0.0235) (AME = -0.0466) (AME = 0.0230) (AME = -0.0061)
Very High 1.03 [0.70,1.54] 1.07 [0.69,1.66] 1.22 [0.78,1.91] 0.84 [0.59,1.18] 0.90 [0.62,1.31] 1.09 [0.73,1.63]
(AME = 0.0049) (AME = 0.0082) (AME = 0.0246) (AME = -0.0346) (AME = -0.0158) (AME = 0.0130)
CCNC Early Adopter 0.87 [0.67,1.12] 1.00 [0.74,1.37] 0.90 [0.67,1.22] 0.96 [0.77,1.21] 1.16 [0.89,1.53] 1.16 [0.88,1.54]
Person-level controls
Age 0.97 [0.92,1.03] 1.03 [0.97,1.09] 1.02 [0.94,1.09] 1.11*** [1.05,1.17] 1.08** [1.02,1.13] 1.04 [0.97,1.11]
Age^2 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00] 1.00** [1.00,1.00] 1.00 [1.00,1.00] 1.00 [1.00,1.00]
Male 1.13* [1.00,1.27] 1.40*** [1.25,1.57] 1.19* [1.03,1.37] 1.06 [0.95,1.17] 1.27*** [1.15,1.41] 1.25*** [1.10,1.42]
Charlson Index 8.03*** [6.92,9.33] 6.28*** [5.51,7.16] 2.05*** [1.84,2.29] 2.05*** [1.82,2.31] 1.50*** [1.35,1.66] 1.04 [0.95,1.13]
Charlson Index^2 0.77*** [0.75,0.80] 0.81*** [0.80,0.83] 0.94*** [0.92,0.95] 0.91*** [0.89,0.93] 0.94*** [0.93,0.96] 0.99 [0.98,1.00]
Eligibility (omitted = subscriber)
Spouse 0.81* [0.67,0.97] 0.80* [0.66,0.96] 0.81* [0.66,0.99] 0.83* [0.71,0.99] 0.92 [0.78,1.08] 0.76** [0.63,0.91]
Other 0.78 [0.35,1.75] 1.12 [0.44,2.81] 0.48 [0.14,1.67] 1.24 [0.57,2.71] 0.48 [0.21,1.11] 0.61 [0.20,1.89]
Plan Type (omitted = CMM)
Smart Choice 1.24 [0.89,1.72] 0.99 [0.70,1.39] 1.15 [0.81,1.63] 1.12 [0.83,1.51] 1.49** [1.14,1.94] 1.38* [1.03,1.86]
Smart Choice Basic 1.15 [0.82,1.61] 0.91 [0.65,1.29] 1.11 [0.77,1.59] 1.06 [0.78,1.43] 1.40* [1.06,1.83] 1.43* [1.05,1.94]
Smart Choice Plus 1.30 [0.84,2.00] 0.87 [0.58,1.32] 1.10 [0.72,1.67] 0.99 [0.67,1.46] 1.10 [0.79,1.52] 1.51* [1.05,2.17]
Practice and county-level controls
# Primary Care Providers 1.00 [0.99,1.01] 1.01 [0.99,1.02] 0.99 [0.99,1.00] 1.00 [0.99,1.01] 0.99 [0.98,1.00] 0.99** [0.98,1.00]
Multisite Practice 0.94 [0.26,3.44] 1.26 [0.26,6.06] 1.69 [0.39,7.32] 0.76 [0.25,2.34] 1.21 [0.30,4.78] 2.02 [0.51,8.08]
Rural-Urban
Non-urban, Non-rural 1.04 [0.77,1.41] 0.95 [0.67,1.36] 0.71 [0.50,1.01] 0.96 [0.74,1.25] 0.99 [0.72,1.35] 0.96 [0.70,1.32]
Rural 0.78 [0.44,1.39] 0.63 [0.32,1.22] 0.58 [0.30,1.13] 0.57* [0.35,0.94] 0.44** [0.25,0.79] 0.37** [0.20,0.69]
Community-based Practice 0.74 [0.44,1.23] 0.87 [0.46,1.65] 0.71 [0.39,1.32] 0.9 [0.57,1.40] 1.01 [0.58,1.76] 1.18 [0.68,2.04]
County Proportion Poverty 0.92 [0.03,25.81] 0.95 [0.03,35.77] 1.43 [0.03,61.23] 0.04* [0.00,0.76] 0.02* [0.00,0.38] 0.02* [0.00,0.47]
Primary Care Providers/10,000 Population 0.95** [0.93,0.98] 0.92*** [0.89,0.96] 0.93*** [0.90,0.96] 0.93*** [0.91,0.96] 0.91*** [0.89,0.94] 0.93*** [0.90,0.95]
County Proportion Race/Ethnicity
Non-white, not Hispanic 0.47 [0.19,1.19] 0.68 [0.23,1.95] 0.86 [0.29,2.52] 0.68 [0.30,1.52] 0.78 [0.31,1.95] 1.14 [0.43,3.03]
Hispanic 0.56 [0.10,3.08] 1.03 [0.13,8.03] 1.09 [0.15,8.18] 1.56 [0.35,6.96] 2.41 [0.41,14.29] 1.98 [0.31,12.66]
Year
2005 0.61 [0.35,1.06] 1.08 [0.65,1.82] 1.04 [0.58,1.87] 1.85** [1.18,2.90] 1.71** [1.18,2.49] 2.01** [1.30,3.10]
2006 0.59 [0.34,1.02] 0.97 [0.58,1.62] 1.01 [0.56,1.81] 1.84** [1.18,2.86] 1.74** [1.20,2.52] 2.11*** [1.38,3.22]
2007 0.73 [0.42,1.25] 0.94 [0.56,1.56] 0.98 [0.55,1.75] 1.99** [1.28,3.09] 2.09*** [1.44,3.03] 2.43*** [1.59,3.72]
2008 0.76 [0.44,1.31] 0.86 [0.52,1.44] 0.94 [0.52,1.67] 2.29*** [1.47,3.56] 1.89*** [1.31,2.74] 2.33*** [1.52,3.56]
Constant 1.80 [0.36,9.06] 0.70 [0.13,3.85] 2.99 [0.39,22.59] 0.06*** [0.01,0.25] 0.20* [0.05,0.83] 0.60 [0.10,3.52]
Average practice intercept 1.27*** [1.15,1.40] 1.66*** [1.52,1.80] 1.43*** [1.30,1.58] 1.07 [0.97,1.19] 1.44*** [1.32,1.56] 1.35*** [1.22,1.49]
N 8307 13024 8902 8307 13024 8902
Notes : A1c is hemoglobin A1c test, LDL is low-density lipoprotein test. Logit models used for all outcomes.
*p<0.05,**p<0.01,***p<0.001
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Table 5.24a: Continued 
 
Eye Exam Attention for Nephropathy
Low (<3) Medium (3-5) High (>5) Low (<3) Medium (3-5) High (>5)
OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI
CCNC Patients (omitted = Very Low)
Low 0.83 [0.68,1.03] 0.99 [0.84,1.18] 1.11 [0.91,1.35] 0.77* [0.60,0.98] 0.97 [0.77,1.22] 0.94 [0.69,1.27]
(AME = -0.0381) (AME = -0.0014) (AME = 0.0237) (AME = -0.0445) (AME = -0.0046) (AME = -0.0080)
Medium 0.80* [0.64,0.99] 1.00 [0.84,1.19] 1.02 [0.83,1.25] 0.81 [0.62,1.05] 1.07 [0.84,1.37] 1.18 [0.86,1.63]
(AME = -0.0476) (AME = -0.0004) (AME = 0.0046) (AME = -0.0346) (AME = 0.0097) (AME = 0.0191)
High 0.83 [0.65,1.05] 1.03 [0.85,1.25] 1.06 [0.85,1.33] 0.87 [0.65,1.15] 1.13 [0.87,1.47] 0.98 [0.70,1.39]
(AME = -0.0401) (AME = 0.0070) (AME = 0.0143) (AME = 0-0.0231) (AME = 0.0164) (AME = -0.0019)
Very High 0.79* [0.63,0.98] 0.92 [0.77,1.10] 0.95 [0.77,1.16] 0.83 [0.63,1.08] 1.10 [0.85,1.41] 1.07 [0.78,1.49]
(AME = -0.0497) (AME = - 0.0190) (AME = -0.0124) (AME = -0.0313) (AME = 0.0128) (AME = 0.0085)
CCNC Early Adopter 0.85* [0.75,0.96] 0.97 [0.87,1.08] 0.97 [0.86,1.10] 0.98 [0.84,1.14] 0.91 [0.78,1.06] 0.95 [0.78,1.17]
Person-level controls
Age 0.96 [0.91,1.01] 0.95* [0.91,0.99] 0.98 [0.93,1.04] 1.11*** [1.06,1.17] 1.09*** [1.04,1.15] 1.06 [0.99,1.13]
Age^2 1.00* [1.00,1.00] 1.00*** [1.00,1.00] 1.00 [1.00,1.00] 1.00*** [1.00,1.00] 1.00** [1.00,1.00] 1.00 [1.00,1.00]
Male 0.78*** [0.71,0.87] 0.85*** [0.78,0.91] 0.89* [0.81,0.98] 1.12* [1.00,1.24] 1.09 [0.98,1.20] 1.05 [0.91,1.21]
Charlson Index 1.87*** [1.68,2.09] 1.76*** [1.62,1.91] 1.40*** [1.30,1.51] 2.56*** [2.28,2.87] 2.05*** [1.85,2.27] 1.39*** [1.27,1.53]
Charlson Index^2 0.94*** [0.92,0.96] 0.94*** [0.93,0.96] 0.97*** [0.96,0.98] 0.92*** [0.90,0.94] 0.93*** [0.92,0.94] 0.98*** [0.97,0.99]
Eligibility (omitted = subscriber)
Spouse 1.06 [0.90,1.24] 0.91 [0.80,1.03] 0.91 [0.79,1.04] 0.93 [0.78,1.10] 1.05 [0.89,1.24] 0.84 [0.69,1.03]
Other 0.91 [0.44,1.87] 0.89 [0.45,1.79] 0.92 [0.34,2.50] 0.86 [0.44,1.70] 1.17 [0.59,2.34] 1.01 [0.31,3.26]
Plan Type (omitted = CMM)
Smart Choice 1.70** [1.23,2.35] 1.40** [1.11,1.76] 1.25 [0.98,1.59] 1.55** [1.16,2.07] 1.22 [0.94,1.60] 1.05 [0.75,1.47]
Smart Choice Basic 1.22 [0.87,1.70] 1.09 [0.86,1.37] 1.00 [0.78,1.28] 1.36* [1.02,1.83] 1.16 [0.88,1.53] 0.96 [0.68,1.36]
Smart Choice Plus 1.64* [1.11,2.44] 1.47** [1.11,1.95] 1.15 [0.86,1.54] 1.28 [0.88,1.86] 1.19 [0.85,1.68] 1.22 [0.80,1.85]
Practice and county-level controls
# Primary Care Providers 1.00 [1.00,1.01] 1.00 [1.00,1.01] 1.00 [0.99,1.01] 1.00 [0.99,1.01] 1.00 [0.99,1.00] 1.00 [0.99,1.01]
Multisite Practice 0.83 [0.46,1.51] 1.64* [1.01,2.66] 1.09 [0.65,1.83] 0.98 [0.48,1.99] 0.69 [0.35,1.38] 1.15 [0.48,2.78]
Rural-Urban
Non-urban, Non-rural 0.84* [0.72,0.97] 0.86* [0.76,0.98] 0.81** [0.70,0.93] 0.83* [0.69,0.99] 0.97 [0.81,1.17] 0.80 [0.63,1.02]
Rural 0.79 [0.58,1.07] 0.70** [0.54,0.90] 0.71* [0.52,0.96] 0.84 [0.60,1.19] 0.83 [0.59,1.16] 0.82 [0.51,1.31]
Community-based Practice 1.05 [0.84,1.31] 1.07 [0.88,1.31] 1.00 [0.80,1.25] 0.76 [0.57,1.02] 0.72* [0.53,0.98] 1.01 [0.69,1.49]
County Proportion Poverty 3.59 [0.59,21.89] 1.82 [0.41,8.15] 1.43 [0.25,8.27] 0.62 [0.07,5.41] 0.03*** [0.00,0.22] 0.93 [0.05,15.75]
Primary Care Providers/10,000 Population 1.01 [0.99,1.02] 1.01* [1.00,1.03] 1.02** [1.01,1.03] 0.97*** [0.96,0.99] 0.97*** [0.96,0.99] 0.98* [0.96,1.00]
County Proportion Race/Ethnicity
Non-white, not Hispanic 0.59* [0.37,0.96] 0.50*** [0.34,0.74] 0.79 [0.49,1.27] 1.25 [0.70,2.22] 2.03* [1.16,3.56] 2.11 [0.99,4.52]
Hispanic 0.44 [0.18,1.09] 0.60 [0.29,1.26] 0.78 [0.33,1.83] 1.51 [0.52,4.33] 0.72 [0.25,2.03] 3.01 [0.75,12.10]
Year
2005 0.97 [0.61,1.54] 0.98 [0.71,1.34] 1.07 [0.74,1.53] 1.96** [1.28,2.98] 1.47* [1.01,2.13] 1.64* [1.03,2.60]
2006 1.13 [0.72,1.77] 0.99 [0.72,1.35] 1.01 [0.70,1.44] 2.00** [1.32,3.04] 1.50* [1.04,2.17] 1.80* [1.14,2.85]
2007 1.67* [1.06,2.62] 1.47* [1.08,2.00] 1.41 [0.99,2.01] 2.28*** [1.50,3.45] 1.51* [1.04,2.17] 1.67* [1.06,2.63]
2008 1.83** [1.17,2.87] 1.65** [1.21,2.25] 1.52* [1.07,2.17] 2.28*** [1.51,3.46] 1.38 [0.96,1.99] 1.65* [1.05,2.60]
Constant 0.24* [0.07,0.89] 0.36 [0.12,1.06] 0.24* [0.06,0.93] 0.04*** [0.01,0.15] 0.28* [0.08,0.97] 0.42 [0.07,2.51]
Average practice intercept 0.29*** [0.20,0.41] 0.31*** [0.26,0.38] 0.35*** [0.28,0.44] 0.50*** [0.42,0.60] 0.56*** [0.48,0.65] 0.68*** [0.57,0.82]
N 8307 13024 8902 8307 13024 8902
Notes : A1c is hemoglobin A1c test, LDL is low-density lipoprotein test. Logit models used for all outcomes.
*p<0.05,**p<0.01,***p<0.001
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Table 5.24b: Average Marginal Moderating Effects of CCNC Patient Load from Multi-Level and Fixed Effects Models, by Primary Care Visits 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
>=1 A1C >=1 LDL >=1 Eye Exam Attention for Nephropathy
Low Medium High Low Medium High Low Medium High Low Medium High
CCNC Patients (omitted=Very Low)
Low
MLM AME
0.005
[-0.046,0.055]
0.026
[-0.014,0.067]
0.025
[-0.024,0.074]
̵  0.022
[-0.077,0.032]
0.025
[-0.019,0.069]
0.033
[-0.019,0.085]
̵  0.0381
[-0.0797,0.0035]
̵  0.001
[-0.037,0.035]
0.024
[-0.020,0.067]
̵  0.0445*
[-0.0878,-0.0012]
̵  0.005
[-0.038,0.029]
̵  0.008
[-0.047,0.031]
FE AME
   0.0196
[-0.0842,0.1235]  
0.0761
[-0.0096,0.1619] 
̵  0.0269
[-0.0745,0.0206]
0.0280
[-0.1007,0.1567] 
 0.0180
[-0.0803,0.1163]
 0.0010
[-0.0501,0.0521]
̵  0.1316**
[-0.2303,-0.0330]
̵  0.0235
[-0.1286,0.0815]
 0.0172
[-0.0557,0.0902] 
̵  0.0918
[-0.1952,0.0117]
̵  0.0190
[-0.0780,0.0399]
 -0.0954**
[-0.1554,-0.0354]
Medium
MLM AME
̵  0.000
[-0.064,0.063]
0.009
[-0.045,0.063]
0.020
[-0.040,0.081]
̵  0.010
[-0.079,0.059]
0.027
[-0.030,0.083]
0.033
[-0.031,0.097]
̵  0.0476
[-0.0972,0.0019]
̵  0.000
[-0.044,0.043]
0.005
[-0.047,0.057]
̵  0.035
[-0.086,0.017]
0.010
[-0.029,0.048]
0.019
[-0.023,0.061]
FE AME
0.0381
[-0.1209,0.1970]
 0.0828
[-0.0211,0.1868] 
  -0.0761*
[-0.1462,-0.0060]
0.0944
[-0.0918,0.2807]
 ̵  0.0017
[-0.1166,0.1131]
 ̵  0.0173
[-0.0906,0.0561]
  -0.1934*
[-0.3754,-0.0114]   
 -0.0436
[-0.1636,0.0764]
0.0339
[-0.052 0,0.1198] 
̵  0.0693
[-0.2267,0.0880]
0.0022
[-0.0789,0.0832] 
̵  0.0909*
[-0.1655,-0.0162]
High
MLM AME
̵  0.015
[-0.078,0.049]
0.006
[-0.046,0.058]
̵  0.024
[-0.089,0.042]
̵  0.047
[-0.114,0.022]
0.023
[-0.032,0.078]
̵  0.006
[-0.072,0.060]
̵  0.0401
[-0.0891,0.0089]
0.007
[-0.036,0.050]
0.014
[-0.037,0.065]
̵  0.023
[-0.072,0.025]
0.016
[-0.020,0.053]
̵  0.002
[-0.046,0.042]
FE AME
̵  0.2799
[-0.6262,0.0664]
0.1001
[-0.0167,0.2168]   
̵  0.1025*
[-0.1870,-0.0180]
 ̵  0.0433
[-0.4609,0.3743]
̵  0.0253
[-0.1543,0.1037]
̵  0.0440
[-0.1350,0.0470]
 -0.4536***
[-0.6900,-0.2172]
  -0.0184
[-0.1513,0.1144]    
0.0327
[-0.0612,0.1267] 
 -0.0939
[-0.2805,0.0926]
 0.0036
[-0.0975,0.1048] 
 ̵  0.1185**
[-0.2003,-0.0367]
Very High
MLM AME
0.005
[-0.055,0.065]
0.008
[-0.043,0.059]
0.025
[-0.031,0.080]
̵  0.035
[-0.101,0.032]
̵  0.016
[-0.074,0.042]
0.013
[-0.049,0.075]
̵  0.0497*
[-0.0948,-0.0046]
̵  0.019
[-0.058,0.020]
̵  0.012
[-0.059,0.034]
̵  0.031
[-0.077,0.015]
0.013
[-0.022,0.047]
0.009
[-0.031,0.048]
FE AME
   -0.3416
[-0.6925,0.0093]
 0.1513*
[0.0094,0.2931]
 -0.0775
[-0.1690,0.0140]  
 0.0136
[-0.3781,0.4053]  
̵  0.0225
[-0.1843,0.1393]
  ̵  0.0749 
[-0.1839,0.0340]
 ̵  0.5312***
[-0.7721,-0.2902]
 ̵  0.0247
[-0.1811,0.1316]
  0.0327
[-0.0659,0.1313]
̵  0.0434
[-0.2191,0.1323]
 -0.0106
[-0.1190,0.0979]
̵  0.1200**
[-0.2048,-0.0352]
Notes: Logit models used for mult-level models. Cluster robust l inear probability models used for fixed-effects models.
*p<0.05,**p<0.01,***p<0.001
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Table 5.25a: Multi-Level Estimates of the Effect of CCNC on Yearly Health Care Utilization, by Primary Care Visits 
 
Continuity of Care
Medium (3-5) High (>5)
Coeff. 95% CI Coeff. 95% CI
CCNC 0.0019 [-0.0188,0.0225] -0.0142 [-0.0301,0.0017]
(AME = 0.0025) (AME = -0.0142)
Ever CCNC 0.0212 [-0.0001,0.0424] 0.0300** [0.0117,0.0483]
CCNC Early Adopter 0.0146 [-0.0009,0.0302] 0.0102 [-0.0057,0.0261]
Person-level controls
Age 0.0150*** [0.0107,0.0193] 0.0108*** [0.0067,0.0148]
Age^2 -0.0002*** [-0.0002,-0.0001] -0.0001*** [-0.0002,-0.0001]
Male 0.0980*** [0.0898,0.1062] 0.0586*** [0.0488,0.0684]
Charlson Index -0.0830*** [-0.0900,-0.0760] -0.0617*** [-0.0684,-0.0551]
Charlson Index^2 0.0051*** [0.0041,0.0060] 0.0036*** [0.0030,0.0043]
Eligibility (omitted = subscriber)
Spouse -0.0202** [-0.0331,-0.0072] -0.0251*** [-0.0371,-0.0130]
Other 0.0031 [-0.0715,0.0776] -0.0312 [-0.1114,0.0490]
Plan Type (omitted = CMM)
Smart Choice -0.0144 [-0.0351,0.0062] -0.0191 [-0.0400,0.0017]
Smart Choice Basic 0.0189 [-0.0029,0.0408] 0.0166 [-0.0048,0.0380]
Smart Choice Plus -0.0524*** [-0.0786,-0.0261] -0.0285* [-0.0535,-0.0034]
Practice and county-level controls
# Primary Care Providers -0.0002 [-0.0009,0.0005] 0.0000 [-0.0004,0.0004]
Multisite Practice -0.0240 [-0.1297,0.0817] -0.0213 [-0.0955,0.0529]
Rural-Urban
Non-urban, Non-rural 0.0137 [-0.0010,0.0285] 0.0048 [-0.0098,0.0195]
Rural 0.0499** [0.0152,0.0846] 0.0484** [0.0146,0.0822]
Community-based Practice 0.0388** [0.0105,0.0670] 0.0222 [-0.0022,0.0465]
County Proportion Poverty 0.0321 [-0.1278,0.1921] -0.0331 [-0.1930,0.1269]
Primary Care Providers/10,000 Population 0.0006 [-0.0008,0.0020] 0.0003 [-0.0008,0.0015]
County Proportion Race/Ethnicity
Non-white, not Hispanic 0.0120 [-0.0326,0.0566] -0.0343 [-0.0797,0.0110]
Hispanic 0.0506 [-0.0386,0.1398] 0.0407 [-0.0525,0.1339]
Year
2005 -0.0329*** [-0.0508,-0.0149] -0.0277*** [-0.0428,-0.0125]
2006 -0.0450*** [-0.0618,-0.0282] -0.0331*** [-0.0489,-0.0173]
2007 -0.0673*** [-0.0848,-0.0498] -0.0550*** [-0.0710,-0.0389]
2008 -0.0784*** [-0.0960,-0.0608] -0.0634*** [-0.0800,-0.0468]
Constant 0.2366*** [0.1277,0.3456] 0.3352*** [0.2326,0.4378]
Average practice intercept -2.6524*** [-2.7371,-2.5678] -2.6089*** [-2.6924,-2.5254]
N 27938 19304
Notes : Robust OLS used for Continuity of Care.
Continuity of Care  models only for patients with >=3 OP visits during the year.
*p<0.05,**p<0.01,***p<0.001
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Table 5.25b: Average Marginal Effects of CCNC from Multi-Level and Fixed-Effects Models, by Primary Care Visits 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
COC
Medium High
CCNC
MLM AME
0.003
[-0.018,0.023]
̵  0.0142
[-0.0310,0.0026]
FE AME
̵  0.0050
[-0.0289,0.0189]
 -0.0158
[-0.0336,0.0020]
Notes : For multi-level models: robust OLS used for Continuity of Care. For fixed-effects models: Cluster-robust  OLS for Continuity of Care
Contintinuity of Care. Continuity of Care  models only for patients with >=3 OP visits during the year.
*p<0.05,**p<0.01,***p<0.001
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Table 5.26a: Multi-Level Estimates of the Moderating Effect of CCNC Patient Load on Yearly Health Care Utilization, by Primary Care Visits 
 
Continuity of Care
Medium (3-5) High (>5)
Coeff. 95% CI Coeff. 95% CI
CCNC Patients (omitted = Very Low)
Low 0.0217 [-0.0028,0.0461] 0.0326** [0.0094,0.0559]
(AME = 0.0217) (AME = 0.0326)
Medium 0.0380** [0.0125,0.0636] 0.0468*** [0.0227,0.0709]
(AME = 0.0380) (AME = 0.0468)
High 0.0463** [0.0184,0.0742] 0.0582*** [0.0331,0.0834]
(AME = 0.0463) (AME = 0.0582)
Very High 0.0501*** [0.0239,0.0763] 0.0697*** [0.0457,0.0936]
(AME = 0.0501) (AME = 0.0697)
CCNC Early Adopter 0.0100 [-0.0065,0.0265] -0.0012 [-0.0178,0.0153]
Person-level controls
Age 0.0157*** [0.0095,0.0219] 0.0084** [0.0026,0.0143]
Age^2 -0.0002*** [-0.0002,-0.0001] -0.0001** [-0.0002,-0.0000]
Male 0.0953*** [0.0839,0.1067] 0.0596*** [0.0441,0.0751]
Charlson Index -0.0744*** [-0.0841,-0.0647] -0.0572*** [-0.0673,-0.0471]
Charlson Index^2 0.0040*** [0.0024,0.0056] 0.0034*** [0.0025,0.0043]
Eligibility (omitted = subscriber)
Spouse -0.0139 [-0.0322,0.0045] -0.0360*** [-0.0543,-0.0177]
Other 0.0460 [-0.0566,0.1486] -0.0258 [-0.1429,0.0912]
Plan Type (omitted = CMM)
Smart Choice -0.0166 [-0.0465,0.0134] 0.0086 [-0.0189,0.0361]
Smart Choice Basic 0.0144 [-0.0174,0.0463] 0.0418** [0.0131,0.0705]
Smart Choice Plus -0.0642** [-0.1038,-0.0246] 0.0047 [-0.0301,0.0395]
Practice and county-level controls
# Primary Care Providers -0.0008 [-0.0019,0.0002] -0.0005 [-0.0011,0.0002]
Multisite Practice -0.0086 [-0.1205,0.1032] 0.0035 [-0.0709,0.0779]
Rural-Urban
Non-urban, Non-rural 0.0253** [0.0063,0.0443] 0.0132 [-0.0055,0.0319]
Rural 0.0589** [0.0182,0.0997] 0.0832*** [0.0441,0.1222]
Community-based Practice -0.0012 [-0.0390,0.0365] -0.0238 [-0.0551,0.0075]
County Proportion Poverty -0.0766 [-0.2937,0.1405] -0.1603 [-0.3743,0.0538]
Primary Care Providers/10,000 Population 0.0004 [-0.0021,0.0028] 0.0006 [-0.0010,0.0021]
County Proportion Race/Ethnicity
Non-white, not Hispanic 0.0344 [-0.0248,0.0935] 0.0120 [-0.0489,0.0729]
Hispanic 0.0505 [-0.0564,0.1575] 0.0436 [-0.0762,0.1633]
Year
2005 -0.0188 [-0.0547,0.0172] -0.0454** [-0.0796,-0.0113]
2006 -0.0248 [-0.0600,0.0103] -0.0436* [-0.0775,-0.0096]
2007 -0.0511** [-0.0861,-0.0160] -0.0655*** [-0.0977,-0.0334]
2008 -0.0569** [-0.0935,-0.0203] -0.0780*** [-0.1113,-0.0446]
Constant 0.2391** [0.0773,0.4008] 0.3873*** [0.2423,0.5323]
Average practice intercept -2.7666*** [-2.9020,-2.6312] -2.8144*** [-2.9507,-2.6781]
N 13024 8901
Notes : Robust OLS used for Continuity of Care.
Continuity of Care  models only for patients with >=3 OP visits during the year.
*p<0.05,**p<0.01,***p<0.001
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Table 5.26b: Average Marginal Moderating Effects of CCNC Patient Load from Multi-Level and Fixed-Effects Models, by Primary Care Visits 
 
 
 
 
 
 
 
 
 
 
COC
Medium High
CCNC Patients (omitted=Very Low)
Low
MLM AME
0.0217
[-0.0027,0.0461]
0.0326**
[0.0085,0.0567]
FE AME
̵  0.001
[-0.057,0.055]
̵  0.001
[-0.057,0.054]
Medium
MLM AME
0.038**
[0.015,0.061]
0.047**
[0.018,0.076]
FE AME
 0.003
[-0.067,0.074] 
 -0.030
 [-0.093,0.033]
High
MLM AME
0.046**
[0.014,0.078]
0.058**
[0.027,0.090]
FE AME
̵  0.020
[-0.097,0.058]
̵  0.026
[-0.098,0.046]
Very High
MLM AME
0.050**
[0.022,0.078]
0.070**
[0.042,0.097]
FE AME
  -0.027
[-0.110,0.057] 
 -0.013
[-0.086, 0.061]
Notes : For multi-level models: robust OLS used for Continuity of Care. For fixed-effects models: Cluster-robust  OLS for Continuity of Care
Contintinuity of Care. Continuity of Care  models only for patients with >=3 OP visits during the year.
*p<0.05,**p<0.01,***p<0.001
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Table 5.27: Median Odds Ratios 
Median Odds Ratio - 
CCNC Models
Median Odds 
Ratio - CCNC 
Patient Load 
Models
>=1 A1C 3.56 3.87
>=1 LDL 3.18 3.39
>=1 Eye Exam 1.34 1.31
Attention for Nephropathy 1.78 1.76
>=1 Flu Shot 1.58 —
>=1 Breast Cancer Screen 1.59 —
>=1 Cervical Cancer Screen 1.79 —
>=1 IP Admission 1.29 1.19
>=1 ED Visit 1.40 1.40
# PCP Visits 1.42 1.34
# Total OP Visits 1.31 1.27
Continuity of Care 1.29 1.27
 143 
 
REFERENCES
Aday, L. A., & Andersen, R. (1974). A framework for the study of access to medical care. Health Services 
Research, 9(3), 208-220 
 
Agency for Healthcare Research & Quality. (n.d.). Patient-Centered Medical Home Resource Center: 
Defining the PCMH. Retrieved August 12, 2012, from 
http://pcmh.ahrq.gov/portal/server.pt/community/pcmh__home/1483/pcmh_defining
_the_pcpc_v2 
 
American Academy of Pediatrics Ad Hoc Task Force on Definition of the Medical Home. (1992). The 
medical home. Pediatrics, 90(5), 774. 
 
American Academy of Family Physicians, American Academy of Pediatrics, A. C. o. P., & American 
Osteopathic Association. (2007). Joint principles of the patient-centered medical home. 
 
American Diabetes Association. (2008). Standards of medical care in diabetes – 2008. Diabetes Care, 
31(1), S12-S54. 
 
Baker, L. C. (1997). The effect of HMOs on fee-for-service health care expenditures: evidence from 
Medicare. Journal of Health Economics, 16, 453-482. 
 
Baker, L. C. (1999). Association of managed care market share and health expenditures for fee-for-
service Medicare patients. Journal of the American Medical Association, 281(5), 432-
437. 
 
Baker, L. C., & Shankarkumar, S. (1998). Managed care and Health Care Expenditures: Evidence from 
Medicare, 1990-1994. In A. M. Garber (Eds.), Frontier in Health Policy Research. 
Cambridge, MA: MIT Press. 
 
Baker, L. C., Afendulis, C. C., & Heidenreich, P. A. (2004). Managed care, information, and diffusion: the 
case of treatment for heart-attack patients. The American Economic Review, 94(2), 347-
351. 
 
Bice, T. W., & Boxerman, S. B. (1977). A quantitative measure of continuity of care. Medical Care, 15, 
347–349. 
 
Bindman, A. B., Wholey, D. R., & Christianson, J. R. (2003). Physicians’ reports of their experience with 
health plan care management practices. American Journal of Management Care, 9, 
SP100-SP110. 
 
Bitton,  A., Martin, C., & Landon, B. E. (2010). A nationwide survey of patient centered medical home 
demonstration projects. Journal of General Internal Medicine, 25(6), 584-592. 
 
Bloom, B. S. (2005). Effects of continuing medical education on improving physician clinical care and 
patient health: a review of systematic reviews. International Journal of Technology 
Assessment in Health Care, 21(3), 380-385. 
 
 144 
 
Bodenheimer, T., Wagner, E. H., & Grumbach, K. (2002) Improving primary care for patients with chronic 
illness: the chronic care model, Part 2. Journal of the American Medical Association, 
288(15), 1909-1914. 
 
Bornstein, B. H., & Emler, A. C. (2001) Rationality in medical decision making: a review of the literature 
on doctors’ decision-making biases. Journal of Evaluation in Clinical Practice, 7(2), 97-
107. 
 
Bradford, W. B., & Krumholz, H. M. (2003). The effect of managed care penetration on the treatment of 
AMI in fee-for-service Medicare population. International Journal of Health Care Finance 
and Economics, 2, 265-283. 
 
Brookings Institution and Dartmouth Institute. (2011). Toolkit: accountable care organization learning 
network. Retrieved April 11, 2012, from 
https://xteam.brookings.edu/bdacoln/Documents/ACO%20Toolkit%20January%202011.
pdf 
 
Bundorf, M. K., Schulman, K. A., Stafford, J. A., Gaskin, D., Jollis, J. G., & Escarce, J. J. (2004). Impact of 
managed care of the treatment, costs, and outcomes of fee-for-service Medicare 
patients with acute myocardial infarction. Health Services Research, 39(1), 131-152. 
 
Bureau of Labor Statistics. (n.d.). CPI databases. Retrieved May 14, 2014 from 
http://download.bls.gov/pub/time.series/cu/cu.data.15.USMedical 
 
Carolina Cost and Quality Initiative. (n.d.). CCQI - Carolina Cost and Quality Initiative. Retrieved October 
20, 2011, from http://www.shepscenter.unc.edu/ccqi/ 
 
Center for Medicare and Medicaid Services. (2007). What the “Guidance on Compliance with the HIPAA 
National Provider Identifier (NPI) Rule” Means for Health Care Providers. 
 
Center for Medicare and Medicaid Services. (n.d.). Physician and other medical provider grouping and 
patient attribution methodologies. Retrieved April 11, 2012, from 
http://www.cms.gov/Medicare/Quality-Initiatives-Patient-Assessment-
Instruments/GEM/downloads//GEMMethodologies.pdf 
 
Charlson, M. E., & Sax, F. L. (1987). The therapeutic efficacy of critical care units from two perspectives: 
A traditional cohort approach vs a new case-control methodology. Journal of Chronic 
Diseases, 40(1), 31–9. 
 
Chernew, M., Philip, D., & Town, R. (2008). Managed care and medical expenditures of Medicare 
beneficiaries. Journal of Health Economics, 27, 1451-1461. 
 
Cherry, D. K., Burt, C. W., & Woodwell, D. A. (2004). National Ambulatory Medical Care Survey: 2001 
summary. Vital and Health Statistics, 337. 
 
Deb, P., Manning, W., & Norton E. (2006). Modeling health care costs and counts [PDF document]. 
Retrieved from http://www.unc.edu/~enorton/DebManningNortonPresentation.pdf 
 
 145 
 
Devo, R., Cherkin, D. & Ciol, M. (1992) Adapting a clinical comorbidity index for use with ICD-9-CM 
administrative databases. Journal of Clinical Epidemiology, 45, 613–619. 
 
Dobson, L. A., & Levis Hewson, D. (2009). Community Care of North Carolina – an enhanced medical 
home model. North Carolina Medical Journal, 70(3), 219-224. 
 
Domino, M. E., Norton, E. C., Morrissey, J. P., & Thakur, N. (2004). Cost Shifting To Jails After A Change 
To Managed Mental Health Care. Health Services Research, 39(5), 1379-401. 
 
Domino, M. E., Humble, C., Lawrence, W. W., & Wegner, S. (2009). Enhancing the medical homes model 
for children with asthma. Medical Care, 47(11), 1113-1120. 
 
Eisenberg, J. M. (1979). Sociological influences on decision-making by clinicians. Annals of Internal 
Medicine, 90, 957-964. 
 
Fields, D., Leshen, E., & Patel, K. (2010). Driving quality gains and cost savings through adoption of 
medical homes. Health Affairs, 29(5), 819-826. 
 
Frank, R. G., & Zeckhauser, R. J. (2007). Custom-made versus ready-to-wear treatments: behavioral 
propensities in physicians’ choices. Journal of Health Economics, 26, 1101-1127. 
 
Freburger, J. K., Carey, T. S., & Holmes, G. M. (2006). Effectiveness of physical therapy for the 
management of chronic spine disorders: a propensity score approach. Physical Therapy, 
86(3), 381-394. 
 
Glied, S., & Zivin J. G. (2000). How do doctors behave when some (but not all) of their patients are in 
managed care? Journal of Health Economics, 21, 337-353. 
 
Grimshaw, J. M., Shirran L., Thomas R., Mowatt, G., Fraser, C., Bero, L., … O’Brien, M. A. (2001). 
Changing provider behavior: an overview of systematic reviews of interventions. 
Medical Care, 39(2), II2-II45. 
 
Gulley, S. P., Rasch, E. K., & Chan, L. (2011). If we build it, who will come? Working-age adults with 
chronic health care needs and the medical home. Medical Care, 49(2), 149-155. 
 
Health Resources and Services Administration. (2011). Performance management and measurement. 
Retrieved from 
http://www.hrsa.gov/quality/toolbox/methodology/performancemanagement/index.ht
ml 
 
Heidenreich, P. A., McClellan, M., Frances, C., & Baker, L. C. (2001). The relationship between managed 
care market share and the treatment of elderly fee-for-service patients with myocardial 
infarction (Working Paper No. 8065). Retrieved from 
http://www.nber.org/papers/w8065 
 
Hellerstein, J. K. (1998). The importance of the physician in the generic versus trade name prescription. 
decision. Journal of Health Economics, 21(2), 337-354. 
 
 146 
 
Kahneman, D., Slovic, P., & Tversky, A. (1982). Judgement Under Uncertainty: Heuristics and Biases. 
Cambridge, UK: Cambridge University Press. 
 
King, J. (2011). Variation in the structure and performance of Community Care of North Carolina. 
(Unpublished doctoral dissertation). University of North Carolina at Chapel Hill, Chapel 
Hill. 
 
Koroukian, S. M., Litaker, D., Dor, A., & Cooper, G. S. (2005). Use of preventive services by Medicare fee-
for-service beneficiaries: does spillover from managed care matter? Medical Care, 43(5), 
445-452. 
 
Kronick, R., Gilmer, T., Dreyfus, T., & Lee L. (2000). Improving health-based payment for Medicaid 
beneficiaries. Health Care Financing Review, 21(3), 29-64. 
 
Landon, B.E., Reschovsky, J.D., O'Malley A.J., Pham, H.H., & Hadley, J. (2011). The relationship between 
physician compensation strategies and the intensity of care delivered to Medicare 
beneficiaries. Health Services Research, 46(6.1), 1863-1882. 
 
Lee, P. P., Feldman, Z. W., Ostermann, J., Brown, D. S., & Sloan, F. A. (2003). Longitudinal rates of annual 
eye examinations of persons with diabetes and chronic eye diseases. Ophthalmology, 
110, 1952-1959. 
 
Machlin, S. R., Cohen, J. W., & Beauregard, K. (2008). Health care expenses for adults with chronic 
conditions, 2005. Retrieved from 
http://meps.ahrq.gov/data_files/publications/st203/stat203.pdf 
 
Mangione-Smith, R., DeCristofaro, A. H., Setodji, C. M., Keesey, J., Klein, D. J., Adams, J. L., …McGlynn, E. 
A. (2007). The quality of care delivered to children in the United States. New England 
Journal of Medicine, 357, 1515-1523. 
 
Marewski, J. N., & Gigerezner, G. (2012). Heuristic decision making in medicine. Dialogues in Clinical 
Neuroscience, 14(1), 77-79. 
 
Mathematica Policy Research. (1992). The Effects of Risk Contract HMO Market Penetration on Medicare 
Fee-For-Service Costs: Final Report. Princeton, NJ: Clement, D. G., Gleason, P. M., & 
Brown, R. S. 
 
McDonald, C. (1996). Medical heuristics: the silent adjudicators of clinical practice. Annals of Internal 
Medicine, 124, 56-62. 
 
McGlynn, E. A., Asch, S. M., Adams, J., Keesey, J., Hicks, J., DeCristofaro, A., & Kerr, E. A. (2003). The 
quality of health care delivered to adults in the United States. New England Journal of 
Medicine, 348, 2635-2645. 
 
McWilliams, J. M., Landon, B. E., & Chernew, M. E. (2013). Changes in health care spending and quality 
for Medicare beneficiaries associated with a commercial ACO contract. Journal of the 
American Medical Association, 310(8), 829-836. 
 
 147 
 
Meara, E., Landrum, M. B., Ayanian, J. Z., McNeil, B. J., & Guadagnoli, E. (2004). The effect of managed 
care on appropriate use of coronary angiography among traditional Medicare 
beneficiaries. Inquiry, 41(2), 144–58. 
 
Mercer Consulting Group. (2007). Final Report to the Division of Medical Assistance. Retrieved from 
http://www.communitycarenc.com 
 
Milliman. (2011). Analysis of Community Care of North Carolina Cost Savings. Retrieved from 
http://www.communitycarenc.com 
 
Mobley, L. R., Subramanian, S., Koschinsky, J., Frech, H. E., Trantham, L. C., & Anselin, L. (2011). 
Managed Care and the Diffusion of Endoscopy in Fee‐for‐Service Medicare. Health 
services research, 46(6pt1), 1905-1927. 
 
National Committee for Quality Assurance. (2009) Comprehensive Diabetes Care: HEDIS 2009 Volume 2 
Technical Update. Retrieved from 
http://www.ncqa.org/portals/0/PolicyUpdates/HEDIS%20Technical%20Updates/09_CD
C_Spec.pdf 
 
Newhouse, J. P., & Marquis, M. S. (1978). The norms hypothesis and the demand for medical care. 
Journal of Human Resources, 13, 159-182. 
 
North Carolina State Health Plan. (2008). The state of member health: trends and interventions for plan 
members. Retrieved from http://statehealthplan.state.nc.us/ 
 
Piatt, G. A., Orchard, T. J., Emerson, S., Simmons, D., Songer, T. J., Brooks, M. M., … Zgibor, J. C. (2006). 
Translating the chronic care model into the community: results from a randomized 
controlled trial of a multifaceted diabetes care intervention. Diabetes Care, 29(4), 811-
817. 
 
Pollack, C. E., Hussey, P. S., Rudin, R. S., Fox, D. S., Lai, J., & Schneider, E. C. (2013). Measuring care 
continuity: a comparison of claims-based methods. Medical Care, Epub ahead of print. 
 
Quan, H., Sundararajan, V., Halfon, P., Fong, A., Burnand, B., Luthi, J. C., ... Ghali, W. A. (2005). Coding 
algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. 
Medical care, 43(11), 1130-1139. 
 
Rabe-Hesketh, S., & Skrondal, A. (2012). Multilevel and Longitudinal Modeling Using Stata. College 
Station, TX: Stata Press. 
 
Ricketts, T. C., Greene, S., Silberman, P., Howard, H. A., & Poley, S. (2004). Evaluation of Community Care 
of North Carolina Asthma and Diabetes Management Initiatives: January 2000-
December 2002.Retrieved from 
http://www.communitycarenc.com/PDFDocs/Sheps%20Eval.pdf.  
 
Schuster, M. A., McGlynn, E. A., & Brook, R. H. (2005). How good is the quality of health care in the 
United States? Milbank Quarterly, 83(4), 843-895. 
 
 148 
 
Scott, I. (2009). What are the most effective strategies for improving quality and safety of health care? 
Internal Medicine Journal, 39, 389-400. 
 
Sia, C., Tonniges, T. F., Osterhus, E., & Taba, S. (2004). History of the Medical Home Concept. Pediatrics, 
113(Supplement 4), 1473-1478. 
 
Steiner, B. D., Denham, A. C., Ashkin, E., Newton, W. P., Wroth, T., & Dobson, L. A. (2008). Community 
Care of North Carolina: improving care through community health networks. Annals of 
Family Medicine, 6(4), 361-367. 
 
Takach, M. (2011). Reinventing Medicaid: State Innovations To Qualify And Pay For Patient-Centered 
Medical Homes Show Promising Results. Health Affairs, 30(7), 1325-1334. 
 
Treo Solutions. (2010). Analysis of CCNC impact on enrolled population. Retrieved October 3, 2012, from 
http://www.communitycarenc.com/our-results/ 
 
Treo Solutions. (2012). Performance analysis: healthcare utilization of CCNC-enrolled population 2007-
2010. Retrieved October 3, 2012, from 
http://www.communitycarenc.com/media/related-downloads/treo-solutions-report-
on-utilization.pdf 
 
Tversky, A., & Kahneman, D. (1974). Judgment under uncertainty: heuristics and biases in judgments 
reveal some heuristics of thinking under uncertainty. Science, 185, 1124-31. 
 
United States Department of Agriculture Economic Research Service. (2003). Measuring Rurality: New 
Definitions in 2003. Retrieved August 10, 2011, from 
http://www.ers.usda.gov/Briefing/Rurality/NewDefinitions/  
 
United States Department of Agriculture Economic Research Service. (2004). Measuring Rurality: Rural-
Urban Continuum Codes. Retrieved August 10, 2011, from 
http://www.ers.usda.gov/briefing/rurality/ruralurbcon 
 
Valuck, R. J., Libby, A. M., Orton, H. D., Morrato, E. H., Allen, R., & Baldessarini, R. J. (2007). Spillover 
effects on treatment of adult depression in primary care after FDA advisory on risk of 
pediatric suicidality with SSRIs. American Journal of Psychiatry, 164(8), 1198-1205. 
 
Virabhak, S., & Shinogle, J. A. (2005). Physicians’ prescribing responses to a restricted formulary: the 
impact of Medicaid preferred drug lists in Illinois and Louisiana. The American Journal of 
Managed Care, 11, SP14-SP20. 
 
Wagner, E. H., Austin, B. T., Davis, C., Hindmarsh, M., Schaefer, J., & Bonomi, A. (2001). Improving 
chronic illness care: translating evidence into action. Health Affairs, 20(6), 64-78. 
 
Wang, Y. R., & Pauly, M. V. (2005). Spillover effects of restrictive drug formularies on physician 
prescribing behavior: evidence from Medicaid. Journal of Economics & Management 
Strategy, 14(3), 755-773. 
 
 149 
 
Wooldridge, J. M. (2005). Introductory Economics: A Modern Approach (4th ed). Mason, OH: South-
Western College. 
 
